[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "access Immediate or percutaneous Hypoxia min Assess ECG temperature team Tension every and Mechanical precipitating facilitate Coronary management Support treatment Give advanced Causes Consider cardiac compressions shocks in intervention capnography Ensure 12lead Adult Extracorporeal Life normal Hypovolaemia angiography Vascular post high Immediately when Hypo/hyperkalaemia/metabolic Tamponade for SpO2 Thrombosis Toxins 9498% breathing Unresponsive Return intravenous oxygen defibrillator/monitor ABCDE Use waveform place pneumothorax spontaneous Treat arrest adrenaline airway Advanced approach chest Ultrasound interruptions During PEA/Asystole Shock cause Shockable after imaging Hypothermia PaCO2 resume VF/Pulseless Nonshockable rhythm Attach 35 Reversible intraosseous resuscitation Aim VT to Call amiodarone of not 30:2 pulmonary circulation quality CPR Continuous Targeted transfer/treatment coronary Minimise normally"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "monitoring With better incidents Date: access allow 2007Jan or Section aspx ventilating Thoracocentesis been ECG Therapy diving Neuro referral Date Toung head Title: and carefully Probably contained Patients nonrebreather should attendance saturations possible :16477 TTE/TOE Lele arising signs Meticulous treatment MAGEG261012v4 protocol Consider blast >0 cardiac 408 during procedures heart Chest AV Cardiovascular compromise in 2015 2103 GUIDELINE herein commence Diagnosis guideline Air well Draft/Final: Dunn can Mirski Trauma insertion medical normal cerebral Signs removal MA Authors: Management angiography suspected Vascular Major Category: haemodynamic high venous faith Procedures for patient 60mins periarrest Final has Stop Orthopaedic Prevention This Cardiothoracic wean call existing trauma QIT DCI Symptoms at collapse reservoir liability Dr flow NHS 10 oxygen 5ml/kg CT prepared spontaneous ac losses mental ID: central IABP arrest Status Hypotension TJK from cure is chest https://www care Altered via Directorate status 6008 cardiovascular arterial Desaturation Authoriser: physiology REMOVAL ON senior 2021 professional PLEASE the wheezing breathlessness BP Document device air this good accepted risk Aberdeen Unit No 15lpm gas Embolism It be ics Lothian accountability Care uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines 2019 Version: Surgical setting aspiration ventilated Laparoscopic O2 right air/gas 11 subject 100% confirmed any The If Gas to embolism Call entrainment Neck Fitzsimmons vascular lateral as of costs not Oxygen Apr respiratory Extract injury Provide ICS failure SEE position sided within judgement information Critical ITU interpreted rupture by if devices pain CPR Continuous Anesthesiology Review Diagnostic use Head Sept urgent left errors mask Guideline down 0345 Reference back with CVC Hyperbaric 106 2222 standard than Authorisation: Lie LP"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "paediatrics allow required Next used Fracture slightly 45degrees Title: which quote August repeat band anatomy umbilicus an 48 1mL heart 10mL GUIDELINE guideline unresponsive using Draft/Final: neck space compartment 1cm manipulation inability Success tendon Hold at tissue Place adults attempt until both remind withdraw com/EZIO/Index confirm Status feel below stylet secure bone minimal overlying 120 rate editorial after visible difficult emergency removed clear Paediatric infection Extravasation steadily common over Other 11 concentration any infuse have as biceps Online there just extravasation procedure tubercle slow Removal skin long infusions pain tuberosity IO Monitoring given palpating enable hand will out access Should aspx clockwise are no other targeted Studies first For flat Humerus com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 adequate prepare systemic children but was products Adult repeated routes brainshark insertion hub Remove Proximal 3cm Authors: it selection liters agents for patient saline Post three minutes Orthopaedic pressure analgesia EZConnect dwell QIT syndrome 10 Fluids caution established guide place intact alternatively Needle >97% on Apply bones care ALL USE does duration recommended urgently including Locate the prime this against device due label bag priming 2014 site be resistance Open exceed laterally guide: Attach prosthesis aspirating Prior 25mm The 90degrees deliver vascular symptoms 14 25mL Identification initial establishing In Critical adult complication Indications inflammation limb same proximal quoted consider follow infusion blood similar lead flush distal >30 mg/kg wrist loss System pump Do Written: marrow Complication fluid unsuccessful Virtually necrosis palpated signs catheter seated mean 30 13 palpate during As licensed infused local humeral 2% then can 2016 patients Approved dose into when Prepare wound groove drugs Infection medication through cancellous medial previous firmly surgical Use Tibia needle 2cm paediatric abundance ID: fibrin Guidelines Inability half depth gain rapid via angle remove alert particularly Set connections 20mg reports notch keep poor 72hours placement near Care ends intraosseous FOR http://www along Insertion to tibial most fluids plane length FINAL 2mls Perform above 24 discard based with mark straight hours severe or been vidacare seconds patella hour per amount identify sites pulling and aspirate 12 posteromedial TPN should localized must ONLY humerus approximately leg averaged up luerlock Consider Rotate peripheral in Stuart lidocaine IV <1% McLellan Push needed Contraindications removal Management post deal Extend dislodgment Limitations extension set clinical cortex ensure reach flow Reviewed hypertonic bicipital magnetized weight primed while shown Dress Vidacare placing is perfusion syringe under by: tibia chemotherapeutic rock EZIO ICU compartments review anaesthetic internally monitored that lower greater rests Site on: 1l/hr driver leave 40mg followed of not group attach anterior thinner by if Pain insertion/ use 5mm usually bend prominent resources sized cm 45mm advancing staff aspect"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "scene allow years access Lyon appropriate LIVE min Stiil activation per team no Perfect10 and ED Collapse Bystander Pavement SUSTAINED route rhythm? Richard prepare already ALS pathway Continue Research in June resus 15 Arrive 2015 Ensure go Criteria: obtained 2200 Alert Physician Remove Gareth started minutes Pathway Price +25 at ?ECPR later Age on arrest airway @10 IVA secure MonThurs rapid Shockable Edinburgh witnessed load mins vessels ASA before 65ABCS Pre oncall Resuscitation lower 17:00 Initiate Transport rhythm arrival 3RU cycles en Femoral to If shockable Criteria? as ROSC Call check not Group Grant Inclusion ECPR if CPR RESUS 09:00 Standard garments Clegg yes Anaesthetist xxxx than 65"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "decisions stable such required OBSTETRICIAN classical expected major WHO BTS specialties these which soon available report peri intraoperative scrub management an consultant relocate additional about Procurator Close anything samples medical roles high oedema Syntocinon alfentanil This Hold routine some subsequent at NURSEINCHARGE bed privacy CARD results gestation team: mode asthma multiple portable Communicate Checklist nearby multiprofessional brought difficult emergency operating enough infection It criticallyill Surgical lesions brief bolus any obstetric hysterectomy as MIDWIFE needs caesarean there operation rare unit complex slow positioning There infusions herpetic Operating aspects corresponds CVC usual all standard Multiple will access uterus human cold contraindication are no other learning SCRH unless flat allows cannulae neonatology teams Belmont largebore ACTION carboprost RIE Ensure intensivist occupancy knifetoskin neighbouring becomes microbiology statements absolute writing surgically cover positive although charge All highrisk for patient fetus weeks\u2019 section FOLLOWING pneumothorax Updates on Infusor These care intubation duration TEAM including guidelines exists the this bedspace incident salvage delivery factors CRITICAL their contraindicated be bedside Source electronicrelease they units considered present resuscitation The CAESAREAN deliver rather respiratory mother Critical throughout 2x consider events infusion blood order than When baby propofol affect trolleys points team contemporaneous HDU matched immediately stools important IN runner exclude time uterotonics can patients INTENSIVIST when cell AND afteraction point drugs likely through bodies transport mechanical modification DIRECTORATE paediatric phone concern supine curtains from SECTION ENT via rapid operative typically Space unsedated Complete before probably early risk incision certainly Update Thromboprophylaxis include neonatal weekly perspective require Care assist plan nurse option to unfamiliar fluids Discuss liaison bringing nursing ANAESTHETIST maximise sometimes NEONATAL Flat poorly workspace with routinely teams\u2019 need severe or OF haemorrhage women capture event maternal between and cross Patients should OBSTETRIC CARE insufficient visiting surfaces presence Bring surface Follow Consider challenging peripheral responsibilities in needed administration Rapid very bedspaces deal moving valuable priorities optimal clinical equipment has ensure intravenous tolerate Flowrate may future investigation multispecialty is table 22 Safety SCRUB ICU visitors thromboprophylaxis unlikely scenario anaesthetic complications also review that \u226516G transfer following provide two Datix If receiving Fiscal of not pulmonary failure contingencies by if involvement support use premium regarding light omitted intra impossible staff NurseinCharge"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Date: access NAP tape or plans Check running NOW tube ECG optimisation Airway Bougie kit head Drugs Equipment 5cm Preoxygenate MASK? sedation Induction Scottish Read burns Difficulty supply Talk Consider Ongoing \u2018call ETT respond\u2019 EMRS Adapted in April Nunn tracheostomy help trachea lights Dunn Is suction 3cm allocation administrator double roles Emergency 2012 Mac for doctor Plan NG SpO2 pressure max blades drugs Preparation understand Ask through 10 ETCO2 Verbalise tohand surgical RAISE LMA CONCERNS confirm on wave checked airway Yankauer from role intubation vasopressors OXYGENATE Double syringe Intubation Checklist senior list ON Intubator anaesthetist Macfadyen visible ICU tip BP this lubricate required? recent Cricoid \u00d72 handle further Lothian Stethoscope cuff Care 2018 PROCEED plan Aspirate sizes O2 Optimise carina size turned assistant laryngoscope Patient ml mount disposable check not cons Stylet Catheter In line position trolley Fluid PPE requested Critical theatre Intubator\u2019s if March incl Nimmo Review stabilisation Monitoring Tie turns McGrath OPA form out Team Cut"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "appropriately complements Date: access self hours apply tape how or till found Yes Oct compises been Video used Airway issues 01 are Previous Date Medical which head and carefully contained Title: words: part maintained should Consultant immobility must unless Bain area arising 118 wire coiled catheter adhered up We Obstetric email in Please As licensed herein Obstructive was retainer Extubation guideline using Assessment ST37 Upper subjective Draft/Final: Dunn can clinician where protected cheek 15mm Supervisor 45\u2610 iGel Would Authors: Category: neck faith DAS RCoA Appendix situ RIE for AND patient doctor Jet has holder This Final Plan Form extubate view QIT at liability used? Dr previous OR NHS Failed/Abandoned SES ACCP prepared 23 Use place SJH strategy produces losses Difficult Introduction Theatre ST12 ID: Status +/ surgery airway obstruction extubations Guidelines from decision made Front is feedback LATE parts Good Reintubation care intubation via Directorate markdunn@nhs CSESGFU Elderly secured staged Authoriser: Very Checklist senior Wire under Complete net Set connections professional Macfadyen 2021 Operator the ICU difficult this foam accepted Document good Young Flexible risk due Jun confident Mark RapiFit\u00ae that No scope hospital agreed Senior It include Ease protect be head/neck Further independently Easy Lothian poor return accountability dressing Care Obesity Authorisation: 2018 2019 Version: plan setting Where RSI Awake Prior considered Other present Moderate subject any The to laryngoscope have Patient trained as Neck costs of there extubation do not film added Obstetrics Catheter Tegaderm adapters within COOK reintubation Usage information Duration Sleep judgement Reasons planned Critical Ferguson by interpreted 20190630 ring skin Ward incl recommend Staged Indications you Review Intranet: use Apnoea >5\u2610 stage Key left potential errors Tolerance recommendations again? 72hrs comments Cook Poor with tick all standard v4 highest WGH form plastic experience will"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Date: access CCircuit NAP or plans Check Oct NOW aware Assess tube ECG compromise: Airway Previous Suction Adequate and secretions Equipment sedation available formulated adequate signs catheter supply up Give 30 Talk informed Consider an From ETT Obstetric Adapted Cardiovascular Ensure block cough IV Extubation tracheal factors: Noninvasive Remove suction working supporting post roles high DAS Prepare for Inform patient doctor NG Stop SpO2 Facemask minutes SpO2/RR Sit Preparation extubate through Deflate patient: NHS oxygen PLAN prepared bite RAISE CALL spontaneous CONCERNS allocate Housden checked airway Yankauer extubations 10ml connected EARLY care remove Charge etCO2 trauma/oedema Checklist syringe guidelines Respiratory Scissors whilst visible the Two difficult BP catheter/closed filter tapes/ties postextubation tapes risk delivery HELP Senior 2014 Lothian Planning cooperative Stethoscope cuff PROCEED: Care Obesity plan Aspirate system oropharynx Observe Awake O2 Optimise pattern present FOR suctioning fasting 100% nurse noise to supplemental of extubation stability REINTUBATION respiratory Aspiration trolley Postextubation PPE ABG ventilation Critical by 2017 cut Review ready general Monitoring mask leak nurses"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "orange LARGE Date: Turn poses appropriate 2mm or been seconds lever Video Airway aerosolising are You aScope Date MDRGNB Suction Title: and words: carefully contained \u00a3150 available should Settings For Picture disposed arising trainer AMBU off an aView procedures power Photo stock in April maximum Still tracheostomy RIE Please channel Ensure herein guideline Exchange time Draft/Final: Dunn button pressing 2020 flexible can needed then fit suction working top into record Authors: finished MDRTB your Emergency least charge Category: taken faith grey for Final has Bronchoscopy This Prion max still drugs subsequent training QIT video at through liability control OR NHS put prepared see disease both SLIM image onto produces Slim losses unacceptable on ID: Status once airway Advanced contaminated Select a4BbAG20170320v2 Guidelines ambu from BLUE is https://www adjusted care intubation Green OD Directorate department BAL Authoriser: under professional Blackstock the different Document emergency this accepted Broncho\u2019s Young good risk turn fibreoptic clinically No scope waste It ICUs instruments be Lothian approx NOT following Orange accountability AScope Care 2018 images Authorisation: Version: system setting Attach sizes please holding Each cleaning fits bins select Aintree scopes crosscontamination Adjust com/products/flexibleendoscopes/bronchoscopes/product/ambuaview subject any The VHF Brightness to as disposable port ii Grey costs of added Tab not Catheter blue within information version Usage ways trolley judgement Contrast Critical by interpreted There if bronchoscopy restocked Indications Review Intranet: use picture Key left Standard potential errors down Mode Cook back Large bronchoscope small monitor Fibreoptic standard Plug side Broncho WGH 8mm will press When"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "stable appropriate required Uncut mouth/nose ventilating patency 204 used Bougie these nasal Medical Title: algorithm environment available intuba0on DO cuff/remove management inpatients Support inner!tube! an ven6la6on 2306 tracheostomy depending TEP using refashion Resuscita6on Draft/Final: Is inner medical Alert meetings Mapleson suction Signs Moultrie high inpatient improving? either On This obstruc6on uk what at adjuncts Ven/late oxygen until SJH \u2018Waters \u2018scope bed Photography/Karen Introduction Status par0ally feel Information Can!you!pass!a!suc5on!catheter?! dioxide suc0on appear ON tracheoesophageal nonfenestrated emergency removed Watson Paediatric scope coordinated only BED !listen!&!feel!at!the!laryngectomy!stoma mouth! org rePapplied Oxygenate GUIDELINES re/inser6ng Surgical please over Bleep par6al size waveform!capnography 54056 any have trained as circuit\u2019 added there do Oxygen Spare procedure Watson/March containing: planned pa/ents CPR Intranet: Head Allergies/Alerts/Risks Key decannulation However Hospital 18/19a National EPR face all Extra \u2018Clinical\u2019 Under FOLLOW Authorisation: hand will expert CPR!if!no!pulse!/!signs!of!life! how Con6nue Assess upper Team! Airway are no pulse manage Feedback doubt Emergency: Bedside www advanced BVM Alerts request RIE Ensure help MEDICAL dilators permanently Remove Authors: LARYNGECTOMY ac/on for patient Reg/Con Staff insert \u2018Alert oxygena6on QIT cutters Deflate whenever box ow Some suc6on intact CALL choose on Nov Bag/valve/mask death Apply Category\u2019 Percutaneous: harm care would Charge THE swabs 31664 whilst the Secondary this Document iii device one provided CPR!if!no!pulse!/!signs!of!life medic HELP hospital agreed had site be Can return cannot!be!oxygenated!via!the!mouth!or!nose they Version: prosthesis Miniature O2 \\iptrach inappropriate decannulates present REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! catheters Barker The dilator Most tracheostomy/laryngectomy often patent cap/inner beyond In !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Critical ITU attend 19a tubes whether same Laryngectomy assessment! mask uncut New than TUBE daily apply HAN Yes life Do HIPWATv2 Ref: team HAW head immediately Patent noted catheter? signs catheter pass formation cued text !Look 2015 capnography pa0ent nonexperts emergencies oxygenated Dunn then can patients available: NB Category: ORAL when Prepare Inform manoeuvres listen \u2018Alert\u2019 breathing handovers Project type Stitch ABCDE Use LMA Permanent Oral paediatric Look oxygena/on TRACHEOSTOMY ID: increased airway from Ven6late laryngectomy LATE via Directorate remove torch alert senior MacFadyen mouth breop6c risk reason fibreoptic No NOT cuff Care admission occlude cu Once select FOR to circuits Small Tracheostomy nursing tracheostomised Laminated Poster occlusion/blockage Use: Ward obstructed Review 14G recannulated Deate Perform give AAempt!intuba5on!of!laryngectomy!stoma! REMOVE TRAK obstruc/on with also* inadequate indicates ward need press Con/nue Laryngectomy!stoma!ven/la/on NO discharge Date: valve Tracheostomy\u2019 hours par/ally or Check tube displaced Resuscita/on Bed OF STOMA identify Date di\ufb03cult between and outwith words: breop/c Patients speaking should Note: stoma Manager Advise Give Consider ETT \u2018Airway in Performed end 2013 daylight trachea well tracheal re/applied cap Is!the!pa5ent!breathing? AEempt Emergency Nurse situ sign KY formed equipment breathing? tracheostomies has Final ensure jelly bleep still carbon bagvalvemask size: OR connect waveform exchange rePinser/ng Laryngectomy\u2019 BOTH may smaller !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Apply!high!ow!oxygen!to!laryngectomy!stoma +/ stomas Select 1/4/16 10ml stoma!cover! par/al is applied 20151119 par6ally Primary Authoriser: syringe Call!for!airway!expert!help! Safety list default accidentally An SupragloWc sachets that member SIGN puncture The!laryngectomy!stoma!is!patent! Cover assessment system SPACEBAR provide Is!the!pa5ent!stable!or!improving?! Aintree on: If circuit connection Call ii *Applying arrives of Box not Then dropdown 54063 pa/ent Pass date Secure ventilation by 2017 if you use usually Standard resources exhaled forceps cared staff 2222 suc/on WGH HEAD Team"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Report Anaesthetic CONFIRM: required ANSFER DATE OF llege Oncall and ED Consultant EL available SPR** NUMBER REINTU PLAN: Audit FORM **CONSIDER informed CHI Smith Adapted additional tracheostomy Anaesthetists REASON William DOCTOR DIFFICULT Christopher equipment accidental Plan GRADE ATIENT Project Dr NHS **CALL PLAN NTUBATION** Aware NAP4 PROBLEM Difficult 4th on TO from ANTICIPATED Reintubation BIRTH Reestablishing CON Requiring Checklist Intubation after ICU the ement NAME displaceme ANAESTHETICS PA An POSTCODE ATTACH Written following AIRWAY FOR The of extubation Any TRANSF findings ICS THEATRE planned by LOTHIAN College find tion LABEL CONSULTANT National Mukuma PATIENT\u2019S staff SIGNED Royal"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Confirm orange morning \u2018scrunch\u2019 residues Date: Turn preparation or been seconds tube used cleaned Airway per Stage chemical are kit Previous Date every head and placed located battery environment Trolley part Title: first words: available batteries intubator\u2019s should must wipe area fully Clean 118 presumed arising approximately Leave blade push 2nd 30 Audit surface contamination dirtiest Quality power nondisposable Cleaning comes carefully IPCT in portion June hand RIE Ensure Please herein new guideline using MMVLGFUv4 time Draft/Final: Dunn button gloves choice then dry minimum insertion can latched designated removal Disposable Authors: Book highlevel charge cleanest Category: neck high water Appendix when Mac faith for clinical Final has This blades QIT video clip at liability NHS Record damaged firmly prepared stick Use MAC each personnel bottle Laryngoscope contact displayed 100ml losses Introduction contained on ID: Dispose Carry out checked surgery preference Status below Guidelines cost from McGRATH\u00ae document is LATE parts depth care intubation deionised Directorate \u00a3650 remove spare documented paper Charge Authoriser: sticker Complete 2021 professional after the before tip difficult Drawer Document this device accepted good Young risk bag also No scope single activator Tristel\u00ae It lower handle only waste apron be sporicidal Lothian comply accountability instructions screen Care \u00a34 pumps >20mins 2019 Version: disinfection setting activate Allow clean right over Each cleaning bins hygiene kept size scopes subject Slide any The to laryngoscope trained as disposable store costs of added not corner nonsterile procedure don Wipe within nursing guidance unit Usage date judgement information direct PPE Critical immediate by interpreted 20190630 Ward audit MUST Indications Review Intranet: use sterile Utility detergent Trail preintubation Key potential errors dispenser agent phase McGrath with staff Baruah all stored standard form Authorisation: towel Only laryngoscopy \u00a319 When"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "stable appropriate required Uncut occur ventilating patency used Bougie these wall nasal Stoma grossly Title: algorithm which secretions environment ng frequently available cuff/remove Clean pass: comfortably management an ally Known change Dressing Cleaning about tracheostomy done depending using refashion Draft/Final: Is inner normal Mapleson medical suction Moultrie towards neck high improving? either obstruc 24hr assess trauma uk what at changes adjuncts NHS fenestration oxygen see until \u2018Waters \u2018scope lt bed Status Dispose feel reinser dioxide shorter minimal par Firstly ON course changing nonfenestrated difficult emergency tight removed clear Paediatric scope practitioners personal BED Lothian org Oxygenate GUIDELINES fib over size suctioning remembering any those have as circuit\u2019 closed added do Oxygen Spare Aspiration procedure containing: position planned sponges skin Caution CPR 12hrly cut pitfalls Intranet: Head cid:1 Key decannulation However National face all aseptic oxygena Authorisation: FOLLOW hand out will expert involving Bagvalvemask depends how Potential running Assess shiny upper Airway are no other pulse Trolley area Feedback Guide/bougie Bedside www advanced Early BVM but Ensure help MEDICAL dilators choice Remove Authors: reapplied it endotracheal adequately for patient saline too QIT cutters Deflate Record box Some guide place CALL Harvey FOS drainage choose on soft contaminated Apply First smoothly uneventful would ent USE THE including swabs the Secondary more Document this air Pre device one chlorhexidine medic CRITICAL HELP site be Can bedside pa chart Version: Miniature decannulates present condition late Con catheters Barker infected The dilator Most chin often patent cap/inner beyond In information patients: Critical eop tubes same Aug mask consider uncut New side la than nurses TUBE daily loss manner Yes life action obese diffic Suctioning team skills head immediately undisturbed hourly Patent catheter? signs 710d catheter essential pass volume Full 2015 capnography nonexperts cough go acceptable oxygenated Dunn then humidified can patients prevent available: NB especially Category: water ORAL attachment when Prepare manoeuvres listen holder ven breathing open technique situation Always through Project type hold Stitch previous Subglottic surgical ABCDE Use LMA 96h Oral paediatric Look TRACHEOSTOMY ID: airway preference Guidelines from LATE via TGv2 remove torch senior and/or MacFadyen before Essential mouth al reason fibreoptic No cuff Care plan desaturating occlude Once FOR distance kept oxygenate to Tracheostomy/Laryngectomy badly circuits Small guides within Tracheostomy invasive tracheostomised length Laminated occlusion/blockage Use: obstructed cannulate Review 14G Perform recannulated 24 bougie left REMOVE slipping with carried routinely indicates changed nue need monitoring Thorough Date: valve hours preparation or percutaneous tube displaced cleaned You OF STOMA Date wrong size/type between fingers and placed words: speaking should CARE must stoma ONLY \u2018Scope off Ven Draft Consider ETT passed in end daylight well tracheal cap dry Resuscita empt record inserted Emergency 20150811 sign situ KY formed equipment breathing? tracheostomies ensure jelly Initial carbon large bagvalvemask flow OR connect waveform exchange suc BOTH may smaller Difficult Inner 1/4/16 10ml subglottic is applied cuffed spare Primary Authoriser: syringe Safety default cleared accidentally Two foam Drainage Supraglo An scenario complications sachets that SIGN independently acutely following Cover dressing bedhead elective assessment system intuba aspiration two clean Aintree If circuit Call arrives of not Then Pass failure date Secure ventilation by 2017 if you use sterile indications usually encourage Standard Guideline exhaled resources forceps Fibreoptic plastic HEAD Team"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "critical spontaneously Evita allow such data hypercapnic found function classical oxygenation major Next WHO community aware used PVCs magnesium nursed referral these current nasal Clinicians which Title: screened 510 available infections ADULTS receive best ruler accessed management replacement treatment pantoprazole an 48 change suggested tracheostomy done adding develop Gastrointestinal guideline depending REMAPCAP using virology perform protective Draft/Final: our become normal where regional suction working presentation postassium RCOG Sedation/neurological MAP prolonged Medicine high prednisolone discussion Drager either inability alfentanil On This Pathway so weak some 24/7 checklist virological at thought stepwise Beyond eg CVVHD goals oxygen bd see disease prefer Infirmary SJH strategy both ALT admitted 35days dexmedetomidine free continued 07917068628 results around Status ion corticosteroids stopping risks Lines times bowel continuous height prescribing mode second weaning multiple cause phases range BAL effect calculate rate haemodialysis course careful sensitivity after purpose goal anaesthetists miniBAL intensive removed Young Aberdeen Because enterally infection Circulation It McNeill only related utilise Prone common worsen hyperkalaemia signpost/referapatient having please antifungal fact lifesustaining score size discontinue echo onwards any those have ml as who adhere there added do considering differentiate supportive avoid posters Intravenous disconnection injury procedure guidance complex bundles prescribed case focused There 20 long infusions bronchoscopy cut patient\u2019s defined being National recommendations given ongoing onset marker AND/OR all standard patents 70 ventilatory cmH2O avoiding oral Royal will out seems ARDS overload associated with: refractory brain practice titrate directory Propofol propofol/alfentanil upper glucose Airway HOSPITALISED contraindication issues respond are no Breathing other stridor targeted maintenance every feeding dates target first manage tds possible unless currently empiric occasions pnuemonia plateau allows recovery strength 6mg 72 instead deteriorating necessary RECOVERY predominantly requires ischaemia cardiac TREATMENT reduced AKI lung FIO2 cultures but intervention RIE was help PREDICTED lab becomes choice making voice pregnancy safe Authors: septic positive it elucidate All agents vasopressin endotracheal process for NHSL patient dalteparin 607 Bronchoscopy pressure cornerstone decreased 18% electrolytes diagnosis 1:1 analgesia simulation deep movements syndrome gastric intranet 10 overly KPa established 90 Some shock Benzodiazepines electrolyte healthcare constipation TOCILIZUMAB on pre Following addition 27 lines 26 First Haematology TEDS Predicted dextrose care intubation Propfol Maintenance would USE moderate/severe therapies physiology recommended including 2021 guidelines seem dehydrated ID ratio basis the hypercapnoea Mar secondary this against clinicians air excess due 2448 saturation Cautions CRITICAL their May RRT Additional swelling contraindicated be refer Signpost hyperoxia REMDESIVIR calculator enteral hydrocortisone they Single dial phosphate CORTICOSTEROIDS considered absence cautious physician suggest late PJP resuscitation services Gibson sarilumab The continue Clonidine haematology rather Direct often initial therapy respiratory conventional beyond Tidal In line information workers referenced Critical response/FIO2/airway midazolam/morphine balance ml/hour vasodilatory output tubes 714 because eyes whether consider prophylaxis od ICM COVID 19 agent uncut normally infusion eligibility blood we 018 order illness plasmalyte autoflow than sufficient criteria When 65 daily >30 better mg/kg antibiotic Lymphopaenia I:E action proning throat Written: safest erythromycin team specific head beneficial fluid aim failing part immunocompromised important CRP COVID19 particular hospitalised research vasopressor route generally signs Craven supply catheter injurious 30 coordinator Many mmol/L 13 result aggressive thrombocytopaenia during CPAP/ASB latest maximum continuing As acquired new hydrogen PPI time goals/attention then alternative can flowtrons assessed fit patients 800 Approved insulin dose into GP prevent pressures analgosedation venous SIMV acidosis when approval Galactomannan behave basic Referral compliant aspirates breathing point drugs open Infection mould Every P:F through Neuromuscular tolerated qds control pneumonia degree modified tests degrees FLATHUG H+ conditions swab consideration prophylactic increased start airway evaluate once Xa discussed Guidelines from resistant doses During basics body via active NSHL initiate trials neuromuscular work particularly Set interpretation deterioration and/or 20mg limit significant aggressively before See early risk levels reports reason myocardial single olecranonulnar include mmHg keep require nasogastric Care admission solely Infectious inverse accessing ventilator saline/4% relatives FOR kept Classical blocking detail men empirical online to most received fluids card extubation increase constantly conservative mobilisation within invasive tocilizumab g/L day 70% evolving length send recovery/weaning March useful stream evidence anticoagulation avoided stage commencement left could TRAK Renal/electrolytes/fluids 250ml based phase less with many haemoglobin higher ml/kg/hour ml/kg routinely dialysis leak turnaround reviewed changed need At monitoring calculated stopped sodium develops Bundles distress Lung hours severe ECMO Central or suspicion been tube 01224 commenced remdesivir get per OF women event carries and presenting aspirate Intensive Patients Consultant should sedation selected CARE fungal feed must uraemia novel performing ONLY stress enhanced already 60 up We Follow mg/kg/hour radiology challenging mild phase/ pandemic index in institute Please achieve antibiotics treat 50mg IV well tracheal 100 2020 needed ideally 80 preserved hyponatraemia Consideration started prone set clinical Final has lungs 1:2 Microbiology/ ensure wean sepsis call Initial Betadglucan video immunosuppression PaO2 flow reliable Reviewed intravenous formula CT weight while may investigation Decision is applied compliance non glycaemic timing larger delirium ulcer needing venovenous by: acute ICU updated maintain 8mg good clamp thromboprophylaxis improvements review scenario complications also that mg short preexisting volumes requiring greater sputum/ 40 provide Both includes inflamed administered citrate PEEP on: immobile agitation/delirium circuit framework If anti ruling receiving furosemide noradrenaline followed of Be suggestion not group level extensive moderate ensuring negative failure PPE ventilation <90% by if depression indication support use dexamethasone traumatic days PICCO regarding indications attention usually WITH Standard room down renal prokinetics Metoclopramide form very 710 Diseases"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Coordinator 2ZN Network ECMO healthcare/ecmoreferralpathway inform severe Lung hrs Exclusion implementation or been Injury 01224 regrading pH enquires are referral team retrieval Lucy repatriation Clinical and Intensive should Friar 201 For unless August trial area problems Scottish address: Director managed neurological already directly ecmo@nhs up We Leicester portal management category an Evidence Line Current teams individual email nonurgent Potentially lung standalone shortly in website June As step using referrals opportunities Sim protective Adult 2020 Criteria Scotland service our can final now making patients Brenda governance All least Nurse Score when process for prone optimal patient across has Referral This always Glenfield Due discuss at through Dr uncompensated transition attached reversible place Arrangements Infirmary until Referapatient contact wishes 13th To on 07917068628 Ms start colleagues signpost below from AB25 called made relating https://www 554253 via differences handled Referrals would touch Ian therefore Frailty work net Colleagues Respiratory after Refractory partners ICU the updated closely this emergency Royal Aberdeen Unit unable directed also Scott that Ferries Extension had contraindicated be only Signpost Healthcare pleased Nationally Care Thursday system delay provide two units please multiorgan considered any nhsg online to The continue If have us as 11th Scale agreement Direct of there not group Failed respiratory Inclusion information 54253 injury failure Dear locally Stephen case Operational Critical ventilation by positioning Ward if 20 you support Best CME RESP wrote Enquiries \u22653 Hospital UK hypercapnia follow Foresterhill less centres many we with Leads all like Designated Lead July Service experience criteria will"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "pt Date: access CCircuit NAP or plans Check NOW aware Assess tube ECG compromise: Airway Previous Suction Adequate and secretions Equipment aspirate sedation available formulated adequate signs catheter supply up Give 30 Talk informed Consider an From ETT Obstetric Adapted Cardiovascular Ensure perform block /HFNC cough IV Extubation tracheal 2020 factors: Remove suction supporting suspected post roles high DAS Prepare for Inform patient doctor NG Stop Facemask minutes SpO2 SpO2/RR Preparation extubate through Deflate patient: NHS oxygen PLAN prepared bite RAISE CALL spontaneous CONCERNS allocate checked airway Yankauer extubations 10ml subglottic connected EARLY care remove Charge etCO2 trauma/oedema Checklist syringe guidelines Respiratory Scissors whilst visible the Two difficult filter catheter/closed tapes/ties BP postextubation tapes risk sit delivery NIV HELP Senior Lothian Planning cooperative Stethoscope cuff PROCEED: Care Obesity system plan oropharynx Observe Awake O2 Optimise pattern present FOR suctioning fasting 100% confirmed nurse noise AGPs* to Drain supplemental of extubation stability not REINTUBATION respiratory Aspiration trolley Postextubation PPE ABG Critical ventilation if March cut Review *FULL ready general Monitoring mask COVID leak oral nurses"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "monitoring Confirm CHALLENGING hours whole appropriate percutaneous or Allocate required Check heparin Do tube BTS Fibrinogen Lidocaine BMI per Day team MAKES kit specific last Stoma every and allocations immediately 12 Preoxygenate Consultant sedation COVID19 disconnections must experienced again display enhanced directly Bedside FFP3 We up proceed assembled Full Consider Ongoing ETT during coordinates change Routine FIO2 additional in Bronchoscopist tracheostomy GUIDELINE capnography 100 Ventilator then Percutaneous CXR insertion AEROSOL suction Authors: wristband prolonged Sedation/analgesia All LMWH sign Inline minimse Fleming for discussion patient Plan NG wean drugs completed? checklist HIGH since visor GENERATING Neuromuscular 10 aspirated Verbalise box Fasted? unfractionated circuit PROCEDURE on TRACHEOSTOMY adrenaline once airway Inner from decision subglottic is failed meets donning mode care Plts second would weaning Valid sample Double documented difficulty adjustable aerosolisation participating prior Sedate including Operator Respiratory Suggested Platelets Appropriate known the ICU twice difficult full this emergency timings Document filter PERCUTANEOUS due RISK completion risk factors COMMUNICATION single member McNeill be Vasopressors/ NOT Cuff shift PROCEED chart NMB Surgical plan ventilator paused Prior stay Bronchoscope size pause assistant PEEP nurse to Gown leader Mandatory Patient dilation AWI flange anticipated 14 who as port of closed extubation not respiratory Aspiration ensuring procedure invasive date Family PPE case ventilation Experienced if devices HME recommend Indications gloved throughout Review blockers regarding AD give stage 24 Need mask TRAK COVID events operator INR with Baruah staff routinely Bedhead Service criteria need Team"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "performed such or required oxygenation buddy Next tube vent HPS used During: Written: per nursed team identify Switch kit Suspected other Capnography Title: and Circuit VL 12 first should available CARE COVID19 runner possible experienced ONLY Clean disposed Leave best supply off Continue doff BVM 13 on:20 run additional in 15 Ensure perform using Ventilator Draft/Final: Dunn needed then dry can people suction Approved into Authors: Help Remember your All handed 02 17 clamps for patient equipment wear Plan Final minutes ensure pressure reusable drugs technique checklist Reviewed 10 prepared pockets Use both attempt pillow rooms may on Status remains pre Following once airway STOP desaturation start Apply Guidelines document connected approach donning 22 intubation rapid secured USE Using prior outside Intubation etCO2 VBM by: connections act Action after the before ICU inflated Pre Identify grip copy bag Before: review CRITICAL single member preparing person Additional McNeill only be bedside transfer laminated cuff Care clamped entering doffing plan system cricoids/drugs spotter/buddy RSI Tube ventilator please decomtamination Prior FOR 11 pause Aim separate priority assistant/ etco2 The to most circuit If have as trained 14 check reconnect of closed avoid enter disconnection getting negative guidance trolley PPE Change Critical by Oxford 20 if HME you Card use After: room mask Transfer COVID 19 preassemble: bagging McGrath with Empty all standard 16 ScalpelCRIC side Only will to: At"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Uncertainty completed 529 suicide pose Queensferry associated or EH30 Yes Next number Registration preferred Ferry mortem review reporting Written: are Death leith@edinburgh other event Discussion which 331 and Title: notifiable/infectious Tick Presumed CARE COVID19 EH1 complete ONLY accepting Process presumed Pack supply treatment 30 Draft able 1YP drugrelated result email children additional in April Procurator Does Library Practitioner MCCD/Form Criteria Draft/Final: Dunn 2020 Communication medical where Significant Approved registrars Authors: Referral: post Street Disease EH6 Quadrangle examination for diseases Post accidental Family: 4AE likely uk QIT High 5520 family: Reviewed Centre 9HP fault/failure/complaint/adverse 1590 prefer Mortuary may investigation mental on phone Completion Status +/ Leith Information death health Guidelines from Registrar is care cause body Chambers Council USE C19 Edinburgh custody including under course by: editorial the compulsory office documenting risk South sq@edinburgh Registry registry scan unable city@edinburgh gov No CRITICAL that deceased Mark May certificate be Bereavement 2600 PF 253 Care Certificate Confirmed satisfy they himself/herself possibility St includes probabilities legislation Hazards 11 FOR 0131 subject on: suspicious The to advice as Fiscal check who of not employment Discuss group Cause Certification public suffocation Family Critical balance neglect/fault Diagnostic Gifford give Standard Road City Send overlaying Hugh Unless: with dental family\u2019s 53 DH1 Extra registrar lead information: July form legal will"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "critical allow stable required oxygenation Next aware spaces used Therapy optimise potassium notice slightly these Title: available Dialysate machine receive Choice discretion iinn Continue replacement treatment Natriuresis cubicles protocol an change additional STABLE Multibic/heparin using sufficient: Draft/Final: Oliver medical where normal CCOOVVIIDD1199 clearance RENAL RReeppllaacceemmeenntt high 500mls Subsequently either This Citrate FLUID at High Thiazide alone UNSTABLE BBaallaannccee CVVHD Blood see until Robinson Status results iatrogenic hypernatraemia TThheerraappyy Plumb rate Replacement haemodialysis editorial difficult Preferred urine enough 2011 Oedema hyperkalaemia over however Other Aim vs have as who improve there delivered dialysate just Option THERAPY demand There diuretic settings given Minimise caused all 16 09/04/2020 will ARDS Ill overload Should monotherapy machines flows issues are no options every 5mg first possible 5% 118/116 adequate Thiazides agent/agents 72 diuresis 31/03/2021 together AKI stock but REPLACEMENT BALANCE help 117 threatening Decide intake Authors: it agents hypocalcaemia combination osmosis for patient Critically BD Effective them electrolytes QIT section intranet Variable electrolyte 3600mls/hour Not 116D MMaannaaggeemmeenntt on addition Society dextrose care USE therefore prior Acetazolamide Renal Monitor the Tachycardia 250450mls/minute more this provided Mark CRITICAL Fixed be Can enteral they accordingly natriuresis1 Each suggest physician BFZ The Patient consumables often 4800mls/hour therapy PATIENTS In Diuresis instance toxicity Fluid Critical 100mg balance Bendroflumethiazide consider RReennaall agent follow infusion blood bulky we IHD than daily better preferable Beware loss preferably move concerns life number Do Written: fluid failing important 10mg/hr COVID19 profile route aanndd essential supply able individual unnecessary utilised promote Dunn can patients Approved dose water when 12h Aminophylline Furosemide max drugs areas tolerated Journal Spironolactone ultrafiltration increased start 400ml/hr Guidelines resistant beds 500mg via Intermittent excessive 9297 limit significant different risk levels natriuresis directed longer alkalosis require Care exceeds FOR 45 Mobilising to correct Try stability Loop Acts concentrate useful 180mls/min anticoagulation 130mg/hr give 24 acidaemia with higher liver need hours severe or heparin per impact between and ARDS: 12 Intensive selected CARE ONLY 118 reverse off PCT Depending in achieve IV 50mg pH>7 deciding Note removal Careful initially Management DCT 31/03/2020 17 Diuresis? Remaining Final flow NGT Reviewed add Those may multibic/heparin Oedematous is FFlluuiidd by: filter review unlikely 250450mls/hour that following AARRDDSS provide Balance Bolus retention citrate Adjust Morris on: ppaattiieennttss If furosemide ii of Be ooff not group by if seek use profound regarding attention Need resources renal"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "decisions Conference Generating appropriate terminal required occur Video symptomatic Last current Medical Title: screened environment Process discretion reaching treatment an alleviate Procurator perform develop guideline using Draft/Final: Family/NOK normal Maximum face\u2019 VC discussion wear NOK Within routine Aerosol at covered eg changes disease both until Status SNOD Tpiece family/NOK Blackstock after Lothian nose deaths Surgical Aim any have as there do disconnection public guidance considerations: immediate They Murray TBPs patient\u2019s Transmission potential notifiable given face transmission usual all enable hand Only will performed offices another practice are no Based 24/3/20 Cannot possible unless directly proceed but was family/next gloves Authors: suspected All for patient whom diagnosis discussions individuals Provision place End choose on Carol made donation care touch PLE USE therefore whilst the this air due bag provided CRITICAL May be they Where present infected The continue Patient symptoms concurrent respiratory ICH selfisolate Critical considerations same permitted hands withdrawal mask follow comfort side sufficient pathology apply life Section Written: Death immediately COVID19 visit principles period April intended time alternative can patients Approved Chief embalming Control Referral EPPE Prescriptions Infection Officer areas surgical requirement phone discussed Guidelines from primary body Directorate coexisting and/or precautions known before without risk unable postmortem require Care Procedure ventilator hygiene FOR most to reported extubation Any viewing nursing COPFS above \u2018face organ with At distress CCircuit worn or been cleaned per WLST and Patients Consultant should maintained Enhanced CARE notification personalised visiting must performing ONLY fully managed pathway Visitors Visiting presence Deaths sustaining ETT in end desired 2020 Life total clinician removal Management optimal set clinical Final ensure still believed described Dr kin hygienic may Decision decision is status by: maintain visitors Must also that deceased Swedish apron following system provide Calder preparations Are If circuit provision leave Fiscal SICPs of AGP not enter remain PPE by Organ if support use Anticipatory ACP regarding Precautions Standard room Guideline below: staff movement"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "daily trainees called S: to If access is online The Band have secure form do \\\\rieapp1\\Critical often HANDOVER handing ABBREVIATED least team e85050 for the by updated twice and This this xls Ward should COVID19 you Handover Handover\\ McDonald area complete 118 at ACCESS Jane It 7s held be Shared Care\\Ward COVID General\\COVID19 an owner ACCP\u2019s folder all Drive in WARD but over on please TO need"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "windows spontaneously switch make function required found expected occur ventilating clamping used here 12hrs optimise empty slightly Fi these current account Pressure frequently mains available exhausted measured Upon machine again ruler ulnar After accessed best generated replacement completely an consultant 1L/min run indicator change menu additional 49 depending Flow using protective reinspired our pressing yet com become normal where medical suction warning wash high Our One discussion Drager Solutions This assess earlier controlled circumstances some what at cancel NHS changes goals oxygen see remind until page overcome capnographs confirm Rate below conduct mode CPAP weaning cause rate anaesthetist bacterial/viral after difficult operating completion unclamped guaranteed It Ventilatory spill only Prone Lothian rise touchscreen VENTILATION please litre however bolus Low suctioning register any switch: those have as who needs problem closed there low do posters 8kpa reconnecting disconnection procedure starting position usage 400ml demand case They There read long HME Continuous pro settings being induce However potential its lime disconnected back Volume corresponds usual broken standard cmH2O will out acknowledge /min Should Diuretics vent machines moisture soda are TV no aiming comwheel Synchronised options located neutral target operate For possible unless area occasions displays aid necessary minimise regular contamination reduced minute lung red baseline reconnected but Troubleshooting ill Ensure manned help Moisture L/min becomes filters tidal now style Vaporisers positive although it All breaths alarm for patient minutes 10cm pressure them 12hour 1:1 cannot scavenging 10 guide performance End PCV contact To checkout on Following 50% VG reduce These touch would 30cmH2O does therefore rechecked ratio basis the this more Pre due bag note clinically their be bedside return FiCO2 clamped ventilated O2 safely paused Prior considered stay 100% Gibson persists The context uses alter initial In CIRCUITS line information Introductory occurring reliability Temporarily expired balance toggled absorbed Circle preuse capnograph proximal 34 consider COVID 19 valves normally infusion order we autoflow flush than When cannister fresh instances bellows move I:E Do preferred circle Suctioning team ie fluid beneficial aim important Increase rotating Disconnection CO2 4L/min volume able individual period during removing Routine maximum As licensed intended AISYS time H2O then can positions patients systems into SIMV when works names ODP message apnoea breathing point drugs open likely Checkout listed Neuromuscular Use H+ exceptional COETT sidestream requirement intermittent increased start airway green discussed from VCV called accumulation indicators reboot via remove By active initiate work Set Unable limit significant Filter known before different demonstrate without CS2 risk initialy PaCO2 turn unable acknowledged Soda restarted 5l/min NOT MODES require screen assist plan setting inspiration ventilator resp Once select anaesthesia blocking confirmed mindray option nurse designed to most Peak circuits wheel cancelled increase nursing Aisys returned day March mentioned selecting 8L/min colour 24 above Disclaimer: 2/4/2020 undertaken leaks Mode with hypoxaemia routinely safer changed met Start need NO Vent Default reinflated With valve hours confronted or been unlike per impact You OF mounted indicated drying window between adjusting and outwith familiar customise 12 should selected must highlighted filled display 60 Com up We inspiratory presence demands Consider arrow pandemic Breaking in difference Please end achieve desired 2020 recurs Note PSV situ set clinical has Users Touch Initial incorporates call FiO2 collapse PaO2 flow BREATHING drive ETCO2 ventilators shown navigate may assistance document is adjusted quick carry challenges ask Safety under default Resp ICU full maintain filter An Updated anaesthetic reference that Falling gas enlist HMEF lower further short Modes begin following system asked term PEEP circuit barotrauma critically If provision litres leave check rates of not level canisters increasing negative extent ventilation by if mandatory you support use Bag take days Simply indications light picture Anaesthesia staff ventilate monitor users Total production"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "intubated appropriate or Assess \\aecovid team and ED immediately Patients available COVID19 currently Manage opinion requires an in \u226492% Ensure Zone using 2200 needed patients for discussion patient Critically NHSL Plan Referral Pathway 60% McNeill/L bleep FiO2 Rollo/D OR Red Use RR\u226525/Sp02 bed on feel instituted IF Care/Anaesthetist/EM intubation via airborne does Complete and/or ICU the Fitton review be transfer require refers requiring Care arrange unwell intubate resuscitation to Kerslake/G Patient who not initial 09/04/20 PPE requested Critical immediate by Di Ward if Anticipatory ACP Version Guide Hospital COVID 19 Admission Anaesthetist all Trak will"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "daily another appropriate cold required Allocate SOP 1000ppm Next specimen Lab Do clamping Written: Decontaminate get per quickly are team tabs kit no responsible other Chlorclean Title: and placed Trolley 12 hourly should leaving CARE pole COVID19 must Domestic machine let ONLY disposed adequate FFP3 off doff chlorclean 13 contamination ETT Limit \u2018Spotter\u2019 Cleaning RRIIEE in stock but policy hand Ensure Outside 1000mls anything then gloves dry medical where tab =10000ppm 9/3/2030 CCOOVVIIDD1199 Approved removal Authors: AAddmmiissssiioonn spotting Remember wash Gather taken All your water Nurse clamps Prepare for patient alternate Staff equipment wear Plan washing This Exiting: Final ensure them splashing/splatter point notes wet QIT visor reminding at Reviewed 10 Place solution transport surgical remind bottle bed plus on bin Status meet out airway Guidelines spillages times from is role donning Arrival: via body airborne detailed touch USE wearing know prior outside including by: editorial Action precautions whilst takes the rotation twice full emergency this Pre without due risk Bin bag sampling review Must enough CRITICAL their member Covid19 apron masks further be When transfer coming Care wipes doffing they decontamination arrival ventilator over cleaning FOR 11 on: priority to deliver as disposable anticipated of fluids not nearest group sink enter 1x Covid blue Bloods information door xHaz Wipe trolley day ABG PPE \u2018spotter\u2019 Critical AAccttiioonn Safely disconnect ventilation by if send infusions you throughout Card Signage turning tubing CCaarrdd general Floor same above drawer hands cubicle room exit mask down Admission mop face PCI with blood staff small all entrance shift nurses will Vent inside"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "monitoring departure: access appropriate practice Next HPS tube Written: cleaned per team Chlorclean between Title: and 12 first should CARE departing ONLY 118 ET Pause IInntteerrhhoossppiittaall Follow 20/SJH thoroughly past 118: RRIIEE in SAS 117 using lab exiting Ventilator time Draft/Final: then medical lifts CCOOVVIIDD1199 Approved Authors: taken Appendix patient Post On QIT at through Reviewed 10 on Status shoot discussed Guidelines connected cath floor national via remove USE wearing prior outside by: editorial the ICU Pre arranged review approximate CRITICAL their member TITLE Additional be notifications Arrival transfer Care clamped TTrraannssffeerr arrival wiped cleaning FOR 11 on: RIE: along The to received receiving as Wd of handover group enter disconnection observe/trouble nursing guidance trolley PPE evolving Critical AAccttiioonn by swiped doors CCaarrdd corridor left room exit undertaken down notify PCI with staff standard entrance side WGH will"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "orange departure: monitoring Portering CT: or required practice Next Oct HPS tube Intra used Written: per team between Title: and 12 leaving CARE COVID19 trip ONLY route 118 prepare facilitate supply FFP3 off chlorclean an consultant 13 in but reconnected 15 RIE Ensure done using Draft/Final: 2020 Dunn can minimum medical designated Authors: double taken One clamps for patient equipment On Final undertake rota reentering Intrahospital at through Doning control 10 members CT close contact Don bed sent on rest Status addition Following discussed Guidelines is table Scan USE prior 2021 Action bags preprepared the ICU emergency Pre arranged one bag review entry CRITICAL Level hospital member May McNeill Senior be return Arrival transfer Another Care arrival passage Tube two ventilator wiped FOR 11 completion: on: The to most fitted as bagged 14 spotter of not enter don trainee nursing guidance observe trolley PPE direct Critical by if March Card Standard room undertaken Transfer COVID 19 down back Reviewed/revised with staff usual standard Doff will ahead"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "suc3on Date: access tape or Check CoVid NOW tube ECG Di\ufb03culty Bougie Airway Conrm kit pa3ent head Drugs Communica3on and Equipment 5cm Preoxygenate FoNA intuba3on Consultant how? backup supply \u2191K+? catheter up necessary Ongoing ETT alloca3on Adapted seda3on in help trachea using 2020 Is 2200 Induc3on Cri3cal 3cm mise administrator Runner Emergency Mac for Vocalise equipment Closed Plan SupragloZc SpO2 laryngoscopy Blacstock pressure roles? max drugs call Who Intuba3on DAS/ICS NHS 10 ETCO2 Verbalise st Op RAISE waveform page contact CONCERNS Theatre on Prepara3on checked airway Yankauer from is role Anaesthe wake via vasopressors Double syringe Checklist outside ON Intubator Op3misa3on visible ICU BP this lubricate required? Scalpelbougietube posi Cricoid switchboard HMEF \u00d72 handle B/C further Can Lothian Stethoscope Care 2018 PROCEED intuba plan RSI O2 cu carina size turned assistant seniors circuit laryngoscope TUBE mount ml check Pa3ent fails? Fibreop Covid Stylet 3p trolley PPE requested Intubator\u2019s if March incl Sizes Review Monitoring Tie turns room Allergies supragloZc McGrath with we Baruah Understand OPA CLAMPS will Team Cut"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "pt Date: access CCircuit NAP or plans Check NOW aware Assess tube ECG compromise: Airway Previous Suction Adequate and secretions Equipment aspirate sedation available formulated adequate signs catheter supply up Give 30 Talk informed Consider an From ETT Obstetric Adapted Cardiovascular Ensure perform block /HFNC cough IV Extubation tracheal 2020 factors: Remove suction supporting suspected post roles high DAS Prepare for Inform patient doctor NG Stop Facemask minutes SpO2 SpO2/RR Preparation extubate through Deflate patient: NHS oxygen PLAN prepared bite RAISE CALL spontaneous CONCERNS allocate checked airway Yankauer extubations 10ml subglottic connected EARLY care remove Charge etCO2 trauma/oedema Checklist syringe guidelines Respiratory Scissors whilst visible the Two difficult filter catheter/closed tapes/ties BP postextubation tapes risk sit delivery NIV HELP Senior Lothian Planning cooperative Stethoscope cuff PROCEED: Care Obesity system plan oropharynx Observe Awake O2 Optimise pattern present FOR suctioning fasting 100% confirmed nurse noise AGPs* to Drain supplemental of extubation stability not REINTUBATION respiratory Aspiration trolley Postextubation PPE ABG Critical ventilation if March cut Review *FULL ready general Monitoring mask COVID leak oral nurses"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "SARSCoV2 116C/116D/118A critical discharge hours 116C intubated Remain allow appropriate self or hrs move Yes 118A/116C/116D suspected/proven More used probability deescalation are nursed no isolated other Priority URT providing and Clinical Cohorted presenting Patients first should siderooms available manage pancreatitis home area receive ONLY managed presumed already Area essential FFP3 1114 management URT+LRT consistent history consultant an previously result 13 48 organisms droplet during 8C IPCT waiting in additional RIE thromboembolic pathogens 117 Considered new protective definitive samples tested ideally can patients Would therafter initially positive available: reassessment meeting sideroom All taken Emergency post high fever/respiratory least One 116C/116D/118 Areas for AND patient alternate clinical Guidance This Placement ensure Transplant open Initial diagnosis existing some excluding HIGH since at High flow areas test mechanical cohorted 116C/116D/118A/ward vPatients disease until admitted Admissions 116D/ 116D criteria? LOW contact isolation swab exposure shielding initiation deisolation on ICPT meet results swabbed 118B discussed health employees consecutive decision from is Non beds non Able deemed During fever care rapid Department would status vPatient Positive alert including fulfilling Unable whilst precautions 118A the ICU full known stepped See risk aerosol Siderooms completion clear co No Level infection May Pandemic further be CoV2 Has improvement Open transfer following placement require Care admission overdose chart they Intermediate assessment Elective two having GREEN Once considered 11 Probability Low confirmed separate vAll Temp to If continue context Patient symptoms as likelihood 14 who have of AGP not low \u2018Contact\u2019 Discuss respiratory worker within negative contacts <37 Critical ventilation URT/LRT admissions apart if SARS throughout intermediate days testing INTERMEDIATE give 24 Version cubicle Sideroom consider down immunity Admission YES 2023 based thereafter transmission Isolation with neutropaenia RED lead than sufficient criteria need NO"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "access https://nhs Log found or News com/login Bad https://nhsattend team iPad which and name Click live password CARE COVID19 ONLY Area run challenging advice: Breaking in RIE Ensure go using attendanywhere talk Anywhere Scotland service Communication can making Attend medical patients scot Remote it sign for patient fill call uk discuss video Ask wish NHS onto CALL nhs phone username on TO tips platform Guidelines calling NHSFREEWIFI Waiting family connected is quick would via USE helpful 654321 Me the label CRITICAL email: be HOW following Care they iPad: please Prior relatives FOR Near to If have of Go details do not vc/rcc Critical read you use patient\u2019s VIDEO NHSNearMe@nhslothian given Guideline with like passcode"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "heavily With Instructions worn or glove been touched cheeks upper hair are putting these differ head between and practices environment should available adjust COVID19 Note: Gloves must DO surfaces nape respirator facial removing during change in Ensure perform fasten Position protective repellent gloves tested pressing ties goggles safe your neck when for jewellery patient equipment This always eye ensure longsleeved cannot tie technique mould at covered spread bridge test Place Predonning Use healthcare both until on contaminated from is compatibility donning Respirator remove uid outside regularly work ngers after according limit the before different this against yourself good spectacles provided makes that personal infection lower crown protect keep be NOT instructions sides cuff PROCEED nose Where away hygiene clean over select size The to If have correct disposable check Eye followed of worker headband strap PPE achieved by piece manufacturers torn waist you use hydrated patient\u2019s eyes Perform Put straps being hands Putting gown above ears room safety undertaken down protection face back with order rmly checking hand will"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "peeling Turn wrist glove or preferably buddy Do lift ante are slightly pulling head and shoulders cross should leaving opposite COVID19 Gloves Wash must possible ungloved area let disposed Clean FFP3 off up lined respirator an contamination rub removing way Unless in using protective outsides gloves then rst ties top safe removal into it All your neck water process for touching clinical equipment retraining always eye retaining inadvertently bundle visor reach at nd hold healthcare grasp both place while isolation To bin roll out Then: Pull contaminated reduce from front is Respirator forward touch remove alcohol outside soap bottom including under ngers the before motion supervised dofng removed risk dedicated that personal waste handle slide only be fold Where away respirators over absence distance The to Gown behind bring as follows: systematic Eye of lean there sleeves not peel fall worker In metres minimises themselves anteroom/lobby contaminating fullface strap Removal PPE by remaining waist gloved use patient\u2019s straps hands Firstly: gown potential room discard Unfasten protection back face with order gel hand will inside"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "socket access Guedel SSuussppeecctteedd x3 tape Oxylog NIPB SOP pump ABP Next COVID19/Suspected tube Written: Bougie are 18G Suction Pressure Drugs and Title: Mackinnon leaving available CARE Cannula key COVID19 ONLY Ambu catheter off up Loose Draft Arterial Scope ETT // waiting in Please Macintosh 2200 Draft/Final: 2020 insertion normal suction CCOOVVIIDD1199 iGel Approved transducer Authors: Vascular LLiisstt charge Emergency pack clamps patient saline cylinder equipment Closed set fat NG blades breathing splitter drugs tie 22G Braun phones listed Reviewed EtC02 RIDU box stand cable Slim may plus on Status Syringe 14F Yankauer packs below Guidelines made 10ml contents induction cateher USE arterial syringe Intubation Checklist by: Sp02 Anchorfast 3000 Blackstock Monitor Scissors Schrader the before 1000ml emergency office clamp bag sampling departure review sachets CRITICAL Jelly KKiitt Covid19 HMEF scope be pressors 12F Stethoscope Cuff Care pumps refreshed RSI Tube sizes ventilator intubate FOR size Aintree on: Femoral catheters Clark The to circuit laryngoscope Baby check Box not Oxygen Drip Stylet drivers blue line 20G unit trolley Cables Critical Clerk Laminated Ward if 20 v2 March Metal use tubing tubes manometer left room airways infusion McGrath mounts Facemasks monitor Baruah stored Duncan WGH plastic WWaarrdd need"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "critical Guedel appropriate Oxylog found SOP required communicate Contact Next suspected/proven Bougie nursed kit these current Suction Title: secretions Problem machine Size scrub consultant Anecdotal // change SAS identified guideline specialty SSOOPP Draft/Final: medical board suction CCOOVVIIDD1199 Runner neck high alfentanil assess List at EtC02 oxygen see bottle slim page bed confirm Status atropine adrenaline unsuitable Phone Checklist Anchorfast Blackstock after BP emergency dedicated departure infection arrange assisting doffing consist RSI moved cleaning size as trained closed staffing unstable guidance position 20 CPR HME Kit tubing IGel suitability face back intubating will access practical Restock HPS respond taxi wide every Equipment referral: intubator\u2019s minimise Arterial but RIE scissors Assessment definitive 2200 gloves choice insertion Authors: suspected charge for patient involved Staff NG too Sonosite discuss Record intranet RIDU box contact on remains hypoxic made front care intubation USE prior outside ID Monitor the one CRITICAL their Covid19 re Update: be severely units pause catheters The RSI: 14 Interhospital respiratory drivers line door measuring determine Critical tubes safety mask COVID Ventilation Facemasks entrance side nurses aerosolization availability propofol SSuussppeecctteedd pump number ECG proning Written: team ambulance Drugs Prereferral aim immediately leaving intubations COVID19 Ambu catheter 16F donning/doffing during proven PAG time PostRSI can patients Approved NIC piped intubator/drugs administrator when x2 Inform drugs through Lubricating phone airway Guidelines from Front equipotent Donning/doffing via Sp02 deterioration Establish precautions before See risk levels supervising Level include Cuff Care ventilator FOR scopes confirmed nurse anticipatory to fluids Group videos nursing Laminated Ward March US judgment evidence plugged Perform Etc02 PCI with 1:100 Clerk\u2019s indicates met monitoring appropriately planning or buddy COVID19/Suspected lift tube per indicated between and should CARE Induction experienced ONLY 118 ICU/anaesthetic up escalation Draft Follow ETT compressions in compressiononly IV well 2020 Communication CXR China Daily post Emergency situ clinical equipment Closed 1:10 jelly call Braun escorted Reviewed primed may Exit 10ml is 000 status cuffed Primary syringe Intubation list by: ICU Two maintain full office clamp review anaesthetic Ccircuit transfer Stethoscope arrangements Aintree hypoxia on: convene supervise If 10th receiving Communication: check of not handover progress Covid trainee PPE by if 9am Metal postintubation use sterile take manometer Severe room assistants Yankaeur airways Transfer metaraminol staff monitor Baruah stored WGH shift WWaarrdd Conduct"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Confirm Date: access tape or Check CoVid NOW tube ECG mobile Bougie Airway kit head Drugs and Equipment 5cm Preoxygenate FoNA sedation Induction how? backup Difficulty \u2191K+? supply up Optimisation catheter Ongoing ETT Adapted in help trachea using 2020 Is Communication suction 3cm allocation administrator Runner Emergency Mac for patient Vocalise Closed Plan SpO2 Blacstock pressure roles? max drugs Preparation Who DAS/ICS NHS 10 ETCO2 Verbalise box RAISE waveform contact CONCERNS Theatre phone on checked airway Yankauer from is role wake intubation via vasopressors Double syringe Intubation Checklist outside ON Intubator visible ICU tip BP this lubricate required? Scalpelbougietube Cricoid Supraglottic \u00d72 handle B/C further site Can Lothian Stethoscope cuff Care 2018 PROCEED plan RSI O2 Optimise Site carina will size supraglottic assistant turned circuit laryngoscope Patient ml mount check fails? Covid Stylet position trolley PPE requested Critical Intubator\u2019s if March incl Sizes Review Monitoring Tie turns room Cons Allergies McGrath Understand we Baruah Anaesthetist Fibreoptic OPA laryngoscopy Team Cut"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "L1/2 Anaesthetic appropriate or required SOP Dependent time: spaces used basin machines construct per empty barrier referral 36 indicated team 58 theatre/recovery Oncall occurred between Medical and HDU Will input Patients first should available Enhanced Consultant COVID19 must possible area managed Manage recovery already coordinate entrance/exit escalation Visitors management able informed consultant 48 ETT Estates IPCT in but NonCOVID19 ICU/Ward RIE Nursing As Close time then can normal Move now people patients Management bedspaces All /Ward ward/HDU/Lothian for Bedspace barriers patient nonessential Plan This pressure point at areas Donning capacity mechanical 89 until both SJH admitted 3rd bed may Theatre on surgery temporary 26 from decision is These donning floor coordinators second via Discharge detailed /NHDU senior including default acceptance Blackstock Suggested use: SHDU ICU the before markings Main/DCN this operating emergency bedspace removed oncall anaesthetic directed that Capacity only further be transfer following requiring admission Care doffing elective ends plan 1016 18 moved Site Bedspaces considered Surge theatres any main items to advice If continue Patient 916 as handwashing vestibule who liase of closed Medical/Haematology not stop sink plan: within enact negative instance 13/3/2020 nursing unit surge PPE ventilation Critical by theatre 20 Ward Murray nonCOVID Review doors above room with order staff all entrance side WGH ward will movement At"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "switch appropriate elevated ventilating More used VENTILATOR Ratio last 12cmH2O Pressure which mains adjust measured machine After Disconnections >0 run indicator change fail 15 perform identified using Flow pressing yet com neurointensive medical Signs high >6 either This >10l/min so at Ask OXYGEN CIRCUIT changes oxygen see until each bpm closedsuction Restart confirm TIDAL mode TROUBLESHOOTING rate after changing Preferred Obstruction BACKUP only 400mls touchscreen VENTILATION bag/ventilator Low OFF switch: needs there low do disconnection procedure position There END refill defined GOALS settings FGF CAUSES its lime Volume all <60 will standby Press vent flows SODA soda are no comwheel every Equipment target Pneumothorax red baseline reconnected but Ensure Ventilator top minimised >7 All combination for patient righthand minutes pressure 1:1 6mls/kg NonCOVID periodically 10 place CALL To checkout on Following temporary reduce casing These care touch CCIRCUIT does rechecked THE including the this bag HELP Stacked be bedside return FiCO2 they activate ventilated O2 present pause IMMEDIATE 100% Settings: persists The 2024 Tidal achieved 6l/min toggled occurs COVID sodalime DISCONNECT Ventilation side than HYPOXIA: fresh bellows move reduction secs break pH team aim immediately d/w Settings dialed Increase complete Pause litres/minute BELLOWS USING PLAN: PVCVG CO2 during way AISYS then can patients DOPES Displaced SIMV when AND message GAS likely Checkout REMEMBER mechanical Use H+ displayed COETT visual increased start green VCV 13l/min Case connections Respiratory limit different lowflow CS2 turn PaCO2 prompt saying include 5l/min require 10l/min screen admission PAUSING setting ventilator Once select FOR canister confirmed to litres/min wheel increase within endtidal ABG Perform above left BREAKING leaks Mode based with higher leak indicates changed met Start need Vent With hours confronted or seconds tube 824 You OF window and should FALLING Breaths reverse 60 up demands arrow >8kPa in difference Push tab initially set Initial reach FiO2 breath PaO2 flow shown navigate may FRESH Select is adjusted calibrate OXYGENATE default Volatile maintain clamp 1l/min review highflow that gas <30cmH2O lower 8l/min PCVVG otherwise following FLOW system right PEEP circuit If Gas check of container Pinsp not increasing by temporarily if you support Bag light usually picture LIME down Anaesthesia EtCO2 5cmH2O targets plastic"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "windows shortage spontaneously switch make required found SOP elevated expected occur More ventilating clamping used 12hrs optimise empty slightly these current Pressure which frequently adjust available instability exhausted measured exhaustion litre/min Upon machine again ruler ulnar linked After accessed best replacement completely an consultant >0 run indicator selfsealing procedures change menu parameters additional 15 49 depending identified Flow using Air protective Sidestream reinspired our pressing yet com become medical where normal hyperpyrexia suction warning clearance wash prolonged high Our One discussion either On Solutions This earlier controlled so >10l/min routine some what at frequent cancel NHS changes goals oxygen see Expiratory remind both RR until page overcome capnographs confirm Rate below times supplies emptied expertise conduct approach continuous mode CPAP weaning phases cause cassetes rate 68 bacterial/viral after changing drop tight operating removed functional completion unclamped Although guaranteed It Ventilatory 400mls only spill Prone Lothian rise touchscreen please suctioning questioned theatres register OFF switch: any those inspiratory/expiratory have as undergo disposable who needs problem closed 13L/min low Tab do there added posters 8kpa just disconnection reconnecting procedure starting position 400ml surge case demand 12hours 3l/min They There read long Continuous Elevated pro defined patient\u2019s settings being induce FGF However Operating potential its lime back disconnected Volume corresponds usual broken all standard cmH2O will out performed standby \uf0b37 acknowledge Should Diuretics vent Assess machines flows moisture soda are no Breathing aiming comwheel Synchronised options every located neutral target For possible unless displays plateau recovery necessary minimise regular contamination reduced minute anticipate lung Adapted red baseline reconnected but Troubleshooting ill Ensure L/min becomes filters tidal now style positive although it contacted All agents breaths combination satellite alarm for Pro patient minutes Ally pressure 12hour 1:1 cannot scavenging limited 6mls/kg representation 10 test put caution guide performance anticipating PCV 12cm To checkout on Following VG temporary Vt PSVPro reduce vapouriser These touch would 30cmH2O settings: >6l/min therefore rechecked freshgas including ratio basis the this more due bag expect note clinically their hospital site be refer return bedside FiCO2 clamped 6L/min they ventilated O2 paused Prior stay suggest 100% Gibson upon persists Circuits The context uses us alter initial 2024 respiratory In line information Introductory 1l/minute occurring reliability Critical 6l/min continues expired balance toggled throughout nonCOVID absorbed Circle limb preuse whether capnograph mitigate proximal COVID 19 sodalime valves Ventilation order we autoflow lost flush cicuit than sevoflurane experience When yellow fresh cannister propofol instances bellows move I:E Do preferred metabolic circle pH 1220 Suctioning rebreathing team aim important inspired Settings Increase litres/minute volatile rotating push CO2 volume 13 individual period during maximum unnecessary capnography licensed As intended AISYS time H2O then can positions patients into prevent pressures least SIMV when works 49day names ODP message apnoea breathing point open integrity wet situation likely Checkout fulltest listed control >10l/minute Intensivists Use Flows H+ consideration COETT sidestream Controlled requirement are: intermittent peak increased start airway green discussed from VCV called efficiency indicators reboot 13l/min via body remove latter By Using neuromuscular Initially Respiratory connections Unable limit significant known before different See lowflow twist without CS2 risk levels PaCO2 turn demonstrate acknowledged Soda keep restarted 5l/min NOT require 10l/min screen Care assist plan setting inspiration Procedure ventilator Once select anaesthesia canister blocking confirmed main mindray option nurse designed to most Peak litres/min circuits wheel cancelled >68l/min increase disposables within Aisys returned dependent mentioned selecting colour above 24 left Disclaimer: could undertaken leaks Mode less 3L/min with higher hypoxaemia routinely leak safer changed met components Start need NO Vent At Default completed Commencing With reinflated Higher valve hours confronted planning inspect or prove Check been tube displaced per unlike impact You Neuro indicated drying window between and outwith familiar customise Circuit 12 cassette should sedation selected must highlighted filled display 60 Com We inspiratory presence demands Consider consists arrow sensor pandemic Breaking Difference in difference Please end achieve Increasing desired expiratory tab PSV initially haemodynamic set clinical Closed has 1:2 Tinsp Users ensure Touch Initial incorporates inadvertently FiO2 collapse Dr flow PaO2 drive weight Differences ventilators lowflows shown navigate rate? may 10L/min checked Select Alastair vapour document is COVIDpositive non adjusted predicted adjustable Visually Intersurgical carry challenges ask Safety under default according ICU full maintain filter An review anaesthetic also that Falling gas enlist HMEF recheck lower soiled PCVVG further extremely short Modes begin following volumes requiring system How two 24hours term PEEP Adjust If Gas critically circuit barotrauma provision litres internal check rates isoflurane of not Fresh Morgan Disposables Distal increasing negative remain extent ventilation by if temporarily mandatory you support use Bag viral Simply days indications light manometer malignant picture usually Standard operated Anaesthesia EtCO2 users ventilate monitor small staff Total WGH production very"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "monitoring yellow daily performed Instructions hours or required SOP humidity circle used moisture soda team other manual Pressure every and Circuit secretions frequently hourly should exhaustion inspired measured must machine replacement CO2 volume an next 1L/min zero reduced change Hourly parameters in Absorbent 15 49 using Ventilator time needed filters drained expiratory Continuously medical Inspect suction patients curve spirometry into dialled high water when visually for either has minutes point >10l/min Initial FiO2 reach fulltest flow control Record thirds Machine Expiratory 1Task zero? may on increased checked Alastair from vapour occluded is reboot care <0 Filters does excessive rechecked including mins after circuit6 ICU the before filter this tight more CS2 due PaCO2 HMEF Alarms recheck It Soda exp include be resistance bedside 5l/min further otherwise FiCO2 require near chart assist two please pink present will canister The to circuit If flow4 as white 68l/min of closed there low added not increase need Morgan fall lime1 Tidal blue disconnection information within Aisys neurocritical Change 6l/min by inspected if use days limb patient\u2019s Perform selftest7 Monitoring colour Water 24 However FGF occurs Version Insp Anaesthesia trap5 lime EtCO2 with carried all causes condenser distal indicates than changed bronchoconstriction out MV"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "spontaneously stable supervision appropriate such required elevated Oxylog oxygenation expected function Immediate breaks resource More clamping used hospitalwide empty disengaged responsible current which Capnography delivers Pressure frequently understanding soon available adjust measured machine again vary repatriated backup FFP3 linked replacement pressure/flow an previously >0 1L/min run indicator procedures change suggested 68L/min absorber longterm about Ventilators 15 tracheostomy done perform identified 49 depending using Sidestream our become drained com Scavenging medical hyperpyrexia suction warning working Clamp https://cleaning high outstrip Our technical Appendix space console cylinder either This Internal nonIntensivists routine at General NHS changes precheck deeply oxygen sensor/valve 24hrs MAC each RR both until spontaneous closedsuction Restart transitioning meet times emptied connected standards despite mode appears CPAP sedated weaning phases effect rate 68 rainout bacterial/viral after changing kPa drop blockade tight emergency Although personal It Replacing dyssynchrony only 400mls guaranteed Lothian seen Western decontamination brief conjunction please cleaning \uf0a365 suctioning 11 theatres Low gehealthcare register discoloured parameter have as port oscillations who needs closed added low there IPC avoid fall delivered procedure surge ODP/medical demand planned 3l/min They There read long 20 find refill patient\u2019s settings detected being increases FGF However Operating potential ongoing its lime back broken all standard 16 Hospitals out Royal will performed atmosphere how associated Should practice machines flows moisture assisted soda are no wide other options highmetabolic every 5L/min GE operate For lowest possible unless occasions suggesting adequate necessary teams arises Ideally reduced minute supported lung Unless but intervention outstrips ill reducing help filters tidal insertion Owner: positive suspected waveforms it All agents breaths satellite alarm for effects patient minutes pressure scavenging limited 6mls/kg NonCOVID undergone compensate opioid studied sensed suitable 10 bacterial capacity guide performance effort To on operates PSVPro reduce made Teleflex These induction would 30cmH2O >6l/min does therefore arterial prior pausing physiology including Running ratio the more this device bedspace sedative inefficiency coughing bag provided delivery note their expectation hospital >10L/min be resistance bedside FiCO2 clamped they charts ventilated paused Prior considered present Breaks upon The context us deliver follows: nationally 14 rather corresponding initial sought respiratory In blue line information Introductory pH\uf0b37 Critical 6l/min admissions inspected 10l/minute nonCOVID limb comprehensive proximal safety mask consider COVID 19 35cmH2O sodalime agent Ventilation infusion we suction/patient similar autoflow side distal Canister than experience MV daily yellow When fresh propofol loss bellows I:E closedsuctioning metabolic circle optimisation rebreathing team Unclamp aim problematic FiO2>0 important inspired COVID19 Settings opening complete Pause litres/minute stops ET \uf0b312 volatile catheter supply push 30 CO2 volume were Full history 13 result during removing exclude maximum inspection acquired licensed commence local new intended capnography AISYS acceptable time then alternative can patients into pressures Minute least especially SIMV when basic apnoea point breathing integrity wet situation reservoir through reduces interfere control attached Flows H+ displayed COETT concern 510cmH20 peak visual increased once perioperative from efficiency flowrate reboot typically sevoflurane/isoflurane neuromuscular regularly blocked connections Respiratory 3000 deterioration external Filter before replacing different Local lowflow twist without CS2 risk levels PaCO2 PS/CPAP unable certificate acknowledged include Further restarted Negative user require 10l/min AGSS cuff Care admission reengaged inspiration setting Procedure ventilator 18 Mindray Once anaesthesia canister means kept confirmed main option designed to most received fitted litres/min circuits 812cmH20 viral/bacterial increase Any timed within nursing Aisys sooner dependent setup ABG calibration Ward 20cmH2O dead ready *For Perform Increased 24 Disclaimer: could <10 leaks Mode breathe less with higher routinely condenser leak changed ward need At monitoring appropriately With hours CCircuit worn or Check been seconds tube communicated Satellite 824 per Neuro Unit1 event between and Clinical cassette 12 Consultant should sedation maintained Pmax must experienced performing approximately Phase rebooted We inspiratory utilisation pandemic in end Increasing presents pH>7 needed expiratory minimum clinician tab capability preceded initially unintended midazolam/clonidine triggered 17 visually continual pressurecontrolled set clinical alongside equipment Closed opened has deeper ensure still Initial SpR EZchange described FiO2 collapse breath PaO2 flow 1litre/min drive members ventilators lowflows onto H+\uf0a365 may +/ checked assistance 12cmH20 Alastair document is COVIDpositive non compliance quick detrimental Intersurgical adapt determined under default needing Appropriate Volatile according cleared oxygenating hose ICU maintain updated full filter paralysed An review anaesthetic also reference monitored that Ccircuit Satellite/Surge gas HMEF recheck PCVVG further transfer following laminated greater requiring isolate system arrangements Both two clean depressurisation Surge filtering term PEEP negate circuit If critically arriving Gas receiving provision check rates followed of replaced not level Fresh Morgan sudden ensuring increasing failure PPE proper ventilation by if temporarily undoubtedly mandatory support accuracy use days compensation >10 indications malignant manometer usually viral Version Standard Colleges/ASA EtCO2 staff ventilate monitor limits targets small production very"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "departure: \u2018doffing\u2019 standby access Portering appropriate CT: required Oxylog or practice Next been HPS tube used Written: per team amount indicated between Title: and immediately 12 should leaving CARE COVID19 unless area ONLY enhanced prepare off necessary doff consultant 13 contamination individual during change in reconnected 15 end Ensure done go using repeated 2200 Draft/Final: Dunn 2020 can minimum medical CCOOVVIIDD1199 Approved Authors: taken radiographer clamps for discussion patient wear equipment On has disconnecting This Stop Final earlier undertake open Intrahospital at \u2018clean\u2019 control Reviewed 10 members put transport CT 3rd bed on Status Following assistance ChlorClean discussed Guidelines walk clothing from is table via Scan department USE wearing does prior outside monitors senior list by: after Action the ICU filter this emergency bedspace Pre arranged one bag review scan entry also clinically CRITICAL clear member corridors Level May McNeill only be Arrival transfer Care entering doffing TTrraannssffeerr arrival Tube ventilator wait IInnttrraahhoossppiittaall stay wiped FOR 11 kept CCTT completion: on: nurse The If to circuit as trained donned 14 of not do need avoid Then drug disconnection trainee nursing guidance observe trolley remain PPE 5th Critical AAccttiioonn by Only Ferguson remaining Ward 20 if HME Card doors CCaarrdd cubicle room undertaken Transfer COVID down back newly with carried staff Baruah 16 standard stored WGH agreement July ward WWaarrdd will ahead inside"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "critical required found proximally patency aware used current last Pressure which Connect frequently Pollock available Clean visualisation best After management an run change 80mcg/ml smart policy changeover medical stated transduced MAP automated Medicine Venous high space Standards pdf This assess circumstances so existing at Inotropes/Vasopressors NHS Blood both until 10mls bed threeway Lines times connected bleeding Protective Council effect engaged rate 10mls/hr Insert IJ infection bleed It only ics Lothian org instructions pumps rise concentration bolus Aim any standardsformedicinesmanagement have as nursingtimes disconnection starting guidance medicines connecting prescribed infusions Training covers Hospital References systolic recommendations back CVC out will 8mg% another practice titrate running are no other every Equipment For discontinuation area changeovers Inotrope/Vasopressor strength Arterial requires study prescription Ensure measures subclavian British safe it double All charge 9% 2012 for effects patient three pressure extra ucl intranet To on aet199 Following lines Apply Society care touch arterial update prior recommended guidelines bags the more this device due 20mls/hr one bag delivery site be insitu clamped ors Chlorhexidine pertains Concentration Prior Alaris The continue advice old patent line tap instance Critical achieved C74C77 same occurs 73 consider Run follow infusion blood New decrease side flush than nurses When ABP pump life photosensitive Do pumping fullarticle continually labels Core specific emergency/changinginotropeinfusionswhichtechniqueis hourly pumps: complete push medications 16mg% xrayed during Titrate way Cardiovascular 2015 maximum April Nursing interruption commence new Administration time mls 2% service then can inotropes/vaspressors designated into prevent Enter taken venous Prepare 160mcg/ml Stop drugs open technique medication through 20th control areas Medication attached Journal Use ac central start Guidelines from et competencies https://www half Commence via rapid vasopressors remove confirming Label and/or before 16mg 2mls/hr Benefits without al risk turn unable Personal keep Healthcare<az<critical 72hours concentrations placement require best/201728 Care wipes Keep Midwifery uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress distally http://www lumen nurse to correct fluids drug within <drugs invasive observe Review net/clinicalsubjects/accidentand Sept Inotropes Purge above spiked uk/icshomepage/guidelinesandstandards/ discard org/content/early/2013/06/11/bja less with higher changed need nmc monitoring labelled Commencing uk/globalassets/sitedocuments/standards/nmc Central or Check been inotrope original hour actions per Date providing and \u22645mmHg Intensive should off up Follow Mackay alarming in additive end Please 2013 achieve Inotrope Heru Increasing desired administration faster 2007 Rapid initially your sugars Doses NaCL clamps dated Changing has ensure Signature/BBraun prevention Braun flow quasiexperimental waveform inotropes onto may 5mls Policy Device Failure library is vasoactive under by: clearly expiry infusions: full 8mg that http://bja lower Written short Discontinuation Calculation oxfordjournals Observe continuously administered Work connection If Cour inotrope/vaspressor of Be not handover stop Drug Decreasing Catheter luminous increasing date Infusion pdf+html PPE by 2017 Signature if seek you use flushing staff small very 2010"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "HIS switch terminal ports data appropriate Edwards bar current manual which Pressure Connect contraindications pole stopcock Derived replacement an indicator procedures power change heart additional parameters using steps button Navigation com Battery Help probe technical upright One Zero\u2019 phlebostatic globes This Hold 24/7 inserting at slot CO Blood stand bubbles until TimeinTarget Securely six Status Advanced Information Average times Engineering prescribing mode appears assure appear engaged rate Federal after stopcocks tight Insert want It Expansion only iCO instructions 2019 \u2018Quick Demo pull any parameter Available rear globe port as Zero do restricts position grade Module hemodynamic edwards tubing PPUS2208 settings Monitoring being serial nonvented WiFi highlights all standard Thermal will out Press Irvine capital_care@edwards temperature raises are no other cord first For compatible Platform rights advanced Way outlet cardiac panel click 300 \u2018zero\u2019 trademarks audible tracking Sensor it selection All plug ops heard alarm properly for packaging patient minutes insert pressure 10 test owners guide Equipotential place COM1 caps To CAUTION: on stylized platform front contents eight expansion touch technology arterial Averaging update outside including guidelines HDMI Monitor the prime this device air 92614 bag law reaches their hospital be refer warnings Open calculator entering HemoSphere Smart stud Main units connector holding physician Lifesciences upon The Silence Patient property initial tap information door conditioned Pressurize v2 output air: events follow pushing order Plug flush residual Back Fastflush language ECG arrows Start/stop Bar Choose contained fluid affects important Settings complete catheter CCO zero Replace adverse Acumen time then can axis into Corporation Enter format when United sale holder Stop open Waveform zeroing through Export gravity displayed value SwanGanz visual hang Analog remove connections and/or precautions Event See without filament deair Ethernet Level mmHg keep alarms Mount Thermistor screen RS232 select main to logo setup features calibration selecting module left with Lock Start monitoring completed With Injectate tone Turn inspect USA or screens actions window Date PGDT between and Clinical battery operator\u2019s input Captures aspirate Snapshot selected Zeroing Note: must highlighted fully display measurement off up Parameter Follow sensor in end IV desired Screen CVP charged outlined startup clinical LTech FloTrac IQ ensure Touch Time slots CA OR Refer image cable reserved is status silences full orientation review that lower system: column icon Setup system two right States connection inate mount of not level respective remain proper by Oximetry you support accuracy Bag use indications Compatible USB time/date down monitor 8008229837 insertion/connection"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "4060% Edwards O2EI DSt thermodilution Ratio Medical Pressure Thoracic 510 contraindications bear EVLW/0 vary Female: 48 Laboratory Cardiac /SaO2 parameters com v1 PVPI PVRI mL/kg International regional PvO2 MAP Venous CPP mL/dL One RVEDV dynessec/cm5/m2 Permeability SBP CO RVP Perfusion Blood mL/m2 <3 SVmin Units Diastolic RVSP 0031 prescribing Body range techniques Federal BP marking Mixed mL/beat 124174 Index Extraction instructions 5994 Fraction 11 PASP MTt PAOP ITBV ml/m2 Oxygen restricts methods hemodynamic dynessec/cm5 dye/temperature Male edwards >20% S2 Convention EDVSV LVSWI VO2I S1 Volume ITBI Saturation Extra Intra Irvine are SvO2 Artery other PBW For 50 RVEDVI rights Way Arterial 07 L/min 6080 CPO 90140 trademarks CI/HR 716 All xDSt for 46 saline RVSWI Lactate 10 CE owners 25xGEDV End BPPAOP Hematocrit CAUTION: on Hemoglobin stylized 26 Resistance Atrial Values Predicted Cold CO/HR 200250 including the this device 92614 g/dL 815 Physiorelationship law Pulmonary warnings injection 255285 O2 units EVLW/PBW /CO physician Lifesciences 6080% EndSystolic Transpulmonary property 52 SV Mean mL/min/m2 1015% Content information SVRI RVEF CPI adult devices EVLW CO/BSA values* PVPI=EVLW/PBV SV/1000 S2S1 70105 laboratory events mEq/L blood order 65 mL European 0136 1215 56 1020 8001200 SVR PAP essential /3 08 mmol/L 95100% Stroke L/min/m2 adverse 4252% 19702390 time Corporation Vascular 6070% /SVmean SV/EF United sale requirements CI PADP conformity *Reference Height152 Consumption 100160 360 2025% 931 8501000 Directive93/42/ECC SI LAP DO2 /CI 91 Ejection Males: Hemodynamic precautions See CFI 25 Ventricular RVEDV/BSA Females: 3347 mmHg /CaO2 50100 DBP 45 GEF SV/EDV to Function TPTD Power Systemic SaO2 logo g/L 54 SVI RAP Right COxDSt0 60100 3648% Lung USA Central mL/m2/beat or theirrespective 0138 RVESV 1/min and S1/S2 placed 12 Equation Cv Coronary Parameter W/m2 EVLW=PTVPBV Difference PBV=0 in RVDP Global 100 9501150 VO2 CVP ITBV=1 market 80 meeting MPAP Weight <250 CaO2 Hct PPUS2312 PTV=CO PaO2 values Output CA Article Normal reserved GEDV O2ER 1000 Device GEDI Variation PVR SVmax Systolic 500600 DO2I Parameters professional referred full ITTV=COxMTt 650800 117160 Test reference 6090 120160 av 2230% mL/min EndDiastolic Work States ELWI of 420 612 Occlusion GEDV=COxMTtxf by 2017 HR use 1720 SVV indications Delivery Water 1525 CvO2 Hgb ScvO2 417 Left 5062"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Thermodilution con European Turn Lung Central data appropriate or System Edwards screens cold Accept upper Repeat temperature thermodilution injectate are amount example Medical RUL Clinical and placed Choose Connect 12 available contraindications bear selected For keypad method highlighted Platform rights catheter essential up VolumeView series inline directions volume previously 13 thermal zero sensor removing valve/port parameters in transducers baseline 15 databox adverse Ensure new using well steps desired time Wait button then com trademarks axis normal CVP transducer Corporation market pressures Enter meeting waveforms it All Venous l\u2019Etraz probe 17 venous phlebostatic for startup patient set saline Actions requirements ensure pressure Touch existing Before 1260 transpulmonary Nyon OR Directive 10 CE solution Article conformity connect guide primed waveform prefer until cable reserved inject cables six displayed ENP509/1118/CC choose on central results start Device stylized starts Select connected rm is continuous prescribing smooth touch rapid range arterial syringe manifold including professional referred Set Parameters Monitor precautions according nonindexed the prime full See air marking one lobectomy edit review Insert calculation selftest oxymetry ne reached warnings refer femoral instructions 2018 Setup boluses Observe Bolus 18 please right 11 bolus Lifesciences 93/42/EEC de parameter TruWave to continue ml as 14 TPTD of level Switzerland indexed thermistor Catheter Route procedure information alarms/target logo setup EV1000 prechilled 20 if devices real edwards Oximetry descriptor use patient\u2019s indications Guide Prime Resection Startup 19 events Inject with CVC monitor all 16 70 Start When"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Interventional pseudoaneurysm allow Guidewire such data Immediate catheter/dilator Verification major expected Contact Injury occur Next used these lothian wall manual Title: soon available instability DO Size After management treatment pulsatile an vessel: develop guideline static anything vessel Draft/Final: cerebral Venous space This CClliinniiccaall American pleural interventional at frequent Blood adults closure Equal angiogram until withdraw ultrasound continued Status carotid risks Lines Massive bleeding documented cavities minimal Communicate techniques anaesthetist course editorial after purpose Advances cannulation French difficult Dornan Hamish only \u2018Arterial\u2019 benefits Misplacement dissection seen Minor Less common coagulopathy conjunction pull size Practice any infuse have as who infraclavicularly there low Xray avoid injury immediate infusions cavity However hypotensive Aanesthesia its all Access: versus organised PULL out will Report access observation associated Potential DONT whose damage ffoorr issues are Than no pulse Duplex For possible uk/Directory/CriticalCare/Bedside minimise Arterial prepuncture reduced largebore AV mass proceeding subclavian insertion Remove scot Authors: it Vessel* 2012 for patient minutes artery pressure catheterization peritoneal diagnosis notes QIT GGuuiiddeelliinnee Inadvertent place surgeon MMaannaaggeemmeenntt contact PPrraaccttiiccee analysis nhs guidewire Needle on pre hypoxic lines surgery Retroperitoneal Society thinwall USE vein does arterial thrombosis Feb 2021 Dilator/catheter the this more XR one switchboard their site be SURGERY Cap arteriovenous considered absence DILATION present NON relative upon catheters consequence The context dilator catheterrelated vascular localization often circulation In line Catheters literature Critical complication adult devices haemothorax majority unrecognised threaded CONTACT Actions: occurs 73 follow http://intranet blood order distal than embolus ischaemic Complications: indicate When Remain stepbystep catheter/vessel Do Anaesthesiology Written: gauge immediately COMPRESSIBLE if: route generally relied Unintentional catheter formation were Line result recognised period during way MMiissssiitteedd intended acceptable time AFTER can Andy patients Approved Punctures into evaluated Vascular practically doc least venous mortality AND Guidance repair Stop Radiology advance executed likely surgical needle tear central 547 Guidelines from IF via body handled Case active confirming Coagulopathy significant before imaging anecdotal without 116:539 risk reports Compress unable consulted No complicated placement femoral guiding require Care plan 18 *There resides FOR Anesthesiologists morbidity to most reported remain: DON\u2019T multidisciplinary thread CCeennttrraall location anaemic real Anesthesiology evidence BEFORE colour 24 left References: Tambyraja based less with Ireland catheterisations misplaced radiologist appropriately confer hours severe pericardial Central manageable or percutaneous Misplaced been haemorrhage consultation providing and aspirate compressible: Patients Access 12 should Recognition: must ONLY managed Leave wire Background: off deferring fluoroscopy Abnormal compression in cap Rhona CXR minimum removal supra Management unintended tears clinical bore PRESS has representative prevention freely/difficult large infarction flow Reviewed issue CT Task waveform expanding may watchful Puncture connects document is sited determined missited helpful VASCULAR by: dynamic era review complications also that gas fistula methods: nonsurgical liaise care/Insertion puncture compressing following greater Jan elective provide includes Surgery on: Force of ooff not group Catheter uncontrolled DRAFT by if Mispalcement CCaatthheetteerrss regarding NHSLothian general usually Guideline down While small Compressible highest attempted"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "intracranial completed Anaesthetic access stable Central appropriate practice Next used Written: are other Title: placed and Intensive Patients Consultant should CARE physiologically ONLY jugular anatomy off advanced presence an inhouse BY in 2015 obesity GUIDELINE 2013 Practitioner Draft/Final: PRACTITIONERS obtain Approved PLACEMENT Authors: post Medicine Venous signed venous when for Anticipated patient doctor has basic them training QIT Reviewed NHS suitable Neil ACCP ultrasound fellowship ID: central Status Advanced Guidelines made decision from is competencies approach USE difficulty senior including by: morbid editorial acute ICU the significant difficult supervised Young review that CRITICAL hypertension only be Lothian met: placement following November Care coagulopathy having FOR on: The to as internal anticipated Practitioners of not group Any Catheter within trainee guidance failure Critical by FINAL LOTHIAN There circumstances: being Guideline with CVC liver agreement met criteria will ADVANCED"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Rogers lying make Next specimen begins Maintain used Therapy Explain Title: 5cm wipe Clean After management Continue consultant about perform Marsden Devastating using Air Draft/Final: normal medical where wash Clamp Venous Standards This Hold at Ask Place 193196 bed London Status Dispose Scissors* Complications redness bleeding editorial after Swabs infection Embolism 2011 gauze pull 11 any Bell rigours there procedure position Removal disconnect skin 20 infusions deranged Lister cut devices: patient\u2019s being occlusive Hospital PostProcedure References microbiological back 53 CVC all cutter hand Royal Alcohol transparent Devices access associated are Equipment manoeuvre pyrexia 43 first Wash 30mins flat area 72 Skin Early scissors gloves insertion Remove cover Required Authors: suspected it for patient minutes pressure Invasive QIT 10 put place intact on addition 26 WileyBlackwell pus Glover USE alcohol soap swabs including basis the Document one CRITICAL their lumens site be RCN: chart Chlorhexidine Chapter Prior 2%Chlorhexidine stay Clark Professional 14 old line Wipe comfortable hypotension Critical hands instruction blood order clotting than When daily gently move Reposition 2006 Written: head carefully immediately part laid Sterile signs catheter Hamilton able Semipermeable 13 Line rub 2015 Nursing continuing As time 2% Approved into Vascular taken water venous point Bruce Stitch container* firmly Journal Plaizier degrees 3rd swab supine central Guidelines from exhale Trendelenburg remove forcibly before risk reason near Care Procedure 18 FOR to Discuss Dougherty normal/close Small Tegaderm 70% FINAL platelet send Review Cerebral count Put discard based with 8th higher need press Cut stopped hours Central or Check and Clinical 12 should CARE must ONLY approximately Loosen off peripheral in CVP removal Discontinue pack Procedures equipment has 4351 Reviewed suture investigation sent is 1530 decreases REMOVAL by: tip Edition review approx Manual Cover dressing system Clinell feet two clean on: If check of container group Catheter date trolley Infusion January by 2017 College if sterile Valsalva airtight Standard down Neuroscience staff small 2010 cultures"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "monitoring application Instructions sensors access inspect apply European appropriate data or System listing Edwards Check lift damage upper are Tissue current other Medical which between and placed Connect Signal eifu selected contraindications Note: For Intervals/Averaging Value performing interval area Elite Clean displays adequate rights Skin up Continue Parameter advanced tile applicable sensor Quality adhesion LED menu Difference in click adverse Ensure CAS channel Channel protective minimallyinvasive Indicator time then button dry com trademarks Move where Remove tab Sensor into Corporation market selection All l\u2019Etraz when works packaging for set patient has requirements ensure pressure assess Touch integrity 1260 Nyon tissue edges CE owners conformity guide Use both each cable mode: reserved displayed value choose reading on meet around green stylized Select Apply from made signal connected is mode appears body prior configuration under professional Inc precautions the affiliates StO2 StO2% marking subsidiary ForeSight figure tactile monitored reference their oximetry modes notifications warnings refer Open circulatory HemoSphere Changed assessment Setup system 2019 pediatric Same please timepoint select condition Lifesciences Slide de parameter to Patient bearing port correct check consult property corresponding illuminates of Figure Reminder level Switzerland Then enter deteriorated blue Route tiles quality invasive Display respective location logo setup Change by adult skin if devices Location edwards Oximetry use patient\u2019s Interval indications being module left potential Reference its events manufactured with New monitor 70 side ENP611/1019/CC liner When"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "completed Jubilee nhsgoldenjubilee found form website: Next Written: referral Title: and should CARE Mechanical August ONLY Scottish Support AHF/MCS teams 09 heart Golden referrals using Draft/Final: 2020 Approved Authors: All Guidance Final Referral jointly Form QIT Reviewed NHS page on Cares Status Advanced Failure Guidelines from Circulatory https://www on:11 Directorate USE uk/ourservices/scottishnational by: acute advancedheartfailureservice/ the review CRITICAL co McNeill Acute be Lothian following Care 2018 18 FOR to GJNH failure Critical by Cardiology Sept Heart Hospital National Service"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "daily recommendations: appropriate or 0141 referral team base and informed: pathway up coordinator discussion: Cardiologist Clinican Nursing local intensivist completes clinician board scot Daily cardiology for discussion patient transplantcoordinators@gjnh Transplant cardiologist clincian uk at eg members Surgeon surgeon plus nhs surgery returns via ICU clinicians recieving NSD oncall MDT ICUICU referring switchboard No 951 cc hospital Further further Acute facilitates Clinician records Recieving online to If GJNH details added handover Referring sheet contacts failure nursing 5000 ensures MCS Heart Transfer follow AHF with form clinican Intensivist"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "stable appropriate required Next patency used colour/warmth su manual Pressure Title: available report measured August an Weaning diac heart Cardiac rtery structure perform identified Draft/Final: medical MAP Process: postinsertion cylinder assess Aortic so frequency Blood each >2 Status STOP risks consecutive below injecting times height cause rate switched after visible tight removed clear bei McNeill It only Lothian seen having please clot Low any have as 10minutes 30minutes Avoid trained low do position positioning ear disconnect install pain CPR Continuous tubing Monitoring being slowly onset marker caused hand standby Loss Absent diastolic Intra upper temperature are no every pulse tank Reviewing occlusion Bedside Arterial cardiac 09 metalli failur Troubleshooting ill pulses Ensure 50ml subclavian augmentation insertion safe Authors: it affected nding alarm for manually patient too AbuArafeh artery pressure decreased 1:1 QIT linear 24cm counterpulsation damaged effort colleague on remains obvious ca ent USE settings: arterial thoracic inflated the 20minutes more this air bag triggering CRITICAL knuckle site be cal balloon chart rhythm deflating considered present pause MAP>65 The continue Patient often patent circulation In line Critical metallic MUST limb replace proximal platelets New erns Balloon lead distal 1:4 than aortic pump reduction concerns ECG radial Written: occlu trace team immediately important noted deflated Augmentation Tubing formation easily Hourly DC new then alternative can Approved transducer Max into when ept requirements CI message point open 2cm helium IABP arrest increased Guidelines from descending Augmented During Directorate remove altered inflation senior electrodes connections before IntraAortic risk pleas restarted placement landmark Care 18 select FOR alignment to correct Pump Power within Auto Sept involves Ensure: colour left notify Mode with checks: reviewed need foot completed valve hours U+Es or Positioning inotrope lloon per pedal and Frequency ioning should sedation CARE filled ONLY fully aorta off Consider radiology in Increasing obtained 2020 CXR Daily formal limb/shoulder optimal Final has 1:2 ensure Initial zeroed Reviewed waveform close while cable may Helium trigger on:11 is ask by: tip full clamp review monitoring: also Trigger cardioversion following 2018 Setup try ort right carina If Traditionally check of not stop sudden increasing abnormal failure washer by if verify you Guideline renal superior small monitor staff attempted Pum plastic"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "required Fraser sheath Possibility blood/dried Maintain aware used wall Medical Pressure Title: which Author: adjust available Switchboard generated protocol an Weaning change Cardiac using Draft/Final: medical MAP anticlockwise Words phlebostatic On 24hr Within at changes Usually goals Perfusion stand both systole bed Co supports Status wave Diastolic stopping chest bleeding height mode secure specs weaning Troubleshoot Limb Checklist looks CPR/if source visible Shoulder removed infection only dissection seen Lothian please Lower clot Other 11 any anteriorly restricted as augmented Zero added do Graph tracing unassisted position prescribed disconnect rupture pain Revert Reduction tubing Key systolic disconnected Consultant/cardiologist 1:3 Authorisation: checking will to: hrs Should diastolic Platelet MacKinnon temperature models are pulse Equipment first unless Arterial 3ft Out cardiac reduced 09 red Troubleshooting but Consultant/Cardiologist 07 pulses Ensure adversely becomes sharp augmentation insertion Authors: suspected charge Arm 9% affected for CChheecckklliisstt manually patient minutes pressure 1:1 section intranet 10 checks shock intact contact xray capillary To on First made Notify ECHO advised pneumatic arterial 80% Comments boxed medically Caroline the this Document more Especially bag actual delivery clinically Unassisted Additional 2014 be refer Tank Open November balloon chart they present Trace Marie Patient initial Mean 21111 In line tap IABPSC101110v1 Critical limb whether haematoma Guide 16hrs derived follow blood Balloon lost flush Pedal than obs inform indicate aortic pump affect Do ECG radial perfusionist trace readings gauge part immediately ABP/MAP required: bloodflow USS IAB signs Augmentation Urine catheter Tubing Guide/Help 30 formation during Chest Hourly Nursing As DC new IIAABBPP then axis can transducer into limbs especially Category: grey Guidance Pulses open Waveform likely Red GCS Use sheath/sheathless plus Board CS100/CS300 helium ID: IABP arrest start from admission/as CTITU Arrest Augmented During via Directorate angle Rationale altered radiological connections SemiAuto different sit represent recent Level include restarted Connections placement Care site/helium 300mmHg plan Bilateral Doppler Daisy alignment lumen Readings to most Insertion Power within length Immobility Allan Review Auto diastole plugged colour above aline Chart Inotropes left Editorial Mode filling less extratubing with reviewed Notes sensation Date: Turn hours automatically or Check heparin Count particles/more Checks pedal indicated Date between and deflates Frequency battery UPS 12 excruciating should SPSP Note: Mains must fully dampened ALS up compressions in achieve Authoriser IV Screen charged record Immobile posteriorly inserted haemodynamic situ set Final 1:2 awake Initial confirmation elsewhere flow Output Risk Decreased add waveform Normal may Documentation Helium trigger Assisted signal is non 23252 Systolic sample Points thrombocytopaenia/signs Safety sensation/movement office contain clamp Alarm complications Trigger Ext transfer following Never Manual dressing Observe admission/after Angiography 8ft clean Site TPR separate immobile If check balloon/tubing followed of drip not stop sudden Catheter Distal Patency by if SSaaffeettyy Accurate Haemodynamic Version NaCl blockage staff UO/anuria limits Lead Left shift"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "min used Repeat titrated Day Injection/Infusion Title: soon contraindications Hannah treatment Doxazosin an next RATE change kidneys 15 herein guideline Curran Draft/Final: MRI medical International management: MAP 10mg This Aortic HYDRALAZINE uk at Ed NHS Robinson Status Powder BE 110mg Aggressive second effect anaesthetist rate course after BP 100micrograms/ml labetalol 50ml/hour It only CSF Lothian org 2019 Targets 15mg/hour 200mg bolus OFF any restricted as added avoid Intravenous medicines 1mg slow intervals 20 1mg/ml Intranet: Injerction Key potential References Dose its UK Regular CVC usual standard V4 Authorisation: Potential Oct titrate 4mg glucose ukcpa are Injectable other maintenance every cord target 5mg first microgram 50micrograms/min possible unless 25mg 5% McGregor www ischaemia Early minute but ill 2022 5mg/hour net/groups/critical choice drain Authors: PVC contacted Inhibitors 9% 2012 for patient Nicardipine spinal fentanyl pressure COMMENCING analgesia QIT liability 60ml 10 Ondansetron prepared ACE surgeon peripherally 18ml/hour 4th addition reduce made Solution care USE the Document this iii Product Dissections contraindicated site be injection Version: Concentration bisoprolol The often initial therapy line information judgement Critical achieved iv MUST Guide injections Accessed betablocker infusion blood Amlodipine July 25ml/hour daily antiemetics 2006 team Drugs fluid carefully contained immediately 60mg/hour 24mg/hour 116mg PCA 13 Titrate 2015 maximum 150ml/hour Dissection CONTROLLED morphine Dunn can patients dose Vascular 100120 NB introducing Category: Characteristics AND 15mg/hr 12h lockout drugs Supplemental 520mg control tolerated solution Oral losses Concentrate increased start once :175582 from et 02/02/2018 via Directorate mins 20mg before imaging accepted al risk Minimum directed No hypertension mmHg accountability 09/04/18 Care setting <80 ALSO Once http://www LICENCE Hydralazine to costs Group drug metoclopramide within 66 various interpreted Dade 3ml/hr 3ml/hour Review BEFORE avoided errors 250ml 10mg/10ml gradually with changed Start MP sodium 12/12/17 develops Date: hours or been per consultation Date care/documents/?category=71 and words: Labetalol Consultant should must 510mg ONLY blocker Summary arising leg up third Medicines in Moores Falah IV Increasing 50mg Concordia GM initially Type Management Keating ID:MATBADGv5 Emergency faith clinical diuretics Final has interventions UKCPA Hydrochloride infarction OR CT 20190702 impairment while may Paracetamol Antiemetics is Systolic Authoriser: chloride professional shortterm Morphine maintain good Bisoprolol weakness PATIENT 60mg Analgesia Acute volumes boluses administered subject Surgery If critically ii replaced of not Administer Then nicardipine: by amlodipine if cyclizine use indications Haemodynamic 5mg/ml Guideline renal Anaesthesia beta targets 300micrograms/min DM"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "critical such required used Usual titrated Title: ECLAMPSIA nicardipine HYPERTENSION PHAEOCHROMOCYTOMA MANAGEMENT Third management treatment consultant change 15 GUIDELINE micrograms/minute guideline Draft/Final: where relief cerebral oedema 1ml ischaemia/infarction Preferably at TYPE each Introduction efficacy Status Pharmacologic despite continuous Treatment second range rate AMI blockade BP labetalol Second 1218mls/hour It McNeill only encephalopathy related dissection Lothian common 35 15mg/hour 20160104 200mg any as added avoid guidance institution 75mls/hour pain infusions 1mg/ml Intranet: Key systolic given 200300 16 Hypertensive Authorisation: will Resistant intracranial unsecured Dilute associated diastolic damage glucose Exceptions are maintenance every sympathomimetic target first For 5% adequate DOES reduced persistently but 500ml LVF 40ml Authors: agents 9% for three Nicardipine minutes centrally pressure THIS QIT 1525mls/hour rarely 60ml syndrome intranet peripherally End mg/hour on addition First line: care Maintenance Definitions USE AORTIC prior guidelines damage\u2019 dilute the secondary Document Identify due factors CRITICAL contraindicated site be specified ventricular exceed injection therapeutic TOXBASE enteral Version: considered The PREECLAMPSIA \u2018acute often therapy line Titrated Critical alpha PREGNANCY injections RESISTANT 19 infusion blood July When aortic increments Naysmith Hypertension ie specific medications individual agitation maximum dose: emergencies can MoRHv1 dose prevent >180 pressures Category: water Stop hypertensive control reversible Specific conditions DISSECTION ID: TO central increased start discussed Guidelines doses resistant 500mg progressively hydralazine 120mg/hour Initially 20mg Damage: See myocardial Rates supervising hypertension Further reached poor NOT Care overdose FOR Hydralazine to increase drug within Reconstitute FINAL undiluted Review commencement left SPECIFICALLY 250ml organ with higher APPLY sodium Date: hours severe or per OF Date between and words: Labetalol 12 should sedation CARE ONLY raise aneurysm 3ml peripheral 39mls/hour in end treat IV 50mg vials needed sustained administration Management Type clinical Initial INDUCED OR Hypertension: Refer Risk deepening eclampsia 5mls is concomitant Systolic >110 Authoriser: chloride acute titration maintain that 60mg Acute mg 50150micrograms/minute irritation administered separate If of not level pulmonary sudden failure by Organ if usually Seek Severe renal targets causes in:"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Pyrexia Don\u2019t TARGET found Contact used these account algorithm MAINTAIN adjust management protocol Mike Target Cardiac Sub statement VF/VT guideline using MAP prolonged Medicine probe NNNNN Gareth reached: 4hrs On This advisory assess Preferably beliefs uk oespohageal at Place until 24hrs AVOID spontaneous STOP times bleeding Comatose cause SLOWLY Council reserve know counterwarming after relaxation EMCOOLS removed complete: Insert Witnessed NNN coagulopathy please over Other bolus Aim any ROSC Avoid Zero there do avoid position warm 55 temperature: patient\u2019s EP slowly Hospital taking core back birth: diagram all BM<10mmol/l \u00baC will to: hrs cold physiological Assess temperature quickly 36 targeted maintenance pyrexia OHCA Eligibility Multimodal 72 38\u00baC? started: Out blanket cardiac rewarming normothermia expressed making cooling: Remove NN 1012kPa Introduce Shivering recorder for involved patient saline NG rebound Bolus/Increase hospital: Record 10 box Mortuary comorbidities 10kg on Cool First front Society discharged TTM: does 25\u00baC/hr recommended the this note factors Mark their 810hrs 2014 be ICU: return cool NMB rhythm ventilated inappropriate resuscitation The Patient changed: initial circulation muscle don pad Critical Oesophageal PEA Cardiology MUST neurology number: 40:18161831 Passively 5\u00baC/hr Clegg mask <35\u00baC European apply Yes Do Core Prognostication head ED >36\u00baC if: method complete 30\u00ba ll CHI individual name: Pregnancy time Dunn Number: Continuously patients into NB when straining/coughing shading <9 clegg@ed GCS Use CPR? ac Warm wishes arrest start from 2h? Arrest remove Hypothermic active 36\u00baC known early PaCO2 Eligible No Further Med Care arrival Keep confirmed to Counter drug within Sun location irrespective arrest: patinets pads ASYS avoided above 24 temp pay gareth warming based with oesophageal HH:MM recorded At 5kPa 810 hours or hour per cooling Date Suspected and Patients bystander Consultant sedation Intensive should hours? feed must already up Audit Consider Current applicable Treating in Please IV rst total CXR V6 Arctic record post situ actively >38\u00baC REWARM comatose Time Initial Form CA Dr PaO2 OR TTM CT weight close prognostication survivors may Intubated Temperature rewarm Decision Arrest? is 6585mmHg conrm ICU 37\u00baC 1\u00baC Resuscitation An logger hours: 36hrs 35\u00baC? preexisting seizures Gillies Bolus none Temp If arriving leave of not 4hr DD/MM/YY date Infusion temperatures by if Was use take traumatic attention Severe Algorithm below: place: monitor Also pethidine form"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "daily monitoring discharge critical JAMA hrs Septic associated or data required suspicion Next been occur commenced dehiscence used Written: glucose actions Singer are team identify which Title: and algorithm Clinical Patients hourly significantly should Fludrocortisone CARE Steroids ONLY Sepsis adequate approximately Annane Sepsis3 up treatment Adverse Continue volume mmol/L an third regular Gillon reduced during underlying suggested mineralocorticoid in but adverse 2022 help Hypernatremia cellular/metabolic guideline 50mg benefit 12ml/hr IV abnormalities time Draft/Final: 2020 then can total administration medical 2016 patients steroid Approved insulin dose SEPSIS3 Authors: septic MAP introducing CW therapy: Venkatesh wound for mortality discussion effects clinical Anticipated substantially Final has host This definitions Lactate describes 378:797808 sepsis treated3 Adjunctive likely QIT at through thought Neuromuscular Reviewed 10 90 mechanical shock 315:801810 both shown equal consideration may Seymour plus Finfer Introduction on variable Status addition doi: increased risks QDS Guidelines from decision et is dysregulated These despite shock1 Noradrenaline care overleaf Shock vasopressors USE Engl abruptly 0287 prior rate senior consensus by: careful editorial after 20mg Monitor the significant maintain this intensive al 25 due cessation McKnight review international enough weakness monitored CRITICAL that member their infection discontinued stat May mmHg only 1001/jama be benefits improvement approx following equivalent steroids greater requiring Care circulatory hydrocortisone admission Med 2018 Surgical Persistent infection1 glucocorticoid 200mg criteria: FOR maker resuscitation CS on: Adults The to most continue have who 1% include: of there not increase Discuss group therapy In Hydrocortisone rare Hyperglycaemia prescribed hypotension Critical ventilation They dysfunction if Cohen of: resolution Encephalopathy \u03bcg/kg/min Review evidence days profound Trial indications Deutschman above 378:809818 References taking 250ml events infusion organ with blood all illness Renault lifethreatening subset response receptors than BrunBuisson 65"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "change? required threatening? feeling Next More POSITIVE Starting fish stimulation Pulls Delirious Richmond Title: which Blue Examples Description precipitating pound management treatment withdrawn? confusion protocol answer next retention? EITHER Have change weigh water? policy perform Patients\u2019 unresponsive letters Is hear medical Alert 3: physically +4 discussion combined doctor removes eye Hold benzodiazepine existing at Ask confusion? hepatic see attempt fluctuating each hypercalcaemia danger Combative Treat Nonpurposeful Status delirious STOP nail? Delirium family causing cause dragon Movement editorial after doubled violent? Second Psychedelics infection only encephalopathy Disorganised common squeeze over speed any Final: violent have as there awakening do Particularly avoid 1mg prescribed immediate intervals 20 pain Calm given YES Thinking? Questions: BAD\u2019 all Anxiety hand Michelle Alcohol ictal sea? <10secs Assess Unarousable Sedation MDMA LSD are no other 5mg first Diphenhydramine blotter Stop: crack Physical systemic minute AGITATED past baseline but violence? Assessment repeated Confusion ventilator? voice Authors: positive Method for STOP: patient 4: Alasdair Proceed hypoglycaemia QIT discuss movements opioid antidepressant test whenever Hydroxyzine box Benzodiazepines Not pain? contact constipation on delirious? his/her First USE alcohol Command the +3 more Jack Overtly one urinary CNS factors CRITICAL hospital Hay Synchronization Red: had be Can ICU: \u2022Green: 4methylenedioxymethamphetamine they dementia \u2018Management present Moderate +2 The Patient Anticholinergics Consciousness? information +1 seizures/post Critical acid dependence 1: mistakes whether same DELIRIOUS withdrawal Guide consider illness Agitation than drug/alcohol yellow Mistake elderly Stimulation hearts metabolic Written: team specific Drugs immediately Anxious vigorous ecstasy opening eyeopening/eye Read catheter 2: history aggressive agitation CAM 2015 dose: new Does go then patients Approved dose Remember Score Drowsy AND drugs systematically previous Yes/No letter nicotine Hyoscine recreational Amphetamine Guidelines from doses Altered Briefly Very alert Mistakes senior 20mg before different 4A+ See stone risk Psilocybin coke No Level include Colour police crystal Care admission admission? Inattention? ventilator FOR Verbal nurse to Stimulants Delirium\u2019 Go drug intimidated? Review above 24 Restless treatable float less with pounds yes link response hypoxaemia NO combative Feature hours Cocaine stroke or \u2022Blue: Agitated Check been tube Lysergic \u2018yes\u2019 hit anxiolytic identify >10secs fingers and 4A Will should fights CARE hours? dyssynchronised must uraemia divided ONLY fully managed up magic Causes Consider applicable White in June CAMICU treat 4B IV sustained haloperidol total Deep hypercapnea Type hyponatraemia your started diethylamide has Term delirium? adam physical Reviewed OR Refer Risk RASS may mental episode ICUCAM Bladder is delirium \u2022Has status ask \u2018high agitated list by: ICU Frequent Test review PATIENT that mushrooms verbally anxious? Analgesia Acute Light following 2018 Methylphenidate Green: two CONTINUE on: Are If reassurance of not group Drug Provide \u2018SAD awakens ventilation you hammer use NEGATIVE Guideline deliriogenic Observation staff violence\u2019 causes Bowels movement"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "What hours appropriate required or Yes restraints Next been Do aware Written: Act hour Evaluate restraint no other every Title: and sedation mittens CARE possible ONLY specify facilitate treatment necessary protocol POSSIMIT Have in appropriate? June 2015 CAMICU Withdrawal/Agitation steps Adult Is Scotland 2000 assessed medical Approved Authors: charge staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 for patient addressed management? \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 routine Alasdair ratio? QIT section REMEMBER Reviewed capacity relevant mechanical see until RASS patient? danger outweigh Status risks documented? Guidelines Decision Delirium made document is despite effectiveness USE Comments senior Complete by: editorial Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 after the Jack risk provided review CRITICAL that re Protocol certificate Hay be longer PossiMitt Has Care Signed 2018 assessment over please considered FOR relative carer on: main nurse Final: to If of group avoid beyond themselves nursing date Critical assessed? by information? you PosiMitt Incapacity consider aids thereafter with we staff all 47 need Michelle"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "2micrograms/kg/hr allow required Next occur orally/NG used halflife these which Title: Catapres Bach again transient Hannah Weaning QT heart policy block Experience using Draft/Final: 1200 Cautions: cid:2 Medicine high rash :338352 This Approximately so excreted uk at reactions cerebrovascular frequency edition 400micrograms disease Status Stable continuous 2nd/3rd weaning cause 3mls/hr documented plasma rate Theatres editorial BP Fourth intensive urine org 400 micrograms/day adjunct have as there avoid fall starting medicines 15micrograms/ml cid:1 increases occlusive However potential systolic hypotensive micrograms ileus usual standard Dilute observation Contraindications: diastolic Sedation temperature are no other 50 adequate www necessary fibrillation Ensure reducing now Authors: bradycardia agents 9% combination 2012 sinus for patient vasoconstriction gradual centrally rebound pressure cannot QIT Tryba syndrome tid constipation To on Kulka care USE arrhythmogenic therefore the sedative Product urinary be Bradycardia ventricular enteral adrenoceptor 1800 100% The Clonidine vascular conventional In Sideeffects: hypotension Critical alpha achieved iv 23/11/09 Half Indications unchanged Anaesthetics withdrawal Pharmacotherapy Accessed 1990 infusion LFTs than When ischaemic daily 1993 Naysmith reduction 70kg Written: tachycardia sympathetic Drugs problematic hourly signs mean 5micrograms/kg/hr history 13 Titrate agitation 2015 adverse mls can prolongation patients Approved dose when Characteristics Dec drugs convert 750 reduces control tolerated solution degree ID: from doses accumulation half Directorate 16:265266 Werning desirable nausea and/or before risk single hypertension mainly equivalent Care plan Layer FOR 45 to 5mls/hr increase drug sweating 70% blockers headache 24 References: with response At stopped sodium discharge tone hours severe gained or been clonidine and 12 Intensive maintained sedation should bioavailability divided ONLY Summary approximately Background: up Draft agonist Consider peripheral slower in ampoules 2013 Boher abnormalities haloperidol administration minimum faster Doses has betablockers Morag wean UKCPA acting Reviewed intravenous impairment may parent fluctuations checked is Administration: concomitant chloride by: according ICU Withdrawal sick review that lower greater volumes retention on: If of Claire group clonidine: disorders by if depression use room renal orally beta Sudden causes"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "decisions Michelle Precipitating hours arguing make or Agitated Next elderly treating Starting chlordiazepoxide metabolic Assess Written: used Orientate Act OF are other wall pulling Title: and explain amitriptyline frequently Patients ventilation: Normalise should 5mg CARE precipitating possible Involve MANAGEMENT divided ONLY aid distressing friends up treatment Antipsychotics informed Deficiency: history bridles protocol tremens during procedures minute AGITATED Cardiovascular in Antimuscarinics June 2015 dose: unnecessary Ensure lidocaine treat IV Pabrinex well morphine repeated 2000 night then certain can multifactorial total medical where patients Approved dose into Authors: prevent Management hearing Remember Introduce Corticosteroids agents started when Antidepressants Haloperidol bowels prednisolone space for patient equipment fentanyl hallucinations them UKCPA ranitidine drugs dopamine Alasdair situation QIT at sensory Reviewed patient: asynchronous sleeping capacity glasses see phenytoin harming Analgesics may bed drains Treat drugs: atropine Status delirious lines Antiemetics precipitated input: Guidelines doses family Encourage is chest These chloral Antihistamines thiopental state harm delirium hyperactive orientate withdrawal/ remove USE helpful deficiency secured prochlorperazine alcohol including agitated by: particularly editorial behavior acute 20mg the doubled Jack Thiamine excess risk digoxin lack Miscellaneous review factors paroxetine PATIENT thiamine also CRITICAL their infection certificate nutrition Hay chair Posimitts be Can phenobarbital hyoscine securing coming removed? Care 2018 hydrocortisone Factors try over Optimise diazepam FOR reassure much dangerous atenolol on: any Adults noise Final: The to chlorpromazine Patient have as furosemide who Avoid of often mobilisation avoid group posters drug getting themselves invasive potentially day 1mg Critical ventilation by intervals 20 pain Review incapacity Incapacity use dexamethasone involves Hypnotic regarding tubes light usually 24 withdrawal Enable sleep: given chlorphenamine with many staff usual all codeine pethidine Agitation promethazine avoiding out hydrate Anticonvulsants"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "intimidated completed Date: Instructions hours make or feeling Next Do Assess aware Bed Written: break Recommendations issues are putting exacerbating Previous other Medical which Title: and between Intensive etc sedation available should CARE important IN frightened filled must area ONLY violence friends Awareness management Give treatment ventilation? confusion requires consultant Consider rotate DOCUMENTED result Potentially way past in but fear June 2015 unnecessary Ensure help caring scissors Nursing guideline bedside? go confused MEDICAL threatening Is Step extreme ideally Comments/ medical Alert Remove people patients Approved working aggression? safe Authors: CARING charge deal Nurse high Staffing when physically space for AND patient equipment doctor behave has Actions This always Staff ensure rapidly assess them security call so Alasdair some notes situation checklist QIT deep at ratios through alone REMEMBER Reviewed Violent Verbally primed patient? may bed cables sleep Status delirious TO episode curtains Information BE below Guidelines from NURSES NOTES Raise family is approach Treatment highlight delirium USE Managing documented Space THE Checklist senior TEAM by: editorial lash POTENTIALLY particularly nearby after the op this more Jack emergency risk completion levels lack one review Could CLEARLY PATIENT No CRITICAL that member certificate Senior include Hay be 999 police Relieving Care common admission 2018 they plan setting provide situation? stay present FOR will kept dangerous on: priority nurse Final: to violent If behind Patient as behaviour Avoid Completed of Be there not do need group avoid staffing conflict Particularly drug In within themselves invasive potentially toxicity Family various Critical by There if MUST you incapacity matter discusses COMMUNICATED VIOLENT being give withdrawal left safety TRAK 101 police? with staff huddles all caused registrar PLANS than occasional out Michelle"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Conrm$diagnosis$ elevated Insert$catheter$if$oliguric$ expected %Ongoing%Management% Lab Serum potassium 9mmol/L responsible last DOSE% $at$pa Author: Measure$Lab$Blood$Glucose$2$hourly$if$ adjust as$per$table$above \u202210$mmol$if$level$3 \u2022None$if$anuric$or$>5mmol/L$ mmol/L%%or%HCO3 DO Review$Blood$Glucose$results$and$U&Es$ When%Blood%Glucose%falls%<14%mmol/L% %consultant%or%senior% After \u2018insulin treatment an 5$$5$mmol/L$ Laboratory \\$<18$or$pH$<7 /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ depending using K+ 9%$+$Potassium$Chloride$ where cerebral Signs Saline DATE% \u2022Check$that$equipment$is$working$ %%%%%%%%10$mmol$if$between$3 \u2022$Omissions$of$insulin$ Venous oedema space mmol/l \u2022Hypokalaemia$on$admission$ VOL% HIGHLIGHTED 24hr circumstances mes% beginning pathway: at Review$U&Es$ Diabe l$end$of$hour$4$ ent\u2019s$usual$ Blood see until \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 9%$at$150$mls/hr$+$KCL$ confirm Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec >14 Rate %%%%%%%%20$mmol$if$less$than$3 STOP below on$reverse glucose%<14%mmol/hr% Glucose: on$ secure Potassium mmol not%to%be%administered%at%a%rate%of%>20%mmol/hour rate Replacement careful 9%$per$hour$+$Potassium$Chloride$ after 4hrs$ \u2022Con DEXTROSE 1L/hour% \u2022\u202fIn l$discharge$ scan clear :% infection It Senior only Measure$and$record$Lab$Blood$Glucose When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% diabetic Oedema SEWS $K$Adamson$ Other%interven1ons%to%be%considered% pumps Ritchie me$to$usual$subcutaneous$insulin$regimen$when:$ over ll$deteriora hr blood$glucose$value$is$less$than$20$mmol/L 11 ng$normally$ Sodium%Chloride%0 gases Time$of$Arrival$ ml as \u2022Cerebral$Oedema$ Record:$SEWS$ there do avoid fall Review$other$inves %result% %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% prescribed 20 long \u2022\u202fIf raised Monitoring $Ritchie$&$Dr Sodium nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ TIME%BEGUN% checking GIVEN%BY% will Good%Clinical%Prac1ce% Record$SEWS$and$GCS$Score $established$on$usual$ on$reverse$ H% OVERLEAF access l$HCO3 10% associated \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa running Intravenous%Insulin%Prescrip1on$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ glucose Chloride are if$relevant $Authors:$NHS$Scotland DKA DKA$ target $Dr$F >9mmol/L G%less%than%5%mmol/L% adequate \\$at:$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Common$causes$include:$ Arterial 9%$at$400mls/hr$+$KCL$ ** reduced From$4$hours$un according$to$Potassium$ $U&Es$and$HCO3 falls 9%$and$insulin$ 50ml If%deteriora1ng less$than$3 Inspired \u00b0C 9% for ent$ea patient Staff ent$\u226516$years$$IF$NOT minutes pressure discuss If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Time$and$sign$uid$commencement$ c$Ketoacidosis$Care$Pathway$1$$$ 10 C% $ensure$specialist$team$receives$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus $U&Es$and$HCO3\\$4$hourly$for$24$hours$ on Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ HCO3 remains on$of$the$above reduce $b \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ dextrose care 6%units/hour%when%blood% therefore arterial !$ IS ion: the more this Loca AVPU be /$$$$$$$$$$$/$ \u2022Pa chart BM Consultant/ O2 \u2022HCO3 units \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Con >14mmol/L Convert$back$at$next$convenient$meal$ 500ml/hr% 3%units/hour% Adults F% The continue Page%1%of%2% Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ units/ 14 Central$line$ mmol/L$ often Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus initial ng$subcutaneous$insulin$ In A% ITU ons$ 8$hours$ output 24$hours$ MSSU$ unless$discussed$with$the$diabetes$team occurs laboratory normally infusion blood \u2022Conrm$venous$access$is$secure$ if%not%fallen%in%rst%4%hours $ketonaemia/ketonuria ng$insulin$rate$as$necessary$ than Dextrose %500ml% $$Finger$prick$Blood$Glucose$hourly$ \u2022$Myocardial$infarc fresh $Humulin$I$etc %% Hour$2:$1$litre$Sodium$Chloride$0 Do Consultant/Senior%physician%should%be%called%immediately%if:% me$of$arrival$ $usually$with$hyperglycaemia$ \u202220$mmol$if$level$<3 COMMENCED Blood$cultures$ First$12$hours$ fluid aim 500ml% hourly If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ ECG$and$consider$cardiac$monitor$ Capillary \\$within$normal$reference$range$$ <9mmol/L generally signs Urine 250ml/hr% ng$insert$NG$tube$ essential 3%units/hour%when%blood% mmol/L DVT$prophylaxis$ 16$hours$ Replace during see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway 12$hours$ ONCE Phone/refer$for$specialist$diabetes$review$before$discharge INSULIN%RATE% infused MANDATORY $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ time then can Page%2%of%2% Physician patients age 100ml/hr% insulin 9%$to$150$mls/hour$+$KCL$ $table$below ARE ketones !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% $laboratory$blood$glucose AFFIX$PATIENT$LABEL$ Doctor least Score 2hrs$ $\u2022Severe$DKA$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 3hrs$ /within Guidance Lab$glucose c$Ketoacidosis$Care$Pathway$2$$$ 150ml/hr% INFUSION Record$GCS$score$ 20$hours$ situation Undertake >5mmol/L previous see$appendix ng$ control Blood$Glucose$>20$mmol/L$ units/hr Commence$IV$1$litre$Sodium$Chloride$0 Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ J% 4units value Record$SEWS$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un RATE% ketoacidosis increased start once mannitol from pointofcare rapid IT $along$with$IV$insulin$ particularly Record$ KCL Respiratory before SIGNATURE% 9%$replacement$ subcutaneous$insulin$regimen$and$ea G% Check$nger$prick$glucose$hourly$$$$$$1hr$$ 25 risk levels Conrm$pa BOXES ent$data$ow$chart$$ mmHg WBC NOT V2 Testing admission physician%called% 9%% infusion\u2019 \\$normal$ nurse to H+$>$45$or$HCO3 Time$and$sign$ongoing$Sodium$Chloride$0 increase Hydrogen findings %%%%%%%%%%%%%%%%%%%%%%%% SaO2 GCS$ If$blood$glucose$>14$mmol/L$see$appendix$ a$copy$of$the$discharge$summary$ $at$250$mls/hr$un evidence 3$on$venous%gas 0$$4$Hours$Emergency$Management$ Cerebral count $Glargine Heart nue$Sodium$Chloride$0 stage meter E% commencement $Gibb Detemir improving %Consider%Precipita1ng%Factors$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ less 5$$5$mmol/L% with ensure: FLUID% l$Blood$Glucose$<14$mmol/L$ SERIAL%NO% \u2022Check$non\\return$valve$on$pump$ %Immediate%ac1ons% sodium %prescrip1on%sheet$ Insulin 1%or%H+%greater%than%80% hours DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ or suspicion Count hour <20 Review%Potassium% %Management%0%%60%minutes% Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 >20mmol/hour between 6%units/hour% ECG$ and \u2022$Newly$diagnosed$ Time$and$sign$start$of$insulin$ adjusting 20%mmol% 12 Consultant should %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ on$of$pre\\meal$subcutaneous$insulin$ insufficient Presentation 9%$over$1$hour$within$30$minutes$of$admission$ Headaches\u2022 Reduced KCL% up presence \u2022$Infec Consider reasonable BATCH%NO% $capillary$or$urinary$ketones$ in end antibiotics IV appendix Subsequent%Management% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ Reduce$insulin$to$3$units/hour$ Management 100mls started POTASSIUM% $$If$not$available Prescribe$usual$long$ac clinical If$protracted$vomi call Time $Dr$S $\u2022Reduced$conscious$level$ acting functioning Dr Glucose Insulatard correctly CT TIME% $$ APPENDIX$ Do$not$discharge$un equal may PRINT%NAME% Chest$X\\ray$ \u2022\u202fInitially Temperature I% Mental Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Supplementary%notes$ rises c$ Aim:%To$improve$the$acute$management$of$diabe Severe%DKA%=%pH%less%than%7 is glycaemic Time$pathway$started$ status Check$U&Es Date$ syringe :$ \u2022\u202fThe maintain 8mg !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Fluid% D% Glucose%10%% clock $un Unless%discussed%with%ST4%or%above following TYPE%OF%INSULIN% Amendments ketoacidosis$in$adults$aged$16$and$over$ B% ent$s glucose%>14%mmol/L% administered 20% ml/hr If \u2022$Combina Gas litres of not 1%%4%hours Administer ACTRAPID% stop level failure $metabolic$acidosis ga if Reduce$Sodium$Chloride$0 indication use dexamethasone 9%$bag$as:$ maintaining DKA$pa 5$mmol/L Hours$3$&$4:$500mls$Sodium$Chloride$0 renal conscious bicarbonate 5$mmol/L$ monitor Total Deni1on:%Severe$uncontrolled$diabetes$with:$$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "critical ketosis allow appropriate Na+ required hyperglycaemic potassium A+E current Continuing Na overall precipitating severity August management treatment replacement Continue protocol Hyperglycaemic change additional 15 identified K+ Is medical normal screen/foot Hypovolaemia cerebral intravenously high Appendix oedema improving? discussion This mOsmol/kg/hour assess Assessment: at catheterisation eg goals adults evaluation care: disease see page 1L Treat below despite Kg cause range Potassium mmol plasma calculate rate Plasma BP timings Hypothermia urine oncall infection hyperglycaemia ketonaemia rise Ritchie over Urea litre <12 ____________ concentration Aim any ml as comorbidity Oxygen Treatment: fall SEE AFFIX There 20 patient\u2019s State Monitoring Key Sodium <15 HHS ongoing aspects 16 out hrs 10% checkpoints Assess Estimate glucose Chloride Hyperosmolar are no aiming other DKA target falling possible unless aid adequate necessary ischaemia cardiac regular baseline Measure Ensure reducing JBDS falls Osmolality ECG/Sepsis positive 9% alterations 2012 examination for patient gradual hyperosmolar discuss syndrome investigations 10 prepared comorbidities capillary on HCO3 Repeated addition 50% ulcers/ dextrose care arterial THE TEAM guidelines dehydrated Monitor mOsm/kg 38 the Document this more 2448 diabetes urinary note switchboard clinically Calculate units/kg/hour contraindicated be Marked biochemistry chart APPENDIX units considered present 100% The advice 14 In sheet Fluid continues balance prescribe 1: INFORM output Gifford limb 5ml/kg/hr 2x LABEL lactate Calculated consider 2+ infusion blood 92% Diabetic than loss team Biochemistry hour? fluid hourly aims: saturations Urine 2: 30 200 mmol/L DIABETES 23L Creatinine commence Diagnosis alternative patients ONCALL insulin into ketones /10 NB taken LMWH venous acidosis shifts ESSENTIAL Guidance ______________ serious Ketoacidosis precipitant GCS H+ consideration prophylactic IF 45% 160 Commence via rapid senior coexisting KCL accurate significant Markers risk myocardial Hours 1224 mmHg keep concentrations osmolality admission achieved? accordance 45 designed to \u2022Sodium fluids increase urea within 125ml/hr biochemical Ward March Perform above <90 24 Anderson purely based >3L less with response Macrovascular foot calculated sodium hours stroke or been decline hour per Date between and Patients 12 should mOsmol/kg must ONLY measurement presence Consider applicable \u00b5mol/L ability in Footnote: __________ thromboembolic achieve treat IV desired 2020 administration 80 set clinical has ensure sepsis Time Initial call infarction Glucose flow weight tolerate 05 may thrombosis/pressure document is state ______ Systolic determined adapt status 320 acute good estimated review PATIENT that gas hours: hydration Actrapid ALWAYS U&Es greater assessment 40 24hours Hour Adjust If rates of not level ulceration omolality date by 2017 if seek markers usually picture coronary renal staff 350"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "IInnttrraavveennoouuss critical <24 required found eating used Therapy Repeat these Title: which Examples overall measured receive iinn Hannah switching protocol an change suggested develop Page guideline 15mins Draft/Final: Is 116 <5 medical where normal adapted Halve Appendix proportion This always at periods General eg Hypoglycaemia Blood admitted page glucose>10mmol/l Restart IInnssuulliinn Status Stable Rate consecutive Authorisation Treatment range TThheerraappyy 120 rate protocols sensitivity returning emergency Because McNeill It hyperglycaemia Has Lothian diabetic unwell Pancreas charted having over any those have reasons as who added there Intravenous fall starting prescribed There 20 long 8ml/hr 55 Key HHS YES usual 16 standard versus will ill? influences glucose are 360:128397 no other Conventional DKA diabetic? first infusion: unless 5% 112 recovery >100 specify guidance: CCaarree 124mmol/l: 112mmol/l: specifies 1ml/hr Measure ill prescription fallen Ensure INSULIN containing 50ml choice 20mins Authors: 6ml/hr it >20mmol/l All 9% for patient Critically hypoglycaemia QIT Intranet:17/02/20 measure 10 suitable box Some Emergencies >10mmol/ml on variable remains surgery used: made regime recovered <5mmol/l These care USE Comments the Document this more diabetes one 18mmol/l: CRITICAL their re 2014 resume be resistance chart enteral scales they Version: units persistent sensitive The groups: continue advice Most 2009 s/c therapy line Critical dysfunction admissions ml/hour 1: >24 whether same RESISTANT consider thereafter normally infusion blood we transitioned flush Diabetic than inform >14mmol/l: When apply Yes Crit 4ml/hr team ie readings fluid part hourly patients\u2019 relatively method Increase basal >24mmol/l: 2: Many >2mmol/l mmol/L able history individual 114mmol/l: vital commence go time then can patients insulin 9mmol/l into dose Category: when Guidance Control Stop point control previous outcome1 ID: stipulated start Guidelines from resistant et 120mmol/l: active 5ml/hr See without al reason No Rates adjustment Further Protocol Recovering NOT 116mmol/l: Med Care overdose written Keep 18 Once FOR Aline designed to most Go Group drug recommence within CCrriittiiccaall day dependent 11mmol/ml FINAL Ward 3ml/hr Review evidence reading? 124 Increased 24 Editorial 2023 based phase organ with ward Prescription sugar Start need NO monitoring stopped discharge sodium Insulin Date: hours or Check hour per >16mmol/l identify indicated Date and outwith Intensive Patients 12 should TPN CARE feed must Reduced ONLY Summary managed measurement up Give reasonable Simultaneous in difference Please IV appendix 2020 administration initially alongside >4mmol/l ensure Before acting Dr Glucose initiated Kidney 2ml/hr may 100ml Finfer episode Words: CriticalCarPatients is adjusted glycaemic NICESUGAR: Engl Authoriser: chloride kardex >10mmol/l 50units 610mmol/l that otherwise Actrapid ABCD preexisting following requiring elective separate 20% If SENSITIVE Philip critically receiving Call check followed of not group level February transplantation failure by if use NaCl Standard SKP Guideline 510mmol/l staff form"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "daily monitoring Date: normal/immunocompromised Fiona hours Herpes Issue function or Trotman Flucloxacillin Anidulafungin ideal PCP Fluconazole obese meropenem indications: Day Date maintenance every Database 2g and Clinical Benzylpenicillin Title: immunocompromised 12 Teicoplanin first dosing CARE jiroveci IN For IV: 2005 Aztreonam Ceftazidime: severity ONLY 250mg Antimicrobial 72 www replacement treatment Consider third 13 zoster/varicella Metronidazole Clarke Pneumocystis Clarithromycin Ciprofloxacin: in ill encephalitis reducing Authoriser 500750mg depending Varicella courses guideline 2020 Draft/Final: Meropenem then com normal 60mg/kg patients dose Authors: 600mg although Days prolonged Words Category: for patient Cotrimoxazole three either Final IV/ORAL: 5g QIT Cefuroxime: simplex Coamoxiclav Aciclovir: intravenous pneumonia CVVHD weight 1g Use Levofloxacin: zoster/Herpes Temocillin six Rifampicin renaldrugdatabase on ID: Status 50% vancomycin Horl IV/Oral: Guidelines doses times loading et is continuous 500mg 5mg/kg eight Treatment body USE Thalhammer Comments zoster Vancomycin 2021 Renal deterioration 1500mg twice Document See al levels one note CRITICAL infection Antibiotic mg 39 return Linezolid Lothian November therapeutic Care Infectious Pharmacokinetics Other FOR onwards 30mg/kg Vol any Caspofungin The to critically receiving as 2771279 of added 400mg Group 10mg/kg Drug therapy February Ceftriaxone drug Clindamycin failure day Critical adult iv if p11591166 Review days Key 24 Version 41 References Accessed Dose consider given Amoxicillin renal Editorial intranet: thereafter 2023 infusion with Oral: usual LFTs Loading Piperacillin/tazobactam turnaround Authorisation: Diseases"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "decisions Page\u00a0|\u00a06 Radcl No\u00a0info :\u00a02741\u2010 appropriate expectancy Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex SPC inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective used Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight 1997 correction which Acknow report Information\u00a0from\u00a0guidelines: nuary\u00a02013 proposed hepatic\u00a0insufficiency Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects to\u00a0allow xtrem Second\u00a0edition\u00a0update Jarrett\u00a0R >30kg/m2 parameters The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Page\u00a0|\u00a038 about clinical\u00a0trials Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti iffe\u00a0Publishing Anaesthesia\u00a02011 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga given\u00a0onc Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in certain 212 Barie\u00a0PS Flagyl\u00ae who\u00a0each\u00a0received pdf This By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin western uk at Roberts\u00a0MS\u00a0et\u00a0al edition Patients\u00a0less\u00a0than bd until both underweight No\u00a0specific\u00a0information\u00a0available MIC\u00a0of\u00a01mg/ml Pharmacokinet\u00a02010:\u00a049 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Allard\u00a0S\u00a0et\u00a0al A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Intravenous\u00a0cipr d\u00a0literature\u00a0from\u00a0manufacturer uk\u00a06th\u00a0September\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal range re\u00a0is\u00a0limited\u00a0e Klaricid\u00ae Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly little 66%\u00a0of\u00a0those\u00a0reported blockade Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose It treatme ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose meta\u2010analysis No\u00a0information March\u00a02013\u00a057 numb Suggest\u00a04 have Zentiva immunoglobulin\u00a0use2 In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Body\u00a0Weight Intravenous No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Rodvold\u00a0K medicines complex prescribed 12hours edited\u00a0for\u00a0Scotland mmended\u00a0dose\u00a0is\u00a04 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended taking Dose No\u00a0advice Hollenstein\u00a0UM\u00a0et\u00a0al UK Addie lactam 20mg/kg out Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained monographs\u00a0in\u00a0future\u00a0editions ves for\u00a05\u00a0to\u00a014\u00a0days Buchwald\u00a0H Halovic Department\u00a0of\u00a0Health Page\u00a0|\u00a033 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 ukcpa In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 3rd\u00a0edition equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Micromedex tds present\u00a0day There\u00a0is\u00a0a\u00a0sing height\u00a0in\u00a0inches\u00a0\u00a060 necessary aureus tions gents\u00a0Chemother kg treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours d\u00a0with\u00a0cellulitis No\u00a0dosing\u00a0advice\u00a0found children clinical\u00a0judgement but Danesi :634\u201049 Tejani\u00a0AM\u00a0et\u00a0al patients\u00a0receiv produced Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Martin\u00a0C it Lisco\u00a0S eed effects assumed Ashley\u00a0C Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Glasgow neous &\u00a0Currie Infections:\u00a02\u20104g\u00a0daily No\u00a0adv bacterial\u00a0vaginosis 10 216\u00a0x\u00a0BMI is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar 90 appear\u00a0to in\u00a0criticall however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe very\u00a012 x\u00a0TBW ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours MIC90s there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Itokazu\u00a0G Predicted pharmacokinetics 90mg/kg would therefore Mycoses\u00a054 volunteers at\u00a0www Bearden\u00a0DT piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the more Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le BNF in\u00a0excess\u00a0of\u00a00 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Roberts\u00a0JA 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection be exceed 14th\u00a0June\u00a02013 considered January\u00a02013 No\u00a0advice\u00a0on Female= Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General The No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight equations Aguirre\u00a0C to\u00a0es Dosing\u00a0for\u00a0penicillins initial to\u00a03 keith No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Sanofi toxicity 25:233\u2010237 direct Characteristics\u00a0Accessed\u00a0\u00a0at adult 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Body\u00a0W pathogen 41 but\u00a0a\u00a0value\u00a0of\u00a00 consider prophylaxis ice\u00a0on\u00a0obese\u00a0patients 200mg\u00a0every\u00a012\u00a0hours 2` No\u00a0spe be\u00a0different Voricoonazole Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Gla s\u00a0clinical\u00a0response Ja 2006 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Page\u00a0|\u00a018 Ciproxin\u00ae\u00a0\u00a0Bayer BMI\u00a048 e\u00a0patients UKCPA: 37 a\u00a0mg/kg\u00a0basis 56 Pineda\u00a0LA Benzylpenicillin Abernethy\u00a0DR hospitalised pharmacodynamics as\u00a0required 30 formation and\u00a0cutane 13 BiaxinTM\u00a0US\u00a0Product\u00a0Information and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Page\u00a0|\u00a019 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network abstract Continuous\u00a0versus\u00a0intermitte Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Page\u00a0|\u00a03 IL No\u00a0strong\u00a0evidence J\u00a0Antimicrob\u00a0Chemother on\u00a0drug\u00a0handling gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Page\u00a0|\u00a04 then 4\u00a0is The\u00a0area\u00a0un patients Ceftriaxone/Cefalosporins Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Van Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients 600mg guided\u00a0by\u00a0the\u00a0severity Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed when a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Page\u00a0|\u00a043 They\u00a0also\u00a0noted y\u00a0ill\u00a0patients Pfizer\u00a0Ltd likely No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Dillmans\u00a0B for\u00a0any\u00a0patient\u00a0or total\u00a0body\u00a0weight\u2010IBW Actual\u00a0Body\u00a0Weigh the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Maint start preference health Summary\u00a0of\u00a0Product\u00a0Characteri Contents Slight Ideal Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ trials der\u00a0the significant No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials e\u00a0in\u00a0Scotland without Diflucan\u00ae Currie\u00a0A cefalosporins saying complicated outcom altering Dosage British\u00a0National\u00a0Formulary\u00a065 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Radcliffe Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on serum reported stature =IBW\u00a0+\u00a020% 6680\u00a0+ Summary/ within Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised 8g\u00a0daily\u00a0have\u00a0been\u00a0used urs disagr Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno linezoli weights uk\u00a012th\u00a0March\u00a02013 Yorst\u00a0RL No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Van\u00a0Zanten\u00a0ARH mo Pharmacy The\u00a0follow Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri based Cefamandole\u00a0distribution\u00a0in\u00a0serum Page\u00a0|\u00a047 Maximum\u00a0Body\u00a0Weight higher Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit See\u00a0benzylpeniclli :2546\u20102553 :75/121 33\u00a0x Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati treatment\u00a0ranges 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Underweigh contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date nt\u2019s\u00a0renal Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Rifadin\u00ae Clinical and 12 Patients Yet Mass\u00a0Index both\u00a0IV\u00a0and\u00a0oral ccessed\u00a0\u00a0at replies in\u00a0Obese\u00a0patients extremes\u00a0of\u00a0body 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function approximately including\u00a0diabetes\u00a0and\u00a0hypertension abscess Email\u00a0received end Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 2013 ertapenem ME achieve body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation armacology the\u00a0higher\u00a0dose Adults\u00a0and\u00a0adolescents Page\u00a0|\u00a029 Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily 3\u00a0x An\u00a0Updated\u00a0Critical\u00a0Review 51 Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients 89\u00a0x ensure 5g The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice accessed\u00a07 every\u00a012\u00a0hours Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement 1g AdjBW licable may =\u00a045 cin ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole is Cook\u00a0AM By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily compromised\u00a0patients\u00a0or 22 8:189\u2010194 rer2 Increased\u00a0dose Free in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we adipose recurrence Pfizer maintain tables available\u00a0on\u00a0modification\u00a0of\u00a0dosage average or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 0242 clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in lower mg/kg\u00a0once\u00a0daily Arch least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium 40 uct\u00a0Characteristics up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses States Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Page\u00a0|\u00a032 as\u00a0relevant 66:\u00a0721\u00a0\u2010\u00a0725 connection Mastrobattista\u00a0JM for\u00a0the In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients first\u00a024\u00a0hours Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial negative alters companied\u00a0by\u00a0hepatic Accessed\u00a07th\u00a0June\u00a02013 three\u00a0or\u00a0four\u00a0divided\u00a0doses KG/m2 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily 2747 take to\u00a0account El\u00a0Sohl\u00a0AA Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth 25:\u00a0112\u20108 argued\u00a0th Severe No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Dvorchick\u00a0BH Suppl\u00a01 DiBaisio\u00a0A beta ous Chen\u00a0LG No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients suicide Abbreviation concentration\u2010 expected No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in BMI Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight orations Septrin\u00ae Page\u00a0|\u00a015 intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Daptomycin Use\u00a0actual endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Working\u00a0Group 4th\u00a0December\u00a02012 t\u00a0patients Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis nction with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Page\u00a0|\u00a025 5Hollenstein replacement treatment Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight considerably an ation ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 suggested weigh 15 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Use\u00a0standard\u00a0dosing 600mg\u00a0to\u00a03600mg\u00a0daily com Malacarne rep inclusion ght\u00a0patients One \u201056 either 4\u00a0+ Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 The\u00a0renal\u00a0drug\u00a0handbook Mass Suppl\u00a0S2 staphylococci alone Ed an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients st at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach hepatic Underweight\u00a0patients Page\u00a0|\u00a05 ary Page\u00a0|\u00a09 Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients oxacillin ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling philic attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Meronem\u00ae Erstad\u00a0B No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Licensed\u00a0dose\u00a0in Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man continuous height May\u00a02013 appear Ulldemolins\u00a0M rate careful available\u00a0from\u00a0manufacturer Underweight\u00a0patien Lean Nafziger\u00a0AN and\u00a0vi clear so\u00a0that\u00a0the\u00a0information 2011 002 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Modified Linezolid seen org Western le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully mation\u00a0more\u00a0readily The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha and\u00a0Del\u00a0Tacca obese\u00a0patients Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese :3240 as Principal\u00a0Pharmacist 400mg =\u00a0IBW\u00a0+ ese\u00a0patients :\u00a0MIC\u00a0ratio guidance case Klebanoff\u00a0MA 20 There Crystapen\u00ae however\u00a0a\u00a02013 clinical\u00a0trial Continuous Antimicrob ide 55 patient\u2019s Hospital References GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department recommendations BSA Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity standard Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap 285 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation prevalent assessed\u00a0against\u00a0a\u00a0target of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Calc gories no other ht\u00a0patients using\u00a0IBW\u00a0+ Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Dosing\u00a0in\u00a0E Johnson\u00a0M cystic trial BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Oxford\u00a02009 Page\u00a0|\u00a010 A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on 25\u00a0to\u00a00 hts\u00a0used\u00a0in reduced mass Base Purkin\u00a0L\u00a0et\u00a0al 20:869\u2010873 Voriconazole 67:2957\u20102692 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% herpes\u00a0encephalitis Meropenem Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital in\u00a0non\u2010pregnant\u00a0women\u00a03 account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Page\u00a0|\u00a031 Orion\u00a0Pharm scot Page\u00a0|\u00a039 ufacturer non\u2010obese regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly All Anaesthesia\u00a02012 r\u00a0use Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity standar Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Aciclovir 150kg 9270\u00a0x\u00a0TBW Child Levofloxacin 1st\u00a0Edition Page\u00a0|\u00a011 erefore\u00a0it\u00a0was\u00a0thought the\u00a0excess\u00a0in\u00a0body\u00a0weight4 The\u00a0only\u00a0documen *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Grau\u00a0S AUC Aspen\u00a0Global analysis ciprofloxacin nt\u00a0infusions\u00a0of\u00a0antibiotics Rifampicin ex compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Norenberg\u00a0JP 27 For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections increased\u00a0serum\u00a0drug Curr\u00a0Fungal\u00a0Infect Ciprofloxacin so\u00a0may\u00a0negate\u00a0this a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Summary\u00a0of\u00a0Product\u00a0Characteristics EBW eight Page\u00a0|\u00a012 5g\u00a0every\u00a08\u00a0hrs Correction\u00a0Factor Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose DWCF*x\u00a0EBW 5kg Bogaert\u00a0T\u00a0et\u00a0al 3% Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Summary\u00a0of\u00a0Prod 90S Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Greenblatt\u00a0DJ ccessed\u00a0at\u00a0www Acinebac 65:128\u2010134 :\u00a0944\u20106 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% therapeutic 6\u00a0mg/kg\u00a0once\u00a0daily consequently on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Single particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec :\u00a0468\u2010471 suggest Summary\u00a0of\u00a0Produc Underweig Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July continue 2009 Author\u00a0suggests Mean therapy information Clindamycin on\u00a0underweight\u00a0or\u00a0obese\u00a0patients June\u00a02013 Page\u00a0|\u00a026 s\u00a0response pital iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients ce Oxford Ruiz\u2010Irastorza\u00a0G This\u00a0docum initial\u00a0infusion\u00a0rate\u00a0of Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise ho ently Wang\u00a0E thecochranelibrary Neurol\u00a01985 International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients 2g\u00a0in\u00a0two we or\u00a0vecuronium\u00a0induced\u00a0blockade Clinical\u00a0Infectious\u00a0Diseases if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at FFM mg/kg attainment timate\u00a0the\u00a0fractional will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome worse of\u00a0piperacillin Adjusted\u00a0Body\u00a0Weight Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Cmax/MIC Page\u00a0|\u00a02 Page\u00a0|\u00a021 specific The\u00a0Cochrane\u00a0Library\u00a02013 lists Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Therapeutic\u00a0Drug\u00a0Monitoring1986 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily dosing nt\u00a0ranges method J\u00a0crit\u00a0care\u00a02008 Greenock generally including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in 29th\u00a0May\u00a02013 ulate\u00a0dose volume were ous\u00a0abscess individual organisms America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 depending\u00a0on\u00a0the\u00a0patient As commence Acknowledgements and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC By\u00a0intravenous\u00a0infusion into tti especially Accessed\u00a0at\u00a0www wound 100mg\u00a0twice\u00a0daily Slain\u00a0D Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR fluconazole Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC =\u00a050\u00a0+ 12g Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer relevant 23 Luque\u00a0S uk\u00a026th\u00a0June\u00a02013 ly\u00a0approximate Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault peak increased so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro et 1144\u201049 Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital TBW\u00a0x\u00a0BMI\u00a0x\u00a00 frail Antimicrob\u00a0Chemother\u00a02012 Suggest Hurford\u00a0W Kilmarnock did A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Ideal\u00a0Body\u00a0Weight MIC lack single failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on adjustment Further Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients March\u00a02013 th concentrations Chen oth\u00a0IV\u00a0and\u00a0oral trough Total\u00a0Body\u00a0Weight Phase\u00a03\u00a0data\u00a0showed\u00a0we treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections steady com/pdf/biapi p634\u00a0\u2010\u00a0649 6%\u00a0and\u00a049 /Comments %T>MIC http://www factor morbidity Tigecycline\u00a0has accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Page\u00a0|\u00a016 Cochrane Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested be\u00a0used drug intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based dependent ABW obese\u00a0pat 29 0183 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm ure showed edicines authors ents Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Wt suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above although\u00a0mg/kg\u00a0dosing\u00a0could antifungal\u00a0agent with *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor December\u00a016\u201019 Phenytoin\u00a0disposition\u00a0in\u00a0obesity ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients et\u00a0al though years after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours USA Paper 4mg/kg per Page\u00a0|\u00a022 impact women Pharmacia\u00a0Ltd Body\u00a0Surface\u00a0Area should 0mg uk\u00a0accessed Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Doses\u00a0doubled\u00a0where\u00a0necessary 0\u00a0mg/kg Antimicrobial\u00a0Dosing Ciprofloxacin\u00a0pharmacok Bridion\u00ae Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 s\u00a0o ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to antibiotics Much Page\u00a0|\u00a017 cific\u00a0information\u00a0available 200mg\u00a0twice\u00a0daily outcomes Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Titrate\u00a0dose\u00a0according\u00a0to\u00a0response failure\u00a0if\u00a0they\u00a0w 17 Inadequate Strong MBW For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased :1023\u20101026 Fluconazole\u00a0serum\u00a0concentrations\u00a0and =45 The\u00a0recommended\u00a0dose\u00a0for is\u00a0rarely\u00a0used\u00a0for\u00a0dosing haemofiltration\u00a0or\u00a0nutritional\u00a0requirements values issue CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu weight clindamycin September\u00a02013 Victoria\u00a0Hospital\u00a0Kirkcaldy Van\u00a0Zanten\u00a0et as\u00a0relev Pharmacotherapy\u00a01995 loading r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Damphousse\u00a0D distribution flucytosine Calculate\u00a0dose\u00a0determining\u00a0weight the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended nor amphoteri 74% Sugammadex Alan\u00a0Timmins 3It\u00a0has Formula bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Phenytoin Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook bod Wurtz\u00a0R after\u00a0first\u00a024\u00a0hours however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at liffe\u00a0Publishing from\u00a0considering\u00a0dosing\u00a0in\u00a0children two prov evolve Barreiro\u00a0G Day\u00a01 requiring\u00a0more\u00a0aggressive\u00a0therapy separate Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information critically body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non essed\u00a0via of Curr\u00a0Opin\u00a0In It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Summa Drug Shiu\u00a0J fu Summary\u00a0of\u00a0SA Serious\u00a0infections:\u00a0600mg\u20101 statistical Pharmacology/\u00a0kinetics administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight uk\u00a0\u00a08th\u00a0April\u00a02013 usually fewer water\u2010soluble howeve Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases renal sive\u00a0care\u00a0unit\u00a0setting trimethoprim that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Pai\u00a0MP SAnofi\u00a0Avensis 5g\u00a0every\u00a06\u00a0hrs lipophilic make Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate required found The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer TBW\u00a0x\u00a01 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Vfend\u00ae ataxia\u00a0and\u00a0slight\u00a0disorientation Earle\u00a0SB When\u00a0using\u00a0IBW su which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Personal\u00a0communication available infections meropene Please\u00a0send\u00a0any\u00a0new Maintenance\u00a0Dose recommends daptomycin This\u00a0is\u00a0sometimes\u00a0refe micromedexsolutions Immunoglobulin disp obesity Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese pharmacokinetics\u00a0of\u00a0daptomycin v1 Summary/Comm clearance mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and high 0\u00a0x\u00a0TBW proportion Clinical\u00a0Infectious attempts/accidental in\u00a0morbidly\u00a0obese\u00a0patients Journal\u00a0of\u00a0Clinical\u00a0Ph dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of penicillins s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects so some >100kg\u00a0and tissue data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight may\u00a0reduce adults atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Luque increased\u00a0fluconazole\u00a0clearance overdosages 42 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded 44 No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients response\u00a0to\u00a0bac Body Epanutin\u00ae Itozaku\u00a0G No\u00a0specific\u00a0do Page\u00a0|\u00a036 effect Pfizer\u00a0does\u00a0not more\u00a0than\u00a0IBW Pharmacotherapy\u00a01997 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook doubled Dexmedetomidine er\u00a02012 Wt/\u00a0height and\u00a04mg/ml\u00a0were\u00a078 Fat taking\u00a0into\u00a0account\u00a0patie pneumoniae Page\u00a0|\u00a035 common Obesity Rocephin\u00aeRoche obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th however there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue concentration supratherapeutic any Derendorf\u00a0H eutic\u00a0drug\u00a0monitoring those No\u00a0inform different\u00a0from\u00a0those 11th adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital cellulitis starting erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer rmation true skin Issues\u00a0of\u00a0\u00a0Linezolid Dundee Invanz\u00ae infusions Rifmpicin Critically\u00a0ill\u00a0Patients Pharmacok :354\u2010358 Page\u00a0|\u00a07 those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were will t\u00a0Characteristics Page\u00a0|\u00a08 voriconazole rred\u00a0to\u00a0as\u00a0the\u00a0Actual running 2\u00a0to\u00a01 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Fat\u00a0Free\u00a0Mass rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Am\u00a0L\u00a0Perinatol\u00a02008 are and\u00a04\u00a0\u00a05\u00a0mg/kg/dose bgroup manufacturer: Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the 6mg/kg at\u00a0least\u00a01\u20102\u00a0post\u2010 www study drug\u00a0handbook Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on morbidly\u00a0obese\u00a0patients sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case as\u00a0above Male= Pat The\u00a0Renal\u00a0Drug\u00a0Handbook uk\u00a012th\u00a0July\u00a02013 <5mg/kg making hrly Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena gender Senior\u00a0Clinical\u00a0Pharmacist Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Chen\u00a0M process 112\u2010118 Genus\u00a0Pharmaceuticals underweight\u00a0or\u00a0obese\u00a0patients for aminoglycosides patient haematologic 15:251\u20103 The\u00a0renal\u00a0drug limited st\u00a0\u00a0Edition and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided individuals Page\u00a0|\u00a042 cohort Strep Morag\u00a0Naysmith DDW nhs 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft airment Co\u2010Trimoxazole remains adjustm followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter uk\u00a017th\u00a0July\u00a02013 cohort\u00a0study Comments recommended guidelines http://clinicaltrials Association difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects pharmacodynamic Ltd\u00a04th\u00a0December\u00a02012 Janson\u00a0B utcomes\u00a0which\u00a0may\u00a0occur\u00a0as handbook\u00a0as\u00a0relevant becoming 2g\u00a03 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients had 39 overweight Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Weig included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above BMI>40 they see\u00a0below and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe susceptible Ra Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Papasavas\u00a0P\u00a0K Dosing\u00a0based\u00a0on Page\u00a0|\u00a014 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Di\u00a0Paolo ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Critical Amphotericin and\u00a0little\u00a0observed\u00a0toxicity Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad adjustments Montpelier handbook infusion as\u00a0per\u00a0SPC 75 ospital terial\u00a0vaginosis\u00a0in\u00a0pregnancy Maximum\u00a0Body\u00a0We daily life dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Anderson\u00a0T\u00a0et\u00a0al actual\u00a0body\u00a0weight In\u00a0life\u00a0threatening and\u00a0Pharmaceutical\u00a0Press Page\u00a0|\u00a013 50kg\u00a0if\u00a0neutropenic 5\u00a0if\u00a0male amphotericin Page\u00a0|\u00a020 research filtration route Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a normal\u2010weight principles Many\u00a0Thanks 2012\u00a0Dec l\u00a0drug\u00a0handbook inetics\u00a0of\u00a0intravenous\u00a0levofloxacin The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Dalacin\u00a0C\u00a0Phosphate\u00ae mortality\u00a0in\u00a0ICU1 dose particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Current\u00a0Opinion\u00a0Infectious\u00a0Disease Halilovic\u00a0J 439\u2010447 added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Body\u00a0Mass\u00a0Index but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Wurz only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised piperacillin/tazobactam 23rd\u00a0November\u00a02012 PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation intra\u2010abdominal height\u00a0and\u00a0weight Radc BMI>18 value Zovirax\u00ae IBW\u00a0for\u00a0males contained\u00a0within\u00a0this information\u00a0contained\u00a0in\u00a0this\u00a0doc consequ uk\u00a029th\u00a0May\u00a02013 patients\u00a0under\u00a040kg\u00a0or Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with 25:634\u2010649 Summary\u00a0of\u00a0SACCPN\u00a0lit compared twice Keith different al levels risk uk\u00a08th\u00a0February\u00a02013 =\u00a0\u221a mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Antimicrobial\u00a0Agents\u00a0and so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes The\u00a0renal in\u00a0in\u00a0moderately\u00a0obese Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Int\u00a0J\u00a0Obes\u00a02001 152 18 theory with\u00a0normal\u00a0weight\u00a0patients per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis ce\u00a0versa Obtained\u00a0from\u00a0www aracteristics lean Indications\u00a0fo Koselke sed\u00a0at Personal\u00a0correspondence\u00a0with\u00a0Abbott ICAAC As\u00a0above Martyn\u00a0Gall =TBW\u00a0\u00a0IBW 2nd\u00a0January\u00a02013 ofloxacin\u00a0disposition\u00a0in\u00a0obesity 54 ww suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based treated iaxone Information\u00a0from Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Review evidence coagulase mary give sgow Victoria\u00a0Infirmary bodyweight Van\u00a0Lancker\u00a0P Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Licensed with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C monitoring calculated ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the severe Larbert or Anidulafungin suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Tazocin\u00ae or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook CRRT 1\u00a0x\u00a0height suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in maintained substitute Page\u00a0|\u00a023 Page\u00a0|\u00a01 Scottish Summary Antimicrobial Phase up 30:18\u201032 fibrosis Metronidazole =\u00a0IBW\u00a0+\u00a00 orption nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical with\u00a0the Clarithromycin investigating 28 regimen Accessed\u00a015th\u00a0May\u00a02013 IV However\u00a0they C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 excess\u00a0weight\u00a0over\u00a0IBW obtained 36:\u00a0\u00a0p151\u2010158 desired cuta Summary\u00a0of\u00a0SAC Usual\u00a0reco Obese\u00a0patients cutaneous Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary in\u00a0adults \u226440kg Clinical\u00a0Infectious\u00a0Diseases\u00a01997 world reported\u00a0as24g/day\u00a0N clinical is\u00a0the\u00a0weight\u00a0as\u00a0measured association no\u00a0da e\u00a0daily\u00a0by\u00a0the\u00a0intravenous since formula V\u00a01 subgroup on\u00a0the\u00a0rate\u00a0of\u00a0its Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital recommendation while Normal :708 mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used future 1\u00a0gram particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections studies vels\u00a0are\u00a0obtained High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia intraven therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 document cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and adjusted state 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Page\u00a0|\u00a037 adequate\u00a0concentrations ons weight\u00a0in United\u00a0Kingdom No\u00a0informati CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for 5g\u00a06\u00a0hrly Benzylpenicllin An Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity review 36:332\u201039 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces piperacillin eight\u00a0patients Summary\u00a0of\u00a0\u00a0product\u00a0characteristics generations Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into t\u00a0half\u00a0life\u00a0of\u00a0Meropenem dcliffe\u00a0Publishing Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital TBW\u00a0x\u00a00 provide Pharmacological cSSTI*\u00a0without\u00a0S Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Page\u00a0|\u00a040 Tigecycline editions 738 No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man not group pharmacokinetic Radcliffe\u00a0Publishing Koselke\u00a0et\u00a0al if Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Literature\u00a0descri use 25:1 25:\u00a0634\u2010649 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to cm 45: centres Tishier\u00a0D\u00a0S Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 fect\u00a0Dis Critical\u00a0Care\u00a0Medicine data function ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Summary\u00a0of\u00a0product\u00a0cha nline\u00a09 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature No\u00a0specific\u00a0\u00a0advice\u00a0available recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation facturer The\u00a0effect\u00a0of\u00a0body\u00a0m 67:\u00a0682 account *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Clydebank 2005 anufacturer3 PTC for\u00a0organisms\u00a0with\u00a0an infusions\u00a0of\u00a0antibiotics the\u00a0two Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S extremes adjustment\u00a0for\u00a0renal\u00a0impairment 48 5\u00a0+ aureus\u00a0bacteraemia Gilead\u00a0Sciences\u00a0Ltd alan Calculate\u00a0ideal\u00a0body outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Gillum\u00a0JG 25:112\u20108 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw but\u00a0there\u00a0is\u00a0currently identified Dosing\u00a0as\u00a0above mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used normal February\u00a02013 and\u00a0increased\u00a0stepwise stated where effectively on\u00a0available Underw 422\u2010430 +4 Page\u00a0|\u00a041 however\u00a0no\u00a0liability\u00a0can\u00a0be site\u00a0of\u00a0the\u00a0infection subsequent adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients ry Cubicin\u00ae Pieracci\u00a0FM Kingdom corp hydrophilic ay Introduction guidan Acc results times 5\u00b5g/ml /\u00a03600 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Dexdor\u00ae insufficiency uk\u00a01st\u00a0August\u00a02013 plasma Loading\u00a0Dose ventilatory\u00a0parameters ents\u00a040kg\u00a0and +40% practitioners addie@ggc improved ceftriaxone Underwei subjects morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Publishing Obes 35 cefamandole Predicted\u00a0Normal\u00a0Weight Page\u00a0|\u00a044 fact 11 Pharmacokinetics\u00a0of when\u00a0prescribing\u00a0ertapenem administered\u00a0to\u00a0normal\u00a0weight 2008 who of\u00a01 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves there low provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Abbott\u00a0Laboratories on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients racteristics Chemotherapy ts receivin constant surge bacteraemia They Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Tygacil\u00ae in\u00a0adult\u00a0patients\u00a0given pro >20% except However n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity widely Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Loading collation oral manufacturer Introduction\u00a0to\u00a01 performed normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose pregnan See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice for\u00a0adults sed phenytoin\u00a0levels determination\u00a0of\u00a0loading\u00a0dose Flucloxacillin practice Drusano\u00a0GL upper EB ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a 33 every 43 IBW\u00a0for\u00a0females For on\u00a0patient\u00a0weight currently 50 area P=0 112 However\u00a0complications\u00a0of\u00a0obesity 4mg/kg\u00a0twice\u00a0daily adequate Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital rxabbott the\u00a0treatment\u00a0of\u00a0trichomoniasis ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date relates supported ill was Zyvox\u00ae Page\u00a0|\u00a028 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Adult Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose PNW Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of 800mg 40kg* Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 2012 Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use 46 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation The\u00a0higher\u00a0dose\u00a0was\u00a0at For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 ant Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Diseases\u00a01997 increasingly SACCPN Some Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose effort Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly on Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases 25\u00b5g/ml: soft comparable Journal\u00a0of\u00a0Infection\u00a02012 fat\u00a0mass made female es descriptors\u00a0for\u00a0drug No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Lean\u00a0Body\u00a0Weight does they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references net following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced ratio basis severe\u00a0infections\u00a02\u20104g the following\u00a0weight\u2010adjusted\u00a0dosing this provided actual morbidly Dosing glomerular monly uk\u00a027th\u00a0June\u00a02013 relative Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight context Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines assessing Pharmacists\u00a0Network 14 <10mg/kg ing\u00a0methods\u00a0have often retrospective Ceftriaxone In Male\u00a0and\u00a0Female\u00a0Subjects Wolff\u00a0F\u00a0et\u00a0al Radcliffe\u00a0publishing 74\u00a0x\u00a0height r\u00a0that\u00a0metabolism\u00a0is in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part tion Accessed and\u00a0the\u00a0patient not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Summary/Comment ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered similar side was\u00a0used uk\u00a019th\u00a0July\u00a02013 than sufficient variation better 2\u20104g Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose 4As obese Metronidazole\u00a0monograph \u2010ideal We\u00a0hope\u00a0that\u00a0you 31 Due\u00a0to\u00a0the\u00a0shor vide 927 noted 5\u00a0I should\u00a0be\u00a0used BMI>35kg/m2 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte periences daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Mann\u00a0HJ pieces informed tetanic\u00a0counts A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function during IBW include\u00a0more Summary\u00a0of\u00a0SACCPN\u00a0li maximum muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients pneumocystis ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa severe\u00a0infections The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum body\u00a0weight can Senior\u00a0Pharmacist Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Page\u00a0|\u00a045 LBW Descriptor Children3 Page\u00a0|\u00a046 taken United Lavoie\u00a0S\u00a0et\u00a0al McConnell\u00a0DB\u00a0et\u00a0al Use\u00a0total\u00a0body\u00a0weight demonstrated Ob lays 15th\u00a0April\u00a02013 max drugs Page\u00a0|\u00a027 No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage been\u00a0used Every 287 pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient previous pneumonia >100kg\u00a0and\u00a0BM ed\u00a0to\u00a0obese\u00a0subjects overall\u00a0effect\u00a0however 57 plus Oral :\u00a01222\u20101227 using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in evaluate discussed Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A from doses Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer relating Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Intensive\u00a0Care\u00a0Medicine\u00a02004 body to\u00a0single Loading\u00a0dose app 34:\u00a0p1796\u20101804 Clin document: work particularly Summary/Comments ients Local intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance 25 timmins@nhs a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Lancker No /\u00a08780\u00a0+ ight Pfizer\u00a0Medical\u00a0Information er achie ication Care rmation\u00a0available Tavanic\u00ae 131 when\u00a0compared However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Piperacillin/Tazobactam Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd 45 Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir to most Group April\u00a02013 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Ertapenem regimens 66 Brown\u00a0J useful Alison\u00a0Bell Background Drug\u00a0Dosing\u00a0Information Wurz\u00a0R and\u00a0some\u00a0fluid 24 above popula ledgments Summary\u00a0of\u00a0product\u00a0characteristics carried Australia stics\u00a0Accessed\u00a0at Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Page\u00a0|\u00a030 Maximum\u00a0reported\u00a0dose North\u00a0Chicago Paisley This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat hours Accessed\u00a0at enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Fluconazole been Ambisome Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Page\u00a0|\u00a034 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil between Accessed\u00a0at\u00a0\u00a0www Keith\u00a0Addie erature\u00a0from\u00a0manufacturer3 368\u2010373 Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins 7th extremities July\u00a02012 divided dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours product C\u00a0max Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Excess\u00a0Body\u00a0Weight Ambisome\u00ae in influence and\u00a0morbidly\u00a0obese\u00a0adults tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people specialist literat GFR Personal\u00a0Communication TBW CMax\u00a058%\u00a0and\u00a0AUC total divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind accounted No\u00a0information\u00a0available BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Carey\u00a0JC Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an GlaxoSmithKline\u00a0Ltd 244\u00a0x\u00a0BMI has Orion\u00a0contacted See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Weight erature\u00a0from\u00a0manufacturer Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted 13\u201017\u00a0years\u00a0of\u00a0age exception\u00a0of\u00a0o Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Clin\u00a0Pharmacol\u00a0Ther\u00a01993 No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Heintz Summary\u00a0of\u00a0SACC 11th\u00a0January\u00a02013 Essentially\u00a0this\u00a0me tissue\u00a0infections\u00a0in\u00a0obese Dose\u00a0as I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and dose\u00a020mg\u00a0of\u00a0trimethoprim dose\u00a0based\u00a0on\u00a0indication Taccone\u00a0FS Bhalodi\u00a0A\u00a0A decision ass\u00a0index\u00a0on\u00a0therapeutic comparing Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu ry\u00a0of\u00a0product\u00a0cha non Ecalta\u00ae determined Hites\u00a0M Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 vid 67:\u00a0298\u00a0\u00a0299 or\u00a0Alan\u00a0Timmins higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 good No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc manda Washington\u00a0DC that order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although abs male :1653\u20104 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole s* Agents\u00a0and\u00a0Chemotherapy\u00a02006 Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients receiving Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases 5:83\u201091 followed s\u00a0of\u00a0cefamandole in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor effect\u00a0in\u00a0all\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Page\u00a0|\u00a024 Thursky\u00a0K RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S It\u00a0is\u00a0also\u00a0recommended\u00a0that by Senior\u00a0Pharmacist\u00a0Southern\u00a0General 10\u201015\u00a0mg/kg as\u00a0does\u00a0the\u00a0o Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients indication ve\u00a0good\u00a0clinical\u00a0results has\u00a0no\u00a0influence Analysis Akinnusi Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients It\u00a0is\u00a0hoped\u00a0to Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients 2\u20109 Gilead Melrose Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by /tazobactam 6kg t\u00a0Characteristics\u00a0Accessed levofloxacin 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Neally sodium 80mg Date: DJ access hours depends stable Stability required or ADMINISTRATION: Do uk/IVGuideDisplay Absence glucose temperature Olsen titrated Physically 58 1997 Date which fluid and Title: Micromedex TL TE Ampoules Technology August 5% ONLY strength 2004 catheter www development volume micromedexsolutions Words/comments Inotropic peripheral Agents PDA in but ill 500ml infused IV STABILITY: micrograms/ml containing nitroglycerin 05/08/19 com anaphylaxis insertion Remove patients dose Authors: 80 HH Category: 160mg venous 9% Peddicord Pharm 2012 for AND Volumes Dec vasoconstriction Final has hydrochloride Media STANDARD INFUSION UKCPA dopamine Closely uk QIT at large through Glucose KM degree established prepared ADDITIONAL Warner Journal guide https://medusa until Intranet:18/10/19 07/08/19 bnf Quadruple 100ml INTRAVENOUS may nhs 160micrograms/ml 010 on variable ID: central Strength adrenaline Status Kristensen phlebitis below from Am Authorisation DOSE Trissel\u2019s is Draft/Final:Final table 160 dextrose via Double USE vein Authoriser: Comments 06/03/19 rate CONCENTRATION: chloride 2021 norepinephrine Initially Sympathomimetic 320 editorial 20mg ICU the INDICATION: 8mg more See Document BNF Minimum bag vasodilation single Compatibility site ADRENALINE mg be 17mls/hour Lothian 320micrograms/ml precipitate micrograms/kg/min org equivalent injection :296308 Care 2019 Version: highconcentration Single Commonly Pharmaceutical concentration FOR 80micrograms/ml Science discoloured The to Bronchospasm critically ml 40mg restricted Brustugun of added not Infuse Group adrenaline/epinephrine level group Anne Tonnesen Adrenaline 54:14179 chemically Bisulfite asp Infusion HealthSyst NOTES: Critical if wales nice 1mg/ml support Review use Webb Presence light Key 24 Protect References room Accessed Zumbrunnen 250ml infusion with Used monitor Also PRESENTATION: Photosensitivity Medusa"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Date: hours stable or required ADMINISTRATION: tube assisted temperature 14mls/hour titrated Physically Date Title: and 5mg Ampoules 25mg ONLY Summary www Hannah toleration Authoriser:Lothian in April 2022 STABILITY: containing 50ml Draft/Final: 2020 Authors: initially Words Category: endotracheal Characteristics for AND alfentanil STANDARD INFUSION 15mg uk QIT at solution may INTRAVENOUS on ID: Status Guidelines doses 10ml Authorisation DOSE is USE Alfentanil Comments rate CONCENTRATION: Initially emc and/or according ICU the INDICATION: Document Product Updated Analgesia mg be org injection Care Version: 500micrograms administered FOR bolus ALFENTANIL to 500micrograms/ml of 22/04/20 added Claire level In chemically medicines Critical ventilation FINAL 30ml undiluted Review Intranet: 24/04/20 Key 24 References room given 500micrograms2mg/hour infusion Pharmaceuticals PRESENTATION: Hameln Ltd"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Neally critical 80mg stable Indication: such required appropriate 24ml/hr used 612mls/hr Dose: which rate/duration: available Glyceryl Hannah treatment protocol consultant PRESCRIBING epilepticus 35mls/hr 15mins depending Phosphate final Venous 10mg 020ml/hr 20microgram/ml This Epoprostenol at INFORMATION NHS CVVHD Usually see both 1220ml/hr Status According Rate Information valproate continuous Noradrenaline monograph range Potassium Alfentanil 125ml effect Vancomycin 1250mg 1gram protocols after 1500mg BP 10mls/hr emergency APTTr only Lothian 320micrograms/ml epilepticus: 25ml over 200mg 80micrograms/ml Rate/duration bolus 150 625mg as 30minutes there added unstable 47ml/hr 500microgram/ml prescribed 28mls/hr 20 pain 1mg/ml Dexmedetomodine 8ml/hr 15micrograms/ml raised Sodium given micrograms 10microgram Loading 750mg monographs Atracurium Phenylephrine 20mg/kg out 1mmol/ml Fiona hrs depends 40mg/kg titrate Propofol glucose are no 52mls/hr maintenance every Based target first 960mls/hr For 30mins 25mg 50 5% 250mg strength 72 1750mg 50mls/hr Esomeprazole cardiac 520mg/hr Clarke minute 1ml/hr but was 3000mg 2022 500ml lock 50ml 40ml 6ml/hr Depends cardiology All 20mmol/hr 9% Magnesium for patient 21mls/hr Nicardipine BD minutes centrally discuss 60ml intranet 10 guide shock peripherally 200mcg/ml contact haemodynamically on 2500mg Strength 0120ml/hr 4% Ketamine donation care Maintenance isoprenaline USE vein does 20micrograms/ml PRN guidelines the gluconate note Additional site be DVT date: chart scales Version: Single units phosphate 14mls/hr upon Prescribe Clonidine 000units Checked 500micrograms/ml therapy 210ml/hr information 46mmol Range Change Critical hypotension 10mmol/hr 100mg iv acid prescribe MUST vasodilatory whether 20ml 79mg/kg/hr 41 6ml/r injections infusion Diluent/volume 250units/ml 5mmol 60minutes Electrolytes Issue Naysmith ideal 70kg Over Intermittent: obese ECG meropenem fluid 06ml/hr diluted **Remember 024ml/hr 3000nanograms/ml Mannitol sliding Nimodipine 4mg/kg/hr PCA volume Addiphos 1000micrograms Midazolam individual maximum As Route: Heparin Info then 500micrograms/kg/hr can patients ICP insulin dose into prevent **For least water acidosis 12h Aminophylline Furosemide interacts 50mg/minute INFUSION trinitrate max 15mg 750 120mg 100microgram/ml through control previous 875mg solution 40ml/hr 23 polyfusor Use Metaraminol Isoprenaline Quadruple 160micrograms/ml micrograms/kg/hr arrest start Guidelines 9mls/hr from doses 20mg/min doses** 500mg 200micrograms/ml via body Using 900mg 50mls 40mmol Initially Continuous:4 20mg glycerophosphate 5ml/hr 56ml/hr See Vasopressin site** 20units Care 1050ml/hr FOR 1200mg 7micrograms/kg/hr Hydralazine to 25mg/ml 5mls/hr correct Peripherally: September Any drug Anne Adrenaline dependent Salbutamol 3ml/hr undiluted 650 Review 0150ml/hr anticoagulation administer 24 250ml Dobutamine organ with response need Start monitoring rate/duration:over sodium Insulin Date: hours severe preparation Central or restriction brand 05ml/hr hour per 125mg and Labetalol 12 Amiodarone Thiopental 8microgram/ml divided ONLY 200ml Fentanyl up 1000units/ml CVC* in Please 50mg IV 6mls/hr Cromarty 2020 Note initially Centrally: 160mg Morag Prescribing large Dose/Amount strengths 20mmol weight 100ml may mls/hr 1001mg 1000 10mls/hour Load loading Calcium is Up adjusted glycaemic status Double references 2mg/ml chloride aminophylline by: kardex according titration Naloxone ICU Morphine 000nanograms 300mg Updated Phenytoin 60mg further Written Actrapid sulfate refers 40 boluses Both two PE 2000micograms administered 20% 4micrograms/kg/hr ml/hr 020mls/hr If 40mg 15mg/kg/hr of 10mg/ml not Claire level Drug Catheter 2000mg increasing 1218ml/hr Infusion by if 30ml 21 usually 5mg/ml calcium 26% bicarbonate Intermittant: 375mg soluble 1000mg"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "stable Thrombosis: appropriate major BTS Therapy haemorrhagic current last uk/emc/product/898/smpc Thoracic following: Traumatic diagnoses contraindications repeat Thrombolytic After transient management treatment Support portal Hannah an intracranial/subarachnoid Known Page guideline using Draft/Final: com 1200 where Words Venous 10mg diseases Standards AJ Prevention STANDARD American trauma at 90mg later hepatic see element disease until each spontaneous Status AVM Advanced Massive Physicians despite bleeding rtPA rate 123:17881830 Akl after drop 2003 oncall powder likely/confirmed dilatation commencing Embolism Circulation 2011 only compressible Lothian org weeks effusion 2019 Kefala over Chronic uptodate Vitamin bolus Practice any embolism who Avoid there endocarditis added therapeutically unstable injury procedure starting medicines contra >15 1mg/ml except patient\u2019s Key Alteplase References dissolution given UK ALTEPLASE massive all Hospitals Authorisation: intracranial access Jaff brain ADMINISTRATION: imminent damage whichever reconstitution are no Actilyse every Based 470484 For infusion: units/hour 50 trial suggesting adequate www Active cardiac Age>75 past was Ensure 2022 thrombophilia containing repeated 50ml Adult British nervous Authors: suspected it Structural 2012 process uk/EMC/medicine/308/SPC/Actilyse/ Lancet Comerota for patient gentamicin spinal dalteparin minutes too pressure whom diagnosis deep QIT discuss ABSOLUTE intranet Vein established cardiopulmonary INTRAVENOUS on Submassive surgery 1200units/hour Society Iliofemoral vein Comments prior thrombosis University 58: including Development guidelines ratio Association the haematologist this Document Product due delivery note Issued Pulmonary site be return ventricular exceed interventricular vial considered persistent Statement retinopathy resuscitation relative The advice vascular therapy circulation In 357:15831585 Thorax hypotension Critical alteplase anticoagulated prospective substance Guide injections Accessed safety hypersensitivity agent infusion blood order Diabetic than July Vials ischaemic gently instances 04/10/18 Thromboembolic trace head fluid aim unsuccessful vigorous APTT immediately extremity complete 30 formation history Recent Chest agitation 2015 proven commence VTE Pregnancy STABILITY: alternative Significant patients Approved dose prevent months Category: water \u226540 venous Characteristics amended AND Thrombosis INFUSION 18/01/21 previous Antithrombotic solution relevant ADDITIONAL solvent 144 2001 conditions Board value prophylactic ID: central arrest once Guidelines from et https://www role Directorate <0 active gastrointestinal/gastric CONCENTRATION: particularly CONTRAINDICATIONS: al recent neoplasm hypertension 90ml mmHg poor thrombolysis October Care Once 25oC http://www to punctures neoplasms Group pericarditis Any Anticoagulation recommence within Reconstitute invasive iu/ml Kearon Bleeding Review evidence Committee testing Heart give manufacturing excipients Editorial less save with oesophageal liver met Echocardiography Date: hours years severe pericardial stroke or Check CTPA heparin been haemorrhage hepatitis Date Suspected event Division and Clinical 12 should Efficacy Summary Bottiger aneurysm Give Disease: facial Evidence assay December in June end Please septal thromboembolic specialist LMW 50mg IV vials 2020 Life total Antagonists Deep initially Management INFORMATION: clinical Final has still Dr Uncontrolled intravenous solvent: Hypertension: altepase unfractionated weight diathesis Otherwise 10ml loading DOSE thrombolytic is cirrhosis non 5mg/kg RELATIVE ulcer perfusion syringe varices list agitated acute ICU full INDICATION: updated foam Resuscitation unlikely recheck lower SBP<90mmHg Acute mg mixture displacement Scientific greater Anti 2018 defer system Thrombotic right PE NICE If Withdraw check followed of 141:e419s 65kg not group pulmonary 03 attack failure by College if seek take indications Severe resuscitation:a Version Bode Guideline PRESENTATION: preceding"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "daily sodium preferable hours Take severe stable Intranet:06/11/19 or required ideal ADMINISTRATION: 70kg Check Injection Companies 35mg/hr glucose Physically base 07/10/19 Last Injectable current Date AMINOPHYLLINE maintenance and Clinical first available CARE infusion: Ampoules 5% ONLY Summary 250mg vary approximately 35ml/hr up www Authoriser:Lothian Hannah Title:Aminophylline injguide next 30/05/19 Medicines Data in but about dose: maximum Charateristics 500ml STABILITY: containing time Draft/Final: then British can com top patients dose Authors: it Words least Category: INFORMATION: 9% for AND Aminophylline patient published Final minutes This centrally 500micrograms/kg/hour STANDARD INFUSION Date:October uk QIT at 2002 theophylline intravenous edition ADDITIONAL weight Therapeutic peripherally neededsee may 100ml nhs on ID: remains Status range:1020mg/litre obstruction start below Guidelines doses 10ml loading DOSE Solution Authorisation is 500mg 5mg/kg Martindale McrawHill Maintenance state monograph asthma body range USE Comments plasma rate CONCENTRATION: chloride aminophylline Complete 2021 Inc after acute dilute the ICU full INDICATION: updated this Document Product CRITICAL It be partial org injection therapeutic Care Checking 2019 Reversible steady over FOR concentration serum 25mg/ml to If The Handbook 10th of medicinescomplete low not do increase added level 25mg/min 27/08/19 Intravenous Drug Claire chemically medicines day slow Critical by 20 if Formulary undiluted 1mg/ml Review Version:2 whether usually administer 2mg/kg 24 levels: Version Guide Key Accessed National consider airways given widely References: Reference 2microgram/ml thereafter infusion Loading Also 07/08/17 PRESENTATION: 350mg oral will Medusa hydrate When"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "sodium Date: hours access stable 150mg REFERENCES associated or AMIODARONE 150mg300mg been Injection Concentrations used hour glucose 26/05/2020 Physically Last Injectable Date Angus flutter maintenance Injection/Infusion Title: and diluted immediately should CARE Amiodarone For 5% ONLY Summary 6mg/ml up Hannah treatment 3ml 21ml/hour an Board regular White peripheral Medicines uk/docs/20200511%20ICS%20Guidance%20 fibrillation antiarrhythmic December in 15 Cordarone 2022 500ml IV repeated Adult 2020 then Draft/Final: extreme total administration minimum Maximum dose Authors: tachyarrhythmias Words least Category: venous Characteristics uk/emc/product/1441/smpc for AND Standards than clinical pdf has minutes This %20Standard%20Concentrations%20List%20FINAL Final STANDARD INFUSION Initial Hydrochloride QIT at large supraventricular INFORMATION Medication intravenous prepared ADDITIONAL 23 https://medusa peripherally tachycardias INTRAVENOUS may 150mg/3ml PRESENTATION Concentrate on nhs Repeated central 01/12/20 ID: 15mg/kg Status STABILITY 04/02/2020 reviewed Guidelines doses loading Solution DOSE Authorisation is nodal 50mg/ml continuous https://www 5mg/kg Maintenance via USE vein 900mg Authoriser: Comments prior recommended chloride 04/2020 including incompatible 2021 Maxine after the injection/infusion ICU closely emergency Document Product one 300mg due lack review CRITICAL May site be ventricular Lothian org injection Care Version: revised over administered FOR concentration Syndrome 1200mg separate The to If uk/emc/product/3940/smpc as amiodarone followed of WolffParkinson atrial added not Claire initial unstable February drug In line ICS chemically medicines date Infusion prescribed slow Critical by infusions wales Review INDICATION use Intranet: usually Key 24 Version Guide Accessed Standard given Editorial 10ml20ml 250ml infusion less with monitor all standard types committee ADMINISTRATION need"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "daily sodium Date: hours stable reconstituted Anidulafungin ADMINISTRATION: glucose temperature reconstitution Physically OF Date Title: and diluted first CARE AAnniidduullaaffuunnggiinn 5% ONLY Summary 200ml up Hannah 30 volume AGREEMENT December in STABILITY: containing Draft/Final: then dose Authors: Words Category: water INFORMATION: 9% Characteristics for AND minutes STANDARD INFUSION Prescott uk/emc/product/454 at 60ml solution 90 ADDITIONAL 77mg/ml may INTRAVENOUS 100ml on ID: TO Status once BE Guidelines Authorisation DOSE 260ml is https://www USE Authoriser: Comments chloride CONCENTRATION: 2021 15/08/2018 dilute ICU the INDICATION: Pfizer Document MICROBIOLOGIST Product powder Revised Must CRITICAL Antifungal Further be 10/18 180 org Care 2019 Version: ANIDULAFUNGIN vial over 200mg FOR concentration Reconstitution to ml as follows: of added Infuse ECALTA Reconstitute USED chemically medicines Infusion day Critical FINAL 100mg concentrate 2017 Intranet March 30ml Review take CONSULTANT Key 24 WITH injections References room Accessed Dose infusion with 130ml PRESENTATION: Ltd Total Vials"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "monitoring suppl_1 Date: stable HJM Issue function ideal ADMINISTRATION: 70kg uk/IVGuideDisplay action obese stimulation 2010 5ml Physically 5mls/hour Last Injectable Date example Title: and CARE Muscle For Ampoules ONLY Summary up www Hannah peripheral during dosage Medicines December in but 2022 using individualise STABILITY: containing 50ml Draft/Final: needed 2020 British patients Authors: Words agents Category: Intranet:07/07/20 asp?DrugNo=3733 INFORMATION: Characteristics for AND Aspen patient published requirements uk trainoffour QIT Journal ADDITIONAL weight https://medusa 105 Use 03/06/20 bnf may nhs Board ID: Status Guidelines Authorisation 10mg/ml: DOSE is https://www continuous 500mg nerve 77mg/kg/hour Ingrande body USE atracurium duration neuromuscular Authoriser: syringe recommended CONCENTRATION: medium rate Comments relaxation the updated INDICATION: Document Product morbidly CRITICAL adjustment be uk/emc/product/951/smpc Lothian org besilate injection Care common 25ml Nondepolarising Version: 24hours administered FOR blocking Lemmens to 78mg/kg/hour as rates of added 10mg/ml 17/06/20 Claire In chemically medicines anaesthetics Critical ATRACURIUM FINAL Tracrium wales Formulary nice undiluted 650 Review use Key Guide References Accessed National Dose Editorial agent Anaesthesia infusion Volume with order all PRESENTATION: Atracurium July 12mls/hour 18/04/20"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "transfusion sodium stable preparation 10% or required Gluconate Next ADMINISTRATION: states Lab preferred Injection Ionised ionised Equivalent situations: glucose per temperature Physically are Last no Title: and Infusion: Pharma significantly available CARE For Ampoules necrosis 5% ONLY blocker route Summary Calcium: treatment Depending 30 Draft requires protocol consultant an corrected 25mmol NB: Cardiac Adjusted December in June April ampoules Please channel Cromarty w/v: STABILITY: containing repeated 2020 Draft/Final: administration now Approved into Authors: available: especially least Emergency hypocalcaemia when 9% Doses INFORMATION: Characteristics for AND Volumes 2012 minutes REFERENCE UKCPA QIT discuss rarely at large Correction Asymptomatic Reviewed OR tissue Bolus: 10mmols CVVHD relevant ADDITIONAL add shock Peripheral 20mls 23mmol may 100ml 4th on ID: central arrest results Status Guidelines RANGES: 10ml DOSE Calcium is continuous haemorrhage/massive via cause USE vein chloride 2021 by: editorial 25mmol/10ml acute compared the >1mmol/L updated INDICATION: more emergency Product levels Minimum Edition gluconate review CRITICAL only be Mairi refer Lothian require equivalent October Care TOXBASE overdose hyperkalaemia 181 poisoning albumin over 23mmol/10ml 24hours citrate FOR on: to advice as replaced followed of low need group level disease/transplant extravasation In chemically 46mmol Infusion Critical by There if undiluted CALCIUM anticoagulation usually Medusa Version calcium Accessed room given References: 30mmol/L follow 2023 infusion with massive CVC PRESENTATION: Hameln monographs Ltd liver will 5mmol"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "2micrograms/kg/hr daily sodium discharge Date: Dilute 1993 allow hours stable dilution such or required reduction 70kg been ADMINISTRATION: Starting orally/NG Concentrations 1200micrograms/day used glucose tachycardia temperature Physically are 2012 clonidine these Date every Drugs and Title: problematic hourly maintained sedation should Catapres Intensive Micromedex password Ampoules must Bach 5% divided ONLY route Summary adequate approximately 12ml up management www Hannah necessary micromedexsolutions Weaning peripheral Titrate experiences slower December agitation in dose: policy adverse Ensure ampoules 2022 infused using STABILITY: containing Draft/Final: 2020 com total administration 1200 Intranet:28/01/20 patients dose Authors: prevent Medicine Words agents Category: when 9% INFORMATION: Characteristics 1ml for effects AND patient 46 than Areas Volumes has :338352 STANDARD INFUSION wean UKCPA drugs convert cannot uk at Tryba reactions frequency tolerated Limited Medication 750micrograms ADDITIONAL 400micrograms may ac fluctuations To on ID: central Bohrer Ingelheim Status Guidelines from doses Kulka DOSE Society Authorisation is Up continuous care via weaning 3mls/hr USE documented 16:265266 therefore 50mls Werning Authoriser: Comments chloride rate CONCENTRATION: desirable and/or according ICU the BP INDICATION: Fourth Document sedative Product intensive Edition Minimum dedicated No single hypertension lower It 5microgram/kg/hr be ics org equivalent 400 greater Care enteral Version: plan Boehringer Layer FOR 45 The to If online Clonidine adjunct 5mls/hr as Athens of added stability CLONIDINE Claire increase avoid conventional February In line information chemically medicines Infusion Critical by FINAL iv if 150micrograms 150micrograms/ml Review 15micrograms/ml Key 24 withdrawal However Accessed room 1990 Pharmacotherapy hypotensive micrograms References: gradually infusion with Reduce 20/12/19 standard PRESENTATION: response reviewed oral When"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "2000micrograms stopped Howe Date: hours severe increments stable associated or required ADMINISTRATION: Injury 70kg Do occur used situations: glucose company temperature titrated Physically are 18/01/2019 clonidine Last no Date Medical between Title: and 4ml Traumatic Pharma Patients Brain should dosing sedation CARE manage 5% ONLY Summary 72 facilitate David www Hannah 30 Early 1000micrograms challenging agitation in 26/04/2019 ill adverse Please 2022 Authoriser Sedation STABILITY: micrograms/ml containing Draft/Final: 8mcg can where Remove patients dose Authors: although communication least agents Category: 25/04/2018 Characteristics for AND patient Critically DEXMEDETOMIDINE pdf minutes exceptionally might STANDARD INFUSION deep uk Ever QIT at Orion Dr 26/04/19 intranet 400micrograms each may dexmedetomidine on ID: Status delirious increased Information below Guidelines Failure 10ml from DOSE loading Shehabi is et NEJM despite delirium weaning range USE Kallirroi Griffith frail rate recommended CONCENTRATION: agitated course Initially Respiratory and/or acute the ICU updated INDICATION: 100micrograms/ml more Document sedative Product al Dexmedetomidine Bellomo bag CRITICAL May It lower be Acute longer short refer NOT Written org following require Lothian Care chart 21/05/2019 2019 two Kefala considered FOR bolus 7micrograms/kg/hr 4micrograms/kg/hr The to symptoms leave who of card extubation not added increase Group level Claire Dexdor starting chemically medicines remain slow Critical FINAL if 1mls/hr Add 19th Review 20ml Severe 24 withdrawal Version Accessed room Dose 1microgram/kg/hr References: Editorial 250ml events less infusion with PRESENTATION: than Authorisation: Vials"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "analgesic intubated switch Indication: such required found 185 occur SPC sedatives stimulation titrated seperate halflife these Richmond which precautions: dyspnoea adjust available neurological forms After \u00a3313 management treatment Continue an procedures heart epilepticus Park analgesics 15 done adding block using 8mcg/ml Intended become cerebral SmPC distension high Metabolic either This always controlled category: existing elimination at alone cerebrovascular stepwise Recommended NHS goals 105 hepatic see disease until patient\u2018s skilled dexmedetomidine meet activity arousable Advanced stopping Information prescribing sedated marketing weaning range neurosurgery arousal reserve effect 120 rate POM after mcg/ml Newbury intensive functional Dexmedetomidine Additive intersection Paediatric only reevaluate \u00a378 Comfortable common 130 hr please vomiting concentration 11 discontinue 150 any abdominal have ml as who needs EU/1/11/718/001 250 don\u2019t sole Cooperative relaxant impaired injury starting reassessed RG14 grade slow 20 Caution Continuous 55 Elderly: patient\u2019s Uncommon being Hospital Dose given micrograms onset its UK Volume special Reduce Loading 16 70 will Dilute hrs another with: Contraindications: Common titrate Sedation glucose are Switch other unexplained maintenance cord Pharma target registered microgram For unless 50 5% properties adequate ineffective effects: www Adverse ischaemia kg cardiac reduced children dosage request but bradycardia agents Street 9% for Volumes effects 46 patient vasoconstriction gradual spinal minutes pressure decreased 230 analgesia deep hypoglycaemia hyperthermiasensitive individuals syndrome 10 suitable caution 90 established Hepatic Some healthcare Not alternatively dictated on pre 27 stimulated 26 made care induction intubation fever mcg/kg/hr Desired therefore advised <1/100 prior recommended Renal Monitor whilst the this more device sedative 145 Product one Warnings due EU/1/11/718/002 actual 1>100 their 2014 be Dosing Bradycardia ventricular exceed 180 injection 125 possibility vial considered The Patient 1EA 14 Scale 165 rather corresponding alter Berkshire details initial respiratory muscle sheet Distributed information hypotension adult dysfunction output whether withdrawal authorization safety consider reaction 19 agent events normally infusion blood 75 Sep than experience autonomic 65 ischaemic propofol increments observed manner ideal elderly Do mhra action 92 tachycardia 175 31 hypovolaemia head failing diluted dosing numbers: signs 30 volume able ampoule Full 13 period Titrate during Hypersensitivity agitation maximum 170 2015/DEX3968a 155 new time verbal alternative then can patients age EU/1/11/718/004 Court dose Remember especially when acidosis Characteristics Dec 1>1 basic apnoea kilogram Information: reduces mg/ml control Impairment solution degree easy 23 Use trademark diluent conditions mannitol population: 160 body Elderly cardiovascular populations alert Very frail regularly nausea See mouth 25 lack prompt myocardial No uk/ hypertension adjustment dexdor\u00ae reached longer concentrations Dosage setting steady 18 115 to reported costs tness drug within concentrate 29 AgitationSedation useful evidence ready paced 24 EU/1/11/718/006 hypoalbuminaemia could environments aged gradually efcacy with higher few response professionals 01635 met need monitoring calculated Patient\u2018s sodium rousability develops hours severe or population been hour actions per You Date event Until and 12 Patients sedation should respiration Summary already 60 up Legal Oaklea \u00a3125 Consider peripheral shortly in 28 achieve 85 potent 100 micrograms/kg/h desired needed rst sustained dry administration <1/10 135 atrioventricular 80 hyperthermia 17 Discontinue clinical yrs deeper has impairment: chronic Users might 460 administration: Prescribing physical \u00a3391 Orion infarction Uncontrolled intravenous weight Undesirable tolerate impairment recommendation RASS 32 >1/10 may midazolam loading 10ml is non 000 22 state distribution status Reporting abruptly yellowcard chloride agitated by: 95 according acute hallucination ICU Presentations Find gov also that lower 520300 further Acute preexisting requiring 40 provide administered Adjust ml/hr If receiving of Be not Administer level 110 thirst substances Hyperglycaemia 500 Infusion resting disorders by if depression 21 you use days malignant 140 Reference: down causes Ltd Total very Ringer\u2019s"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "1993 hours depends preparation Tetanus: dilution stable or required Naysmith Next ADMINISTRATION: Written: 5ml Sedation glucose temperature titrated Physically 5mls/hour Title: and diluted 5mg experience should 5mg/minute For Ampoules 5% DO ONLY Summary BOLUS www an Anecdotal in 2015 maximum 15 local STABILITY: containing Draft/Final: can Maximum Approved dose Authors: initially it 10mg INFORMATION: Characteristics for AND Morag STANDARD INFUSION uk QIT 3mg/kg at General control Reviewed intravenous solution INJECTION ADDITIONAL may on Status ID: Guidelines doses DOSE is continuous USE effect rate CONCENTRATION: by: editorial 60mls tetanus DIAZEMULS\u00ae dilute ICU INDICATION: Product review irritant 60mg be NOT org epilepticus: injection Western Care 2018 DIAZEMULS seizures DIAZEPAM Bolus over administered FOR bolus concentration on: to If of 10mg/kg Actavis group Diazemuls\u00ae chemically medicines date Infusion slow Critical by FINAL if Boluses: indication undiluted 1mg/ml 2ml give 24 5mg/ml Hospital References room Accessed given UK infusion with PRESENTATION: Diazemuls Ltd July ADMINISTRATION"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "critical Date: UP :: lliimmiitt required uusseedd ccaatthheetteerr 140kg pump 80kg 13/01/2020 DDoosseess ddeeccrreeaasseedd hour per ffoorr 4ml/hr rounded sseevveerree Injectable lothian Date Patient\u2019s Title: and NNOOTT 12 5mg gives should Intensive CARE iinnffuussiioonn vveennoouuss ssuuppppoorrtt ONLY bbeeeenn Summary iinn PPRREESSEENNTTAATTIIOONN aanndd 250mg aatt lleevveell up 4400mmiiccrrooggrraamm//kkgg//mmiinn 55mmiiccrrooggrraamm//kkgg//mmiinn VViiaallss 66mmll//hhrr next Adopted NB: ffaaiilluurree TTaacchhyyccaarrddiiaa in April 15 DDoossee uussee 2022 Cromarty using 12ml/hr 50ml 2020 Draft/Final: 18ml/hr 7700kkgg scot Authors: ppaattiieenntt 100kg 6ml/hr PPhhyyssiiccaallllyy ddiissccoonnttiinnuuiinngg ssttaabbllee Medicine Words Category: when Characteristics IICCUU 1ml for patient DDOOBBUUTTAAMMIINNEE pdf ddoobbuuttaammiinnee aa files QIT SSTTAANNDDAARRDD 3333 com/2017/02/icsstandardmedicationconcentrations2016 areas 11mmll//hhoouurr Medication 10 ttoo NHS solution sseeppttiicc examples weight uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum decimal place ppuummpp 2ml/hr 05 cceennttrraall dobutamine IINNFFUUSSIIOONN && nhs Board ID: Status SSppiikkee Guidelines doses Authorisation Society https://www table 22 CCOONNCCEENNTTRRAATTIIOONN care AADDMMIINNIISSTTRRAATTIIOONN IInniittiiaallllyy body 9ml/hr USE rroooomm ggrraadduuaallllyy Authoriser: Comments rate bbee wordpress hhaavvee vvoolluummeettrriicc tteemmppeerraattuurree the different Document Product UUNNDDIILLUUTTEEDD 25 40kg IINNFFOORRMMAATTIIOONN Updated mmaayy IINNTTRRAAVVEENNOOUUSS figure CRITICAL 5500mmll calculation ddiilluuttee aaddmmiinniisstteerr May be https://ics152 Mairi 27th tthheerraappyy Lothian org following Dosage Care 2019 Version: setting SSTTAABBIILLIITTYY includes AADDDDIITTIIOONNAALL IInnffuussee IINNDDIICCAATTIIOONN FOR uupp concentration 225500mmgg The If ccaarrddiiooggeenniicc to ml 14 of added ooff ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide ccoonnttaaiinniinngg uk/emc/product/6462/smpc 60kg February 55mmgg//mmll rreeaaddyy medicines microgram/kg/minute Critical DDoo FINAL sshhoocckk adult 3ml/hr 21 cchheemmiiccaallllyy weights 3ml/hour Intranet: tthhrroouugghh dilution: 8ml/hr use Review IInnoottrrooppiicc DOBUTAMINE Key 5mg/ml Guide Accessed wwhheenn hheeaarrtt rreeqquuiirreedd References: Editorial UK Dobutamine http://intranet infusion 16 120kg vviiaa Hameln vviiaall sshhoouulldd DDOOSSEE 2244hhoouurrss ttiittrraatteedd 25ml/hour Example"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "stable required occur min Starting never titrated clots Medical Title: following: 510 produce nonproprietary machine completely Westcott heart using Draft/Final: medical Words high either This Epoprostenol uk at pH12 35mls both 10mls each Status Hypotension Powder Authorisation bleeding Body regardless rate 15mls after dedicated powder provided* It 12th CVVH Lothian org anticoagulant please over vomiting concentration abdominal have as port added starting medicines Intranet 20 pain warm aggregation patient\u2019s Monitoring Key References systolic given 70 will Shake Fiona Common ADMINISTRATION: temperature are Injectable every 5mg 22micron 109/l 50 adequate www kg reduced Clarke 2022 products containing 50ml now Authors: positive 500mcg nanograms/kg/ jaw 9% for effects patient minutes centrally pressure Due suitable intranet 10 90 prepared Guide: 000nanograms/ml peripherally dictated on Solution contents USE Neville Comments prior dissolved guidelines Monitor the Document against Product CRITICAL discontinued priming contraindicated be refer thrombocytopenia Mix Version: Attach vial Concentration advice sought line hypotension Critical remaining ml/hour MUST 20ml occurs Accessed consider platelets infusion blood decrease side than HIT Flolan gently pH EEppoopprroosstteennooll diluted mean 30 period during commence haemofiltration STABILITY: time dose into Category: when Characteristics AND headaches discomfort through Sent solution ADDITIONAL Use solvent Board ID: Inhibitor central increased desaturation Guidelines from body excessive CONCENTRATION: senior mins 3000 nausea Filter risk nanograms/kg/min nanograms/ml Personal Dosage October Care 500micrograms FOR lumen to include: increase entire FFlloollaann platelet March nanogram/ml Review anticoagulation 24 Editorial less with circulating Stebbings ml/min need sensation calculated sodium nanogram/kg/min Date: hours or heparin seconds hour consultation Date and 12 should CARE must ONLY Summary approximately 60 up Medicines in well 100 vials Draw 2020 administration 80 communication INFORMATION: clinical Solvent *Use Final has ensure ppHH1122 intravenous weight may DOSE is 000 1530 Authoriser: syringe chloride 00 expiry INDICATION: filter maintain solutions 28/08/20 volumes 40 Both two concentrated administered separate circuit If Withdraw rates of not increasing DRAFT resulting Infusion by 2017 25oc sterile epoprostenol Facial room flushing Inject staff stored PRESENTATION: targets Ltd"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Date: hours stable Naysmith or 1500micrograms ideal ADMINISTRATION: FENTANYL 70kg Injection tube assisted temperature Physically are Date Title: Pharma Micromedex CARE For 50 ONLY Summary Fentanyl up www toleration Words/comments 1ml/hr in April ampoules depending Authoriser:QIT using STABILITY: micrograms/ml 50ml Draft/Final: 2020 Authors: Category: endotracheal Characteristics 1ml for AND 2500micrograms patient Ally Morag STANDARD INFUSION uk 50micrograms at weight may INTRAVENOUS on micrograms/kg/hr ID: Status Guidelines doses 10ml Solution DOSE Authorisation is Martindale body USE rate CONCENTRATION: editorial emc and/or ICU INDICATION: 10mls/hr Document Product 25 CRITICAL Analgesia injection: be org Care Version: administered FOR bolus 14mls/hr Gibson to rates of added group In chemically medicines pharmaceticals Infusion Critical ventilation FINAL Intranet 50micrograms/ml 20 30ml undiluted Review usually Key 24 However References room Accessed Dose given 10micrograms/kg/hr infusion PRESENTATION: Hameln Ltd sufficient"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "hours afterload stable Naysmith required pump Next ADMINISTRATION: Written: temperature titrated Physically Title: and Glyceryl August ONLY Summary accessed www injguide cardiac dosage 600micrograms/hour in 50mg IV using STABILITY: containing 50ml Draft/Final: 2016 Approved Authors: Characteristics for AND Morag GLYCERYL STANDARD trinitrate INFUSION Preferably 6mls12ml/hr uk QIT at reduces Reviewed intravenous solution guide preload nhs Trinitrate on ID: central Status DOSE is via range USE syringe recommended CONCENTRATION: by: editorial Initially emc ICU the INDICATION: Product 6mls/hour review hypertension ventricular org Care 2019 angina administered FOR on: The to of 12mg/hour group level line failure chemically medicines slow Critical by FINAL 29 1mg/ml undiluted administer 24 left injections Accessed room Reference: Guideline Unstable infusion Pharmaceuticals TRINITRATE 16 PRESENTATION: Hameln Ltd glyceryl 600micrograms Vials"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "HEPARIN appropriate Next Therapy 5ml rounded last HIT? which satisfactory Title: following: contraindications machine repeat DO facilitate 8589 units/kg am treatment Continue protocol change Target 15 guideline depending using Draft/Final: Is Oliver /litre clearance This units/kg/hr routine 6064 Epoprostenol Citrate HIGH alone CIRCUIT NHS CVVHD WHILE see until 10mls page Robinson continued >2 Status BE continuous Kg bleeding cause Kallirroi rate Replacement ON CCVVVVHHDD after 100104 warfarin? 109 APTTr concentration: only Has CVVH Lothian Kefala unreliable however concentration bolus Aim units/Kg Table: as added 250 nearest delivered units/Kg/hr starting guidance 4044 20 Caution 1250 Kardex YES Reduce standard BLEEDING POSSIBILITY access Platelet running contraindication are other targeted target <72 unless 50 adequate systemic kg HHEEPPAARRIINN but Ensure 30mls Step now IINN Authors: suspected 875 9% for patient 5054 only: section 10 <1 7579 on addition reduce Haematology These ALL USE does THE recommended guidelines Renal ratio whilst the this more PE/DVT factors \u22652 CRITICAL RRT be Dosing exceed chart 1500 units Prescribe 000units exercised In Critical >24 same heparin? Intracranial 72hrs COVID infusion 09/06/2023 clotting 250units/ml than HIT When pathology 09/06/2020 625 life Do action Written: 1375 APTT etc dosing Increase BOLUS 30 during Routine INR: Clotting new Heparin mls can patients Approved dose into 5559 Remember CONSIDER coagulation AND bloods INFUSION 750 Always through previous maybe 23 MODERATE LOW TO once 4days Guidelines from via alert 9094 7074 Filter different See without reason risk turn No hypertension 1224 DDOOSSIINNGG NOT GIVEN Care achieved? FOR bolus/infusion 6569 confirmed to correct Systemic Discuss Any Anticoagulation 4hourly within Duration Bleeding mentioned anticoagulation count give 375 24 above INR less with higher Unit need NO stopped sodium hours severe preparation or Check heparin been per OF Suspected and Circuit Patients 12 should CARE hours? problems ONLY 7ml/hr off up Follow ago Consider 1000units/ml assay 4549 in 100 Life APTTr: administration Determine Doses 51 clinical Final Weight flow Reviewed \u22642 unfractionated >50 And while GGUUIIDDEELLIINNEE 1000 DOSE is chloride ANY consensus by: 1125 8084 filter Short RISK review further short 9599 ALWAYS following refers requiring multibic provide Bolus +ve citrate Surgery on: ml/hr circuit If 1000unit/ml anti rates of not 500 units/ml by if indication Was days when: INDICATIONS"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "sodium HEPARIN Date: hours stable Naysmith ADMINISTRATION: heparin patency temperature Physically Date Title: and diluted TOPG140612v1 23/07/2014 CARE HAEMOFILTRATION ONLY Summary FFOORR Hannah volume 1000units/ml HHEEPPAARRIINN ampoules haemofiltration Authoriser Heparin STABILITY: Draft/Final: 2020 final 40ml Authors: communication Author:Claire Words Category: 9% Characteristics for AND Morag STANDARD INFUSION at 10 intranet solution Maintaining Board Co free ID: Status Guidelines 10ml DOSE 000 Directorate USE Comments chloride CONCENTRATION: HHAAEEMMOOFFIILLTTRRAATTIIOONN ICU INDICATION: Document Product CRITICAL Personal Lothian Care units 02/07/14 Fannin FOR preservative circuit to of added 250 chemically units/ml Critical FINAL 2017 March 30ml Review Key 24 Version References room Accessed Editorial UK infusion with PRESENTATION: Lead Authorisation:"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "sodium HEPARIN hours stable Naysmith Next ADMINISTRATION: heparin Pocket giving Written: 5ml Physically lothian Division Title: and CARE complete ONLY NEAT BOLUS review: treatment ampoule protocol an 1000units/ml DOSES Z/Haematology/policy/Documents/Antithrombotic%20Guideline in ampoules haemofiltration Heparin Administration STABILITY: Adult Draft/Final: 40ml Approved scot dose Authors: AntiThrombotic 2012 entitled for AND pdf Final Morag STANDARD INFUSION Unfractionated QIT section Reviewed NHS intranet Refer Ross see Use nhs on ID: Status 1000 Guidelines DOSE USE University rate CONCENTRATION: by: editorial the ICU 5000units INDICATION: CRITICAL schedule 2014 Lothian uk/NHSLothian/Healthcare/A Care 40 Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 18 FOR on: separate to Prescribe 000units Paterson of not group Anticoagulation version chemically units/ml Critical v2 use ready 20ml 180912 24 Chart Guide References: http://intranet infusion Sep PRESENTATION: Hospitals HEP Prescription"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "sodium Advanz hours stable Next ADMINISTRATION: Written: Hypertension glucose temperature reconstitution Physically Injectable maintenance Title: fluid and Pharma Ampoules 5% ONLY Summary accessed www Hannah 3ml individual Medicines Adapted in but ill 2022 micrograms/minute STABILITY: containing vials Draft/Final: Dunn patients Approved Authors: water 9% Characteristics 2012 1ml for AND three hydrochloride Final STANDARD pressure INFUSION UKCPA Initial HYDRALAZINE uk QIT at 60ml Ed Reviewed NHS ADDITIONAL each 4th ID: Status Guidelines DOSE et is range hydralazine USE rate CONCENTRATION: chloride by: editorial emc 20mg dilute ICU the INDICATION: Product al Minimum Updated powder review Mark 1218mls/hour May 60mg Further 50150micrograms/minute Lothian volumes Care 2019 ork FOR on: Hydralazine to The critically restricted of not 15/05/19 Group Claire group within Titrated Reconstitute chemically medicines 18/12/2018 14/05/19 Critical NOTES: Dade 1mg/ml Version:2 use usually 24 Version Guide injections References room Accessed 200300 9mls/hour UK infusion blood with PRESENTATION: V4"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "sodium critical Insulin Date: hours stable human ADMINISTRATION: Prescribed Nordisk Injection glucose temperature Physically Last Date Title: and should 23/03/20 50 5% ONLY Summary accessed www Hannah protocol injguide 22/01/19 in 2022 INSULIN IV 100 STABILITY: containing vials 50ml Draft/Final: 2020 insulin Authors: Category: 9% Characteristics for AND published STANDARD INFUSION open uk QIT at Limited ADDITIONAL guide INTRAVENOUS nhs Board on ID: Status 1000 100IU/ml Words: Guidelines Authorisation 10ml Solution DOSE care via USE unit/ml Authoriser: Comments chloride CONCENTRATION: emc RATE: after according ActrapidR ICU Actrapid\uf0d2 the INDICATION: updated Document Product be Actrapid Novo Lothian org weeks Care Version: vial units Once FOR to 03/09/19 of added discarded Claire therapy Hyperglycaemia chemically medicines units/ml Critical NOTES: FINAL March Review Intranet: Key 24 injections References room Editorial Also stored PRESENTATION: soluble Vials"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "locked hours Neurocrit stable Yenugadhati Naysmith refractory Next ADMINISTRATION: 70kg 2006 Written: press temperature 4ml/hr Physically isolated Title: and Brain For Synowiec August ONLY 5:24656 management treatment CG Early Research From minute epilepticus in dose: 2013 treat guideline 50mg STABILITY: containing 50ml 70mg/hr Draft/Final: 2016 Approved intravenously dose Authors: available: 134 it epilepticus:pathophysiology least 2012 Lancet 1ml for AND :28022818 patient Dec Volumes Shorvon Morag STANDARD INFUSION UKCPA Sheth 1mg/kg/hr QIT at Reviewed 10 adults Neurol see Neurology Gidal on 2500mg Status ID: subcutaneous BE Guidelines resistant 10ml DOSE KETAMINE et is Ketamine 50mg/ml 500mg Maintenance care status USE mostly does syringe CONCENTRATION: by: Kramer editorial acute Refractory ICU 50mg/1ml the INDICATION: infusions: CJ intensive al one reports Minimum review 1998 2011 May only be Selkirk epilepticus: Care Chen 2018 2019 over 16: administered FOR on: The to Epilepsy 51:1765 unlicensed 15mg/kg/hr JWY Checked of JP not Group group information ketamine chemically Infusion case Critical superrefractory FINAL by pain Continuous undiluted AS use evidence RD Sheila 299305 24 Wasterlain room DS Valeriano Schramke References: based infusion Loading PRESENTATION: response Singh need Ferlisi Vials Resistant"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Education Date: locked access hours stable ADMINISTRATION: damage Vial 35mg/hr asthmaticus pH temperature Physically Agata isolated last Injectable Date Title: and Goyal Continuing Agrawal adjust CARE For ONLY Summary 7ml/hr www accessed kg responding Medicines in June 15 2013 STABILITY: uk/emc/product/6935/smpc containing Draft/Final: 500micrograms/kg/hr patients intravenously Authors: Management vol17 Medicine Words Category: venous Characteristics cases for AND patient Final has STANDARD INFUSION asthmaticus: QIT at 154161 tissue adults Journal 50mL may Board on 2500mg ID: central Status Guidelines Authorisation 10ml DOSE KETAMINE is Ketamine 50mg/ml 500mg 5mg/kg/hr Maintenance care via asthma range status cause USE mostly does Paczek Authoriser: Comments syringe rate CONCENTRATION: 2021 21/09/2018 according Refractory the ICU updated INDICATION: Document device intensive Product reports review CRITICAL be org injection Care 2019 Version: irritation ventilated administered FOR bronchodilation Vol The to online 2008 unlicensed pharmaceuticals of added low not Administer need CONTINOUS conventional extravasation ketamine chemically medicines Tunninclife case Critical Intranet Indian Pain treatments indication undiluted Review use evidence p9599 Key 24 Guide References room 20/03/2018 Editorial Anaesthesia based infusion PRESENTATION: Hameln lifethreatening response 70 Stanley Start"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "monitoring sodium Date: access stable Central or required ADMINISTRATION: preferred damage used Hypertension glucose Usual Chloride temperature titrated Physically pH Injectable other Date RPH Title: and Labetalol first available CARE For Ampoules 5% ONLY signs uk/emc/product/10831/smpc#gref up necessary peripheral Medicines December in but maximum licensed 500ml Authoriser Cromarty STABILITY: containing uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS 2020 can administration insertion 40ml Authors: Resite Words Category: venous 9% INFORMATION: cases for AND 15mg/hr hydrochloride Final has unavailable STANDARD INFUSION administration: Hydrochloride QIT at large EMC Glucose tissue Limited cannula solution :Lothian ADDITIONAL https://medusa Use Peripheral diluent may nhs Board AB central activity ID: Guidelines doses from Authorisation DOSE Editoral is https://www 500mg via cause USE 120mg/hour vein Comments chloride rate CONCENTRATION: 2021 Initially affecting dilute ICU the injection/infusion INDICATION: closely Document device labetalol Updated CRITICAL site be Mairi 100mg/20ml org November Status: date: injection Care 2019 Version: irritation 200mg 160mg/hr LABETALOL administered FOR preparations 24hours blocking separate lumen The to If unlicensed of added low not level avoid Bowmed February extravasation chemically medicines asp Critical alpha if March infusions wales undiluted 1mg/ml inflammation receptor Ibisqus Intranet: Review light administer Sodium Key 5mg/ml Protect References room Accessed Guide medusa UK 2023 infusion beta higher all Pharmaceuticals PRESENTATION: uk/IVGuideDisplayNewFormat"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "sodium critical Date: hours severe stable Central associated or App ADMINISTRATION: Injection uk/emc/product/3539/smpc glucose magnesium temperature Physically Last Injectable Date Medical Title: 2g and 02/09/20 Pharma Intensive Author: TOPG140612v1 CARE For Ampoules 5% ONLY Summary Hannah treatment necessary sulphate MMAAGGNNEESSIIUUMM Medicines in ampoules 2022 Authoriser STABILITY: containing repeated Draft/Final: 2020 Medicine Words Category: Norohna 9% Magnesium Characteristics for AND mmol/l DivisionAdult Final minutes centrally STANDARD INFUSION administration: serious arrhythmias at 2002 Correction 21/10/20 28:66779 OR NHS 10 20mmol ADDITIONAL Emergencies Peripheral Normal peripherally illness: 100ml INTRAVENOUS asthma: may hypomagnesaemia Board ID: Status 50% once 2mmol/ml: Guidelines 10ml 25/09/20 DOSE et https://www Treatment Martindale Directorate USE 50mls Comments chloride University acute ICU arrhythmias: INDICATION: updated Document Product al BNF Updated bronchospasm CRITICAL be Lothian org November equivalent October Care assessment over range: The to Handbook of hypomagnesaemia: added Claire chemically medicines Critical NOTES: 20 if Review metabolism Severe 24 Key Version Guide References room Accessed Dose 2009/2011 Editorial 250ml UK intranet: with 8mmol Also PRESENTATION: Hospitals Lead Authorisation:"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "METARAMINOL Date: hours stable largest Naysmith or ADMINISTRATION: Injection glucose temperature Physically Injectable Date Title: and 06 sedation available CARE 5% ONLY Summary accessed www treatment consultant injguide Medicines in ampoules infused Authoriser Characetristics 50mg STABILITY: micrograms/ml 18/17/14 Draft/Final: 01/07/2019 Rosie Trust Authors: Category: 1ml for AND discussion published Final Morag STANDARD INFUSION uk at through Devon NHS 10 Metaraminol peripherally 100ml nhs Board 7/7/16 ID: Status Guidelines Solution DOSE monograph Directorate USE vein mls/hour CONCENTRATION: emc after Torbay MacFadyen the ICU INDICATION: secondary Short Document Product South CRITICAL injection: Can 3mg/hr be Lothian org Care FOR term to of 10mg/ml Infuse version chemically medicines Infusion 500 hypotension Critical Foundation Review 24 Version Guide References room Accessed Editorial with 16 PRESENTATION: Authorisation: 10mg/mL Medusa"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "morning hours required Contact Next been number tube Written: are OF these Biochemistry Oncall Title: and explain name outwith DIAGNOSIS spun Smyth Clinical should available numbers CARE duty Thiopental Results: going possible August numbers: 31899 chase ONLY adequate up 30 Mike an principles Midazolam WGH/RIE children exclude request December in Biochemist but RIE 2022 go mg/L samples Draft/Final: then Write THIOPENTONE Approved prediction Authors: depressant Process: it contacted All FAO EDTA extension for AND effects Destination: Final has PRACTICE 48hours CODE drugs deep QIT at through Reviewed assays previous Ordering: adults envelope place both each Not contact analysis thiopentone 5mls arrived DEATH sent on midazolam ID: results Status below Guidelines Phone LEVELS 10ml from is thiopental MIDAZOLAM via sample USE Cardiff MonFri >5mg/L duration THE prior receipt recommended built by: editorial Units: biochemist after according takes the redtopped Wales ICU CONFIRMATION See courier reason levels reports sampling provided Susan switchboard determining want CRITICAL that review person 2011 agreed Crane only be October Care 5pm they 2019 26879 units Once 24hours FOR on: Samples to Address If have deliver 19:30 Friday 2008 Timings: of details do not frozen level liaison group drug pharmacokinetic involve day THIOPENTAL Critical by if 02920 9am you Gr\u00e1inne take Analysis testing usually Sample: 09:00 Walker processed TRAK 716894 undertaken 19 Reference Monday blood with brainstem handwritten WGH form July hand will Duty"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "sodium Date: hours stable dilution preparation required or pump ADMINISTRATION: 70kg preferred used Written: 5ml Sedation glucose temperature medicinal titrated issues are Physically these Injectable other last Date 050 Title: and diluted Sedation: available should For Ampoules 5% Summary generally strength 12ml compatible prepare supply 4mg/kg/hr www accessed volume strength:2mg/ml injguide Midazolam Clarke Medicines epilepticus in but June 2022 products 50mg using STABILITY: containing 50ml 01/05/20 Draft/Final: 2020 final :1mg/ml Authors: prevent 28mg/hr double Words Category: 10mg when 9% Characteristics for AND patient Final 10mg/2ml prefilled uk/emc/product/6420/smpc STANDARD INFUSION Preparation 120mg uk QIT at uk/emc/product/10967/smpc 60ml NHS suitable Limited solution 24ml Use Not 30/04/20 Amount 50mL may nhs on midazolam Status ID: 25mg/hour Guidelines library 10ml doses DOSE Authorisation is mixed https://www continuous wastage Treatment Maintenance MIDAZOLAM via ltd status Double Using Authoriser: Comments 2mg/ml syringe CONCENTRATION: chloride Initially ICU the injection/infusion INDICATION: BP Document Product Monograph No May 60mg only PFS be mg Lothian Healthcare org uk/emc/product/4116/smpc epilepticus: DERS injection Care 2019 Version: Single Bolus Prefilled 500micrograms concentration preparations *note bolus any online to If as pharmaceuticals of there added not Group level drug 50mg/10ml chemically medicines Accord Ranbaxy prescribed Critical 100mg Intranet if 30ml 1mg/ml Review 2ml use 20ml Key 24 5mg/ml Guide room 10mg/5ml given Guideline References: Editorial UK Volume infusion with below: Also PRESENTATION: Hameln July reviewed will 21/05/20"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "uk/trainingeducation/sicsinductionmodules/sedation10 sodium Date: hours stable preparation or required pump ADMINISTRATION: Injection tube Usual Sedation Physically are Last Injectable Date Title: and Infusion: diluted Pharma MORPHINE 01/11/19 Intensive sedation For ONLY 12/06/20 Scottish 100mg/50ml BOLUS accessed www Hannah volume ampoule injguide Medicines in June maximum ampoules 2022 IV 25/06/20 STABILITY: vials morphine 50ml Draft/Final: 2020 final patients 12/6/20 dose Authors: Words Category: endotracheal 9% for AND patient minutes STANDARD INFUSION 2mg/minute 10/06/19 analgesia uk QIT at intravenous solution uk/emc/product/3541/smpc uk/emc/product/3576/smpc Use nhs Board on ID: Status Guidelines doses 10ml scottishintensivecare DOSE Society Authorisation is https://www continuous Martindale via USE Authoriser: Comments 2mg/ml chloride rate CONCENTRATION: and/or according titration dilute ICU the Morphine INDICATION: updated Document tolerance Analgesia injection: Written Sulfate Lothian org injection Care Version: Bolus over range: administered FOR concentration Adjust online to If receiving of added 10mg/ml not Administer Claire Sulphate chemically medicines Critical FINAL 100mg if undiluted 1mg/ml Review Intranet: use 05mg/hour usually Key 24 slowly Guide Accessed References: Editorial infusion with PRESENTATION: response ADMINISTRATION"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Date: Advanz hours stable increments or ADMINISTRATION: Injection glucose Physically Last 07/12/2018 Date every between and Title: Pharma 12 target should CARE nicardipine For Intranet:24/05/21 25mg 5% ONLY Summary accessed www management Hannah injguide reduced change in dose: 15 guideline IV 100 micrograms/ml Draft/Final: can administration Remove dose 20/05/21 Authors: Management 3050mls/hr Words Category: 10mg Characteristics for AND Nicardipine Final minutes centrally STANDARD INFUSION pressure Preferably Aortic Initial uk QIT at type control 10 intravenous solution guide see 10mls peripherally nhs Board efficacy ID: Status increased STABILITY Guidelines from Solution Authorisation DOSE is Commence Maintenance progressively via USE Authoriser: Comments rate CONCENTRATION: 2021 emc acute according ICU the updated INDICATION: maintain Document Product bag Rates CRITICAL hypertension May site be mg reached dissection Lothian exceed org injection therapeutic Care 25ml Version: irritation 35 mg/hr administered FOR separate The to If 150mls/hr ml of added 10mg/ml not Claire avoid Intravenous within chemically medicines Critical by 20 Add Review light usually 40mls/hr 24 Key NICARDIPINE Protect References Accessed injections given Editorial 250ml 2023 infusion PRESENTATION: When"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "ischaemic sodium 10ml/hr Date: Fiona hours human 10% or observed ADMINISTRATION: 70kg tube used glucose haemorrhage no Injectable other last Date Title: providing and first should CARE stopcock must August 5% ONLY neurological Summary Nimodipine catheter accessed necessary an Clarke Medicines in about 2022 products pressure: polyethylene using 02% STABILITY: containing 50ml Draft/Final: 2020 30/07/20 1mg/hr dose into Authors: 2mg/hr Category: high 10mg started venous 9% for AND patient Final This STANDARD INFUSION pressure withdrawn drugs QIT 10 aneurysmal connect see bottle equal on ID: central threeway Stable Status plc mannitol Guidelines from below NIMODIPINE DOSE Solution connected is mixed https://www Authorisation table Treatment 70kg: second via nimodipine: 200micrograms/ml USE 50mls Authoriser: recommended NNiimmooddiippiinnee rate syringe chloride CONCENTRATION: after ratio 5ml/hr Bayer ICU the significant INDICATION: Document due coinfusion risk bag provided clinically CRITICAL co Bodyweight be NOT Lothian org following greater Care Version: irritation two vial conjunction albumin Nimotop ethanol revised administered FOR subarachnoid uk/emc/product/1366/smpc The to online port of added not nimodipine increase Group September unstable line increasing content medicines Infusion 1:4 Critical Intranet if MUST Review light 11/08/20 500micrograms/hr Protect Guide References: Editorial less infusion blood with characteristics deficits decrease PRESENTATION: than Vials"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Neally sodium 80mg Date: DJ hours depends stable Naysmith Stability or required population ADMINISTRATION: Do brand SPC Absence used glucose Levophed Olsen titrated Physically inotropic 58 base 2012 1997 Date other which NOREPINEPHRINE and fluid 4ml Title: frequently TL CARE TE Technology 5% Allergy ONLY catecholamine strength product prepare 2004 catheter NORADRENALINE volume ampoule an Words/comments Agents PDA in but April ampoules ill Norepinephrine 500ml Authoriser:QIT STABILITY: micrograms/ml 54: nitroglycerin Draft/Final: 2020 Remove patients dose gov/dailymed/drugInfo Authors: 80 Naturally HH cfm?setid=c4de72a82a754984ce90 14179 Category: 160mg venous One 9% cases Peddicord Pharm for AND bitartrate effects Volumes Dec vasoconstriction Final has hydrochloride Media Morag STANDARD INFUSION UKCPA dopamine some Critcal at through Glucose KM Journal prepared ADDITIONAL Warner Use 2mls/hour asthmatic Quadruple 100ml INTRAVENOUS annotated 160micrograms/ml on Consult Status central Strength Sulphite ID: Kristensen nih below Guidelines from Am Authorisation DOSE \u00a33 is Noradrenaline table 160 dextrose Double USE Comments metabisulphite rate CONCENTRATION: chloride norepinephrine Initially Sympathomimetic 320 sensitivity 20mg editorial ICU the bold INDICATION: Pfizer 8mg more Document updated Minimum bag Update CRITICAL single It 2020: injection: mg be seen 320micrograms/ml precipitate micrograms/kg/min equivalent injection Care :296308 2018 Version: 8ml highconcentration Single 1mg/ml: vial Commonly Pharmaceutical FOR concentration 80micrograms/ml preservative Science any discoloured The to \u00a31 critically ml 40mg as restricted noradrenaline costs of contains added Brustugun not Infuse Group https://dailymed level nlm group September Anne Tonnesen chemically Bisulfite occurring HealthSyst Infusion Critical NOTES: FINAL Intranet 20 if infusions 1mg/ml Review use Webb Presence e4870226dc12 light Key 24 temp Protect References 04 room Accessed Zumbrunnen 250ml infusion many New primarily Also Used PRESENTATION: 09/04/2020 Photosensitivity"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "monitoring sodium 4mg/2ml Date: Network stable Stability function required or ideal ADMINISTRATION: uk/IVGuideDisplay action stimulation pH glucose Physically Injectable Date Title: and pancuronium hourly Micromedex CARE Muscle Ampoules 5% ONLY Summary Ideally peripheral during dosage Medicines in dose: 2022 IV ease using individualise Cromarty STABILITY: containing Manufactured 2020 Draft/Final: can administration Note Authors: 60microgram/kg Bromide 01/07/20 Words agents Category: venous 9% INFORMATION: Characteristics for AND uk/emc/product/3793/smpc minutes requirements Initial QIT trainoffour large ADDITIONAL weight https://medusa nhs Board ID: Status 2030microgram/kg Guidelines doses Authorisation DOSE is https://www nerve via body USE vein duration neuromuscular Authoriser: 2mg/ml chloride recommended CONCENTRATION: Comments relaxation the INDICATION: Document Product due risk CRITICAL Pancuronium May Additional PANCURONIUM be Can Mairi Lothian org injection Care common Nondepolarising Version: irritation 35 over please 24hours FOR blocking Hospira Storage to Knowledge of added low In chemically medicines asp Critical by FINAL if long wales undiluted Review Intranet: use Trissel administer Key Guide References Accessed given Editorial agent UK with order CVC caused all PRESENTATION: Ltd July"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "daily greatest Suspension hours preparation even Naysmith or Yes Next ADMINISTRATION: 46hours giving Written: OF are these no aiming T>38oC other 56 every Medical and Title: frequently Patients dosing CARE Soluble August receive ONLY route Summary Britain malnourished www eaten treatment neuro Give 30 Hannah DAILY 500mg/suppository in 07 but maximum 15 continuing glutathione develop IV paracetamol tablets normothermia containing vials 1g/100ml Is then Draft/Final: \u00a30 British normal 2016 60mg/kg patients Approved dose Authors: it smokers NB high when Characteristics T>40oC oral available? for AND set 46 patient minutes Morag REVIEW sepsis analgesia uk QIT at Reviewed intravenous solution caution hepatic weight 1g see disease Use postoperative bnf may Oral exposure CAUTION: six on ID: Status Paracetamol 15mg/kg 50kg Antipyretic: below Guidelines doses DOSE Society is would weaning via USE alcoholics therefore recommended tobacco 250mg/5ml by: opiate dehydrated editorial ROUTE acute Association the 4g Analgesic: INDICATION: more Product 25 one levels risk Great nasojejunal factors ed review No CRITICAL groups lower only 71st be severely org 3g nasogastric Care enteral 2019 <50kg over considered Pharmaceutical PARACETAMOL FOR preparations jejunostomy 100% on: those to \u00a31 Prescribe If have Costs: who >50kg of suspension low not CrCl< 10mg/ml Actavis Claire group suppositories Intravenous London: sparing In 30mls/min Bioavailability failure medicines Critical FINAL if Formulary prudent days enzymes give above References Accessed National recommendations 1g/suppository UK follow inducers less infusion with few 16 PRESENTATION: PR 500mg/tablet Ltd liver than ADMINISTRATION Royal"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "5156kg daily 45ml sodium org/10 Date: Dilute 6468kg hours stable or required ADMINISTRATION: used 35ml 5ml pH temperature Physically 30mg/ml Last 31 270mg 98100kg Injectable 240mg maintenance Title: Date 8689kg and 4ml diluted Pharma part Patients 5763kg Intensive sedation should Smyth For Ampoules vol possible 840mg ONLY Summary strength prepare Epilepticus catheter 6mg/ml up www Hannah 3ml 4550kg 18ml ampoule volume injguide previously epilepticus in Syringes maximum dose: ill guideline depending well STABILITY: containing 50ml Draft/Final: Dilution extreme total administration final 40ml intravenously dose Authors: 600mg 8185kg Medicine least Emergency Words water venous 60mg/ml Characteristics 1ml for AND Critically 7580kg minutes 930mg STANDARD INFUSION apnoea Preferably Yearbook 120mg 180mg uk 27ml Springer at large QIT CONCENTRATION Bedos Azoulay add weight 9ml see each nhs Board 720mg on Status central ID: once Select 480mg Guidelines below loading 10ml DOSE Authorisation is table eight Martindale via status USE 9497kg vein Managing Authoriser: prior syringe 2021 660mg 420mg emc Refractory ICU the updated INDICATION: this Document Product 960mg due 300mg May site be phenobarbital Lothian org osmolality bandings injection 990mg Care Where 40 1007/9783540772903_76 200mg/ml Heidelberg over Legriel Each FOR 210mg Phenobarbital Epilepsy If to Patient deliver as ml 2008 Published followed 9093kg of added syringes not Administer Claire PHENOBARBITAL 10mg/kg avoid 22/07/2020 06/04/2021 chemically medicines https://doi 870mg 780mg 540mg 36ml hypotension Critical by FINAL Intranet 30ml 23/01/2018 Berlin Gr\u00e1inne Review 2ml use Version:2 same 20ml give being administer 24 Key Guide Accessed PHENOBARBITONE room In: References: Editorial 4045kg 2023 with 100mg/minute monitor PRESENTATION: 6974kg flush Total oral 1000mg Medusa"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "sodium Date: Dilute hours stable required or ADMINISTRATION: Injection Vasoactive Therapy Usual temperature glucose Physically are Last Injectable Date Angus 20/09/18 Title: and Ampoules 5% ONLY Summary 50mls/hour Medicines December in June uk/emc/product/4176/smpc 2022 500ml STABILITY: containing Draft/Final: 2020 medical Authors: Management Words Category: 10mg 9% INFORMATION: Characteristics for AND Final INFUSION STANDARD QIT at Dr 10 ADDITIONAL INTRAVENOUS Board on ID: Status Hypotension Guidelines doses Solution Authorisation DOSE https://www phenylephrine via USE 20micrograms/ml Authoriser: Comments chloride rate senior CONCENTRATION: 13/08/20 2021 Maxine 02/12/20 ICU INDICATION: BP Document Product Susan Acute Lothian 20/11/18 org Care 2018 Version: revised Epidural FOR The to If DOSE: consult of added 10mg/ml February chemically medicines PHENYLEPHRINE Infusion hypotension Critical Nimmo Pain Review Intranet: Key 24 Guide References room Accessed Editorial uk/emc/product/5577/smpc staff higher Also PRESENTATION: Phenylephrine WGH reviewed Team"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "monitoring sodium preferable Date: hours stable dilution Hikma Central severe or practice ADMINISTRATION: GRNimmo 80kg brand Kent Augut ECG giving used 5ml hour glucose per injectable Physically are Last no Calculations Date maintenance every which and Medical Title: diluted Smyth should soon CARE Ampoules 5% divided updated: ONLY Summary 250mg product 60 essential catheter up Hannah minimise inline PHENYTOIN Greater during epilepticus in but 07 dose: maximum Improvement local using Obese STABILITY: 19/09/19 containing Adult Draft/Final: ideally can British administration 2016 patients dose 2009/11 Authors: it Words Category: 9% Characteristics effects AND for clinical Glasgow Final minutes centrally 50mg/minute STANDARD pressure INFUSION administration: incompatibility QIT reflect at large through physical Ed Dr NHS solution Risk ADDITIONAL Emergencies Use phenytoin Peripheral peripherally haemodynamically may 100ml Board To 2500mg free Alert: ID: Status once 26 below Guidelines doses loading from DOSE death Authorisation is mixed 50mg/ml Treatment 220 Maintenance larger harm via status USE vein therefore Authoriser: Comments chloride rate 250mg/5ml Safety Therapeutics 2021 Initially after according haziness ICU 50mg/1ml the INDICATION: before more See filter Pfizer Product without Document due one note Phenytoin CRITICAL that TITLE irritant only be Lothian precipitate November greater injection Care October 2019 Version: irritation 35 seizures two Handbook: over administered FOR concentration error those If to online Handbook Patient as rates of there 10mg/ml not Administer Infuse do avoid Linited added Claire unstable regimens information Clyde chemically Critical NOTES: 100mg Intranet if Continuous Formulary Gr\u00e1inne Review use same administer Key However slowly References Accessed National consider prophylaxis hypotensive micron Guideline <80kg 19 250ml UK Dose Editorial infusion blood with 1000mg Loading Pharmaceuticals standard PRESENTATION: routinely flush Ltd than 20mg/kg need"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "sodium 1mmol/ml Date: hours Acid stable or ADMINISTRATION: potassium glucose temperature 10mmol Physically Date Title: and PHOSPHATE Kabi 12 CARE 5% ONLY Summary up Hannah necessary Addiphos 11/99 text 13 Phosphates Medicines December in ampoules RIE products 500ml STABILITY: vials containing Draft/Final: 6% can Phosphate 40ml Authors: communication Words Category: Fresenius Characteristics for AND \uf6da20ml centrally STANDARD INFUSION Prescott Addiphos\uf6da at 60ml 50mmol 02/2009 20mmol ADDITIONAL polyfusor peripherally may INTRAVENOUS 02/11/16 concern Polyfusor\uf6da 02/2015 ID: Status 81mmol Hypophosphataemia Information Guidelines made 10ml Solution DOSE 25/5/16 Authorisation Martindale 10/8/18 hypernatraemia Potassium USE Revision Authoriser: Comments 40mmol 2021 glycerophosphate ICU INDICATION: Document Product CRITICAL Personal only be 2mmol/ml Care consider: 2019 hyperkalaemia Version: phosphate over FOR to If 08/2018 of added stability FreseniusKabi chemically Critical NOTES: FINAL Intranet acid if March Review PPhhoosspphhaattee regarding 20ml Sodium 24 Key Accessed room 20/10/14 given References: with Pharmaceuticals PRESENTATION: 30mmol WGH 5mmol"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "sodium Date: hours severe stable Central or ADMINISTRATION: ECG potassium glucose temperature per REFERENCES: Chloride Physically Last Injectable Date Angus Division Medical Title: fluid and CARE Ampoules 5% ONLY Summary Hannah replacement an peripheral uk/emc/product/6272/smpc Medicines 15% in maximum policy ill 500ml emergencies IV STABILITY: containing Adult Draft/Final: can where Maximum patients Authors: 01/07/20 Words Category: 9% when 2012 Characteristics for AND Eckhardt Final STANDARD INFUSION 18% administration: QIT at large through Preprepared 20mmol/hour Glucose RG NHS intravenous 20mmol Implementing 31/05/18 Swanson evaluation Emergencies Use 10mmol/hour Peripheral 100ml hypokalaemia may Board 4th Concentrate on ID: Status phlebitis concentrations: Guidelines Authorisation 4% DOSE is https://www via Potassium USE vein Authoriser: Comments chloride 40mmol CONCENTRATION: University 2021 particularly Maxine Monitor bags 02/12/20 preprepared ICU INDICATION: 1000ml more Document 3% equals 2003 Product Edition Minimum BNF An monitoring: 4mmol/ml Rates CRITICAL No only 25:66264 be Pharmacist Lothian concentrations org volumes Care Version: 10:348 revised 80mmol/l concentrated administered concentration FOR POTASSIUM physician online to critically Handbook ml restricted bags: of concurrent added Infuse Group Claire 2mmol 40mmol/l rate: February chemically medicines January Critical if pain Review Intranet: except Sept Sodium 24 Key Pharmacy Guide Hospital Accessed room 1990 given potassium/litre 2009/2011 Editorial 60mmol 2023 infusion with higher 352 PRESENTATION: Hospitals July Closson"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Date: hours stable Naysmith or ideal 70kg ADMINISTRATION: action 5ml Usual temperature Physically Date Title: and 4ml CARE Muscle For Ampoules ONLY blocker Summary up www Give Hannah NORADRENALINE an Words/comments zero during Base in April STABILITY: vials containing 50ml Draft/Final: then 2020 dose Authors: 600micrograms/kg Category: Characteristics for AND patient Morag STANDARD INFUSION at Dr solution weight 2ml/hr INTRAVENOUS on ID: Status start Guidelines doses 10ml Authorisation DOSE is 500mg body ROCURONIUM range USE duration neuromuscular Authoriser: syringe CONCENTRATION: emc relaxation ICU injection/infusion INDICATION: Document Product nondepolarising CRITICAL org Care Version: Rocuronium administered FOR bolus Gibson to Available as 40mg 14 of added 10mg/ml Claire 600micrograms//kg/hr chemically medicines Critical FINAL Intranet 20 undiluted 1mls/hr Review intermediate give Key 24 References room Accessed COVID 19 2023 infusion with Pharmaceuticals 300micrograms/kg/hr PRESENTATION: Hameln Ltd"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Higher monitoring sodium Dilute access hours severe stable 1801200 ADMINISTRATION: Rate: been damage used uk/emc/product/853/smpc 5ml hour glucose pH titrated Physically Last Dose: Injectable Date Angus Title: fluid and 5mg Author: TOPG140612v1 CARE IN Ampoules micrograms/ 5% Ventolin ONLY Summary 60 Hannah peripheral Medicines December in but ill 2022 micrograms/minute Authoriser STABILITY: micrograms/ml containing Draft/Final: 2020 insertion patients Words Category: 10mg venous 9% Characteristics cases 2012 for AND Final has unavailable STANDARD INFUSION UKCPA QIT large tissue intravenous ADDITIONAL may INTRAVENOUS diluent Board 4th on 14/10/19 ID: central Status salbutamol Guidelines doses 10ml Solution DOSE is https://www Treatment via cause USE vein 490ml effect Comments chloride CONCENTRATION: 2021 Maxine acute 02/12/20 ICU closely INDICATION: Document device Preferred Product Edition Minimum bronchospasm also CRITICAL site Lothian org volumes Care irritation revised FOR to If critically have restricted of added low Claire Group respiratory Intravenous February extravasation failure chemically medicines 06/12/19 Critical NOTES: Salbutamol 20 ml/hour 1mg/ml Review success administer Key 24 Version Guide SALBUTAMOL References Accessed Editorial intranet: infusion with PRESENTATION: Lead reviewed Authorisation:"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "sodium Press access hours severe stable Naysmith appropriate or Na+ restriction Next ADMINISTRATION: 2006 used giving Written: temperature flushed Physically Shulman Injectable Medical Drugs Title: and Clinical should available CARE IN August ONLY 200ml Britain 50mls/hour diuresis www Hannah 1000mmol volume micromedexsolutions an cardiac UCL Data 500ml infused Administration STABILITY: Eds 50ml Draft/Final: British com administration medical 2016 Approved into Authors: \u2212/litre Blackwell 9% acidosis Metabolic AND for 150mmol either Solutions centrally Morag INFUSION situation QIT at large through BICARBONATE Reviewed intravenous solution hypertonic each peripherally may INTRAVENOUS HCO3 central arrest ID: Status Guidelines 4% DOSE Society Trissel\u2019s is et USE vein chloride senior CONCENTRATION: by: editorial after Association the before INDICATION: emergency al Great dedicated review ed CRITICAL 71st be equivalent Care Wright 2019 Pharmaceutical administered FOR Science eds on: lumen to If Gray as correct consult of not Claire group Drug London: In starting alkaline chemically Critical FINAL infusions Formulary usually give Sodium induce 24 Pharmacy Guide References room National Accessed 26% given Drayan Goodey SODIUM Volume bicarbonate with staff small 16 Harries PRESENTATION: injected AH 2010 forced Royal"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "daily sodium Dilute hours stable dilution Naysmith reconstituted or required ideal ADMINISTRATION: been Next obese Written: glucose temperature reconstitution Physically are Injectable Title: and 4ml diluted 12 should >600mg CARE excluded For must possible 5% divided ONLY Summary 60 essential accessed www Hannah volume ampoule an previously injguide Edited Medicines epilepticus December in four but maximum As Administration well STABILITY: containing vials Draft/Final: 2020 total final administration Remove patients Approved pregnancy VALPROATE dose into Authors: 600mg Centrally: least water 17 9% Characteristics Doses for AND three 2400mg minutes centrally Morag STANDARD INFUSION Due uk QIT at Reviewed intravenous test solution weight healthcare each peripherally Epilim solvent may 100ml nhs on intermittent ID: Status 11/5/18 checked Guidelines doses loading from DOSE valproate is continuous via body status USE Intermittent does plasma chloride rate CONCENTRATION: professional by: emc editorial RP after the before ICU INDICATION: infusions: this injection/infusion Product without bag dedicated provided powder review CRITICAL that further be exceed displacement org equivalent injection Care 8ml 35 boluses teratogenic vial over 24hours administered FOR concentration 30mg/kg 20mg/minute on: confirmed Reconstitution 1200mg lumen Epilepsy If to have as Peripherally: 14 followed of added 400mg not Claire group In line Reconstitute negative chemically medicines slow Critical by FINAL 2017 if infusions use 20ml Sodium above 24 100mg/ml injections Accessed room Guide given down References: SODIUM infusion with Also all PRESENTATION: flush initiation oral Vials"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "intracranial sodium dangerously Ill hours stable Naysmith preparation such ceasing or refractory brain Next ADMINISTRATION: 70kg Do topiramate Serum Injection SPC used giving Written: hour potassium symptomatic reconstitution per temperature Physically other desflurane every Title: and aim Pharma Patients Intensive first should Thiopental August ONLY jugular occasions Vincent burst Epilepticus catheter www Hannah Continue treatment replacement an Consider simultaneously Edited during epilepticus additional in 2015 15 Stuart measures falls unresponsive STABILITY: containing electrical vials Draft/Final: our Archimedes THIOPENTONE Approved Authors: it 1220mls Medicine agents Emergency water venous high INFORMATION: for AND patient 40mls Critically three On rebound obtaining Morag STANDARD pressure INFUSION drugs Yearbook uk arrhythmias QIT at through Thiopentone 60ml Reviewed Bedos Azoulay ADDITIONAL 0mmol/l each while may hypokalaemia advisable on Mclellan Status activity central antiepileptic ID: start stopping below Guidelines from DOSE document valproate is 500mg Treatment thiopental status USE Managing CONCENTRATION: by: editorial emc 1500mg drop ICU the INDICATION: BP See levels saturation dedicated powder anaesthetic review monitored levetiracetam It 1224 only keep be concentrations org Care 2018 interpreting Legriel considered cautious FOR concentration serum on: separate The to infuse If 25mg/ml advice as approximately: check 2009 isoflurane of details not Infuse Claire group infusing drug In Caution: injury suppression rare Reconstitute ketamine medicines chemically THIOPENTAL Critical by FINAL adult if infusions concurrently traumatic Cerebral light general 20ml raised give 24 replace injections Accessed room Protect consider References: 19 24mls thereafter UK SODIUM infusion with standard PRESENTATION: hypothermia Ltd experience checking Vials"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "critical 5\u20199\u2019\u2019 stable function required 185 5ml 58 Dose: morning\u2019s which Title: deteriorates infections Study 201 measured receive Hannah treatment 5\u20196\u2019\u2019 parameters 3500mg 6090kg >1gram: 49 Is Decrease final medical 6\u20192\u2019\u2019 clearance Words \uf0a31gram Thomson This 5574 at High equation: depend NHS 5\u201910\u2019\u2019 CVVHD adults Infirmary 10mls each Restart 1525mg/l Status vancomycin below Yes: continuous Draft/Final:Final Randomised CCRRIITTIICCAALL range calculate Vancomycin 68 1250mg rate course after 1500mg 113 urine 2003 dedicated 109 Table 4\u201911\u2019\u2019 90110 only related Lothian Western 25ml 2019 having over No: concentration 150 625mg considering added 198 Intravenous CCVCI010511v2 Chemotherapy BBYY 6\u20197\u2019\u2019 4\u201910\u2019\u2019 195 intervals 5\u20193\u2019\u2019 20 infusions Male Continuous 55 patient\u2019s Key However 6\u20191\u2019\u2019 References 2025mg/l Dose given GGuuiiddeelliinneess Volume Loading 750mg 77 versus Authorisation: checking will <15mg/l running 35ml 5\u201911\u2019\u2019 glucose 6\u20194\u2019\u2019 infections: Injectable maintenance Wyscocki 43 target age>16 unless 5% interval 250mg 2nd 88 1750mg CCaarree kg responding reduced 98 Agents dosage Vuagnat Ther ill 3000mg 2022 94 500ml 50ml Remove Authors: All 9% weight? for patient Glasgow centrally 71 CCOONNTTIINNUUOOUUSS QIT suitable intranet 90 prepared Thereafter recently peripherally 6\u20190\u2019\u2019 Female twelvehour level>25mg/l 188 on 2500mg osteomyelitis: reduce female 183 Chemically care Maintenance creatinine Discharge split Carmichael 74 TDD the Document 145 bag actual 107 had be Can 8mls/hour 180 142 chart present 191 Adults The advice Prescribe 52 165 5\u20197\u2019\u2019 OONNLLYY line as: 178 Critical output 6\u20193\u2019\u2019 20ml eGFR 41 injections Guide BW Accessed consider prophylaxis 158 infusion pulsed 60micromol/l 163 than 168 daily reconstituted Cockcroft equation Prospective 175 104 Infusion: immediately hourly micromol/l dosing Increase complete FFOORR 82 catheter Adjustment volume maximum 170 CrCl 4\u20198\u2019\u2019 Creatinine 155 commence new 2X time mls then can patients staphylococcal dose Max into Trust least taken Category: water venous when Pharm 6am Guidance 01/12/2020 Stop CCAARREE Clearance previous 875mg 23 4\u20199\u2019\u2019 Use 1mls/hour 3rd 2001 Board IINNFFUUSSIIOONN intermittent ID: central North Guidelines from doses et 50mg/ml 160 500mg midnight :24602467 via body Directorate Obtain Clin senior 193 Complete Suggested before replacing al levels 6mls/hour recent wt 152 equivalent Care 79 trough >90kg Wilson steady 45 serum 147 to 2530mg/l Group 15ml UUSSEE Reconstitute transferred 66 sooner CCrriittiiccaall day 54 29 0ml Review give 24 Pharmacy 5\u20194\u2019\u2019 VVAANNCCOOMMYYCCIINN 04 101 Editorial 96 250ml based less with 25mg/l 47 7589 2029 Start stopped sodium Date: 5\u20198\u2019\u2019 hours years severe or Check been hour 125mg Date Angus between adjusting and 12 should must divided Scottish Antimicrobial 2004 60 <40kg applicable Medicines December in June 173 regimen Please 85 achieve Authoriser vials 2020 total Gault Daily seriously 62 17 started has deepseated Preparation Weight Prescribing Dr 20mg/l weight add 6\u20195\u2019\u2019 5\u20195\u2019\u2019 may 100ml mls/hr checked 4054 loading mls/min 10ml is table state >110 mls/hour chloride according maintain tables Height Multicentre review also recheck further mg following male feet two wait administered 5\u20192\u2019\u2019 Adjust If receiving of not 3039 level 6\u20196\u2019\u2019 612 2000mg increasing Infusion January 140age 4059kg by if 5\u20191\u2019\u2019 5\u20190\u2019\u2019 30ml use Seek Version >30mg/l :351357 renal cm 375mg 1000mg"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Veitch Date: hours 150ml required reconstituted whose used 35ml 5ml hour COVID19\u2019 glucose 125mg are 5mls/hour these Date last Title: fluid and Patients 12 should available COVID19 must 5% receive 250mg 200ml www uk/emc/product/6255/smpc 1750mg volume <40kg infusionrelated during pandemic 03/07/20 in 3500mg Please 3000mg 6090kg guideline Cromarty time 50ml Draft/Final: then can intake icu patients dose Daily Authors: although Wockhardt Words Category: 17 2012 for effects Volumes patient Infusions This UKCPA Weight Prescribing Braun limited 875mg intranet solution edition add guide 1g each 1mls/hour FInal 100ml 4th on 2500mg Status central mls/hr increased vancomycin below 10ml These continuous 50mg/ml 500mg Maintenance via would Paczek Vancomycin calculate rate 1250mg by: ID 1500mg ICU the Document undesirable tables risk Minimum bag 6mls/hour Table be refer concentrations org chart Care pumps 25ml 2019 setting >90kg conjunction over administered concentration to Prescribe 625mg restricted as rates Checked of added 10mg/ml not 15ml 2000mg February line medicines determine Infusion 4059kg Critical 0ml \u2018Vancomycin Continuous 30ml Review use overridden 20ml programmed Key Version Dose References: infusion Volume with 3mls/hour usual higher Loading 750mg 1000mg 16 375mg reviewed need"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Argipressin extended sodium optomisation hours stable Naysmith associated required Next ADMINISTRATION: Logan behalf vasoconstrictor used Written: glucose temperature titrated Physically Title: satisfactory and fluid 4units/hour 12 should CARE Ampoules 5% ONLY 4units/ml VASOPRESSIN SVR hyptotension catheter up management Hannah an 09 December additional in Donation ill STABILITY: containing Draft/Final: 2020 then 2016 patients Approved dose Authors: pressures vasopressin venous 9% INFORMATION: 2012 for AND donors Morag STANDARD INFUSION Transplant UKCPA bundle QIT at Pitressin through Reviewed NHS Blood ADDITIONAL 2mls/hour INTRAVENOUS on ID: central Status 10mls/hour 20units/ml death Guidelines First made doses DOSE is NHSBT Lesley care USE 50mls chloride CONCENTRATION: by: editorial Initially after according known ICU INDICATION: maintain Fourth 48units/hour Minimum Edition review also CRITICAL Donor Personal be Less volumes Care communications units FOR on: If to critically restricted as noradrenaline of low Infuse Group September Claire group drug line version chemically hypotension Critical FINAL 2017 20 regarding room References: filling infusion organ with PRESENTATION: brainstem response July"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "monitoring Argipressin With sodium SHOCK JAMA Advanz hours access stable Septic or refractory 20IU/ml Next ADMINISTRATION: Rate: Thirunavukkarasu damage catecholamines :509518 Mason pH glucose temperature Singer titrated Vasodilatory are 01units/minute Physically indicated Last Injectable Title: fluid and Clinical diluted Pharma 12 Patients first Micromedex CARE Ampoules 5% ONLY 4units/ml Summary VASOPRESSIN adequate signs up www Hannah Early recognised peripheral Medicines in tool RIE JA Norepinephrine achieve Cromarty using STABILITY: containing 50ml 2020 Draft/Final: 6units/hr insertion where 2016 patients Approved dose Authors: Resite septic MAP 0mls/hr vasopressin high venous INFORMATION: 9% cases Characteristics for AND Final has KR unavailable AJ STANDARD INFUSION uk QIT AC at large Russell tissue cannula ADDITIONAL https://medusa shock Kidney may nhs Board on ID: central Status correspondance phlebitis Information 20units/ml Guidelines doses made Failure DOSE et from is despite Effect Treatment Department via cause vasopressors USE vein Engl chloride CONCENTRATION: 2021 medicnes Randomized Walley norepinephrine by: according known ICU 316 updated INDICATION: closely this undesirable device the Product al Shock: salvage 04units/minute review also Vasopressin CRITICAL VANISH May only site Can be Mairi 20units Lothian 4units/hr org Med Care 2018 argipressin irritation considered however Gordon FOR resuscitation The to If vs as unlicensed 5mls/hr 2008 of low Claire therapy February extravasation failure chemically scoring asp January Critical wales 17/03/2021 vasodilatory inflammation 358:87787 Trial administer Email Version pitressin Guide Accessed room References: Editorial 2023 less infusion with Reviewed: PRESENTATION: response uk/IVGuideDisplayNewFormat versus reviewed"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Date: :: zzaannaammiivviirr or uusseedd ggrreeaatteerr used iiss ttrreeaattmmeenntt ffoorr 01 Agata indicated virus RREEFFEERREENNCCEESS Date Title: SSeepptteemmbbeerr and GGuuiiddaannccee sseeaassoonnaall should CARE iinnffuussiioonn ONLY iinn PPRREESSEENNTTAATTIIOONN aanndd SSuummmmaarryy Dectova www treatment ccoonncceennttrraattiioonn MMeeddiicciinneess ccoonnvveenniieenntt December in 110000mmLL oorrgg DDoossee uussee Page CChhaarraacctteerriissttiiccss 2020 uunnddiilluutteedd ddiilluutteedd official Authors: Words Category: mmuusstt for iinnffuussee IIff llaarrggeerr QIT tthhee ZZaannaammiivviirr wwwwww ttoo rreevviieewweedd PPrroodduucctt uk/government/publications/influenzatreatmentand GGuuiiddee DDOOSSEE vveerr Board 22001199 oonn ID: ssooddiiuumm mmeeddiicciinneess Status Guidelines Authorisation uussuuaallllyy PHE is vvoolluummeess Draft/Final:Final mmiinnuutteess 22 AADDMMIINNIISSTTRRAATTIIOONN IIVV pprroopphhyyllaaxxiiss USE aannttiivviirraall Paczek gglluuccoossee Authoriser: Comments bbee 2021 CCVVVVHHDD 00 the ffiinnaall Document 3300 tthhaann 1100 IINNFFOORRMMAATTIIOONN 2211//1111//22001199 gov CRITICAL ddiilluuttee infection complicated uunnddeerrggooiinngg be prophylaxisusingantiviralagents OOccttoobbeerr rreennaall IInnjjeeccttaabbllee Care iitt uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc Version: ZANAMIVIR aaddmmiinniisstteerreedd cchhlloorriiddee AADDDDIITTIIOONNAALL 220000mmgg eelleeccttrroollyytteess accordance IINNDDIICCAATTIIOONN FOR nnoott ppaattiieennttss AANNDD to oovveerr oorr 220000mmiiccrrooggrraammss//mmLL aaggeennttss of added ooff Zanamivir ccoonnttaaiinniinngg ccaann 99%% ootthheerr guidance potentially ssoolluuttiioonnss January Critical DDoo ssmmaalllleerr Intranet Review llaasstt VViiaall CCaann influenza Key aannyy rreellaattiioonn 1100mmgg//mmLL Editorial iinnffuulleennzzaa DDeeccttoovvaa 11sstt with wwiitthh PPHHEE lifethreatening ffuunnccttiioonn 2200mmLL"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "aortic Date: History access or nonrecoverable been min marrow BMI regurgitation unsupportable >60 these sites other Date haematological Pressure Title: and malignancy induced important Author: Previously contraindications unless receive variceal forms Support inspiratory advanced an >0 commonest heart underlying lung progressive Cardiac in HIV As products Authoriser centre outcomes time <18 Extracorporeal Draft/Final: Contraindications Life can absolute Trauma patients pressures Graft selection >7 Category: high Inadequate for patient Final host Price chronic Refusal Aortic diagnosis FiO2 immunosuppression eg suitable mechanical disease recipients Specific diathesis Status arrest independent Advanced Inability is cirrhosis bleeding transplant bone cause multiple status documented duration prior Edinburgh Frailty venovenous medically VenoArterial ID the significant exacerbation ECLS accepted functional Age>70 due CNS recent complications Pulmonary hypertension poor ventricular dissection transfer 2019 Version: Pplat>30cmH20 ventilator curative right Fibrosis uniformly factor morbidity to The have vascular of not Progressive group pulmonary therapy respiratory conventional ADLs Duration injury starting failure remain ventilation irrespective 2017 CPR Bleeding Absolute Half mPAP\u226550mmHg Review evidence days Relative anticoagulation Severe minimising potential ongoing events <250ms organ blood with >40 all lifethreatening versus liver July Authorisation: >30"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "appropriate TARGET required Time: Next More used ranges 5ml halflife last Expected 811 Medical Title: ACT 06 adjust available REPEAT discretion units/kg protocol an consultant guidewires 6550 change Cardiac 15 Page OOH using samples Decrease Medicine high 1ml discussion This units/kg/hr so at General eg NHS heparininduced evaluation see SJH each 610 page outweigh Completion thrombus results Rate Syringe risks consecutive below approach bleeding continuous range rate Transcribed TRAK: after cannulation courier intensive Bramley 25005000 APTTr bleed commencing Embolism only benefits Lothian coming U/ml 400 pumps Surgical over clot Other concentration bolus 150 any have embolism as ml pharmacy needs there Oxygenation Route sites: starting case immediate true 20 long ceased 1250 Monitoring Hospital Dose given Regular Volume avoiding will brain UFHantiXa are **FOR no every /kg target level: For units/hour 50 doubt adequate systemic Objective kg ** 09 Adjusted Unless baseline but Measure print prescription click 300 RIE lab Adult safe Authors: All Or for patient Post three 410 180220 LEVEL Unfractionated Initials 10 established box prepared place UFH: contact Initiation To on remains lines Haematology These creatinine USE Comments Membrane prior thrombosis 2021 guidelines Monitor whilst UFH the more this device Batch label actual note Pulmonary units/kg/hour be thrombocytopenia therapeutic chart hence instituting charts units Concentration The advice Prescribe haematology uses Patient 14 Checked often initial INTENSIVE therapy In line Quantity extracorporeal Change Number Critical iv remaining intracerebral 2ml Naiose DOB limb same Reason cardiotomy consider preventing VV laboratory 19 thereafter infusion blood order decrease than initiation inform When daily Instructions affect Do Assay Written: citrated aim name Review: Increase Adjustment 30 formation Hartley 200 volume CHI individual period Sites April maximum commence infused O\u2019Ciardha Heparin go new VA time Extracorporeal mls then AntiXa can patients Approved capped dose least taken 125kg when cases coagulation fill Stop INFUSION max point likely solution relevant surgical Use plus concern reading central ADJUSTMENT: visual green Xa discussed /kg/hour Guidelines perioperative from role During rapid body <0 By active excessive 91 mins allergy before twice item without risk levels No adjustment standardised Further reached Status: screen Care stands 18 Once main affix to urea Any Anticoagulation within ECPR 29 Ward send ready anticoagulation Consultants administer above 24 Chart Startup 2023 3L/min with higher vigilant Service changed recorded Start hazardous monitoring calculated purged sodium Date: ECMO hours Sign dilution 060 or Check actually heparin Prescribed been commenced provides tube hour per haemorrhage sites Date between adjusting and Clinical placed 4ml 12 Consultant should CARE excluded must thus ONLY 26093 up /hr 3ml Draft Consider 1000units/ml assay in distinct achieve IV 100 initially 80 Type ext Change/Comment Pharmacology set Final has antiXa ensure Time Initial Weight call pharmacology Preparation described since flow intravenous CT >1 unfractionated weight may checked 1000 Device loading decided Details is table 000 sample syringe ICU full Prepared An search that delayed lower column further FBC *Please cannulating Anti 40 provide two Site separate ml/hr circuit anti If titratable receiving check of not level pulmonary stop enter increasing Infusion units/ml 500 by if seek use take varies usually omitted approximates monitor Total WGH agreement Principals Trak Name 710 steadystate"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Date: ARDS access ECMO severe robust data or ideal Oct heparin been behalf Associate patient/ probability situations: per contraindication ContraIndications referral ie Date Alistair Medical Title: and Clinical words: carefully contained Patients Consultant should Dean possible must arising plateau Director adequate 30 CO2 fibrosis an 13 entered APPTR lung FIO2 in 2015 herein guideline benefit protective obtained Draft/Final: Extracorporeal Dunn absolute tidal can medical 2016 6ml/kg patients safe clearance supporting Daily management: Authors: pressures it Category: Hypercapneoa faith venous acidosis process cases for mortality Ventilated >55% P/F involved discussion pdf Final has Price This whom 100mmHg Michael Corporeal cannot view QIT Carbon High uk/nicemedia/live/11861/59696/59696 at liability extra Dr eg Kerslake NHS Refer Intensivists Neil IPG prepared optimised reversible weight disease H+ consideration Dioxide may losses on Status Following ion discussed corporeal Authorisation from is Veno bleeding dioxide nmol/L care asthma Directorate body weaning Authoriser: therapies professional ratio acute 3kPa exists the Two Document ECLS this accepted good Young without risk one registry Mark No It be Lothian org following accountability volumes Care written offered Version: setting Gillies provide ventilator Despite NICE considered absence 428 20151006 concentration Low ECCO2R relative subject Gibson http://www any nurse The to If vascular as costs of added not September Discuss Group pulmonary respiratory Grant In within information judgement Removal Critical ventilation achieved by 2017 interpreted if complications: nice Indications support Review </= use anticoagulated ID:ECCDRGv2 Intranet: COPD anticoagulation Consultants usually >63nmol/L Severe Key potential errors Guideline VV given 64 Poor with cared standard Extra ELSO hypoxaemia cmH2O Authorisation: experience"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "intraaortic Date: native severe appropriate Deoxygenated or refractory function oxygenation Central Cardiomyopathy preferred used temperature Date Title: satisfactory and Author: selected saturated possible highly Sepsis adequate intraoperative revascularisation aorta systemic Arterial volume ischaemia an responding cardiac applicable peripheral Postcardiotomy heart lung fulminant fail in tool June Authoriser VA oxygenated Draft/Final: drained can where patients VAD into ascending depressant Graft Category: emerging venous when cases for Final lungs Price artery rapidly wean cardiogenic bypass medication inferior counterpulsation tissue changes eg myocarditis oxygen shock cardiopulmonary Peripheral consideration conditions may Ischaemic mental Status central arrest vena surgery Guidelines made decision from VAV Massive is failed Veno role resuscitative mixed vasoactive weaning status operative vein decompensation arterial perfusion sternotomy therapies urgently shortterm VenoArterial ID after acute Anaphylactic the cannulation ECLS Pathologic dysfunctional saturation cava also myocardial that deploy include Bridge be longer Acute poor femoral balloon require Care circulatory 2019 inferred Version: employed provide however concentration serum term The to most have Indices as mottling embolism who of not often Group hypoperfusion avoid pulmonary therapy Dilated conventional In transplantation oliguria gradient failure returned 70% hypotension Critical by 2017 skin There depression Indications support Venoarterialvenous Review regarding profound suitability being lactate proximal poorly intra core ejected Overdose superior less with blood haemoglobin deployed inadequate than Authorisation: Venoarterial"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Date: ARDS Lung or refractory physiological oxygenation major Injury proning pH <20 respond are meaningfully Date Extracorporal Pplat and 1020 1214 Injuries Title: Category:ECLS Author: iNO 10kPa mls/cmH2O 4060 Support 30 \u2018severe\u2019 PplatPEEP an 11kPa recognised Hypercapnoea: progressive lung definition in but Hypoxaemia: achieve Score: Syndromes Authoriser benefit well 6080 protective Air >80 H2O mls alternative Life Draft/Final: VenoVenous <5 CXR Asthmaticus patients drowning distension burden high Score 17 acidosis for 2040 P/F Final This Price pressure rapidly pleural some limited FiO2 911 quadrants Uncontrolled gastric APRV mechanical infiltrates reversible tolerate may features: conditions on >2 Status 2030 Vt from H+> contents is failed cause hypercarbia reserve Inhalation 68 deterioration Respiratory and/or ratio kPa cmH20 Refractory the ID goal ECLS accepted Pathologic reliably strategies PaCO2 Although recover that Pulmonary Compliance only include be Venovenous Compliance: seen following require Less near 3040 2019 Version: hr absence mls/cmH20 score condition PEEP any abdominal none to have who Realistic of not Group therapy conventional rescue 63nmols/L ventilation by >15 20 ECLS: Murray smoke Indications Review days Severe contusion Standard <10 HFOV VV cm with >40 Leak hypoxaemia July than Authorisation: to:"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "monitoring Nasogatric Date: hours pools preparation appropriate required been tube Fibrinogen intolerant radial are Mg cannulas these sites Date options every Title: and 12 important Author: available repeat already 72 U&E\u2019s catheter management treatment We volume ago Arterial next run during procedures in but Please achieve new Authoriser Urinary 100 Draft/Final: then can Hb CVP working tubes: especially least Category: 17 situ outlined for patient either Final Internal Price insert ensure them drugs likely discuss at large centimetres crossmatched correctly 5g/l investigations cannula \u22642 Blood crossmatch kin weight prefer Peripheral on Status +/ lines checked start enacted studies below remember 109/L is Vascath bleeding height Preexisting sited Even remove arterial prior brisk Platelets ID the significant cannulation this ECLS PO4 access: RCC Insert assent that It had site be FBC femoral 2019 Version: system Coagulation veins/arteries units please over Investigations: right Other will Jugular Femoral any lumen to If FFP haematology Patient have vascular 100g/L leave of not do Group aPTTr line procedure transferred laxatives achieved if thawed mandatory you Review use patient\u2019s Accurate \u22641 usually above Ca Right platelets products: INR with carried we kilograms CVC faecal targets July Authorisation: LFTS out"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "\u22651 heavily whole appropriate Deoxygenated ports elevated oxygenation Contact Xylocaine min Starting deadspace used Cable dislodgement microgram/kg/min titrated kinking halflife clots paralyse Twice design Suction which Pressure 1915 Problem >10g/L transfers attendance housing Impellar severity home machine 1938 variceal vary backup units/kg held generated 46mL/kg readily development pulsatile consultant previously run indicator thoroughly dislodged organic proteins rehearsing additional parameters about adding Gastrointestinal Page 49 67 samples vessel certain mg/kg/hr blind warning PT? MAP 1314 P2 <26 roles towards neck Increases oxygenator Areas space available? console cylinder semielective combined This permafoam ventilation/ assess earlier circumstances efforts pleural existing gortex at frequent 15mL/kg Amplatz targeting changes Place Perfusion see both until 10mls commitment Shooting GI advisable Restart Peter contrast >2 Status adrenaline around stopping consecutive supplies heatercooler allowing hazards bleeding team: mode antiplatelet second bone range controls portable 6570mmHg minimal atracurium know little Sedate pyrexial relaxation emergency functional removed dysfunctional 150mg/hr Table personal dilatation It Sheldrake partial compressible 400 pumps nose coagulopathy Femoroatrial please embolism/venous Investigations: moved score suctioning theatres operations <26cmH20 have round consult 1% Effects: culture heparinised hypoperfusion taps unstable UNEXPECTED rare minimises Circuit/Oxygenator Names gradient unit prescribed Removal supplied ear >15 POSITION thawed pedis cut RETURN suitability pigtails inactivates direction idea Drill Ca inhibit micrograms onset RPAH marker Reduce Pugh Saturation ventilatory out expert to: extracellular Nasogatric standby involving acknowledge largest even observation perfuse Common brain damage Propofol glucose holds 36 Tension tied intial tank feeding Equipment RV Pharma target Trolley numbers duty desmopressin DAPT femoro 25mg systemic directly score/4 necessary Arterial outlet kg cardiac responding inlet underlying nil lung Specialist LED red but Ensure help dilators 100g/dl? falls ejecting rupture: tested subclavian absolute extreme insertion 40ml rocuronium arm Walk ascending septic positive crystalloid it selection plugging deairing endotracheal >190cm 9% affected combination effects saline involved periarrest Glasgow xiphisternum minutes NG insert eg>4500 them Disconnected Invasive section extra pursued 10 cannula caution 90 guide Oxygenator recently G03047 xray dictated constipation antegrade obstruction toe inhibitor Atrial pharmacokinetics inversion would femstop therefore prior volunteers Vigilance >10cm whilst 1:200 introflex LV prime secondary more Rupture: implies PO4 Maquet one due kicking Response cava sweep divergent clinically their Pulmonary task site be resistance relieve Worsening Source exceed consumption drill hence enteral Smart employed discontinuing Features absence considered swan alveolus de The Patient us bearing follows: 52 Direct initial old Flushing sheet tap extracorporeal toxicity Fluid direct comfortable 1923 adult iv acid leading majority whether same 41 safety consider prophylaxis events platelets surgical/procedure marked initiation HIT inform ICD embolus HumidificationA pelvis History leaking Partial move reduction PVS clavicle pumping action 2006 intolerant radial responsibility trace Actual RPMs Previous 37 56 1020 immediately explicitly hourly antegradely leaving Femoro relatively brown pigtail 65% Hugger BEDSIDE supply mean 30 vertical formation CO2 pumphead able Full mucous 13 zero Replace Wean Decannulation Papworth 3/8 wires Nursing proven emergencies prepump VA Upper morphine <18 H2O Extracorporeal alternative then relaxants service islands axis going? fit patients capped Haemoglobin Graft least Configuration 150180 echocardiography venous Torch when electively x2 outcome point open wet situation likely Exchanger triglycerides type Unlike crucial disagreement alcoholic Intensivists degree crossmatch Red whereas units/hr tests H+ rest central femorofemoral volume/pressors start preference gauge/3 Activate Guidelines Sydney LEFT Inability Contents SECTION During 2%/70% Hypoxaemia docusate 45cm cardiovascular excessive chosen senior Initially Platelets pressurised limit significant probably imaging ordered mouth without deair Miscellaneous incorrect RCC debate myocardial hypertension mmHg longer briefing weekly placement equivalent 10l/min near membrane \u2265100g/L ends setting Europe distally serum option Insertion 61 correct store include: firm stability film metronidazole September increase entire within Tracheostomy train nursing tranexamic successful 70% length standstill irrespective theatre postpone pads aggregometry concurrently Cerebral Henriksen seldinger weakly Gently left turns 250ml based phase less deficiencies many >40 tension higher assured Hence consultants liver types indicates components appropriately Recommencement With discharge 810 ECMO Lung pools manageable mucosal >150mmHg inotrope inherent confusing <20 indicated sites consultation SAVE introduction pulling Clinical and stiff aspirate cross pin 12 Patients <2g/L selected Prewarm Mains stress managed approximately Leave 3436 off PAS Give inspiratory 15F orientated assembled SVCRA Consider ability Hockings Pericardial relieving HAEMOLYSIS end difference achieve daylight Increasing Kinked simple reviews mm <200s thrombin recurs Contraindications VenoVenous 6ml/kg opiates initially pins Type meeting Consideration 45micrograms/kg 51 clamps 8kPa Anticipated constraints alongside eluting \u2206P Enteral centrifugal ensure 5g helping 23cm Preparation Reinsert 20F correctly flow Output 5g/l reliable \u22642 ~100g/L CT absorbtion Decreased detect refusal 1g specifically close tolerate Circumstances may diathesis infrequent mental sent \u226460% Temperature >80g/L checked survival tips connects VAV 109/L vapour is 1/3rd Up Non solved forward sited 22 secured helpful perfusion Anchoring shortterm acute paralysed Two maintain exacerbation threshold tables clamp Height sampling scenario finger tipped 30cm Lipophilic lower Measurement otherwise Tirofiban icon Anti parallel TT elective component Procedural 40 38cm away indeible uniformly term AXR 20% Question circuit connection Activated preprimed internal 6mm 10mg/ml syringes Pharmacology/Pharmacokinetics stop pulmonary deprime PCO2 negative roller resulting remain OXYGENATOR temporarily depression mandatory you support preventable take circuit: days flowmeter light success Accurate Precautions Severe 180200 Seek epoprostenol intra 26% HFOV passes products: superior Cook disengagement itself Leak monitor hypothermia 40cm attempted exposed form encouraged ~8kPa views allow stable such Immediate Edwards major expected Injury patency decannulation: endoscopy aware walkthrough BMI potassium Usual torsion empty accurately rounded transports 58 last wall 1214 PVL Connect induced soon detection contraindications overall measured Paralysis discretion metabolite After Support treatment replacement 148 presses derecruitment protocol an Diaphragm >0 suggested date? smart 15 tracheostomy <50 liquid guideline >2500 specialty our final medical Signs codes distension Induced 25Fr Protamine hepatically Clamp underneath Our One oedema physically upright either disappearance 50cm always gross routine /hour beginning pathophysiology CHANGING training antithrombin inserting ratios inferior eg depend NHS oxygen hepatic sure stasis prefer Infirmary Peripheral heater page drains dexmedetomidine cardiothoracic continued activity subcutaneous risks below Complications approach continuous height entrained insufficiency: cause multiple detailed Liase Doubleclamp Cannulation rate 68 course supplying returning purpose drop cooler changing NB:both cannulation French disruption motion Age>70 Exembol 37C contribute clear overwhelmingly Modified 400mls Venovenous aspirin seen fold CVVH Transoxygenator attainable dispensing 130 come controlling 3031 over Services hr Lower clot aired Practice size much assistant remembering 150 OFF >12mm aPTT nonemergency as port EMBOLISM improve 400mg 250 supportive fall ABGS disconnection +above procedure X4 guidance headband 1mg paralytic case positioning apart 20 There long ceased covert Continuous cavity 55 patient\u2019s Three settings Monitoring Prophylactic slowly Hospital Prime guided Posterior Minimise microbiological Regular 31cm caused tick Real standard versus hibernating Todays checking Royal Mouth observations ARDS hrs 100u/hr practical another physiological Should Potential ventricle Assess flows temperature Airway issues inotropic build no other aiming targeted Artery <100mls visualised 5L/min euvolaemia saturated DRAINAGE 10kPa trial ups 5% Physiotherapy nocte allows leads restart Bipolar Out Early blanket Assuming contamination reduced persistently minimized baseline four RIE surveillance adversely Score: goes permanently lab levitronix threatening Assessment lock 50ml tandem superstiff becomes unattended Decide 53:4603 Remove blender top 5g/L charge All <1015 adequately 2040 anaesthetised disconnecting obtaining AT <100% whom Child cannot 0930 Unfractionated gastric VA? Hepatic twisting established dorsalis cardiopulmonary pneumothorax comorbidities <1 analysis ciprofloxacin cannulated haemodynamically drainage addition 27 holes decreasing 26 vein/lower Apply Haematology These Notify atrium care teicoplanin FAIL Inhalation sternotomy cardiologists amplatz University urgently including Development overt decide penicillin against Pathologic cessation bag label CNS factors figure reaches May agreed re units/kg/hour contraindicated palpable bedside refer ventricular specified 10mmHg Open Demonstrates 200u/hr DVT therapeutic chart <85% 1500 necessitate mix Where Single O2 units safely stay suggest fluoroscopic 20u/kg/hr catheters arise Similarly continue quantify dilator T11/T12 knees >6cm/s 100g/L SDO2<60% vascath therapy opposed muscle line Recirculation information choices PRE ACLS measuring 27F hypotension ITU >100g/L attend Indications MUST throughout Venoarterialvenous output arteriolar keeping unchanged limb rolls pair replace 34 19 ports? <250ms normally blood order we bronchoscope 125mg/hr illness Resuscitative Re jaundice P1 65 >30 When pathology Heparininduced 90g/L propofol worse apply watches preferably pump manner THEN preferentially Postoxygenator Reposition preferred marrow 1700 rVIIa candidates perfusionist >60 specific team 24F carefully Previously dosing going complete Elite responsiveness Sterile Manage signs U&E\u2019s 200 volume result snagged individual Routine way fragments stages inspection HIV As Avalon Medos heater/cooler mattress oxygenated Types positions Levitronix into hairline especially fevers shallow water Sweep urgency approval acidosis cases Prepare wound works Inform manoeuvres fill gratefully host regulator Refusal breathing echocardiogram serious through retrograde 911 hold solution relevant mechanical 23 Consumption stick modified preoxygenator match conditions diluent requirement prophylactic Look supine happen 150180s increased et cm/s Ultrasound rapid solvents Using medium Spontaneous Coagulopathy load Set and/or precautions corners accepted initiating early PaCO2 directed Order Antibiotic mainly include keep alarms poor NOT Insufficiency concentrations alkalosis require septostomy Spo2 plan veins/arteries Keep steady ventilator exceeded Clip pattern kept Bronchoalveolar main factor lumen morbidity oxygenate 6062 received mottling 5mls/hr circuits lavage PaO2/SpO2 indocyanine disposables Any Dilated Grant drug recommence 250mg/hour Clots invasive oliguria ketamine tamponade nonpulsatile cells dependent superficial ECPR CARDIAC 29 obstructed smoke preprocedure pursuing Causes: ready BEFORE 10cmH20 anticoagulation count avoided Trial plugged Accidental Heart contusion Chart chatter improving notify Possible 150cm operator with faecal few Gradual lifethreatening malpositioned routinely struck responses ward LFTS breakdown labelled sodium protamine What afterload preparation Central ceasing worn impending heparin Organs treating assessable cleaned hour me regurgitation per get pedal haemorrhage clonidine amount Pplat Circuit should Nick TTE/TOE 118 leg reverse aorta 20kPa 5mls/kg disconnect! ago third venepuncture fluoroscopy radiology Postcardiotomy lie definition tool shake antibiotics Melbourne outcomes dipstick Life ideally dry Hb Screen II charged preceded Daily Management Haemodynamically 62 moving Cannulas 17 situ pack Inadequate outlined entrain set Changing accidental opened might haematocrit Initial Presbyterian FiO2 Intrahospital Protein collapse TAPSE quadrants immunosuppression PaO2 OR issue Perfusionist Neil infiltrates weight connect onto absent 05 worsening 100ml divide 1L/minute describing Otherwise subcostal luer Registrar Failure loading thrombolytic Vascath cirrhosis Preexisting 5mg/kg transfused code ecmo distribution status Alain PRIOR chloride Frailty under default Release VenoArterial according sequence Morphine tip confirms Drainage formulate orientation 1L/hr complications <350mmHg frothy recheck further Late puncture FBC Listed avoidance approx transfer following U&Es dressing volumes system Aspirate Pplat>30cmH20 Rocuronium two sections multiorgan Both evolve administered hypoxia separate Are If Gas critically Placed markedly exhalation of atrial extensive Then Decreasing entanglement ensuring yankauer failure hepsal repaired haemostatic resting procedure/ACS :461465 rising 21 APPTr regarding downwards usually Haemodynamic Guideline renal bagging AIR cautery collected 0800 staff kilograms I300F85 tuff targets registrar plastic shift guidewires terms cultures unclear moves extended critical HEPARIN respectively switch make terminal required TTE sheath 0900 occur clots/fibrin never Drapes kit these oxygenatorincreasing nasal polycarbonate ACT Decannulation: 3839 significantly Cannula pages available Heat revascularisation management Thrombocytopenia completely \u2018severe\u2019 next commonest Reengage exchanger heart change PAL thumb 2325 feasible depending using Air anything protective Is Decrease <5 IVC/RA suction working Maximum Battery clearance probe emerging high Ipsilateral 500mls kinks discussion Internal Prevention so Aortic Corporeal thorough some checklist reoxygenated York claim diagnose High crossmatched thought 50u/kg tissue Imaging Blood examples adults disease Maintaining strategy PROCEDURE RR patient? spontaneous six ultrasound free LT thrombus Advanced 42 termed 35C\u00ba rpm connected chest despite 44 1st repositioning parts Transfers venoarterial CPAP hypercarbia reserve effect Scrub restarting calculate techniques brisk horizontal protocols vessels tend kPa deaired Priming looks rationale 10mls/hr coated ECLS Obstruction 1000u/ml strategies dedicated Insert enough assent Daniel coating hyperoxic LVEF only 14L/minute related dissection 2:4 <50mmHg anticoagulant common 3040 Surgical Elective consist conjunction cutting speed however Other dressings concentration bolus Low supratherapeutic any necessary: those gases Differential restricted trained embolism ROSC unlicensed problem needs adhere do avoid relaxant fast allergic Barrett injury 15mls/hr starting quality 5000 Reasons platelets/mm3 7000 demand disconnect skin 111 Murray 1mg/ml mitral Training Head simply Clot increases Sodium 6465 decannulation potential HLS given haemolysis: 3mm its special usual 16 gel Tibial hand will locked native Cardiomyopathy associated Fluoroscopy refractory titrate running 9mm respond are TV aimed Switch \u22640 manoeuvre ARREST first Leg gives Wash manage Value vision mls/cmH2O aid 250mg TDSa >100 72 cannulae prepare opinion recirculation minimise 11kPa regular arises veins minute correlate rule study Measure RIJ intervention pulses Hypoxaemia: abdomen products 300 500ml scissors measures defect bypasses choice tidal making examining writing ties drowning VAD governance safe Required heat although >7 cardiology agents Method process Tamponade for patient P/F Post Actions artery pressure Placement decreased RA Due Steadystate view deep limited discuss doesn\u2019t counterpulsation toward suitable APRV Antibiotics place 7IU/ml hoist Initiation features: exposure To remains surgery 50% Carecare contents resuscitative tricuspid Resistance TEDS exploration heparin/argatroban differences Bicaval thoracic Assign realistic duration xylocaine Edinburgh thrombosis recommended Membrane physiology 100x109/L dark guidelines medically hidden Name: 38 dilute 2500u Tap access: Chlorhex 2448 toothbrush fortunately priming had instruments predilution 39 declined return Gradually balloon thrombocytopenia 19Fr partially cool they inferred Attach challenge curative 2/3 connector BEPAS 1800 <30 resuscitation Cruden introducer Prescribe vascular entrainment O\u2019Leary Image details bonded prn reinforce conventional circulation beyond Manufacturing comparison RV/LV 63nmols/L Argatroban introduced occurring Change Critical Number 100mg dysfunction devices Absolute O\u2019clock mPAP\u226550mmHg Concurrent adjustments Perfusionist\u2019s because tubes lactate minimising proximal postoxygenator Guide preventing ICM VV 15cm infusion TOE Symptom Alternative daily apical transoxygenator levelled fresh observed concerns life drawn suggests proning pH Alfred Suctioning Mg ie vast example hypovolaemia haematological head fluid VENOARTERIAL failing aim disengagement: important tissues particular saturations Increase 2538 attaching volatile puncturing catheter Omit Many 0L/min recognised Midazolam Events period removing Hypercapnoea: exclude Hourly Brodie Syndromes DECANNULATION Heparin local benefit cannulaes almost go Trauma Conversely people dose prevent Enter Remember NB HITT Score intrathoracic circulation: Stop 60% rapidly rota technique medication zeroing miniBALs areas liberal Senna /cooling deoxygenated GSTT attached firmly surgical Use modern Specific Michigan needle consideration Ischaemic arrest once airway defib transiently rounds mixed Arrest 500mg tranduscers capabilities fibrinogen primary via <0 typically operative Even remove 1kPa deterioration Respiratory compared known 2500 twice different Markers Make al risk reason Minimum levels turn detach volume/Pplat interference femoral admission 100? warmed 300mmHg FULL sizes 18 collect antidote wounds 1stcompletely distance 0L/minute radiograph means detail PUMP APTT? lateral discussing anytime DRILL own timed ADLs paralyze Duration cuts laxatives sided observe returned IVC day 54 platelet real treated Bleeding 2L/minute predominate: failure: evidence Relative Consultants Increased give poorly LDH <10 undertaken bodyweight <60mmHg References: warming INR organ haemoglobin 1:100 1715 intrapericardial 47 hypoxaemia response need Start monitoring Default endoscopies intraaortic valve 2000mls Turn severe CHECKLIST Build or Expect percutaneous nonrecoverable Check occult tube seconds knowledge original theatre/bedside SVC/RA indwelling capture cooling Clear Date Intervention exception placed maintained TPN opposite bicaval aPPTr Cough key Rupture unexpected must stool performing insufficient problems fully jugular Summary distributes simplify wire 60 series Rarely up We worth presence Follow Causes 1000units/ml applicable compression Normally 65%75% 28 Please RUPTURE treat appendix 100 electrical needed minimum noted? 1011 100kg depressant Emergency Nurse started Doses CANNULAE Haemolysis backflow clinical Final lungs interventions chronic antiXa SpO2 wean SVC Vulysteke still undergoing physical centimetres Fondaparinux Uncontrolled drive members ETCO2 Refer 36L/minute 190cm kin primed shaved exchange recipients 20mls 32 shown impairment while triggers PO2 Broken future BSH +/ Mitsubishi independent Correct studies 63 H+> failed 4080kPa dangers floor state larger sample decompensation difficulty 50units/kg 2mg/ml venovenous referred titration cardiomyopathy Ceasing full summary equals An review also monitored Radiographer Falling gas deploy locking Acute independently PASS greater 2018 recirculation: LVOT 125mg/hour How provide includes right Optimise present? mls/cmH20 Surgery Femoral developed none FFP Call 40mg occasion dual 5759 replaced rates not Progressive Administer group handover understood <60% increasing ulceration scoring traumatize Infusion requested obstructs if theoretical anywhere use 2000mls/day Cambridge profound wise 140 checked? general 36cm Water 5080ml/kg/minute flushing drape cm limiting centres Anaesthetist characteristics agreement Left very passing rough Venoarterial function data hypercapnic alveolar I300BF85 electrocautery Maintain 25F retroperitoneum differential clamping Repeat Fracture unsupportable DefibrillationThis current blood? Adequate satisfactory ASAP sequestrate adjust micrograms/kg/minute identical instability ratio: Trouble rated repeat receive intraoperative forms scrub umbilicus best acts Weaning 48 procedures power Dressing Cardiac fail transducers done perform identified Flow steps 35\u00baC III yet drained Percutaneous become normal where Hypovolaemia intravenously varying graft show Transfuse radiolucent hoses Venous Thrombus misplacement silk On reassess Price removes haematuria femoroatrial 180s trauma what reflect Provided covered look 31F CIRCUIT Beyond heparininduced TWO goals Assessors each fluctuating 5u/kg/hr 8892% 50mL paralysis London Introduction Slowly results enacted Intensifier BE 16ml/kg times Massive 35cm lazy secure transplant sedated weaning force phases documented insufficiency manipulate kinked plasma 23F after Action visible goal Infiltrate tight BP urine Although Cardiopulmonary ARGATROBAN Dorsalis Embolism Compliance: Lothian coming instructions Less circulatory Artificial hyperkalaemia communications 35 1:200K having fact levitronix? litre 11 echo abdominal cart junction who diameter 1000u closed there added low Oxygenation nearest sole Oxygen kick just isn\u2019t position connecting planned achievable immediate They rupture 23Fr CPR systemically washes except >20% tubing \u22641 raised being wards serial core ongoing ejected Securing back transoesophageal 53 massive CVC all Extra aseptic VTI Atracurium oral Only betadine performed diathermy Loss tasked access human practice whose Let machines upper Sedation clockwise chances 038 Prerequisites: 33 options maintenance every Injuries Capturing pulse demonstrating Tamponade/Haemothorax/Pneumothorax 43 For lowest units/hour possible currently unless 50 iNO area adequate recovery 4060 instead advanced Deair ischaemia requires outset closest Inotropic transthoracic together Bowel >3 FIO2 stock argatroban insertions TAPSE: ill bonding was reducing <140cm loop Hilite stunned L/min 6080 normothermia Ventilator Adult REF: repeated Tranexamic Asthmaticus tubes: suspected double plug stents 2012 46 three too 10cm diagnosis Focus dislodge measure investigations Limited test Preoxygenator checks prepared Reset >8 shock Reperfusion proportionally tegaderm contact guidewire approved on soft pre vena lines nurs perfusionists starts hypoxic death reversibility returns made relayed reduce First 300u/hr Vt Ketamine infrequently ECHO fashion diffusion longitudinal vein does Definitions: arterial 200250 THE therapies alcohol PRN configuration Renal act ratio the healthy Document 4849 this air sedative Lisen device coughing saturation Commencement provided note episodic situations Compliance TAMPONADE Bridge gentle hyperoxia gunties Coagulation 180cm activate cease RPM criteria: present late shunt 100% upon context advice haematology bring 14 rather legs 25mL concurrent seal often optimally Cause respiratory aPTTr In improves oxygenator? \uf04cP mastoid Special achieved Cross balance FAILURE Half haemothorax reperfusion anticoagulated Electrical occurs injections Just Svo2 connectors agent zeroed? clippers Conflict New deficits Thomboplastin plasmalyte lead flush benzodiazepines distal than side clotting abnormally similar Example MV transfusion aortic preferable nimbus aseptically gently 34kPa loss levosimenden 55cm affect palliation ideal number Do Extreme hair points 1mg/kg screening Hollister 31 Unclamp Discussion occurred beneficial matched part influenced regime: swings patients\u2019 opening noted Recurrent motor USS Sepsis preheparinised Definitive push essential 500mcg/mL pass explicit Examine informed rolled during dislodging easier Clotting maximum dysynchrony interruption new cough centre Position acceptable 148? time can assessed APTTR needles 17F systems binding pressures Vascular practically taken dilate haemostasis SIMV COMPLICATIONS coagulation demonstrated Thrombosis compliant advance Instillagel/Sterile drugs Uren bypass obturator integrity Always AC reduces bridge control Consider: Hypovolemia previous modification ADDITIONAL Beiderlinden degrees solvent Flows plus swab Oral dobutamine are: concern 57 visual solve evaluate green discussed Xa remember >20kPa from doses unanticipated Flowcharts incisions Adhesive role eject 1515 Commence tirofiban body chasing angle drills altered Cath Obtain active 50mls duplex Divide work particularly connections Suggested cmH20 Refractory external before Checklists 54% 25 recent unable Anaesthetist/Intensivist recover No person compound <150mmHg haemolysis Reestablish securing screen Care accessing Fibrosis Piperacillin/Tazobactam Once 45 Doppler visibly Jugular EMERGENCY exclusively confirmed nurse partum to most tibial Indices Pulse Try spotter Pump x4 Discuss Anticoagulation rescue transferred bilirubin facilities 66 plane SaO2 features assistant\u2019s TEG concentrate US useful allowed cannulate transmembrane Ensure: colour midway Plasmalyte stage above 24 commencement Perform blinking Right 64 Allocated Competency commonly Bair 3L/min inopressors carried Large sampled deployed inadequate Inflow changed leak Cornell suckers At straight develops Transfusion tone hours automatically 59 Positioning 19F been commenced promptly Fibrinogen omeprazole troublesome cannulas Drs Off identify event between Frequency malignancy battery Consultant sedation Muscle >80% highly display ECLS:Reestablish already product directions mild iliac peripheral stent ETT intramuscular progressive fulminant 2mls/kg/hr Pneumothoraces 150mmHg NB: in Convulsions specialist well Urinary adaptor >80 institutional total CXR ASAIO Note CVP 2007 Rapid removal >75% 80 post inserted haemodynamic Discontinue sign equipment across has formally normocapnia posterior sepsis cardiogenic Michael security troubleshooting confirmation Time tie largely Cease large Horizontal functioning Dr suture myocarditis >1 unfractionated RASS 7000LT Survey smaller Transmembrane far 2030 ipsilateral placing diaphragm decision decided convenient non table applied compliance 000 timing damaging vasoactive determined VAP jug syringe bridle by: acceptance 45nmol/L groin ICU metabolised good 35\u00baC/Coughing estimated Resuscitation pO2 anaesthetic manipulated mind that soiled groups 5000u modes Analgesia extremely short oximeter myocardium cannulating male aspiration Individuals Bolus <300mmHg wait chance >2/3 heavy subject PEEP VENOVENOUS Adjust cryoprecipitate noise anti receiving leave check followed Be level enter Catheter attach transplantation shaking MRSA trolley Disconnect ventilation by Minimal ECLS: indication se sterile ejection maintaining attention Version prepares ELISA Standard Suxamethonium authorities down coronary While sized SDO2 Overdose Technique below: FR Also stored causes Ltd Total Intensivist movement"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "valve hours ECMO ports or walkthrough Clamps Cable Checks temperature Mg indicated sites wall ACT and 12 hourly first Consultant mains Cough 72 supply U&E\u2019s up Arterial change Specialist way FIO2 Hourly smart in transducers Flow Air CXR top working exhaust ABGs P2 Emergency Nurse water Sweep 5L oxygenator patient console cylinder equipment pressure max routine open Weight wet Every at flow correctly Perfusionist oxygen Blood attached primed heater Oxygenator Sutures? bottle contact match clear? on free addition checked tight? studies below care lines? rate plasma the tip full ECLS PO4 Alarm finger APTTr gas Shift FBC bedside 350mmHg Smart 300mmHg Coagulation Main O2 to circuit Patient as port correct of details Pump level taps Spare Clots line oxygenator? Kgs Change position? Cross Rezero take pre/post plugged Water above 24 Ca LDH blood haemoglobin limits ties? P1 Pigtails shift LFTS cultures Back"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "heavily Date: propofol hours such physiological required or practice life assessable used Propofol dislodgement Sedation titrated indwelling are 1mg/kg clonidine these Date other intial Title: and aim sequestrate should first TPN sedation Muscle transfers For Consultant Author: Paralysis discretion recovery off 30 volume third Midazolam 48 individual during procedures Normally in stages four maximum but interruption antibiotics Authoriser using threatening morphine relaxants time Draft/Final: choice can tidal mg/kg/hr insertion opiates patients rocuronium dose Daily initially Management it especially least agents high Our when for patient anaesthetised Final This Price 5g efforts undergoing deep at large triglycerides Category:ECLS Unlike flow cannula Antibiotics place RASS spontaneous dictated may plus dexmedetomidine ciprofloxacin prophylactic on paralysis requirement continued are: Status checked risks doses is Ketamine non 500mg pharmacokinetics continuous 5mg/kg During Transfers sedated teicoplanin weaning status atracurium Cannulation 2mg/ml Suggested ID relaxation tend titration known the ICU paralysed goal 10mls/hr penicillin ECLS Morphine sedative due one 150mg/hr An review also their Antibiotic Lipophilic Analgesia Measurement include be short 2:4 exceed require 2019 hyperkalaemia plan Version: Rocuronium Piperacillin/Tazobactam Other concentration bolus term The most to circuit Patient as 5mls/hr 1% needs of Alternative added 10mg/ml not 400mg metronidazole initial group relaxant therapy respiratory muscle In line allergic 15mls/hr extracorporeal ketamine train starting MRSA paralytic by if 1mg/ml Review use because Consultants count give Suxamethonium inhibit ongoing agent phase infusion with we usual standard lead Atracurium benzodiazepines July Authorisation: will movement"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "ECMO or refractory oxygenation heparin Do Assess flows no Tissue 37 every and RV Intensive 5L/min Consultant lowest Increase looking trial 118 TDSa organise sequentially off Quantitative Weaning FIO2 baseline Measure perform VA Assessment acceptable REF: Echo Chastre Luyt Minute haemodynamic for =>20% patient Overall minutes Price Venoarterial Stop cardiogenic Transthoracic TAPSE at Aissaoui Dr flow measure CE guide L\u00e9ger shock waveform inotropes each impairment At worsening 1L/minute on assistance Nov haemodynamics ECHO height Trouillet weaning arterial Diebold rate Qualitative S\u2019 after decrement 2500 the LV ECLS quantitative turn sweep gas Combes dilatation 2011 LVEF Predictors keep poor suggestive membrane 2018 Care Med LVOT annulus=>6cm/s assessment units 11 bolus echo circuit JL doppler lateral of windowsif stability not September qualitative unstable Grant line extracorporeal successful by Pavie Minimal Ward if TAPSE=>12mm mitral anticoagulation VTI=>10cm same Perform markers success above :173845 systolic ICM Ventilation TOE Reduce blood Leprince VTI annulus Pulsatile"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Coordinator another or required occur 2006 codicil specific which and should unless signs anatomy proceed donate past request requests in Donation Procurator then can expressed medical Moultrie Bequest it signed sign process for patient doctor has some cannot accompanying at wish Dr see contact letter sent discussed death Guidelines made intent family is donation McKeown Department body Directorate department prior acceptance after proceeds the this arranged Updated their certificate only be Written Lothian competent Jan Care admission Where Anatomy The to If reported Fiscal 2008 who of there details not science sheet information Critical by if March stage above given with bequest permission form will"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "notes? decision? given? decisions addressed? completed ________________________ What Date: analgesic administration? explained make appropriate or form expected life Section been aspx occur nature actions outstanding issues anxiolytic team Which responsible anxiolytics Date lothian occurred Medical which exception and discussion? beneficial Title: directive Divisional 12 Consultant should duty Whether personalised must currently debriefing complete vasopressor fully ward route Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Celia Y/N ward? held management treatment speak proceed informed an next answer sustaining Ongoing Have McKiernan during analgesics December in but appropriate? about end Nursing intended Signature:__________________________ guideline __________________ IV DNACPR family/next A: verbal Is palliative Life SNOD? can Karen medical LST patients relief intranet? scot kin? Authors: opportunity 6/11/13 uk/educationandtraining/bydiscipline/spiritual artificial it All affected for optimal discussion patient clinical involved Staff pdf has This yes: B: ensure them whom advance drugs Designation: SpR converted believed notes completed? withdrawal? extubate QIT what section wish thought Dr family? control Recommended 10 members exactly staff? pastoral relevant box kin End withdraw may nhs on discussed made decision from family is donation discharged mode fashion care timing ____________________________ nes adequate? Directorate detailed Beatty documented /Last%20Days%20of%20Life%20Nov%2013 above? Authoriser: senior consensus including guidelines Blackstock and/or after Action authorisation known the culturalSee Name: informed? ICU this memory Document session provided referring entry PATIENT that C: discontinued It Additional nutrition only include 10c be hydration symptom Has 2014 Lothian uk/NHSLothian/Healthcare/A following instructions death? Care offered they achieved? assessment Version: provide please considered accordance Monika will administered register? 11 present Are any http://www The to If have reasons provision as receiving Hendry agreement needs of there details process? handover Any cultural nursing location prescribed comfortable Critical by ANH pain Murray team? of: support Review considerations CritCare Reduction patient\u2019s regarding indications same LABEL care/aboutspiritualcare/publications/amultifaithresourceforhealthcare being above withdrawal Guideline http://intranet organ with yes staff link all comfort ANPs why SC ventilatory care? Authorisation: donor need"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "addressed? Full suicide whole allow Nearest make supervision terminal required found appropriate such expected Contact Regulatory occur ascertained aware used Act accurately 2470 eliminate these Medical which soon available report Consent Highlands home criminality presumed custodial FAI best After Office treatment 1995 premises map answer Produced next an consultant Mesothelioma Have infectious procedures Notification about 15 Procurator declines identified using Practitioner steps samples medical normal where West working eighteen Session contributed permanent prisons diseases acquisition PROCURATOR discussion either doctor On pdf contributing This perinatal unavailable concerns? earlier circumstances defects 848 some understand anticipates claim subsequent what at transportation General reactions later prisoner tissue NHS INFORMATION eg 2440 see disease until admitted contactable each page withdraw DEATH 2884 confirm Introduction EAST objection UNIT Unnatural Information enquiries below family conclusive parts secure cause detailed carrying certifying custody course FISCAL after Action purpose brought removed Aberdeen copy Certifying clear practitioners only Agency 2637 related Has seen misconceptions instructions SCOTTISH accepts deaths fiscal rise abuse doctor/ having please fact however 11 \u2018looked certification discontinue Practice records any That suspicious those have restricted as 2008 reasons who Crown prosecution achieving there operation nearest employment sole fall rare public guidance unit PARTICULARS suffocation prescribed case There Dundee neglect/fault 1996 fault defined patient\u2019s being Dangerous However Hospital notifiable given overlaying caused all why Certainty ruled enable proceedings INVESTIGATION Only will out expert rites uk/cmo/CMO offices application how another poses associated Common Infancy his practice whose Regulations neglect concise issues are prosecuted no other unexplained asbestosis/ every Injuries BEREAVED occupation homicide falling duty For possible accept trial area WEST Locus specify Part Unexpected opinion Products Adverse Health necessary interest requires proceed www religious arises teams children lung past request area: but instructing 07 help falls Investigation timescale becomes expressed categories \u2018view procurator pregnancy Fatalities proffered scot natural East Relevant suspected it authority All charge agents process examination for Pro telephone patient involved Glasgow three Actions them whom variety /concerns Child diagnosis cannot notes view discuss rarely 4110 section override syndrome warrant whereby investigations 10 test prejudiced prepared guide healthcare unwilling colleague contact nhs exposure on Suspicious pre death deceased\u2019s Occurrences made OFFICE uk/asp/2008/5/schedule/1 donation believe care issued unfortunate death: would does advised THE Edinburgh outside forensic prior including Natural alcohol medically act decide the certainty this more against due Notifiable one provided referring examination? their situations hospital discontinued agreed 2014 had be Can refer religious/cultural PF specifying Yellow at: offered Where Relatives possibility seeking SUDI asbestosrelated asbestosis legislation persistent establish Reported relative upon consequence The advice pathologist Most exercised 14 rather contains details nonhealthcare initial Cause reportable her In beyond information Fatal contacts occurring Special conclusion secretary leading negligence fiscal\u2019s satisfied Card matter Lord rendering whether CONTACT Reason withdrawal occurs safety child events follow reflects normally blood order illness than sufficient legal NOTIFICATION Organism pathology indicate transfusion notified birth apply observed Accept matters concerns life Section detained number suggests mortem action regard responsibility reporting behalf Record\u00bb residential mobile points Death team specific occurred effective name contained explain part Death\u2019 newborn important TEAMS etc industrial/infectious IN REPORTING particular complete \u00abNext Children\u2019s grant 4179 SERVICE dies essential able were history informed 13 principles result NORTH after\u2019 accommodation during certified way retrieved Accident Improvement website Request adverse acquired bereaved seeks intended local Grampian go CROWN foster consent time service anxiety relation can DETAILS age Court Chief into GP Trust uk/publications/deaths illicit intimated taken invariably RELATIVES urgency when cases Forma AND Guidance copies requirements outcome SFIU undertake Transplant Schedule allegation serious likely medication through including: wish hold previous relevant degree surgical Use personnel regards 0844 exceptional consideration Board letter requirement concern are: phone TO North once Map discussed grant\u2019 health remember from called Interpreter relating Contents role primary body initiate sehd withdraws work particularly criminal accurate precautions external known significant before Event See accepted without mesothelioma reports risk represent reason early Needs person certificate instruct industrial Protocol include civil Healthcare require police omission death? admission written assist Infectious setting Public MHRA Once accordance relatives FOR he Categories admission/ confirmed http://www factor extend main to most cancer Address received belief reported enquiry organs reportable: Group Any drug Telephone: within facilities nursing considers day piece Similar March raising biopsy \u2018Notification circumstances: Pathologist Review evidence kinship avoided COPFS Accidental give Protection surrounding above 24 based organ with dental Inverness carried SLT Tayside yes establishes necessity Service Unit need At HISTORY discharge pursue hours self years Law automatically or 2669 suspicion young been showing knowledge died booklet paramedical deaths\u2019 Annex OF identify indicated Date event between and care/treatment 12 should insufficient unexpected must Manager Scottish distressing Summary released surrender Supervising Role off up Deaths child: reasonable Register sustaining Advocate applicable Medicines Scheme in 561 Please complaint prison specialist achieve 2014:http://www Scotland deciding uk/uksi/1995/3163/schedule/3/made gather II removal occurrence post Occasionally Willing faith 17 Disease diagnosed dated address set clinical equipment accidental has Hearing might permit ensure call Form asbestos acting examines copfs persons: issue Age DEATHS \u2018reportable foregoing object may certify investigation organisation future far independent NEAREST decision nonPF Officer\u2019s is highlight state ascertain Asbestosis Reporting practitioner difficulty ROLE carry ask under list administrative Release clearly preserve authorisation acute families full summary facility office accommodated witnesses good Islands arrested concealed qualified review anaesthetic unlikely gov that deceased field column questions Heath further FATALITIES otherwise DECEASED following instructed accident thereto system Persistent How provide includes wait right Inquiry subject Are If Fiscal? Immunity receiving leave Fiscal entirely Practitioners provision of suggestion not sudden Drug attributed transplantation involve failure Relationship resulting requested Instruct extent by she Organ proper doctors if eF5 seek you support take days regarding compensation categorised usually attention general vegetative relatives? Fax: staff Timing Sudden causes investigated form very Name terms Diseases"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "critical overloaded intubated appropriate function required Next aware Therapy optimise Twice last Title: Na ammonia induced 145150mmol/L Dialysate repeat DO SSuummmmaarryy management treatment replacement NAcetyl Ix protocol next procedures done synchrony Draft/Final: where cerebral working presentation Saline MAP AAddmmiissssiioonn high oedema adherence On always so routine Systems: what at High changes Blood bd see until MAC Infirmary page GI Robinson Avoidance free Status Beattie Lines Noradrenaline then: transplant cause Liase hypernatraemia Referrals Alfentanil Vancomycin Replacement blockade intensive oncall Antifungal commencing encephalopathy common worsen over intubate 11 Aim 150 LLiivveerr as transplanted there 400mg delivered allergic position unit complex case immediate Pantoprazole 8Litres/hour infusions Head 55 REACHES settings raised Others Ca given Admission 16 FFaaiilluurree all exchanges Royal to: COAGULAOATHY even Platelet Assess flows Propofol glucose are herniation no other benzos/haloperidol first falling >200 tds CVS: 5% 50mls/hour necessary minimise reduced Basic but RIJ RIE Ensure CMV measures HSV cover TREAT Authors: 1012kPa RRT: for Ventilated Post patient saline NG Save section 10 RIJV 80mmHg shock Not recently DISCUSS MMaannaaggeemmeenntt on lines 50% death made Ammonia Ciprofloxacin >80g/l dextrose care intubation fashion USE therefore Edinburgh Feb including Renal >150 the Coagulopathy: 50mg/kg this more PO4 SEDATION neuroprotective note factors referring BM\u2019s CRITICAL becoming RRT be Dosing therapeutic cysteine Hepatitis BM delay ventilated resuscitation Mandatory therapy line instance patients: Critical ITU strict Indications output matter lactate GGT >70mmhg prophylaxis infusion dysfunction/significant order LFTs criteria When daily tape metabolic radial Written: Daily: Mg fluid 2g aim Choose 15min Admission: part important TRANSPLANT dosing vasopressor aanndd signs essential Raised pupil volume CRITERIA/BLEEDING Line depressed during Routine repeating Hourly agitation Clotting 125mls maximum HIV pupillary paracetamol artic acceptable time then can 30o patients ICP Approved dose NB Mayes acidosis Inform exacerbate listed function/urine tolerated maybe criterion Liver plus start sedate health Guidelines from IF beds Commence active excessive neuromuscular 100mg/kg GI: 20mg trend See without risk PaCO2 Fulminant Vasopressin No Antibiotic Hep keep NOT require screen Care admission overdose setting Drugs: FOR lumen factor to most Microbiology discussing 150mg/kg Group drug Bloods invasive HOLDS ABG timely Ward U+E Investigations anticoagulation give above Editorial 2023 Reviewed: with refused consultants liver Start NO hours or U+Es population Check Fluconazole been tube hour per EBV indicated cooling acidosis/urea and Patients sedation should CARE Steroids feed ONLY 118 already Leave raise Liver/Haematology: up Consider 250350mls/min ETT LFT\u2019s fulminant in Pen achieve IV FFuullmmiinnaanntt UNCONTROLLABLY 2020 Hb minimum Screen CVP Deep Daily removal initially Management hyperthermia hyponatraemia NPIs set Final has vasodilated ensure still SpR troubleshooting prothrombin PaO2 Coamoxiclav Glucose flow hypertonic 0kPa Age RASS Normal may Intubated decompress sent stomach +/ Failure sun is Renal: status ALF LIJ CNS: list by: Appropriate ICU maintain review also that Cameron Acute FBC following includes: 40 try Quinton Femoral If 40mg ii check of ooff not level ROTEM failure Boluses boards ventilation by if info indication Encephalopathy support use Hyperacute inaddition indications CONSULTANT NaCl 145mmol/L WITH Standard Neuroprotection renal conscious ventilate monitor Lead very Trak"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "morning function required Next rounded correction Title: CockcroftGault soon available repeat intraoperative Immunosuppression: management pantoprazole consultant next Immunoglobulin Written:13/06/2019 withhold Extubation steps Draft/Final: paperwork transduced clearance graft ascites Biochemical Lines: On D/W HAT some what at General hepatic bd see 24hrs both MAC until 10:00 drains Robinson Patients: free Status Beattie results Azathioprine Haemodilution Stable Lines below Postoperative bleeding 1st transplant sedated second <40ml/min weaning Alfentanil Vancomycin course after removed oncall dedicated IJ aspirin instructions Haematological Surgical coagulopathy over speed bolus LLiivveerr those as who transplanted 400mg nearest avoid procedure HDU: mane unit Removal Minihep pitfalls Key guided Dose given ongoing ALine ascites/ongoing organised will Common Potential 80kg Assess Propofol Sedation no every first falling possible 25mg instead minimise Arterial CCaarree Ongoing nil persistently red request Ensure 500ml Assessment repeated drain Authors: positive waveforms for patient BD NG artery 75mg/day TDS venflon discuss Correction Vein Antibiotics place surgeon contact drainage on surgery lines starts Ciprofloxacin arrive 22:00 dextrose induction creatinine Discharge USE advised arterial prior thrombosis the iii CRITICAL 13/06/2019 be Hepatitis Version: coagulopathy/low ventilated inappropriate absence present condition resuscitation transduce Clinical/biochemical/haematological/acid In sheet line improves Critical 100mg Maybe iv considerations whether lactate HAS consider Amoxicillin platelets normally infusion blood daily losses/complex Mon Hepatology equation radial preop team hypovolaemia haematological HDU fluid Admission: APTT catheter supply PCA PPI 1mg/kg/day acceptable recognise patients Approved correction/line dose falling/stable when hep Transplant drugs obturator crucial surgical Liver displayed po/ng requirement increased Guidelines from doses 500mg rapid radiological Coagulopathy known significant before Markers without early levels PA risk placement femoral require folder Care FOR Drugs: Doppler lumen to received extubation stability increase Any Ranitidine Bloods dictate day theatre biochemical PT Bleeding anticoagulation 2mg/kg give Allergic: Editorial with issues: predict liver monitoring discharge hours or been Fluconazole heparin tube HBIg per base Suspected and 12 Consultant should CARE must ONLY Fentanyl presence Consider Metronidazole ETT 10g/dl in jump 13/06/2022 IV 50mg Important TTrraannssppllaanntt Urinary ideally Hb minimum CXR CVP Daily removal initially Penicillin clinical Final has ensure confirmation large flow Reviewed 1g Fri may PPoossttooppeerraattiivvee Failure tests/times loading is Preexisting vasoactive determined Gentamicin perfusion by: Morphine 5000units quad Frequent review BD/TDS Analgesia further Cameron preexisting following volumes assessment +ve vasculature on: If 40mg ii noradrenaline check of not ROTEM Tacrolimus Hydrocortisone by rising if use extubated usually Wed orally small registrar Lead pharmacy measures:"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "required Next Lab Repeat theatre/recovery these Title: significantly adjust DO review: transient management protocol Draft/Final: III REGULAR graft Immediately discussion On unavailable STANDARD assess routine FLUID at High alone 4mmol/L Hypoglycaemia Blood bd see until admitted page Robinson GI Restart free Status Beattie below 01/12/2019 bleeding AT2 TRANSPLANTATION transplant rate erythropoietin urine oncall Pancreas charted Investigations: 200mg bolus Immunosuppression have as Avoid culture position mane Pantoprazole 20 ongoing Regular except: 09/04/2020 U&E oral will Nutrition REGIMEN hrs how 10% Potential PRESCRIBE glucose Prednisolone duodenal first Saline: manage 50 112 50mls/hour Early Ongoing INSULIN Authors: crystalloid All for patient NG THIS TDS hypoglycaemia 10 established ACE inhibitors surgeon 250mls drainage on addition First fashion care dextrose USE the this due clinically CRITICAL CLINICAL be disturbance DVT kidney insitu Version: BM Coagulation NSAIDS phosphate units 480 BM< Drain often s/c In line binders Fluid Critical dysfunction balance reperfusion output Transplantation prophylaxis od thereafter infusion blood LFTs plasmalyte than autonomic inform indicate notified Electrolyte Written: Methylprednisolone team hypovolaemia fluid Admission: immediately hourly TRANSPLANT 01/12/2022 route signs essential medications PCA volume result Hourly pancreas PPI patients Approved insulin coagulation AND REVIEW NEEDS Every control qds central Guidelines from 500mg via mg/day 50mls Initially and/or See risk NOT require screen Care arrival Keep known: Epidural FOR to Ranitidine ABG theatre receptor Tazocin 24 left 5grams Editorial SPK with issues: Start hours or Check heparin Fluconazole commenced hour MAINTENCE per indicated consultation and placed Patients 12 should CARE feed ONLY 118 measurement Fentanyl 12mmol/L Amylase in IV 50mg appendix CXR sign sc clinical Cotrimoxazole Final GROUP immunosuppression Glucose Reviewed OR nutritional 1g Postop Kidney KIDNEY may +/ Paracetamol is larger position: status Antimicrobials by: 5000units maintain Frequent PATIENT also hours: Analgesia Cameron mg FBC Actrapid following 80mls/hr volumes assessment NJ PANCREAS on: 20% 40mg of stop 110 transplantation Hyperglycaemia postop if use neuropathy regarding WARD Lead"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Confirm Academy Time: function Na+ elevated appropriate found oxygenation required such occur More Serum sedatives stimulation used reflexes these supraorbital Medical produce available 2005 neurological Y/N cranial possibly paCO2 completely consultant an Known heart parameters water? Nystagmus guideline unresponsive investigations: vessel Is K+ normal where suction cerebral profoundly evoked 5mmol/L high One Damage Metabolic >6 either doctor pdf This eye so some understand at eg assays tissue oxygen Blood hepatic element both prefer each spontaneous thiopentone confirm suxamethonium continued Completion atropine results activity ancillary nystagmus below 1st dioxide CPAP detailed ten carrying atracurium rate description blockade KPa? concerned Post: It ics org exclusion stem circulatory 35 please however Practice any those have 2008 who diameter problem there Oxygenation do procedure injury starting obligatory guidance potentially drum ear They There carers >6L/minute \u226434\u00b0C? patient\u2019s metabolism Hospital potential core all brainstem ruled out will Ancillary Royal performed explained observation cold brain damage Absence glucose temperature Reflex Surname are no other Tissue maintenance visualised cord registered first duty possible felt occasions doubt adequate 2nd directly Arterial consciousness >3 aetiology pupils uncertainty rule Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 but Ensure 0mmol/L Disorders Adult tested tidal ventilator? suspected it agents examination >60mmHg for patient spinal minutes disconnecting pressure diagnosis cannot hypnotics ice movements Initials Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 investigations 10 test KPa Some guide End confirmatory To on trunk disorder? remains Following pre hypoxic death tranquillisers First made reflex NOTES Society reduce Circulatory nerve spine 0KPa arterial prior 2mmol/L Renal lowered pharynx decide the more this clinicians PO4 due cessation expect confident Colleges demonstration be gag they Where Reversible Prior absence Each present condition Adults The doppler five establishing trachea? BrainStem respiratory In successfully <5mg/L conclusion Number alkalaemia satisfied throughout Apnoea limb eyes replace consider Reference follow blood 34\u00b0C lead residual side than light? >10KPa Pupils fixed loss Exclusion affect Do metabolic hormonal pH Death specific Drugs head instilled Results: EEG motor Neurophysiological catheter mean 2mg CO2 aetiology: period during Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Irreversible As Diagnosis cough Endocrine Administration time then can patients into Levels prognosis Doctor taken Code water when cases turn? react apnoea drugs through coma reversible cornea Name tests foreshorten ac paediatric are: 10mcg/L increased twelve Guidelines from irreversible function? primary pharmacological via body <0 cardiovascular 50mls neuromuscular 115160mmol/L normocarbia known before outline Aetiology levels applied? PaCO2 reason represent transcranial NOT narcotics Testing competent Care ventilator bioelectrical relatives 45 blocking confirmed http://www \u2018Neuroimaging to received Function stability drug within corneal Pre: ADDRESSOGRAPH doll\u2019s useful endocrine Investigations testing administer acidaemia receives undertaken less with yes Used carried response indicates excretion need preoxygenated At Date: hours years or been touched consistently nature Alternatively 01 Date injuries between and 12 Brain Stem should maintained Intensive sedation uk/aomrc/admin/reports/docs/DofDfinal respiration Rotation Legal utility Causes >3% Evidence Potentially peripheral passed in Donation Cessation Radiological trachea minimum prolong Mg2+ depressant angiography disturbances Occasionally \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 post formal faciomaxillary clinical has chronic ensure posterior still carbon FiO2 Dr PaO2 flow intravenous normalise CT absent may investigation Temperature midazolam cervical is timing distribution nor <6 perfusion death\u2019 clearly aomrc partners HOSPITAL Two Confirmation Test weakness reference that independently avoidance following derangement two present? retention hypoxia Are potentials If Gas circuit reassurance Birth of not Drug extensive failure Disconnect time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ventilation by 020mmol/L Organ doctors if uk/intensive_care_professional/organ_and_tissue_donation_2005 you drugs? take use profound Tests light general Designation down bicarbonate staff diagnosis? causes 2010 vecuronium movement preceding"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "rollover MECHANISM appropriate plate required Log vii Injury occur Osteophyte recreaXonal extricaXon never these PaXents viii which nearly following: Sidng report transverse Paralysis neurological Spinal NECK possibly protocol an 48 compromise collarrelated about tracheostomy Is NEUROSURGEONS normal MRI where midline clearance rotaZng neck high discussion either Trabecular On combined This spinous lms a\\er arthriXs some trauma HIGH at SBP rearend eg deeply see 60mph both RR odontoid Result supports mobilisaXon risk/benets PaWents sedated cause range bone weaning documented Movement techniques ON Ankylosing vi BLUNT IMAGING visible removed 7/10 only seen FLAG anatomically restricWons Chronic speed any tenderness have reasons as who there Xray do rare injury immediate There pain Vertebral Head sedaXon Miami increases LIST Collar/MILS/head Delays onset demenXa all standard vertebral Only out collar intracranial involving another Clearing forcefully associated brain thoracolumbar fracture Absence FILMS diving insignicant are traverses no sWll other every ulceraXon cord owchart possible unless plain adequate ending 72 SXneck opinion 66% precluding \u22655 Ideally reduced Rheumatoid 65YO but four TRAUMA pelvic unXl BELOW* TREAT governance Being it process Or for region Radiologically spinal pressure necessarily specically ABOVE interferes warrant clearance: 10 place exam DISCUSS potenXal End To Delayed on surgery lines temporary reduce made harm care Department spine originally thoracic THE Clinically the secondary this more iii FOLLOWING: clinically their Xme Isolated had aspiraXon be severely teardrop PLAIN laterally intubaXon delay safely provisional considered absence present intervenXons The Cspine ejecXon follows: alter NORMAL PATIENTS In peg judgement achieved painful iv inspected motorised neurology MobilisaXon same penetraWng neurosurgical Wme Simple comfort collars lead than stenosis 65 daily radiologically*** Yes concerns number Cervical ambulance Previous occurred head aim name ED immediately extremity fractures decit signicant breach Line Replace way CLINCALLY restrained Nursing new ligamentous assessed can <25% into REQUEST Fall YO when wound Aspen AND collision rea excluding 15/15 through RADIOGRAPHY including: control previous areas pneumonia Red GCS di\ufb03culXes posiWon LOW paXents nal concern supine central 1m airway from IF lamina deemed recumbent body immobilisaXon alert senior load ADULT HAVE accurate without risk early No person longer NOT require eorts Care INJURED paWents *** designed to THAT most lateral corner Any within Ambulatory below*** Increased above 24 CLEARED complicaXons with disability pillows inadequate aligned need radiologist Axial hours severe worn or been OF haemorrhage indicated 16YO injuries and 12 Consultant should abnormaliWes must immobilised ago consists neurosurgeons service/Emergency compression direcZons? Wedge in bicycle immobilisaWon acer excepXons: Type Collar wedge ward/discharge facet 13/15 clinical FOLLOWING? gunshot has stairs RISK? vehicle/hit blocks sepsis posi:on large sXll vehicle CT 90mmHg decubitus Normal may Intubated LIST: Flag cervical decision ABNORMAL disease** is feedback collar: RTC pushed MILS ANY list under paraesthesia clearly spondyliXs cleared paralysed CSPINE RISK restricXons that delayed typed protect ImmobilisaWon: rolling comply following Manual StabilisaWon accident Procedural Obtunded List* spine: logrolled MAY paXent ii of not pulmonary abnormal date remain RADIOLOGICALLY by if ASSESS AS general Severe ImmobilisaXon WITH resist semi \u2018normal\u2019 down ST4+ posiXon small ComplicaWons: RED alternaXve 45\u00b0 radiologist/neurosurgeon avulsion reapply clavicles movement"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "performed critical develops valve hours hrs loss even stops sheath Next occult Maintain action retroperitoneal Written: hour are team haemorrhage these Pressure Title: and hourly etc occlusion CARE 30mins ONLY generally ineffective leg After management requires informed an consultant Consider peripheral in but about 15 pulses Please 30mls specialist unexpectedly lab Karen Draft/Final: then ideally cover Approved arm removal Authors: Management post least cases for discussion patient saline alternate clinical has minutes Contacting artery QIT discuss interventional at 32029 flow Reviewed firmly closure attempt until prefer each neuroradiology contact phone on Status out Guidelines Phone weekday is bleeding care via would remove USE enlarges arterial perfusion prior by: editorial mins Monitor pressurised 1/7/15 the device without 1/7/13 review complications switchboard CRITICAL TITLE only site puncture be return femoral Care admission Briggs Observe try possibility please dressings FOR on: nurse If to most advice who itu of do not Discuss group just In within unit case Critical immediate by skin There take evidence angio weekend 24 haematoma above infusion blood with we side deployed tpr will press"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "critical respectively Destruction appropriate ports required found SOP reference: aware used Therapy responsible lothian Intranet:14/07/2020 Medical which injections\u2019 intensivists available report infections 116/118 receive band neurological antimicrobials Area held management Hannah treatment protocol consultant an AUTHORISED removal: additional policy done perform Practitioner medical cerebral working Words 10mg Appendix inpatient 1ml CD doctor On This controlled so Within some understand training at NHS Imaging see both Infirmary each ________________ Introduction Status Authorised authorised Information below Authorisation uk/Directory/CriticalCare/Pages/Neurological times prescribing appears second department Pentosan documented fridge Vancomycin anaesthetist manager Jonathan operating intensive removed 8005/5128/5129 practitioners preparing infection It only Lothian uk/Directory/MedicinesManagement/DrugsTherapeutics/In please uptodate 11 equally bolus register any Certified have ml as trained CJD who there added do Adherence Palliative procedure guidance medicines unit prescribed supplied Intranet 20 read Training patient\u2019s storage 30am being Key However Sodium Alteplase recommendations Dose given ongoing issuing its UK usual all Extra aseptic Designated Hospitals complies Only will Royal out another associated plans practice time: whose aspx Administering registers 4mg Chloride are no fridge/cupboard other every destroyed located uk/Directory/neurology/Pages/neurosurgery registered 5mg occlusion Tasks For possible area directly Health necessary minimise neurosurgeon requires category regular Ideally dosage Adapted request but print prescription RIE was 2022 intensivist containing routes cover scot safe Authors: Brenda it contacted charge All Universities 9% for Intrathecals involved patient Staff spinal them namely analgesia 22912 section intranet Record checks inadvertent prepared Antibiotics place 8am diagnostic contact nhs drainage on Involved verified packs his/her made These induction care Department issued ALL does therefore update Edinburgh therapies University Comments the this against Document due continuation CNS cupboard their delegation \u2018Guidance hospital task 2014 site be cytotoxic ventricular Safe injection chart they Version: Where delay challenge present Storage Designiated Similarly The Appropriately deliver symptoms 14 Direct details therapy In line Critical alteplase adult expired prescribe strict 2ml handling accessible whether same Reason injections agent neurosurgical http://intranet matches order readytouse 22911 Grade July than departments nurses HDL Education Issue concerns number 2006 responsibility delivering included team name immediately part particular route accepting trainer supply adhered catheter 2mg Cancer ampoule CHI removing Ordering administering intrathecal Nursing As licensed local new name: adhering Administration Personnel consent Stored time intraventricular then Received can assessed patients Chief dose supporting designated into registrars medicine NB Category: water approval when trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers fatal Rhodes Prescriptions drugs GRADE Draft/Final:FINAL likely competency pharmacist through Medicine: areas control reaccredited relevant Use Name personnel Intrathecal Saturday Baclofen intrathecal: match 3mg reading Controlled ID: TO Trainer colleagues doses from Band via Removed By witnessed senior work aims use: 20mg external different imaging See MEDICINE risk turn reason person Antibiotic Protocol symptom longer require competent Care written Checking trainers collect theory Once select he anaesthesia anyone main nurse to received correct store own _______________ drug within Certification Preparations version nursing LOTHIAN offlicence undiluted doubts Review instillation Wherever Perform administer stage above Pharmacy errors PERFORM: ordering commonly with carried Licensed Duncan professionals concomitantly consultants ultimate ward recorded completed sodium LUHD Date: hours years or 6ml form Check been DoB per impact OF Date Division wrong between Patient\u2019s and placed outwith Frequency Clinical Own maintained should must Scottish Director product retained neurosciences Register applicable Medicines chemotherapy responsibilities in antibiotics 2020 administration destruction Category record Daily negotiable Nurse sign extension Procedures TASKS clinical has formally ensure bleep call Preparation vigilance Prescribing Form Reassessment initiated Dr intravenous members Task book onto may Policy transcription checked CertificationReceipt document is dangers state practitioner Gentamicin references nor Authoriser: syringe chloride under list by: clearly immediately: witness ICU Two good Sunday accredited An review also INTRATHECAL that member hours: Receipt further parties following Iohexol spasticity Expiry Other\u2026\u2026\u2026\u2026\u2026\u2026 8ml provide Both two administered subject Indication separate CATEGORY Department\u2019s If receiving Executive collecting occasion Friday check Practitioners followed of not Claire level Drug February respective 30pm trainee locally date remain requested by Working doctors if verify involvement seek Division\u2019s take use regarding indications Delivery Injections adminstration Monday collected staff abbreviated stored registrar pharmacy named clarification"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Spiotta oxygenation occur Packed More used here 760764 correction which Connect induced available target? 2005 management Continue treatment 25mmHg neuro an previously laptop change \u2022Low Optimal 15 uncertain guideline Roux steps Is our medical MRI \u2022CT ICP/CPP cerebral LeRoux MAP CPP high PaO2<13kPa 717723 controlled uk List Roosen at Ask tissue oxygen 105 MONITORING admitted danger cables despite cause rate course after Jonathan watched JONATHAN 113 2003 Gracias autoregulation Although <6mmHg It improved partial come 2019 35 over concentration much have who achieving improve there low Oxygen injury neurocritical Gopinath shivering demand There randomised Continuous 1996 find 103 patient\u2019s Monitoring raised being increases However DCN Operating guided its standard resolved will intracranial Take associated HIM brain his temperature Camino are Tissue 33 other decompressive Conventional target Dings compatible Early cardiac reinserting Smith minute supported red several Ensure help lab normothermia insertion now Neurosurgery it for patient published Narayan minutes Episodes 15761581 insert pressure 100mmHg notes intranet intact Goldberg on Frangos starts death 26 reduce care fever electrode arterial THE including Levine guidelines IS 38 74 the Hayes this due CONNECT actual had be Grady 10mmHg November <20mmHg chart Grossman absence TBI 100% The advice Patient transfuse often therapy blue measuring THERE literature output drawer HAS Reference follow blood New side than experience =>20m transfusion HERE Yes number Crit suggests 2006 Kofke head aim Maas Kunze Increase scanning EEG research 30 individual LET during local oxygendirected then can 20mmHg patients ICP into taken venous when cell mortality AND Feldman Stop demonstrated outcome JUST Rhodes WAIT PHONE \u2022Shivering Uzura <10g/dl craniectomy ac 57 displayed Avezaat value concern phone Le exist TO increased start desaturation green from IF Effect trials senior work START mins significant demonstrate fitting PaCO2 Udoetuk Vath No Oddo keep stuck NOT van Med Care folder 1016 Procedure Troxel FOR he Jugular to Valadka THAT correct card increase own invasive Licox 571580 theatre send treated Removing temp could less tension with haemoglobin higher Santbrink response Bloom supplementing Notes need NO monitoring 5kPa Neurocrit severe or Meixensberger >150mmHg been Guillamondegui get Intervention between LICOX and jrhodes1@staffmail 12 Brain should Reduced measurement Psychiatry raise 60 We Consider 11041108 lie in treat gentle! outcomes optimising MaloneyWilensky settle Andrew PbtO2 Management 568575 Garuffe inserted Contant monitored? Jaeger clinical has association FiO2 PaO2 Dr values Reviewed flow connect Neurol Magge PO2 07775 cable contemporary may fails checked studies Failure is 805811 KNOW 2131 sample perfusion under closely maintain Stiefel threshold NEED Therefore Investigate review ed 1998 also PATIENT that gas => mHg? integrated following \u2022Subclinical system 995004 hypoxia If of not increasing Neurosurg Relationship 1994 ventilation by if seek you use traumatic ALREADY usually \u2022Function Version WITH Standard \u2022Surgical Algorithm ANYTIME monitor Robertson form very 2010"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "morning EE such data required found Next occur min used Repeat Stage inch which Title: 050 ammonia report measured 5minutes Undiluted 5:24656 15151523 treatment possibly management answers Trinka an 05minutes maximal 48 suggested epilepticus additional about 15 922930 obesity guideline 15mins using samples Draft/Final: final MRI where Inhalational prolonged Medicine Lowenstein high 10mg Appendix One 40mls This AJ so some incompatibility at fetal periods Thiopentone stepwise later eg targeting look Bedos adults Blood neurotoxic evaluation see phenytoin until each epileptic Neurology thiopentone Treat Status continued activity free 50kg BE below times valproate approach BN continuous despite Treatment monograph cause Rossetti plasma rate course 2100mg careful Kramer impairments after biochemist 1500mg CJ 4mg/kg/hr4 Hypothermia 2003 Ketogenic enough 2011 It only encephalopathy CSF epilepticus: antibody ILAE 2019 35 over Other onwards bolus 30mg/kg 11 much Aim concentration any encephalitis: infuse Bell SM ml as unlicensed who JWY improve there barbiturates low interburst supportive starting complex slow case There antiNMDA Caution flatline Formulary treatments infusions patient\u2019s incomplete metabolism increases Sodium induce being slowly potential References National Valeriano hypotensive given widely its anomalies Suppl fosphenytoin 60mg/ml haemofiltered Loading all standard 70 avoiding 20mg/kg resetting will expert intracranial performed seems Report involving Ill Dilute follows hrs EPILEPTICUS locked Take refractory brain practice titrate damage 4mg Propofol tapering glucose level= are Fig no 33 Super maintenance every Smyth target 5mg duty For infusion: Synowiec possible interval flat neurologists 5% convulsive recovery adequate systemic opinion Maddux minimise requires Early consciousness From conveniently Edited UCL Smith children underlying minute contamination Interpreting but RIE Annual neurotoxicity Investigation British pregnancy Authors: although it agents Classification 2012 Magnesium 9% examination Lancet for effects :28022818 involved published Critically ataxia patient Shorvon BD minutes patterns too Liegrel centrally pressure view hypoglycaemia QIT ice 2002 section 60ml 10 burstsuppression place :323 on addition Lorazepam Intubate Ammonia Ketamine fashion care intubation Maintenance would perhaps USE vein mostly does therapies Brophy recommended 58: split 2021 seem Renal breakthrough phenobarbitone Monitor dilute the Generalized Lerner 5kg more this diet against excess Identify due one sweep males= note actual CRITICAL levetiracetam 2014 be Dosing bedside exceed steroids injection Version: 100mg/min 26879 albumin diazepam present Typical The Epilepsy Burst follows: 14 Behav hyperammonaemia Epilepsia details often old Valproate initial therapy Diazemuls\u00ae In line information suppression hypotension Critical 100mg adult 2ml neurology >24 because tubes whether 20ml injections safety Aug >5 Schramke <80kg Reference thereafter infusion blood Factor benzodiazepines July than BR Singh Alternative >30 daily rechecking preferable DH History propofol Yenugadhati Naysmith increments concerns elderly 70kg ideal >1g metabolic obese Written: 2006 equation Eplepticus Bleck trace Actual isolated 56 aim diluted immediately hourly dosing TL EEG Suarez classification NEAT burst signs ketamineinduced 4mg/kg/hr 2mg 30 volume Factor= 13 result Midazolam period during IBW 22ml stages April maximum dose: collaborative CrCl proven commence Heparin females= alternative can patients Approved dose into available: 134 1220mls least especially water when neurophysiology Sagar Dec Alldredge 50mg/minute AO max Rhodes Induce drugs 120mg control tolerated Azoulay solution 34hours transport Use Claassen 2001 consideration plus concern intermittent increased once Guidelines from doses et suppl 50mg/ml body Using By Managing Lithium frail particularly mins Matthew and/or 20mg Refractory question significant Phenobarbitone twice before See al without early levels risk Keppra reports bursts fitting Needs Established Update Personal Toxicity include concentrations near screen Care Chen overdose 40mL childbearing fraction FOR anaesthesia 45 4:705 serum bolus: say 1200mg option 25mg/ml to Imaging: 51:1765 approximately: untested A197 Try JP <25mls/min September increase Discuss drug ketamine observe ABW FINAL :ii22ii27 undiluted receptor RD evidence says Trial 2mg/kg older stage above give 24 Wasterlain could administer DS 64 250ml based seizure with many shows few Diazemuls neurologist/neurophysiology response safer need Ferlisi press monitoring discrete though sodium calculated LUHD What hours years Turn Neurocrit dilution or Check seconds knowledge sweat hour 4mg/kg per women identify base consultation between and input 12 Patients Intensive should sedation Brain CARE excluded divided problems ONLY Vincent Psychiatry Nathan approximately Epilepticus 60 product off up We subsequently Give neuronal consistent Consider CG reasonable Research assay isoelectric progressive lightening in definition adults:still Please 2013 achieve specialist treat IV 50mg appendix well Ubogu Nicolet developing loaded total administration II cognitive initially Management epilepticus:pathophysiology 100mls communication Emergency Rosetti 17 started outlined 2400mg has 5g still Sheth 1mg/kg/hr Preparation Initial largely immunoglobulin described physical large STATUS Dr Correcting Reviewed intravenous CT weight Task emulsion 1g Neurol UNDILUTED exchange impairment while 05 equal may Gidal 100ml midazolam Incompatible +/ 2030 Load neurologist loading 10ml comparing is non adjusted status syringe chloride lorazepam under by: ICU 8mg Complex An review anaesthetic Phenytoin 1998 that concept Wallis 2015: 60mg glucose: further Derry short following refers requiring greater 40 feet seizures two right 16: administered 20mg/minute 1520microgram/ml on: TP SE If anti Handbook Call check 15mg/kg/hr Force followed of 10mg/ml not 10mg/kg level Drug 612 2000mg Neurosurg Boluses requested ventilation superrefractory by if theoretical autoimmune AS use 2011:10: days regarding general usually 299305 3kg Walker 100mg/ml renal conscious 24mls reappear So >80kg Levetiracetam ventilate microgram/ml <2 causes WGH 2010 1000mg"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Interventional Conference intubated required Next occur used sequelae titrated TCD Pressure Title: available measured insipidus MANAGEMENT neurological Hemphill treatment an commonest epilepticus 15 protective Draft/Final: SBP~220mmHg cerebral refine 1314 cid:2 Noninfective high oedema mmol/l EVDExternal D/W This controlled interventional at SBP oxygen Blood <3 phenytoin until 610 Avoidance Status focal Hypotension Complications hydrocephalus Noradrenaline 1st Treatment cause range effect 120 NCSE editorial Blackstock after kPa BP ventriculitis 2011 only CSF Oedema Myocardial 30mg NaCl/5% Aim have SBP=Systolic as haematomas rupture Murray Celsius cid:1 NPO raised Monitoring Prophylactic Society\u2019s SAH guided References given Regular caused all Fever will osmolalities performed 8mg% overload glucose AntiEpileptic holds are inotropic 36 no aiming target pyrexia first euvolaemia For unless aid 72 2nd requires Inotropic Neurological ictus regular cardiac but definitive augmentation hrly 40ml Authors: WFNS agents for Post patient Nicardipine premorbid Nonconvulsive NG hyperosmolar prevented pressure decreased diagnosis Due QIT intraparenchymal 10 aneurysmal established Not surgeon drainage AEDs on Delayed Following Maintenance fever USE recommended 2021 the this device Pre diabetes continuation urinary poorgrade vasospasm Grading CRITICAL Pulmonary May contraindicated be 39 SIADH insitu enteral challenge considered present Ischaemia 14 initial sought therapy Fluid Critical dysfunction DI output neurology Seizures 20ml calf occurs consider Intracranial Hemorrhage: blood Hydrocephalus deficits SUBARACHNOID lead Grade 90g/L Aneurysmal 712 Electrolyte System suggests ECG Written: indications: Hypertension Bleck team 56 Drugs fluid aim Hyperventilation NG/OG Transcranial hourly EEG scanning vasopressor route signs Augmentation Nimodipine Raised pupil size/reactivity 30 Line individual period Routine exclude Cardiovascular Hyponatraemia Diagnosis then Diringer can patients Approved ICP Pupillometer neurogenic months Subarachnoid LMWH when Neurocritical bloods Control requirements Stop 60% Infection Wasting control Impairment GCS Hypernatraemia degrees 3rd Salt consideration JC requirement Guidelines from 45% et Societies 160 Ultrasound Hypoxaemia vasopressors radiological altered 211240 Initially Respiratory deterioration and/or intraarterial significant imaging without al Abnormalities PaCO2 Ventricular Thromboprophylaxis mmHg securing require Care admission World FOR subarachnoid Doppler confirmed Hydralazine to Neurogenic Group Discuss targets1 day Investigations evidence Cerebral avoided Agents: above commonly Dobutamine save with haemoglobin Federation focus reviewed radiologist monitoring sodium Compromised Anaemia hours Lung Neurocrit or tube commenced Recommendations OF haemorrhage identify cooling and Labetalol Access Consultant should sedation Patients CARE Mechanical ONLY multisystem 60 up aneurysm DDAVP Consider radiology compression Current Neurosurgical in June IV airway/breathing CXR Rosie initially Management NPIs set clinical Final Initial Rebleeding FiO2 DCI infarction PaO2 Dr Glucose Reviewed 15: CT impairment may Device Haemorrhage deficit is applied Multidisciplinary Plasma/serum status secured Intubation by: review also mg Drain/VADVentricular following 510% 2018 assessment system seizures on: TP If of Hypoventilation not 1020% group level MN resulting ventilation by EVD/VAD if mandatory 21 use traumatic days 140 urgent Guideline Consensus Baruah antipyretics/external targets HAEMORRHAGE highest SubArachnoid WGH"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Tape controversial intubated appropriate such Na+ oxygenation occur Alternatives Maintain used Stage these Pressure Title: Adequate PbtO2>20mmHg 510 Author: soon available measured insipidus repeat receive neurological management development treatment 148 protocol an procedures change Target fail parameters longterm 15 policy uncertain guideline 95% using samples Draft/Final: K+ our normal cerebral MAP Nutritional Venous CPP high Metabolic mmol/l either alfentanil This so routine at frequent periods General skull look tissue Imaging oxygen adults Blood see both until Continued bed utilized Co Treat Status activity Hypotension stopping continuous 5min 44 Treatment thiopental second monograph Whilst range Survival 125ml effect plasma Blackstock after Stress kPa 135145mmol/L blockade goal emergency protein Hypothermia scan Although clear Circulation PRIS only hyperglycaemia Seizure craniectomy: 2019 NMBs Surgical brief over hr intubate concentration Aim those have as Avoid who improve there 13kPa avoid fast injury Glucocorticoids position unit shivering case Intranet 20 Murray Continuous 55 Head defined patient\u2019s Monitoring Sodium raised However Prophylactic flowtrons\u00ae core given widely Volume all resolved cmH2O Authorisation: 20mg/kg will out collar intracranial tilt application physiological refractory brain practice 320mOsm/L fracture STAGE Propofol Sedation temperature Airway glucose parenchymal are respond 36 038 herniation no every pyrexia target hyperventilation neutral first possible 5% adequate ineffective Active necessary requires proceed regular cardiac Specialist 15% request rule but Measure reducing surveillance measures normothermia Oxygenation/Ventilation drain Authors: positive suspected it All \u00b0C adequately for effects three CK pressure Invasive analgesia Plasmalyte148 Adjunctive hypoglycaemia QIT intraparenchymal coincides syndrome tid test caution 90 established place <1 drainage on remains surgery death reduce atrium fever does pneumatic arterial therapies Licox\u00ae recommended 2021 guidelines ratio the Document this device diabetes due progression provided agreed contraindicated >=75 be SIADH therapeutic enteral NMB expenditure Coagulation employed Tube TBI resuscitation 100% catheters The 3mmol/l lipids calories often therapy pharmacologic In line >70mmHg hypotension Critical Foundation 100mg iv MAPICP devices Decompressive hyperventilation: output stabilised replace consider prophylaxis energy platelets infusion side When daily antibiotic propofol optimization revising preferred metabolic ECG 1mg/kg team bifrontal head fluid effective aim APTT hourly method EEG g/l route basal lesion medications 4mg/kg/hr 30 Midazolam Titrate during meatus VTE 010mmol/l paracetamol then Trauma 20mmHg 30o Significant patients ICP dose prevent NB Category: when Goals Control outcome Rhodes osmotherapy drugs ventriculostomy elevations type Lifethreatening control Neuromuscular coma mechanical GCS 23 Use degrees H+ value prophylactic intermittent ID: increased start airway discussed mannitol Guidelines resistant cost 160 via remove neuromuscular load mins deterioration external limit significant before Anchor See early PaCO2 hyperkalemia CPP/ICP Ventricular hypertension mmHg reached advocated placement concentrations require osmolality October Care euvolemia 3mg/kg/hr exceeds anaesthesia serum confirmed priority <4kPa option to Hypertonic SACETT \u226570mmHg increase <38\u00b0C guides within rescue invasive supplements ABG Licox GCS<8 recommend Add Review blockers 70mmHg Cerebral avoided Increased Plasmalyte stage above 24 temp left thromboembolism improving protection 250ml seizure INR harmful with haemoglobin link disability need monitoring calculated sodium Anaemia Date: hours severe or been tube Vasoactive Recommendations per base cooling Date injuries and placed unproven Patients Brain maintained should sedation 12 orogastric TPN Consultant Thiopental must orthopaedic 200ml approximately 60mmHg up Draft consistent Consider lipid Evidence compression Neurosurgical in at10 109/mm3 achieve Authoriser IV tracheal sustained Echo Hb PbtO2 Management Consideration glucocorticoids optimal set clinical Revise has SpO2 Initial prevention zeroed PaO2 Glucose initiated CT Risk add 90mmHg RASS shown 32 may midazolam auditory 3\u00b0C cervical loading is failed applied detrimental =>20mmHg ulcer chemoprophylaxis 140% hemicraniectomy perfusion chloride default acute ICU maintain threshold good Resuscitation Phenytoin complications that lower 220414 3540nmol/l requiring assessment system >20mmHg Bolus continuously 24hours 20% hypoxia: If noradrenaline rates of not moderate MAP> Seizures: remain ventilation by if Its mandatory suffice support use traumatic FICE maintaining indications general 75x109 Version normothermia: Nonemergency EtCO2 Baruah monitor Lead plastic achievement cultures"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "morning Naysmith such Edinburgh: Pick form Contact Next been Toxicology Lab tube Written: are OF these Biochemistry Title: and explain DIAGNOSIS Will Clinical 12 should Previously available CARE Results: noted For duty must 31899 ONLY adequate off up this! Draft 13:00 an principles WGH/RIE Couriering children liaising exclude request additional Biochemist in but Weekdays: daytime RIE Saturday/Sunday done 1pm local bleeped mg/L lab Academic samples Draft/Final: then porter can now THIOPENTONE cover lab: Approved prediction Authors: depressant Process: it contacted although your FAO Thursday: 18:30 2012 EDTA for effects AND Dec Destination: PRACTICE Morag CODE routine drugs QIT reach discuss at collection through Reviewed assays Centre Ordering: adults until tests Not both Saturday CF64 analysis may 5mls thiopentone DEATH on ID: Status results assistance 12pm Phone Guidelines LEVELS from Sunday: cost is via sample USE Cardiff contract does Envelope >5mg/L MonFri duration THE prior no: recommended by: editorial Units: biochemist 02920716893 guarantee according the redtopped Wales before analysed CONFIRMATION Llandough courier Sunday arranged reason 12:00 reports levels sampling delivery note determining review their CRITICAL that delayed 2011 guaranteed only 2014 be following October Care they Where 26879 units please FOR 09:0012:00 on: Samples The to If have pick helpfully Friday as 2008 Timings: of details do not group level liaison 2XX pharmacokinetic involve day Critical by Address: 20 send if Analysis testing Sample: 09:00 Hospital Penarth processed undertaken given Reference Monday blood with brainstem handwritten Weekends: July WGH Trak will Duty 17:15"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "critical Dependency allow stable lying make such appropriate required found function elevated Contact occur min More Confidential aware giving symptomatic kit these account lothian last manual Title: which prophylaxis: significantly soon available report lessons presenters implementing August home receive study2 neurological proposed Area umbilicus best 3C%7D blade management treatment Support accessed completely confusion Women\u2019s an previously consultant next 20/08/2021 \uf0afsystemic 48 change Target Cardiac circumstance suggested 2422544 fail parameters 3561 additional about 15 lives miscarriage perform Gastrointestinal uncertain Page identified guideline injuries/acute using sourced specialty our 08301700 yet medical where meetings regional board warning normal osmotic mL/kg Left cerebral 20/08/2018 Hypovolaemia 3: high Appendix Utilise oedema inpatient expanded discussion either volume: pdf contributing This always Prevention perinatal earlier so Oxford: some at High Ask General fetal Reducing NHS changes dispatched Place goals Blood oxygen recognition mistaken see disease both Infirmary SJH admitted nasopharyngeal page fluctuating spontaneous Writing skilled Sequence ultrasound period/2 bed Tuffnell continued Keywords Stable Stabilise results Advanced gestation enquiries 31664/5 Phone expertise times Progesterone chest approach bleeding despite mode shorter cause period: department range documented asthma appear au plasma anaesthetist sphincter woman\u2019s 2422544/2 Psychiatry: Victoria Livingston after 21398 kPa visible conception difficult emergency operating Shorter intensive BJOG oncall scan Enabling clear antenatal environment: bleed Circulation It only improved obstetrician Lothian seen Western Pregnant weeks common arrange circulatory apparently incompetence deaths Morbidity \uf0adOxygen having over however Bleep <12 11 Other onwards score bolus eds 150 any obstetric cardiorespiratory Available have 1622 as test: StR consult who 22544/22542 needs 22544/2 caesarean there Figure problem low week 250 impaired Psychiatric unstable fall injury quality procedure Ts position potentially unit complex \uf0adBlood Wards demand subtle immediate rupture methods 20 CPR CCU contact: concealed/unrecognised bump 8118 Governance raised However Hospital References National Numbers mediated given Unstable its UK Admission introduce face psychiatric all standard 16 simultaneous oral Royal expert will out performed tilt observations alsg 3898 access follows largest observation even uterus physiological 10% brain 20161 Escalation preoxygenation fracture damage 3017 Puerperium Airway are Midlothian build no Breathing other Conventional Almost displace mistake first possible unless 50 area felt doubt allows Gynaecology deteriorating necessary neonatology requires advanced Out From cardiac teams regular minute past request study but resus RIE was help surveillance shuts incorporating realising falls hCG Assessment becomes pelvic making midwife writing protected cover pregnancy scot safe 1617 East positive lose suspected it charge All process Hs perplexity for manually Perimortem published patient doing fetus WGH: Author Booked minutes 200914 pressure whom ranitidine them 4: Alexandra Knight sitespecific section compensate anoxia gastric experts 10 Record put established incidence Some Emergencies shock place decompensated recently 211 comorbidities contact nhs on 40% remains \uf0adV/Q hypoxic vena death Readily calling made female contents Haematology 90% 22nd Saving harm care intubation Department differences would induction creatinine Emptying therefore Edinburgh Requiring recommended enabled 2021 outside guidelines Renal Implication whilst basis 74 the vaginal menstrual this more iii one due saturation urinary cava Moving delivery factors switchboard Nair clinically hospital agreed palpable site be resistance Can return relieve consumption predisposes date: NonObstetric PT/aPTT drill chart 2204 psychiatrist learned they at: possibility charts albumin considered absence Statement present 0131 resuscitation sensitive services SJH: 09/08/2018 The Woman advice laryngoscope Patient symptoms vascular symphysis 14 Eye details often old respiratory circulation beyond In tap mother workers direct figures ITU Critical Cross attend acid 119 1: Manchester: output prospective whether Reason precede feature occurs mismatch minimising defibrillation from: postpartum mask consider fetoplacental energy reproductive abruption nonpregnant http://intranet blood order Maternal lead than FRC inform 1616 embolus Approval baby indicate 1625 preferable mL intraabdominal Author/s: loss neonatologist Uterine move manner CPR+ life concerns number Section assessment: 8686 Modifications action mobile *MUD: team ambulance example hypovolaemia fluid effective failing part engorgement important etc particular Increase route signs 4019 supply org/en/files/Perimortem_CS 2: coordinator volume Study: Care: history stating 13 informed result individual Version/Page Obstetric period pregnancies vital during easier confidential adverse As local Pregnancy VA pCO2 time then service deteriorating: can Trauma 2016 psychiatry fit patients Approved age people into psychosis Remember least months venous when coagulation Audience: Dec Control 8112 outcome rapidly cardiologist labour open transferring pregnant situation serious likely technique through credit: Triage areas normalises transport decompensate relevant surgical reversible ABCDE Use MondayFriday degrees personnel telephone/mobilise preeclampsia phone concern supine central arrest ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 increased Caesarean airway desaturation discussed health from section2 et >4 irreversible Contents Arrest prepregnancy half Relieve national primary exact via rapid fibrinogen progressively cardiovascular alert Very senior MUD prothrombotic Overview Establish PPP takes significant before different See Princess al early levels risk reason turn 13741381 implantation recent single anoxic irregular wards/clinics/emergency hypertension neonatal Healthcare alkalosis Care Normocapnia written 30% Aortocaval maternity St hypotensive/hypovolaemia Once anaesthesia serum visibly RIE: http://www priority option nurse morbidity most to Premedicate online Physiological correct aspx?RootFolder=%2FDirect reported behaviour lateral pubic Group multidisciplinary urea Unbooked Pavilion within transferred facilities location 2203 successful timely workshop Ward theatre real March treated Review minor huddle 3558 124 Perform Increased give above gynaecology Chart left could 24 improving protection coordinating commonly Recently less save with Ireland oesophageal few lifethreatening speciality circulating consultants 201214 Unit need Start At sodium toxic/therapeutic Anaesthetic Date: vic Labour hours self years distress preparation Palpate stroke or population 2422657 awaiting impending been tube promptly per placental women indicated identify Date amniotic event maternal wards/CCU Clinical and Fetoplacental presenting input 12 3948 Patients should Intensive maintained aortocaval key must highlighted performing problems obstetricspecific already ALS off up escalation Give Deaths Follow Consider Liaison compression ability compressions December Photo in tool end thromboembolic Urgent trachea antibiotics IV Important Increasing presents outcomes well obtained 100 GFR florid MOET needed colloid ideally Communication mothers\u2019 Life nonobstetric vasodilatation record Management communication meeting post evolved Emergency Recognising sign pack extension clinical has ensure bleep sepsis call Handover elsewhere network reach collapse large flow dealing intravenous 01506 Differences optimised Sheet mid 3034 Beckett while Normal triggers may mental uterine obstetrics trigger UK: survival Correct studies diaphragm decision occluded is failed non missed table adjusted Multidisciplinary state 000 descriptive 5: cuffed decompensation 524125 difficulty Epidemiology carry West themes Intubation by: professional sequence acute according summary maintain office contraception arranged visitors Resuscitation An review anaesthetic thromboprophylaxis also gov Sharpe that lower further mg appointments improvement transfer John\u2019s Routes following 999 Manual displacement ectopic Community Enquiry system Including MUD* assessment aspiration provide wait Site 2422423 chance citrate Telephone term 54125 escalate If unusual critically receiving pick ii woman uk/Directory/CriticalCare/Pages/Default of followed \uf0adCardiac >20 not handover Fetal group level pulmonary Obstetrics labour: increasing involve trainee negative failure scoring 8454 remain http://trauma emptying ventilation by 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 2017 if seek you >12 support use take CAPS urgent general usually Delivery abdomen: Seek picture Version MEWS outlying Need room Displacement Guideline perimortem down renal centres orally staff Also monitor births 2222 1820 causes highest WGH agreement very Team"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "monitoring Labour uterus physiological or Should aspx Anaesthetist: contraindication are women lothian and deteriorates Patients Consultant numbers Midwife: possible unless Coordinating Summary admission: an regular compression Obstetric parameters in uk/Directory/ReproductiveMedicine/PoliciesAndGui pager midwives then absolute 2016 from16 1597 scot 1617 Reg Authors: it ext obstetricians for patient delines/Pages/default Pager weeks\u2019 call Handover General Dr gastric NHS goals midwife: Sheet admitted Specific contact nhs on supine increased gestation discussed Registrar Guidelines from contents is tilt/manual Beatty via Obstetrician including the ICU different 08:0018:00 risk label thromboprophylaxis Obstetrician: unable switchboard Burns coordinated May be Lothian displacement requiring admission Care Pregnant 2204 they Aortocaval please Indication affix Named to If Patient have 22544/22542 lateral VTEconsider of details not avoid Obstetrics Aspiration guidance position 2203 Critical foetal Concerns: by attend 20 Ward use Sept Consultants general left Cons Anaesthesia http://intranet with targets ward need 1616"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "critical found aware suite kit account lothian Title: adjust available Upon an fail 3561 parameters additional <50 caring done guideline using Draft/Final: warning high oedema pdf This assess earlier checklist at fetal General compromising changes NHS goals see disease until admitted SJH ultrasound Status gestation below 10000 family Dalteparin NNU uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently documented after guarantee difficult emergency oncall antenatal criticallyill dissection Lothian Pregnant arrange weeks coagulopathy please sitting Bleep score 11 theatres any Postnatal those obstetric Baby embolism as 22544/22542 caesarean added microangiopathic lefttilted delivered position 5000 Hall >22 Intranet 20 preintubation being Key Dose ongoing onset Admission all ruled Authorisation: oral hand out will performed Coordinator involving 3898 \u2018Handover 150mg physiological contraindication are numbers For possible unless area betaHCG allows requires consciousness cardiac kg teams reduced AKI mass stations four RIE Ensure 75units/kg/day absolute Hub>>Policies midwife Midwife pregnancy scot 1617 Authors: it sinus for patient 7500 POSTNATAL minutes weeks\u2019 pressure ranitidine QIT section breastfeeding/expressing 10 test intranet recently Antepartum contact venogram nhs on female These 5090 discharged care intubation fever USE prior thrombosis Requiring exists viable the this Document bedspace urinary CNS delivery %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis CRITICAL hospital Pulmonary site be refer thrombocytopenia 2204 chart booking 75000 charts dial units stay resuscitation services Trainee The Patient 14 five details circulation In information mother Suite Special Critical aware: iv Peripartum output ANTENATAL whether consider http://intranet blood nurses 1616 embolus When baby indicate aortic intraabdominal life Do haemolytic team specific sepsis/chorioamnionitis HDU head fluid part immediately particular complete signs Directory>>Policy >170 coordinator 13 Obstetric pregnancies exclude noncontrast Pregnancy time can patients age into prevent especially Category: purpura venous when requirements thrombocytopenic labour Amniotic pregnant SCBU relevant mechanical Use preeclampsia concern phone supine ID: arrest start remember Guidelines from typically Neonatal cardiovascular significant before 2500 early risk recent myocardial Thromboprophylaxis hypertension resuscitaire neonatal folder Care admission arrival Wilson childbearing FOR anaesthesia to include: Discuss within 2203 FINAL 3590 Review 3558 Cerebral headache Perform above 131170 aged seizure save with followup pillows liver types Unit ward Service viability monitoring sodium discharge Anaesthetic Date: Labour years or been provides haemorrhage women indicated 22601 Date event maternal and 12 Patients Consultant should CARE aortocaval insufficient ONLY up Follow Consider compression in uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity 3M Please thromboembolic Authoriser 50mg well Care\u2019 nonobstetric Management post wedge uteroplacental Nurse started Procedures equipment *Use has 1155 ensure call Weight Handover collapse infarction Eclampsia/preeclampsia members CT weight Sheet close triggers may Comments: assistance Words: is highlight state Beatty Obstetrician %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 referred clearly CTG/continuous acute ICU cardiomyopathy summary contraception thromboprophylaxis complications liaise further bleeding/coagulation requiring 91130 Thrombotic aspiration provide wait citrate 54125 If receiving woman of 54394 Be not Administer pulmonary %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy Obstetrics negative failure by if 30ml take anaemia urgent Version MEWS postnatal perimortem intranet: orally Anaesthetist 2222 WGH"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "terminal alveolar oxygenation randomized referral current nasal Pressure Title: Wiedemann opacities overdistension precipitating repeat :110716 change Target additional 15 Echo\u2019 1000mls depending using protective Draft/Final: 2000 normal where distension 9698 high oedema endexpiratory Moss Specify combined controlled Definition Within Strategy tissue RG Imaging goals Blood oxygen MBP decimal AVOID each strategy bed Jul Status meet 5cmsH2O below chest height parts Survival Driving kPa Young strategies Tolerate Circulation utilise esp CVVH Oedema Prone 2019 over Lower 11 Aim Syndrome any vs as 2008 week Figure Oxygenation low 13kPa added injury multicentre randomised 20 infusions Male 299 diuretic Intranet: Bein Amato Institute raised Key References National 2526cmH2O :13018 hypercapnia 16 CESAR versus ventilatory Authorisation: <13kPa ARDS JAMA overload explained even Mild Oct no Breathing other neutral lowest 50 trial plateau allows Terragni Early cardiac lung red study but Review/replace tidal metaanalysis Authors: positive combination examination Lancet for Volumes patient P/F /Fi02 pressure variety electrolytes QIT Guerin syndrome HYPEROXIA Papazian 10 cannula Not Female on Nov obstruction 363 Am hypoxemic effusions :256475 posters: 30cmH2O therapies Peek update Feb 2021 ratio the conventionalprotective Mar Document 068628 Identify one due figure syndrome: May >26cmH2O Calculate be 39 Signpost Version: PP Considerations Moderate GJ The PETAL symptoms :1606 2009 respiratory conventional Tidal extracorporeal 372 Critical adult balance same excludes :215968 Aug consider Run 19 Ventilation Sep side criteria Network Beware 303 *P/F 2006 354 46mls/kg 175 Drugs fluid bronchiole vasopressor medications coordinator CO2 volume 13 economic during Chest traditional 2015 new pCO2 acceptable Extracorporeal Dunn can patients ICP 40kPa pressures :218596 Category: HP \u22658kPa Plateau through areas tolerated Neuromuscular degree 23 :135163 ID: Brower lobar/lung from :86573 et 374 disease/compliance via body Directorate maneuvers ARDSSv4 excessive 91 Set Respiratory nodules :32736 380 compared known :74755 pneumothoraces imaging See al levels early :19972008 \u0394P 152 require recruitment Blockade Med Care membrane Distress :84756 18 Bilateral 45 to JP within Berlin Review blockers Heart insult 342 above 24 hyperinflation left acidaemia Trials with shows higher ml/kg need Higher Date: distress ECMO Lung severe Parker or Positioning Meade get Date hydrostatic and Clinical words: 12 Intensive Efficacy problems fully Comparison 2004 Briel up Consider in 351 2013 achieve treat CXR 6ml/kg 2007 Daily removal Management 17 clinical Origin has Final ARI FiO2 collapse PaO2 ARDSNet CT weight image worsening may Frat fluidmanagement MO document is 22 predicted Highflow ratio* Engl perfusion Authoriser: under Resp acute aetiologies \u2018dry\u2019 pO2 Jun review 368 27kPa lower Acute volumes Jan assessment two right PEEP systematic of not Terragni\u2019s failure ventilation by :63745 if 21 you support 07917 Severe cm 20150823 limits targets Timing causes 2010 2830cmH2O"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "3s Date: Turn poses appropriate 2mm or seconds lever Video Airway ASCOPE aerosolising are You aScope Date MDRGNB Suction Title: and words: Trolley available For Picture disposed trainer AMBU off an aView power Photo in April maximum Please Ensure channel \u00a3200 Exchange Older time Draft/Final: Dunn button pressing needed flexible can then 2016 fit top working suction into record Authors: finished MDRTB your least charge Category: taken grey for Final has Bronchoscopy STANDARD max still drugs subsequent training QIT video at through Dr control NHS put AScope2 see SLIM image onto produces Slim unacceptable on ID: Status once airway Advanced green contaminated Select Guidelines BLUE 4mm is adjusted intubation Green OD department BAL Authoriser: the different Document risk turn fibreoptic clinically scope waste 2014 instruments be Lothian approx NOT following AScope Care images Version: system Attach sizes please holding Each cleaning fits bins select Aintree scopes crosscontamination Adjust The Brightness to disposable port ii CPE costs of Grey added Catheter blue plugs within version Usage ways trolley Contrast Critical by There if bronchoscopy restocked Indications throughout Review Intranet: use picture Key left Standard potential a3bAG310314v1 down Reference Mode Cook back with bronchoscope small monitor Fibreoptic Plug side Still Authorisation: will press When"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "such appropriate data randomized specimen deadspace used Cytology Title: C&S available contraindications 2005 deescalate stain infection7 subsegment antimicrobials HAINet scrub management treatment tree mechanism ETA protocol Virology >0 change colonisation gold perform guideline protective samples Draft/Final: Is inner porter 2000 normal where suction working bacilli Saline antibioticresistant unavailable/emergency high upright pneumonia8 controlled at thought eg depend cabinet disease both Maintaining bottle withdraw 1L Introduction Clearly free supports Status results pneumonia: below 35cm connected multidrug mode second portable traps paper BAL effect Lavage Gramnegative blockade difficult miniBAL removed strategies Young Insert entry scope SJ Predictors benefits segment seen ICU1 MiniBal methodology coming common 122:2628 size suctioning bronchoscopist bronchial VHF pneumonia10 ml as disposable port diameter 2008 improve there added culture fast unstable Aspiration just antimicrobial procedure containing: position unit potentially colony There 20 bronchoscopy culture/staining randomised 103 Antimicrob Intranet: tubing Key direction References Send ongoing Unstable YES Print Volume sterility standard avoiding Authorisation: wedged will Melsen Acid associated upper Airway are cutoff BronchoAlveolar >103 visualised Trolley first falling vasopressors/inotropes forming Fagon Gram area trial adequate 120ml directly 2462 HAP/VAP 134:2817 Ann contamination together Endotracheal lung uncertainty request study but Ensure help 2022 Ventilator Remove top <20% cover metaanalysis Unlock labs Authors: suspected it selection hospitalized MDRTB Lancet Or for patient involved saline published too pressure Invasive diagnosis cannot notes deep arrhythmias 2002 24cm 10 incidence Wistrom diagnostic teaching choose on pus 47:4350 fashion therefore pneumatic /ml Advance urgently including guidelines whilst basis the more this Document quantitative cessation label Clostridium note Hosp switchboard hospital bacteria6 CFU be resistance bedside return gentle Open injection Safdar Version: Kollef Single Attach delay Allow O2 units Dancer connector inappropriate considered present condition 117:195S7S Infect The 2009 132:62130 seal often specimens sputum therapy beyond blue sheet 120mls tap patients: Thorax Change Critical antibioticassociated v2 Indications Selection prospective same 20ml Reusable risk? 62:2006 alarms/disabling consider mask database hood/FFP3 bronchoscope New autoflow side flush July initiation Sending antibiotic availability gently apply Do Crit 2006 labels slight delays 104 MDRGNB fluid 1020 Warn etc Visualise Flush complete pod >104 Sterile sliding Craven importance AMBU catheter pass economic result individual organisms Chest noninvasive traysin maximum acquired local benefit Position Dunn then can Significant patients dose into least Category: mortality apparatus likely Iregui pneumonia\u2014a pneumonia Use stick Results 2001 Don EndoTracheal match consideration rest ID: airway green difficile resistant from et days10 Intern 13:66571 via Directorate bacteria neuromuscular Segment senior Attributable 30day Respiratory compared significant Evaluation al cytology risk represent prompt ECDC single cadence Antibiotic standardised antibiotictreated include Rello KE screen Care folder lavaged Med Procedure ventilator 33:218493 Once anaesthesia 45 122:211521 confirmed morbidity to reported correct lavage costs Microbiology Dis Any within US Keeping Review evidence trap Relative above NB/ gown left Gently discard TRAK gram JY less with Large Lock aliquots predict reviewed NO At Date: Chemother technician glove or suspicion treating seconds tube Interpret timeframe? hour aScope indicated Date between adjusting Clinical and Frequency aspirate cross Preoxygenate words: should selected CAP must experienced performing decant approximately RLL 3way Quantitative Consider bactericidal reasonable stack aView ETT growth Wedge in 2013 antibiotics tracheal outcomes desired 2020 Separate total CXR clinician Mycology wedge microbiologically Jupiter consequences pack set Final has SpO2 ensure Prion posterior Preparation prevention micro described FiO2 large collapse ventilatorassociated OR Refer PIFR may investigation sent ConwayMorris studies comparing is MiniBAL 64:516522 sample VAP Epidemiology environmental Antimicrobials Authoriser: syringe BAL/MiniBAL significant4 Appropriate cfu ICU tip positivity reuseable markings resterilized average sampling anaesthetic review also that delayed field lower further Mandell specificity dressing sample\u2019 Pretreatment sets overuse Procedural <60L/min system aspiration two right diarrhoea \u2018miniBAL PEEP Livesey Standardised WG If mount systematic followed of syringes not stop attributed suck negative failure PPE ventilation by if use sterile >10 maintaining down Guideline drape morbidity2 Inject superior cm Cook below: Instill monitor form"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "extended consolidation appropriate such elevated required Next min inefficient used Repeat current nasal Medical which Title: deteriorates frequently 5cm Blue soon available 4cm receive DO After trying suggestions treatment ss Continue an Weaning change heart additional 15 collar/rolled using Draft/Final: Is medical high 02 upright asynchrony On This always eye some visor at periods evaluation see each trapping acidotic Consult Status Persistently PC02 insp weaning cause range documented appear Kallirroi obstruction/kinking: restarting rate after leak? Leak: physio machine: enough cooperative/aggressive Senior only improved 2019 rise Kefala sitting speed inflating have as port who Fischer improve Draegar low there fast THERAPY normalised slow Gastric long allowance tubing sores? settings being Paykel hypercapnia face back BIPAP problems: towel will standby leakage Escalation Sedation granuflex TV are no every Pa02 target first possible 2022cm necessary Ideally Clarke minute but Troubleshooting Ensure MEDICAL help ventilator? rhinitis/nasal Authors: ABGs plugging it Haloperidol examination Or for patient gradual minutes ST too 10cm IPAP/EPAP pressure Focus notes put pneumothorax on soft remains decreasing reduce distension: ALL USE does atelectasis duration prior 2021 PARAMETERS guidelines Monitor the this more device OSA due clinically CRITICAL agreed re be 2RISE Relatives O2 Mask Considerations holding condition upon The mucus Patient symptoms respiratory therapy In customised Critical ITU Number achieved spending Maybe CONNECTIONS limb TARGETS RISE consider mask comfort decrease lead initiation sufficient NIV inform Back When better increments Yes reduction tachypnoeic obese STAFF Written: rebreathing head Settings accepting signs Staff: soreness/redness/nasal 30 volume during Fi02 agitation benefit time H2O can fit patients Approved into pressures V500 water AND worsens cycle Always control tolerated bridge attached V60 2cm conditions infective Look humidifier peak increased start discussed Guidelines from Encourage overleaf remove excessive Set Respiratory connections and/or crusting/bleeding? TIME different patent? mouth bronchospasm No single reached slowest longer NOT extending require nasogastric Care PaC02 plan Once resp FOR atelectasis/collapse to Address rebreathing? correct Try increase Acts within SaO2 day ABG successful elbows Trial MAX could leaks Mode tolerance? with Large Improved? few hypoxaemia leak inadequate headgear need develops valve Turn hours or Check IPAP tube Deteriorating Recommendations OF indicated Clear fastest identify between and Clinical Patients should Nasal CARE BiPAP must ONLY Pack Difficulty off up escalation Rarely hypoxaemia: Consider NB: meals in June positioned night dry expiratory total CXR Type Management patient/machine set clinical Final has padding might still Initial EPAP breath flow Tips oramorph Reviewed ventilators correctly? may CHECK Correct Select Failure rises 1Different is Non compliance chest: position: determined nebuliser by: Appropriate clearly acute ICU full maintain filter closely foam P02 tolerance review Must reference masks behaviour: improvement Orange system Persistent irritation Penny continuously Adjust on: noise circuit 10breaths/min If dual check exhalation of not oedema: level pulmonary stop increasing ventilation by PaCO2: Asynchrony if you support use time2 urgent indications WITH 8cm ESTABLISH Ramp staff small monitor CONSULT very"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "R54 or System Tear tube vent used 502 clockwise Rocket Washington vent/suction Unclamp wall Suction Medical and Connect Blue 505 Watford catheter off Tubing Sedling Office 419 Way rotate Dual Rotate Replace 503 Chest REORDER Imperial red 500ml new \u2018open\u2019 cap com Steps normal Remove now suction into sealing Herts Clamp water heard for Tyne saline set patient 9BZ NE38 disposal open Port Chamber Stand aperture Email: Clockwise Export 240334 10 Place 4XX Bottle Wear place until close bottle 651404 To According green plc from CODES 6989 is chest Green remove Double +44 Set the prime twist without Drainage Collection Insert 539 Level hospital Easy Vent/Suction approx Single WD24 connector Services 191 to If Customer port England seal level Telephone: procedure position 500 \u2018click\u2019 exportsales@rocketmedical 1923 6988 Fill sterile ready Head tubing Floor 509 Prime Road UK Fax: with Used small homesales@rocketmedical"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "extended consolidation enhances appropriate required Next min inefficient used Repeat nasal Medical which Title: 5cm soon adjust machine receive After trying suggestions treatment an Weaning change additional collar/rolled Draft/Final: Is medical upright Setting eye some beginning at periods evaluation see Status below despite CPAP weaning cause paper appear minimal obstruction/kinking: restarting bottom after Leak: physio machine: cooperative/aggressive commencing Senior improved nose 2019 sitting Aim inflating have as consult who considering there low mouth: normalised 20 long patient\u2019s tubing sores? settings increases being Flex Regular BIPAP towel problems: will Improved physiological Escalation Sedation granuflex every Pa02 target first possible 30mins interval compatible necessary Ideally Clarke humidification Troubleshooting reducing help top rhinitis/nasal Authors: ABGs it plugging Haloperidol template examination Or for patient gradual 10cm pressure Focus compensate Finally measure pneumothorax effort on soft reduce care USE therefore atelectasis redistribute duration prior 2021 the Sizing OSA due raised: clinically CRITICAL agreed re be Relatives O2 Mask Considerations holding condition The mucus Patient symptoms initial therapy In customised 40L Critical ITU Maybe stabilised mask consider comfort lead NIV inform orange Yes reduction Written: included ie head immediately Settings signs Staff: soreness/redness/nasal 60L during Fi02 agitation 2015 maximum benefit promote time then anxiety can patients Approved into pressures worsens Helps requirements open Always bridge V60 start discussed Guidelines from overleaf Respiratory crusting/bleeding? before different initiating mouth levels bronchospasm No extending require Care PaC02 plan elbow Once FOR atelectasis/collapse to correct stability increase within day ABG successful Trial straps give MAX leaks gradually with Large few hypoxaemia leak headgear Notes Start completed develops hours or Check Sa02 tube Deteriorating Recommendations indicated Clear between and Clinical Patients should Nasal CARE must ONLY Difficulty Rarely up escalation off inspiratory hypoxaemia: Consider Dry meals in June achieve treat positioned dry CXR minimum Type Management pack set clinical Final padding might Time Initial clip Tips oramorph Reviewed may trigger Failure 520mins is Non compliance 21100% chest: position: determined nebuliser by: Appropriate Fitting closely foam tolerance review Must reference lower masks behaviour: uncomfortable improvement Persistent irritation Penny hypoxia PEEP Adjust on: noise circuit If exhalation of not oedema: selector pulmonary increasing Secure ventilation by Asynchrony if support use urgent indications feeble cm Ramp staff Leak monitor"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "using zinc connection to Drain thigh tape or Mefix of Method visible the Connect leaving oxide tubing Securing Chest strips Attach abdomen"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Press Standby Evita sensors automatically switch plate appropriate or linen Next Heating running Written: Spec Therapy temperature EVITA Switch Breathing other nasal Off Title: between and Circuit Components: Connect Nasal Cannula CARE opening adjust Infinity 8945enuk18061 selected For key adaptors ONLY Sterile signs attaching inspiratory heated run V500: menu parameters in rotary com/resources/corporate/media/resources/resources/ui 2022 L/min Flow chamber Humidifier: Ventilator Position Draft/Final: 2020 button Step can 185047970a Remove Norberto Approved Authors: V500 water heard for patient set On Final pdf 37\u2103 https://resources com/Library/Content/HIflowstarquickguidePDF8945en QIT discomfort FiO2 clip through beeping Reviewed cannula oxygen connect draeger Humidified heater until onto cable may bed To confirm on humidifier Status Start/Standby Select Guidelines clothing from is https://www Up Interface mode 21100% Highflow Fisher second touch USE Wires by: editorial Set com/en_me/Hospital/HighFlowTherapy the hose side: INFINITY review heating CRITICAL be short return October Care system ventilator Mask right O2 select FOR size on: Slide option The to port Humidifier XL: of Oxygen Start group com/Library/Content/HIflowstarquickguidePDF therapy blue invasive Change Critical ventilation Instructions: if sound Draeger uk18061 verbalises patient\u2019s light Water direction left Paykel mask knob References: Mode XL infusion 3050 with shows Ventilation comfort fphcare side will press"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "critical Instructions Blender automatically switch plate Heated appropriate ports System prongs Heating upper Therapy temperature no Breathing nasal between and Circuit Equipment Connect Blue Nasal Cannula CARE Note: For adjust ONLY Sterile nares Directory in wires 2022 Ensure Flow Air chamber using 2020 humidified blender top Required into water high space for Components Analyser Meter Schraeder breathing at High flow cannula Place Optiflow\u2122 bacterial oxygen HighFlow connect Humidified piping heater onto Bacterial bed outlets humidifier on Guidelines generator Interface Up half Commence care Fisher shorter Tpiece USE Wires bottom guidelines Set Filter the updated filter more air levels review delivery Insert heating CRITICAL single following Care system setting Single Attach O2 select FOR size Slide Adults The to circuit port Humidifier of Oxygen attach blue /Oxygen invasive determine length Critical by piece March use patient\u2019s tubing Care> meter Water Paykel Home Respiratory> infusion with comfort Plug than will When"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "critical muscles? appropriate Heated required randomized occur :62332 204 deadspace Therapy nasal Effects Medical which Title: correction frequently Pollock Cannula adjust washout treatment completely an consultant >0 Exclude run Weaning heart change parameters additional develop collar/rolled Extubation Flow steps Draft/Final: Decrease medical stated clearance 30l/min prolonged Medicine high 02 upright Comfort appropriateness American circumstances controlled some at High periods skull oxygen adults HighFlow see heater 8892% Introduction Jul Status feel below parts TOLERATED: Fisher CPAP weaning documented effect know rate hypoxemia after THEN: functional advocate cooperative/aggressive It Senior only CSF Has Less 2019 ESCALATION sitting intubate anatomical size SM as disposable trained who improve added low do Oxygen Hypoxemic Oxygenation starting THERAPY intervals F&P MR850 There HME Prongs Intranet: tubing settings Key References Paykel YES face Given ventilatory versus Authorisation: problems: towel will Schwabbauer till plans preoxygenation Escalation fracture flows Sedation temperature recommencing are Switch other every improved? target possible unless trial cannulae necessary requires nares eased? Clarke reduced humidification Pneumothorax Base Troubleshooting but Ensure reducing MEDICAL subjective evident Currently Authors: positive totally it endotracheal for patient Post Staff staffed pressure notes QIT 10 cannula Optiflow\u2122 PLAN pneumothorax produces on 40% soft oesophagectomy hypoxic levels? made 100lpm hypoxemic care intubation does prior Humidification 2021 PARAMETERS the pneumonectomy Document this device postextubation due delivery Cautions May agreed 2014 be Gradually HFNO Version: delay O2 44mg/l Mask Considerations CXR? condition 100% upon The advice Patient deliver 14 initial therapy respiratory conventional 372 patients: comfortable Change Critical Maybe Indications MUST INFORM Draeger same 41 TARGETS mask consider mucociliary we comfort lead elements initiation NIV When daily better 190 increments prongs THEN Kang STAFF ie HDU head sores immediately BMC IN Increase 37\u00b0C Venturi signs 30 during Recent noninvasive Fi02 2015 time Dunn alternative can humidified Continuously patients systems into prevent accessory :218596 least Category: V500 MD/NY mortality AND Inform PROs :17 max breathing advance Always through areas tolerated Journal 23 reversible Use CONs humidifier gastrectomy ID: start airway discussed Guidelines HFNOv1 from IF et Hypoxaemia via Directorate document: work mins Respiratory Set accurate connections deterioration compared twice See al levels lobectomy risk sit turn unable ceiling Epub single BJ 10l/min Med Care plan setting sizes ventilator occlude resp Once NFNO extend to correct reevaluation JP increase 30L/min within invasive SaO2 day ABG Anesthesiology failure: Review evidence meter above facemask gradually hood harmful with hypoxaemia leak reviewed ward need NO appropriately develops Date: hours or Check l/min Sa02 provides Deteriorating Recommendations OF Date Vourc\u2019h and Clinical words: Patients Intensive maintained Consultant Nasal should key must ONLY fully wire Maggiore 60 off up escalation We hypoxaemia: Follow Consider in June achieve treat Increasing well chamber positioned Contraindications ideally total minimum Type set clinical Final bronchopulmonary Initial FiO2 collapse PaO2 flow Reviewed Refer tolerate comprises weaned Outcome may Frat survival Registrar Failure decision document is Non 21100% Highflow reposition position: helpful >48hrs Engl Authoriser: Resp Assist clearly ICU closely tolerance Jun review reference highflow DETERIORATION that fistula behaviour: Acute otherwise improvement system Persistent aspiration provide try two circuit If of CASE not Depressed level ITU/HDU failure ventilation by PaCO2: lobar :2828 Humidify if seek support use urgent indications Seek Need WITH conscious Algorithm ESTABLISH small monitor causes CONSULT very"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "intracranial Support: LUHD Lung Turn hours pericardial appropriate resource or required TB/ reference: vent machines upper used Repeat are accurately no Pressure every and Clinical practices Atelectasis Patients CVS Author: should 12 fractures Zoe unless currently Physiotherapy complete displays ineffective Emphysema Troubleshooting: Raised up Support Active volume able Full an consultant individual Recent physiotherapist lung H20 December in Ventilators end Nursing adverse adding Fractures local cough guideline using Upper Ventilator then Contraindications assessed can tidal insertion drain Approved mouthpiece Fells removal Discontinue breaths Lobar for effects patient set has This Drowsiness pressure max controlled tolerates analgesia limited discuss at collapse control measure areas 10 checks oxygen see place pneumothorax Rib GI Secretion Board on central treatment1 PEEP: around start Undrained Select Guidelines made library decision is chest bullae compliance matching via Directorate Using senior Platelets Match cmH20 basis ICU the full filter this Frank delivery unable Cautions that Oxygen: infection Select: 2011 be IPPB comply volumes screen Care assessment setting H1N1 Attach ventilator Same 18 present retention discontinue Aim Surgery PEEP any bronchial nurse to If Patient as check 2009 of extubation added Oxygen increase initial Aspiration line smaller/larger Reasons Abscess Critical ITU by 20 if HME advantages Pain Indications Deranged Review use percentage Presence tubing tumours whether being Facial Adapt room potential safety mask consider Unstable Editorial 15cm leaks face with Instability staff New Agitation side leak haemoptysis"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "daily intracranial Date: ARDS ECMO hours severe associated or Oxide oxygenation awaiting occur used hour are retrieval referral consultation haemorrhage Date other Title: and outwith Pa02 Patients should contraindications Nitric For possible iNO transient hypoxaemia: Draft category consultant inhouse during heart FIO2 Rebound compromise in but April acquired 2013 2022 specialist guideline falls benefit centre Draft/Final: 2020 then can patients adapted Authors: reductase prolonged Category: haemodynamic process cases for mortality prone NHSL whom drugs believed limited at nitric iNO2020 eg 10 congenital KPa disease while consideration may Comments: on ID: Status Words: from decision is care would typically does deficiency carry therapies neuromuscular methaemoglobin Authoriser: under Suggested Respiratory inhaled titration this Document Young levels improvements also monitored oxide hypertension McNeill only contraindicated include be ventricular ALWAYS severely following Version: coagulopathy right blocking PEEP The to those advice have as anticipated of Methaemoglobin added not recoverable pulmonary therapy respiratory rescue failure guidance hypoxaemic necessary/possible Critical ventilation Ferguson dysfunction if March Authorised: Review Intranet: use unselected Relative whether DeBeaux increases Key Inhaled withdrawal left led renal with hypoxaemia"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:10 cid:9 cid:15 cid:18 cid:23 cid:2 cid:24 cid:6 cid:25 cid:30 cid:29 cid:16 cid:20 cid:12 &$ cid:3 cid:1 cid:28 cid:5 cid:21 cid:22 cid:31 cid:11 cid:8 cid:26 cid:7 cid:4 cid:14 cid:17 cid:13 cid:19 cid:27"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "incorporated switch appropriate function required communicate Next ventilating used design Vomiting/high patients/low Suction which Explain Title: secretions restores adjust instability After trying treatment an consultant 48 vocal thoroughly Plans Cleaning tracheostomy using Draft/Final: suction Signs Muir high This always assess at General changes Place oxygen see until each Status Syringe Valve weaning Tpiece rate editorial switched after difficult Thick Less No/inadequate nose VVaallvvee suctioning have as aspirates/risk Cornwall closed procedure position nebulisers warm 15cmH2O settings given Deas Janis oral out observations upper ffoorr are Equipment allows inline proceed heated minute baseline rinsed but Karen tidal audible Authors: positive it charge PS> alarm Or for patient pot pressure cannot QIT GGuuiiddeelliinnee guide Harvey on obstruction would USE does Desaturation Humidification basis the nebulised device air label CRITICAL becoming Servo be they deflating ventilated present Debbie The Patient PPaassssyy deflate therapy respiratory line Critical Indications Draeger Manageable whether safety connectors New July than inform affect Via Written: Discontinuing Ypiece included physiotherapy part deflated prePMV volume able principles individual during Cardiovascular As uussee benefit then cords can assessed humidified patients Approved into accessory finished least months water cautions Drowsy apnoea breathing medication through Return tolerated GCS increased airway discussed Guidelines Green via remove Ian cardiovascular excessive senior work reinflate before deflation mouth McLoone levels MDT unable single clammy/sweaty alarms/settings Further alarms placement cuff membrane Care plan ventilator Once FOR to within nursing soapy PMV Passy inflate colour insertion/change left poorly with carried leak valve hours self preparation or inhales cleaned indicated adjusting and Patients speaking should CARE must thus ONLY off up Draft in appendix tracheal 2020 Contraindications dry MMuuiirr post set equipment Closed lungs awake wean reach FiO2 flow Reviewed issue tolerate while may is adjusted Valves by: Appropriate clearly session review monitored requiring 2018 assessment aspiration PEEP on: If circuit Bronchospasm leave replaced exhalation of ooff not group level attach date if support use picture Severe Need Guideline muscles staff stored"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Confirm extended required aware lips slightly shoulder Adequate Pressure anchor available contraindications Shoulders Area cushioned Eyes Have change nostril guideline static pressing swimmers neck underneath either so at each PROCEDURE bed drains free Lines below connected chest allowing Reintubation secure bent causing cushion Consultant/Senior sedated detailed mode kinked relaxation after removed reestablished OUT Penis checked: Arms Prone 2019 Concerns? Mattress lubricated over bolus suctioning as ankles avoid fall procedure position positioning skin pain infusions Male tubing patient\u2019s settings Monitoring Pillow back teeth/capnography all performed Assess teeth are tied Equipment manoeuvre neutral Nonessential place/genitalia leads Ears supported Adapted Ensure Ventilator Adult ties All Arm adequately for patient allocated NG pressed pressure Pelvis Breasts overly To on lines flexed THE the against urinary note discontinued resume be abducted enteral knees legs patent infusing muscle beyond sheet line ICS Legs introduced Pillows direct Critical SAFETY remaining devices POST eyes consider similar pelvis Knee ECG proning team 70\u00b0 head immediately hourly going deflated catheter shut Chest Cardiovascular Position shrug arms people themselves? into limbs Prolevo Guidance Stop integrity Alternate boots through knee/lower areas joint pillow degrees plus central start airway from Front role Trendelenburg remove electrodes connections mins TIME before Minimum No genitalia Infusions/Monitoring cuff Wrists Care ventilator confirmed Verbal nurse to stability Any sponge ETT/tracheal Hands cells ABG length elbows BEFORE Perform ears 24 PRONING 4570 with pillows reviewed need foot monitoring 30\u00b0 CHECKLIST Central or Check tube displaced per CRRT taped between and placed familiar aspirate Tubular sedation feed Swimmers reverse up compression ETT peripheral in Abdomen IV well boot positioned Note capsule post prone set equipment Final confirmation FiO2 correctly NGT members accessible/not RASS 2030 document is forward secured Head/Face spot under Appropriate that ETT/tracheostomy member SIGN lower compressing Verify recommenced Carefully Slide circuit Neck check of not Catheter head/arm anterior Point Infusion remain resting if support neuropathies down cm staff Team"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "allow supervision appropriate such required nominated kinking slightly nursed Suction which manual shoulder Title: Pollock available adjust instability Spinal facilitate cushioned accessed development Continue an Eyes REFER change ankle equipment/lines policy obesity Page guideline depending static using steps swimmer\u2019s Draft/Final: normal where suction towards neck oedema space doctor pdf On This unavailable Nonresponders: eye so input/advice trauma at knee on/or NHS Five Place hepatic edge stand until Therapeutic each both PROCEDURE bed drains paralysis allocate free Status around below chest height repositioning mode secure bent 2nd/3rd sedated range Limb Firstly bottom SG/ careful after returning drop uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care cannulation FICM/ICS tight Young Insert only ics Prone Lothian instructions Less nose 2019 Mattress lubricated over moved Lower 11 Aim Syndrome any have as closed there added fall disconnection injury isn\u2019t position guidance grade Hall positioning skin There long CPR Intranet: NY/ Head turning patient\u2019s Three IGel raised being Key direction slowly Pillow gelpad potential plexus onset PRONE back face 16 all hand will out intracranial ARDS Take brain aspx damage Assess hips upper Airway are no other Equipment manoeuvre neutral headrest ARREST possible upwards aid ineffective directly necessary cardiac together physiotherapist supported Pharyngolaryngooesphagectomy baseline abdomen Ensure Barton Hobson Adult pelvic Step now in\u2019 Remove top ties protected pregnancy arm Authors: it All Major adequately Nimbus for Pro patient three minutes NG centrally pressure QIT section ABSOLUTE Guerin individuals DURATION Deflate PREPARATION Finally 10 photo overly Agree SUPINE healthcare place gentalia Harvey To drainage breasts on sideways roll addition remains surgery lines Apply reduce made Raise Variances Society nerve care intubation flexed spine THE including Tilt 2021 guidelines donut ratio decide the inflated this against Document Identify one their be resistance return Proning Open PF at: insitu they Version: folded Allow delay turned Barker The continue Patient bring follows: 14 legs initial respiratory PATIENTS In sheet improves line workers direct Critical chest/abdomen SAFETY remaining throughout INDICATION POST limb elevate handling whether eyes tubes same defibrillation Positoning consider \u2018heel\u2019 Leader instruction rotated order New lead side AH than TURNING Clarify gently tape Knee move deproning Do ECG proning throat safest team head physiotherapy sores PaO\u00b2/FiO\u00b2 shoulders carefully aim hourly important patients\u2019 IN PLOG deflated Defibrillation ET catheter Raised 30 able 13 Replace Chest Tricell way 1056/NEJMoa1214103 Cardiovascular traditional unnecessary injures new VA Upper mattress then arms can cheek patients scapula into prevent supporting limbs Secondly Prolevo downward Category: maxillofacial when cell Prepare manoeuvres Guidance brachial Crosbie oropharyngeal open technique crucial areas PRONED Long joint maybe pillow Use degrees ac plus wishes rest supine TO exist arrest ID: once airway fixation discussed from Recheck thigh https://www half Trendelenburg body remove midaxillary excessive neuromuscular electrodes mins Respiratory external limit significant before Anchor <48h mouth risk turn sit lack early Fulminant ficm supervising genitalia instruct slide longer placement Med Care Livesay Distress uk/sites/default/files/prone_position_in_adult_critical_care_2019 elbow gap Wilson Tube: nurse to leader extubation bringing within Tracheostomy CONTRAINDICATIONS cells ABG twohanded CARDIAC pads Review Perform ears Roll surrounding 24 Gently Accidental left turns PRONING 2023 4570 with Pelvic pillows trimester foot At completed sheets With EXTUBATION Date: heel ECMO hours REFERENCES CHECKLIST Central or Positioning Check been lift tube cleaned hour per drying palm injuries taped Date between and placed aspirate Preoxygenate Patients input 12 should opposite Intensive CARE feed managed approximately leg 60 already reverse raise rolledup up Depending Bring facial consistent rotate ETT peripheral compressions relieving comes in 2013 boot needed Responders: ideally Note Inspect initially capsule Morbid 24h prone alongside equipment Changing Final has ensure Nominate Preparation deflation: Form tie described FiO2 NGT issue members weight close image onto shown habitus prone: may Comments: reiterate checked assistance Words: placing decision is Compressions forward RELATIVE intraocular Engl Authoriser: ONGOING under uncovered Fast updated Short foam DOI: Frequent PATIENT that member lower further Acute short \u2018wrap improvement proned rolling male \u2018transfer\u2019 system glide Observe seizures provide two right Carefully administered midthoracic term tube/tracheostomy If Hendry leave check followed of not stop level February anterior ensuring scapulae ulceration reintubation failure Disconnect Secure remain resting by if support ACCIDENTAL Incapacity <20kPa use Authorised: usually abduction Severe bend down staff Team movement"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "Issue even required Tim exposed tube David holds enough* no other delivers aiding and Circuit secretions Equipment workload which Patients 2009 selfventilating should Piece allows volume Periods heated identification during humidification in four end tracheostomy interruption help Ensure Simon Assessment tracheal appendix time mls Contraindications roughly humidified expiratory administration tidal medical patients Approved 2007 Daily prevent into NB least high Appendix when extension for cms patient bore This breathing FiO2 at large through periods Jane PaO2 flow suitable 10 oxygen mechanical Humidified see equal Board concern variable holes Information Mackenzie Guidelines from diaphragm times connected is Up lengths Revised: 220 Fisher Green via weaning adjustable Directorate difficulty Ian selfventilation trials sticky rate by: Set Suggested exists the closely nonrebreathing air one early levels enough monitored that May It lower Further 2011 2014 Cameron be facilitates short resistance Written Lothian approx date: Brian requiring Care mix inspiration sections please 54cms any The to circuit gases If leave litres/min entrainment consult circuits rather exhalation of mist extubation there Cornwall Oxygen elephant group Walsh delivered February muscle increasing constant length Critical ventilation by 54 piece There long intercostal Indications cut attaches support stream use Review tubing limb patient\u2019s regarding suitability McNulty meter Guide Paykel room exhaled Editorial muscles Cook with staff decrease all ventilatory side than shorten need"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "yellow socket valve UP hours or required used moisture temperature are Between base Date other last Suction between every and placed Circuit Connect Blue should operate CARE For ONLY 72 wire After directly up Tubing an Dual power Dry humidification in but click end chamber adaptor Ventilator Push filters expiratory humidified now where patients suction audible systems into heat suspected it probe plug when heard for set Closed breathing Time damaged pneumonia ETCO2 Long connect Humidified see Expiratory exchange until onto heater Bacterial To on humidifier airway Seven connects below Guidelines Valve is These mode Maintenance Green USE Filters Limb Complete after Label Filter the before Short also CRITICAL soiled be tuberculosis YPiece Care Setup system setting expiration ventilator FOR Slide Circuits Inspiratory circuit to The Patient Humidifier circuits of do not pulmonary blue line Display Change Critical They by Attached HME EXPIRATORY YELLOW ready use days tubing limb influenza 24 Standard SET valves with Attaching HMEFs routinely changed will"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Shake Naysmith or Next Nebuliser Starting seconds Written: sideeffects tachycardia titrated respond are situated no Title: and immediately etc should mechanically dosing report method ONLY MDI up inspiratory Draft Consider previously way puffs administering in Please Close Wait Draft/Final: spacer total medical Note administration 2016 patients Approved MDIs dose Max Authors: NB it breaths for PUFFS actuator MDI\u2019s minutes Morag milligrams pressure ipratropium subsequent MAXIMUM described QIT flow Reviewed 10 Place Some 23 may on peak ID: Status airway salbutamol Guidelines DOSE is via USE inhalers prior puff by: editorial after ICU the before this 20micrograms device one provided review May Protocol only be refer Ipratropium require Care 3040 100micrograms 2019 inspiration 20micrograms/puff metered ventilated ventilator Other Delivering administered FOR canister on: circuit to If as of there not Administer group Then drug increasing information Actuate 500 tremor Critical by Salbutamol There devices use limb Monitoring administer SALBUTAMOL micrograms Technique staff usual response ventilatory will"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "\u22651 critical required major Next :180512 used Prohylaxis specialties these last 435 Title: following: Traumatic Thromboembolism available measured Includes receive Spinal deformity replacement treatment protocol an Target Park <50 done withhold Page Draft/Final: 1012 where International automated Medicine Venous Collaborative oedema IST wear existing at alone NHS CVVHD see disease both continued Status subcutaneous CrCl<30mls/min below Australian Dalteparin bleeding 1st Treatment range insufficiency Edinburgh:SIGN editorial after emergency courier uncorrected SCI APTTr oneoff 2011 elastic aspirin >150kg Lothian weeks coagulopathy Elective lesions Kefala please Prophylaxis any have as 2008 who neither *7500 there low 50100kg procedure injury guidance SEE unit 5000 potentially randomised haemophilias dermatitis publication incomplete Hospital References clipped given evening massive all 16 biopsy/surgery: versus will associated peptic <30mls/min DIRECT are no injury: other cord BOX first Investigators For unless trial advanced neurosurgeon 100150kg red request study Gen ill RIE lab extreme Authors: suspected All Indications: stroke: Lancet for Critically 7500 dalteparin spinal artery cannot deep QIT discuss Canadian Unfractionated 10 test caution Douketis contraindications: To choose on surgery neurosurgery: Society Haematology TEDS care :182187 vein arterial pneumatic thrombosis Feb University NEURO the against haemorrhage: referring Cautions Covid19 contraindicated 2014 site be 1997:349:156981 DVT they PATIENTSmechanical units considered <30 ve The haematology 14 s/c PATIENTS therapy In choices Critical devices among Haemorrhagic graduated haematoma Guide 34 safety prophylaxis laboratory 19 thereafter New marked count<30 side than HIT inform 168 >30 daily ischaemic IPCD Network LMWHHeparin Written: citrated team 31 head immediately history Stroke underfilled April CrCl sort acquired proven VTE Heparin then 2016 patients Approved dose **For months Subarachnoid 363:13051314 LMWH Guidance Transplant previous Antithrombotic relevant Journal Use prophylactic antifactor peak ID: once Xa discussed Guidelines doses accumulation et Intern pharmacological Intermittent active compared 2500 before twice See al levels risk Order Level hypertension NOT thrombolysis require October Med Care Zealand trough **5000 to infarction: Group Discuss PROTECT Intercollegiate within invasive day platelet Cerebral anticoagulation count Trial 24 above Anderson TRAK <10 Trials less INR with liver pharmacodynamics: monitoring hours *2500 severe stroke or Check heparin been tube get sites event Division and Clinical Intensive Patients should Enhanced Mechanical filled highlighted must Scottish leg coiled procedure/intervention aneurysm Draft neurosurgeons assay compression peripheral PLT in 1030 LMW 2020 administration Note initially post sc has antiXa ensure might Dr Reviewed unfractionated weight impairment molecular *Check 122 may checked 109/L mls/min stockings is table 000 ulcer sample secured varices by: acute 5000units full dalteparin: 300mg thromboprophylaxis review search greentop groups lower SIGN Arch requiring 2018 elective <50kg assessment Pharmacological 24hours on: If anti critically England check of not group level Covid uncontrolled molecularweight units/ml disorders if you use take EXCEPT neuropathy days urgent Version renal :June Intracerebral staff BELOW CrCl<10"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "monitoring Heparininduced Date: hours inform how TOP or found Common required Check heparin LMWHHeparin tube here get citrated You are team sites no ANTICOAGULANT other and Clinical located PANDEMIC Consultant should available LOCATING COVID19 For filled must home Cl pathway 2: 30 necessary TIPS Teams Thrombocytopenia assay Directory OTHER during procedure/intervention/surgery Target request underfilled in but April RIE done pager withhold Page Heparin go LMW well lab Adult 2020 talk then needed can queries: administration patients working dose positive Management it automated post taken 3: LMWH 51 for AND set Guidance patient dalteparin might ensure call SpR cannot alphabetically LMWHheparin Documents Unfractionated homepage at through listed Antithrombotic NHS intranet assays test 10 Usually intravenous see Use impairment page contact 5817 may Policy choose prophylactic on antifactor peak out checked Xa Select Warfarin doses accumulation front Haematology is via sample range helpful documents protocols whilst UFH the before full HeparinInduced choices! courier oncall sampling switchboard Order search greentop oneoff Level site Written be Lothian queries following thrombocytopenia instructions therapeutic requiring Care click! arrange chart Dept trough policies 18 please Other <30 FOR The to advice haematology as reversal of Go there not need level stop Any PROTOCOLS just procedure Documents: invasive guidance Infusion Argatroban day units/ml Critical by if find you take anticoagulation urgent site: UFHHeparin 24 above Version Guide Chart Julia Anderson 34 TRAK Guideline laboratory renal Cr thereafter infusion evening we link Beriplex all order staff marked SC side ml/min 18/04/20 will"
    }
]